data_2roa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2roa _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 14' ' ' GLU . 23.0 t -57.24 -45.88 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.654 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -58.64 -54.75 43.54 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.768 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -60.83 -49.1 78.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.941 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -60.82 -34.31 74.35 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' VAL . 84.3 tt0 -68.61 -42.61 77.88 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.087 0.47 . . . . 0.0 110.527 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -40.05 88.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 81.7 t80 -65.78 -49.62 67.67 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.96 -42.65 96.93 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.56 -41.31 94.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -64.09 -39.4 93.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLY . 36.3 t0 -80.18 54.79 2.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -39.02 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.54 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.3 m-20 -86.42 -27.22 24.29 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.186 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.75 12.53 84.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.697 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 47.5 p30 -66.39 -16.61 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.747 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 104.98 -12.53 49.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -140.9 145.21 35.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.729 0.3 . . . . 0.0 111.151 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 4.6 mp -105.31 120.15 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -81.75 169.09 17.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.708 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.37 -43.53 77.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.149 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.43 -43.25 99.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.14 0.495 . . . . 0.0 110.328 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.7 mt-10 -66.96 -40.02 87.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.041 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.92 -45.45 92.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.71 61.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -61.77 -42.58 99.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.749 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.68 -49.7 67.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 36' ' ' ILE . 1.3 mp -61.14 -39.04 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -56.45 -41.29 76.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.447 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 40' ' ' ASP . 42.3 m -65.79 -37.18 85.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.856 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.04 22.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 38' ' ' SER . 62.5 m-20 66.21 16.58 10.49 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.333 0.395 . . . . 0.0 112.03 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -136.92 145.53 44.39 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -149.94 82.18 6.67 Favored Pre-proline 0 C--N 1.331 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.36 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.71 163.98 34.99 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.947 2.431 . . . . 0.0 110.729 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 11.5 p -82.66 159.08 22.73 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 44' ' ' THR . 79.3 tt0 -38.33 -47.28 1.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 109.82 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.84 -63.1 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' O ' ' SD ' ' A' ' 51' ' ' MET . 15.4 mp0 -56.02 -41.39 74.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.86 -43.01 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -65.45 -52.35 53.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.419 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 65.5 t0 -58.88 -38.04 77.93 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.56 ' SD ' ' N ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.17 -47.92 47.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.821 178.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.22 -47.33 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.888 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -58.2 -45.61 87.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -44.2 -29.86 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.821 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -114.98 -31.12 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.66 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t70 -58.9 86.22 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.03 -34.99 70.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.5 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 18.7 p-10 -93.2 -21.9 19.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.844 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.66 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.74 64.77 3.69 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 53.9 p30 -107.79 -13.22 15.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 117.045 0.422 . . . . 0.0 111.547 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.08 7.48 58.46 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.419 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 32.9 p -135.06 164.39 27.74 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 mt -121.03 128.34 76.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -103.92 174.29 5.94 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.54 -52.1 64.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.565 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.82 -45.11 86.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.133 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -44.76 84.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.245 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.76 -44.36 96.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.59 -42.05 99.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.779 0.323 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 t -63.92 -45.81 87.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.246 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.77 -42.09 88.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.547 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttt -71.81 -51.63 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.946 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.519 179.134 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.5 mt . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.55 -47.71 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.078 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -66.1 -44.71 83.58 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.979 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.77 -49.57 75.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.971 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -60.03 -32.36 70.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.335 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.19 -39.63 89.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.168 0.509 . . . . 0.0 109.985 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.7 -46.99 85.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.705 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.56 -49.01 75.09 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.85 -45.79 78.72 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 tt -62.8 -39.48 94.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.248 0.547 . . . . 0.0 109.728 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.28 -42.96 96.18 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.278 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 57.8 t0 -81.23 54.15 2.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.195 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -37.75 -32.54 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.605 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p-10 -81.21 -25.42 36.73 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.704 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 77.38 14.51 82.44 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 51.6 p-10 -62.33 -4.03 1.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.978 0.389 . . . . 0.0 110.691 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 84.71 -17.0 33.03 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 9.0 m -130.43 130.5 44.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.611 0.244 . . . . 0.0 110.915 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.1 mt -93.77 111.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -77.66 164.58 25.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.59 -35.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.554 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -42.23 91.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.149 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.55 -38.05 83.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.332 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.55 -44.89 92.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.66 72.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.677 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -62.48 -43.32 99.1 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.76 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.83 -48.11 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.615 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -65.83 -39.73 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.172 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -59.52 -42.45 92.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.712 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 t -83.13 -14.41 53.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 11.0 tp -65.4 -43.25 91.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 2.7 m-20 155.66 -1.04 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.259 0.349 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -148.5 163.52 36.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -137.51 75.09 45.57 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 111.341 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.82 162.9 29.99 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.795 2.33 . . . . 0.0 111.003 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -82.54 152.22 26.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -39.38 -41.9 1.0 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.842 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.43 -50.69 51.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.482 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.93 -41.84 99.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.159 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.22 -42.43 99.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.196 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.26 -51.28 66.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.19 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.68 -36.39 78.64 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.559 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.0 mtt -71.45 -47.0 58.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.964 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 52' ' ' ILE . 79.7 mt -64.66 -43.43 96.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t -58.69 -45.14 90.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.897 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 54' ' ' GLU . 3.6 tm-20 -51.04 -28.66 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.031 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -110.73 -32.55 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -63.52 80.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.93 -35.38 64.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.019 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -90.39 -20.06 23.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.551 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.81 39.89 97.87 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.244 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.511 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 48.2 p30 -83.73 -17.09 42.45 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.718 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.66 56.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 43.8 p -133.08 165.52 24.55 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.66 130.94 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -104.28 176.12 5.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.323 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -56.03 -52.39 64.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.857 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -60.51 -44.5 95.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.005 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -63.41 -45.22 92.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.961 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.73 -41.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.68 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.25 -39.61 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.317 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.5 m -62.56 -45.9 90.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.325 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.43 -40.89 98.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.439 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 1.1 tpt -62.97 -53.64 50.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.289 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 110.398 179.603 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 C--O 1.231 0.128 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.85 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.016 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -57.06 -54.18 49.68 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -62.14 -50.82 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.889 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -54.42 -38.12 65.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.161 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.41 -39.89 89.25 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.959 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.84 -48.5 80.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.967 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' ' CD1' ' A' ' 27' ' ' ILE . 61.7 t80 -62.89 -49.06 76.31 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.806 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.18 -47.92 65.69 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.31 -38.52 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.9 m-30 -66.39 -46.14 77.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.509 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 14.6 t70 -79.19 50.58 1.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.92 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -39.51 -26.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.836 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 42.7 p-10 -81.3 -27.71 34.94 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.642 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 80.21 12.73 82.88 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.895 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 53.7 p30 -63.78 -10.07 17.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.157 0.478 . . . . 0.0 110.658 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.36 61.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 3.8 m -133.73 135.38 43.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.605 0.241 . . . . 0.0 111.095 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 65.4 mt -99.58 115.54 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -77.85 165.18 24.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.551 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.18 -40.21 76.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.537 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.19 -42.28 98.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -69.28 -39.33 78.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.381 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -45.2 93.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.66 -39.17 73.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -62.53 -44.33 96.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.972 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.94 -44.74 99.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.848 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mm -62.74 -41.7 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -57.1 -41.59 79.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.952 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 t -73.28 -33.13 65.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 29.4 mt -61.58 -44.26 97.34 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 9.8 p30 147.38 2.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.661 0.601 . . . . 0.0 111.497 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -129.07 165.04 21.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -152.14 70.74 7.73 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.01 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.72 152.85 79.77 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.666 2.244 . . . . 0.0 111.015 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.9 p -82.43 162.45 22.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -40.54 -46.96 2.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.953 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.93 -54.05 22.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.493 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -64.62 -43.71 92.86 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.459 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 mt -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.875 0.369 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.48 -50.33 67.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.436 -0.505 . . . . 0.0 109.871 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 67.7 t0 -61.89 -35.04 77.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.396 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.5 ttp -72.37 -48.49 41.28 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.8 mt -64.21 -44.18 97.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.6 m -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -46.29 -27.45 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.6 p -115.75 -24.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 14.1 t0 -63.77 77.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.03 -34.42 77.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.427 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 19.1 p-10 -87.86 -23.28 24.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.649 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.74 67.87 1.9 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.275 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 51.4 p30 -112.89 -15.21 12.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.936 0.368 . . . . 0.0 111.536 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.99 10.19 57.7 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.517 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 64.6 p -141.05 170.77 15.1 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.54 127.4 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -99.01 167.55 10.66 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -52.78 -49.48 65.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.464 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.34 -42.4 95.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.154 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.89 -43.9 86.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.1 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.83 -44.01 97.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.355 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -63.35 -41.81 98.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.1 m -64.95 -48.88 72.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.742 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.0 tp -58.92 -41.18 86.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 110.651 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.1 mmm -68.59 -57.62 5.47 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.095 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 179.322 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mm . . . . . 0 C--O 1.231 0.129 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.83 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.831 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.68 -44.63 96.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.929 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.43 -49.86 69.84 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.008 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -64.1 -34.05 77.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.47 -38.07 88.72 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.321 0.581 . . . . 0.0 110.268 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.68 -39.07 87.96 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.176 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -69.92 -48.58 57.99 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.16 92.17 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.96 -37.04 85.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -70.33 -40.12 74.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 110.557 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 23' ' ' GLY . 32.2 t0 -78.01 50.83 0.91 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.208 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -37.02 -31.2 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.695 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 22.6 m-20 -75.28 -28.14 59.64 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.543 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.81 7.47 88.26 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 26.9 p-10 -68.26 -8.14 36.74 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.91 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.66 -6.82 83.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 m -130.51 131.83 45.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 110.799 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.6 mt -98.72 114.89 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.2 p -82.65 163.68 21.24 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -58.18 -38.97 71.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.511 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -62.54 -40.57 97.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.264 0.554 . . . . 0.0 110.645 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 31.9 tt0 -71.49 -36.75 71.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.036 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -45.06 95.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.03 -40.29 73.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.799 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -61.64 -43.4 98.93 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.803 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.449 ' O ' ' OG ' ' A' ' 38' ' ' SER . 75.6 t -67.19 -48.89 77.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.189 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mm -63.61 -36.92 78.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -57.06 -40.36 76.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -66.45 -36.19 82.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.662 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 40' ' ' ASP . 84.9 mt -70.46 26.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.4 OUTLIER 60.48 19.85 9.59 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -138.62 150.67 46.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -154.74 83.86 3.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.72 170.85 3.15 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.61 2.206 . . . . 0.0 110.931 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 45' ' ' GLU . 55.2 m -84.7 168.64 15.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.495 ' N ' ' CG2' ' A' ' 44' ' ' THR . 80.4 mt-10 -53.05 -45.66 68.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.253 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 18.2 pt-20 -56.84 -44.49 82.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.888 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 50.6 mt-10 -64.81 -43.82 91.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.957 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.37 -44.86 96.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.823 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -67.74 -47.78 68.3 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -61.47 -40.26 93.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.0 tpp -69.87 -46.44 65.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 56' ' ' ASP . 82.1 mt -65.23 -44.33 95.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.4 p -61.67 -36.09 79.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.933 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -56.74 -32.01 65.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.782 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.42 -26.75 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 52.3 t0 -73.27 85.83 1.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.88 65.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.709 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -101.11 -23.37 14.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.223 -178.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.89 38.78 85.41 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 19.5 m120 -72.99 -16.54 61.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.874 0.337 . . . . 0.0 111.332 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.2 1.61 64.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.8 p -137.18 166.89 22.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.5 mt -114.46 126.02 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.74 178.66 4.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.321 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -56.8 -52.59 64.45 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.757 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.43 -43.31 96.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.901 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 95.3 mt-10 -65.65 -44.55 86.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.958 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -61.19 -43.09 99.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.458 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -40.76 97.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.3 t -63.22 -45.4 91.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.262 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.42 -42.12 86.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.966 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.5 tpp -77.09 -41.08 43.61 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.246 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.454 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.6 mt . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.86 -48.43 88.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.827 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.65 -47.37 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.926 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -60.04 -46.95 87.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -57.24 -36.4 70.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.31 -38.12 89.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.963 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.99 -44.4 92.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.092 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -65.87 -49.44 68.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.877 0.37 . . . . 0.0 111.186 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.82 -45.28 86.34 Favored Glycine 0 C--N 1.33 0.231 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -65.32 -41.49 93.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.502 0.668 . . . . 0.0 110.376 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLY . 19.1 t70 -81.05 58.06 3.33 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.544 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -36.73 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.51 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -80.02 -27.51 39.5 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.33 7.23 82.21 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -64.29 -19.11 65.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.667 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.32 -11.95 51.4 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.467 ' SG ' ' OE1' ' A' ' 64' ' ' GLU . 57.3 m -128.06 127.56 43.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.92 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.29 111.96 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.12 166.93 19.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.9 t -55.7 -44.12 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.447 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -53.96 -43.19 69.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.858 0.361 . . . . 0.0 110.198 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 43.9 mt-10 -67.75 -46.03 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.746 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.12 -46.66 88.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.6 -41.77 66.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.151 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.468 ' HG1' ' NH2' ' A' ' 37' ' ' ARG . 3.3 m -65.11 -39.76 93.57 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.349 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.2 -48.63 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.04 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 36' ' ' ILE . 47.0 mm -61.67 -43.68 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.361 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH2' ' HG1' ' A' ' 34' ' ' THR . 88.6 mtm180 -60.35 -41.8 94.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.352 0.596 . . . . 0.0 110.626 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -75.38 -22.64 57.34 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.737 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 3.2 tt -66.17 -44.88 82.77 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 5.1 m-20 151.11 2.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.844 0.715 . . . . 0.0 111.418 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -143.33 154.01 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -133.24 79.09 62.45 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.63 159.29 53.28 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.858 2.372 . . . . 0.0 110.839 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -86.21 162.25 18.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -40.66 -47.91 2.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -47.31 -58.98 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.713 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.05 -41.88 97.43 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.396 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.02 -43.46 98.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.882 0.373 . . . . 0.0 110.256 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 53' ' ' SER . 85.8 mm-40 -64.07 -49.69 71.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.969 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -61.28 -36.0 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.6 mtp -72.93 -46.95 49.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.83 -45.19 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.665 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' GLN . 65.1 m -58.15 -45.27 87.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -48.62 -27.47 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -113.73 -32.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.83 81.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.51 -32.68 71.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.419 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.0 p-10 -93.21 -21.87 19.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.804 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.82 31.68 78.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 49.4 p-10 -73.41 -16.91 61.32 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.524 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.19 6.28 55.69 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.413 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 31.7 p -139.94 173.66 11.3 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.8 mt -121.92 128.31 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.467 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 13.4 tp10 -94.66 168.13 11.03 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.461 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 14.7 t80 -54.72 -50.49 68.2 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.702 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.48 -39.78 88.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.103 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.46 -42.28 92.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.243 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.78 -40.28 96.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.64 -41.01 98.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 t -64.32 -44.78 90.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.532 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 tp -58.81 -40.93 85.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.9 mmm -66.8 -56.63 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.339 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.648 179.505 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.6 t -57.7 -47.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.935 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -65.28 -48.63 72.52 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.012 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.598 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.29 -48.7 80.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -59.03 -33.45 70.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.84 -38.6 86.71 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.185 0.517 . . . . 0.0 110.182 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.7 -46.39 85.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.91 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.04 -48.63 73.17 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.53 84.97 Favored Glycine 0 C--N 1.33 0.23 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.92 -37.99 89.43 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.1 m-30 -66.09 -41.51 90.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.374 0.606 . . . . 0.0 110.058 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ASP . 25.8 t0 -83.97 56.39 3.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.239 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -38.48 -19.04 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.697 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.1 m-20 -88.37 -26.89 21.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.378 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.08 11.47 83.98 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.729 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -65.18 -17.19 64.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.722 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -13.06 56.56 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 m -134.06 136.66 44.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.711 0.291 . . . . 0.0 111.111 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.5 mt -97.54 113.92 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.426 ' CG2' ' N ' ' A' ' 29' ' ' VAL . 89.4 m -78.3 164.85 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 28' ' ' THR . 8.2 t -56.12 -46.49 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.36 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.03 -41.57 83.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 94.4 mt-10 -67.26 -41.54 85.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.317 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -44.42 96.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.38 70.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.859 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -61.38 -44.38 97.25 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.789 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.0 -47.97 85.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.082 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mm -61.73 -38.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.09 -41.24 78.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.294 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 40' ' ' ASP . 37.6 m -64.82 -35.67 81.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.92 21.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 38' ' ' SER . 98.1 m-20 63.3 18.41 10.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -134.0 139.41 46.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.29 76.73 37.2 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 120.754 0.311 . . . . 0.0 111.169 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.9 169.38 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.992 2.462 . . . . 0.0 111.092 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 47' ' ' GLU . 6.9 p -86.72 149.73 24.68 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 57.1 mp0 -39.6 -42.72 1.22 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.44 -49.03 36.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.195 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 44' ' ' THR . 46.0 tp10 -66.48 -41.85 88.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.211 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.56 -43.05 99.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.126 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -62.97 -51.21 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.293 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.92 -33.16 71.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.479 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.6 ttp -74.74 -45.84 41.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 56' ' ' ASP . 80.4 mt -63.42 -43.95 98.7 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.864 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -63.94 -45.51 88.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.209 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.34 -33.4 65.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.209 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.43 -32.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 58.8 t0 -74.56 104.98 5.46 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.53 64.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.538 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 2.4 p30 -95.58 -23.22 17.16 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.622 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 63.08 41.22 99.85 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.472 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 49.6 p30 -80.3 -16.44 54.64 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.73 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.91 -0.84 51.75 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.458 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 18.5 p -129.83 170.87 13.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -118.99 125.27 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -95.22 167.3 11.44 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -53.72 -49.7 67.53 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.681 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.01 -41.24 87.25 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.233 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.73 -42.34 86.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.259 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -65.39 -41.08 94.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.881 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.2 tp -62.59 -41.59 99.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.522 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -66.16 -44.98 82.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.39 -42.0 98.78 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.107 0.48 . . . . 0.0 111.182 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.598 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 27.0 ttt -60.97 -49.05 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.07 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.3 179.205 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.4 -46.72 95.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.045 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -60.41 -39.71 88.37 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.55 -56.21 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -39.32 81.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -64.72 -35.54 81.38 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.979 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.59 82.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.464 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -68.15 -47.26 68.53 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.32 98.13 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.16 -37.56 87.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 0.0 109.688 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -70.99 -38.64 72.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 t0 -87.62 48.91 1.71 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.156 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -35.41 -28.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.363 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.6 m-20 -71.91 -28.04 63.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.512 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.44 8.64 87.62 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -68.48 -9.82 51.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.848 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.83 -5.65 84.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.9 m -129.03 131.57 47.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.69 0.281 . . . . 0.0 111.096 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.5 mt -100.27 114.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 ' HG1' ' H ' ' A' ' 31' ' ' GLU . 7.3 p -82.2 164.12 21.45 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.21 -42.26 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.615 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.4 -38.86 78.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 0.0 110.229 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' H ' ' HG1' ' A' ' 28' ' ' THR . 95.8 mt-10 -71.28 -37.92 71.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.442 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.31 -44.59 96.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.29 76.48 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.78 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -64.1 -41.3 97.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.43 -47.39 80.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.498 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.88 -38.5 82.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -59.44 -40.91 88.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.657 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.34 -34.99 65.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.381 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 38.0 mt -61.4 -41.93 97.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 112.641 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.56 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 71.8 m-20 141.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.345 1.028 . . . . 0.0 111.18 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -137.76 158.19 44.88 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 13.2 p-10 -155.42 69.04 5.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.956 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.79 169.53 5.61 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.678 2.252 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 64.8 p -80.44 148.69 30.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' THR . 75.5 mt-10 -37.69 -36.67 0.19 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.887 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -55.22 -53.37 56.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.386 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 12.8 mp0 -61.08 -41.75 97.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.95 -42.14 97.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -68.12 -42.6 79.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.318 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.13 -39.62 95.21 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.744 0.306 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 mtm -69.57 -44.01 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.211 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' ASP . 85.6 mt -66.18 -44.42 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.989 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -33.93 75.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.072 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -59.57 -33.63 71.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.788 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.6 p -109.92 -31.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 43.9 t0 -64.56 77.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -55.82 -23.68 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.266 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' OD1' ' CG ' ' A' ' 60' ' ' ASN . 3.3 p30 -97.46 -22.53 16.52 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.607 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.09 46.21 89.27 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.749 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -88.97 -17.19 29.98 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.63 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.636 ' N ' HD21 ' A' ' 60' ' ' ASN . . . 95.63 10.63 56.53 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.749 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 33.1 p -139.47 159.4 42.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.1 mt -113.83 128.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.42 171.89 8.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.37 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.67 -52.49 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.875 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.7 -41.29 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.6 -45.08 84.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.023 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.7 -42.29 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tt -63.97 -42.12 97.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -63.0 -46.08 89.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.231 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.8 tp -63.11 -40.29 97.21 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 110.551 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mmm -59.3 -42.72 92.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.613 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.346 179.427 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 CA--C 1.521 -0.139 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.4 t -63.95 -46.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.443 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.51 -42.74 91.75 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.12 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.25 -51.95 65.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.065 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.93 -32.09 71.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.247 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.31 -39.6 89.42 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.963 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.65 -45.87 88.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.896 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.76 -49.56 74.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.54 84.5 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.2 tp -61.73 -40.64 95.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.002 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 4.6 m-30 -65.16 -43.08 92.94 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.239 0.543 . . . . 0.0 110.274 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 22' ' ' ASP . 34.5 t0 -81.56 50.47 1.49 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.739 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.5 m-20 -89.51 -27.85 20.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.109 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.05 14.27 82.09 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -69.23 -16.36 63.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.666 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.28 62.32 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.6 m -134.06 136.71 44.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.725 0.298 . . . . 0.0 111.08 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.4 mt -100.1 117.27 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.5 m -77.82 162.7 26.7 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.686 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.6 t -57.03 -46.86 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.496 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -58.39 -42.49 87.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 110.273 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.431 ' CD ' ' OD2' ' A' ' 22' ' ' ASP . 63.2 tt0 -66.8 -35.79 80.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.275 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -64.01 -43.15 96.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.1 -40.2 70.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -43.23 99.25 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -65.42 -48.44 83.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.105 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.3 -39.69 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.94 -41.88 71.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.548 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.5 t -64.86 -39.65 93.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.42 20.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 38' ' ' SER . 12.7 m-20 67.56 18.64 9.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -135.29 147.66 49.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -150.95 72.56 8.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.53 167.35 13.41 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.768 2.312 . . . . 0.0 111.022 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.4 p -83.26 153.42 24.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 44' ' ' THR . 77.3 mm-40 -38.49 -45.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 110.137 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -47.11 -55.71 7.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' O ' ' SD ' ' A' ' 51' ' ' MET . 50.1 mt-10 -60.16 -41.16 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.217 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.19 -42.52 98.73 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.029 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -65.29 -53.81 38.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -59.17 -38.06 78.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.528 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.26 -48.19 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.28 -44.48 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 m -57.52 -45.6 84.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -45.81 -29.56 1.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -112.72 -29.28 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 9.5 t0 -60.68 81.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.23 -36.25 77.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 8.0 p30 -92.38 -21.14 20.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.827 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.75 69.47 1.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 6.6 m120 -109.76 -11.75 14.69 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.116 0.458 . . . . 0.0 111.428 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.14 3.91 65.06 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -138.54 170.85 15.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -120.03 127.71 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.027 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -104.75 175.52 5.47 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -57.07 -54.75 43.2 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.646 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 33.0 p-10 -54.06 -46.0 71.83 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.094 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.498 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 99.5 mt-10 -64.04 -41.85 97.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.863 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 59.0 t80 -63.3 -37.57 87.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.08 -43.25 99.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.308 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.8 m -65.46 -44.9 85.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.084 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -45.67 80.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.43 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 75.2 mtp -65.91 -49.46 67.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.016 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.492 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 9' ' ' ILE . 38.9 mm . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.11 -47.2 93.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.814 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.1 -42.56 99.61 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.834 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD2' ' SD ' ' A' ' 72' ' ' MET . 3.5 m-30 -60.3 -46.37 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -59.71 -33.55 71.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -66.62 -37.91 85.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.252 0.549 . . . . 0.0 110.168 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.03 85.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.917 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -63.3 -47.44 82.29 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 111.084 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.05 91.89 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.19 -39.0 93.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.023 0.44 . . . . 0.0 110.229 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -67.54 -40.42 85.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.278 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 23' ' ' GLY . 34.5 t0 -81.82 58.34 3.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.922 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -37.54 -21.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.843 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 m-20 -88.15 -26.36 22.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.586 0.231 . . . . 0.0 111.443 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 74.51 10.14 82.36 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -64.3 -17.58 63.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -11.72 56.38 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.9 m -130.71 131.39 44.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.853 0.359 . . . . 0.0 111.326 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.2 mt -96.99 114.28 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.3 p -79.16 165.66 23.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 t -57.67 -44.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.589 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 54.0 mp0 -56.94 -41.68 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.009 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.3 mt-10 -68.58 -41.59 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.468 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.21 -44.86 94.14 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -55.3 -40.33 70.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.407 ' HG1' ' NH2' ' A' ' 37' ' ' ARG . 4.5 m -63.36 -42.85 98.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.866 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.98 -49.34 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.694 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mm -65.64 -41.13 89.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 49.2 ttp180 -57.75 -40.97 80.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.362 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -85.05 -14.05 48.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.526 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 9.9 tp -68.08 -43.4 78.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 3.4 t70 154.63 -4.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.414 0.446 . . . . 0.0 111.108 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -139.92 158.74 43.59 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -135.19 72.06 67.07 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.83 155.74 62.08 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.664 2.243 . . . . 0.0 110.913 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -82.88 156.78 23.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -40.03 -43.8 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -50.48 -52.43 38.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.52 -42.88 99.81 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.142 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.08 -42.31 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.54 -49.77 75.34 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.076 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.52 -35.26 75.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.69 0.281 . . . . 0.0 110.446 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -72.96 -45.84 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.813 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' A' ' 56' ' ' ASP . 85.1 mt -64.8 -44.5 96.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.956 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -45.7 91.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.552 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -57.77 -31.66 66.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 m -106.63 -24.51 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 52' ' ' ILE . 66.7 t0 -81.57 95.94 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.41 68.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.795 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -94.91 -24.15 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.244 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.516 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.28 35.35 82.48 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.069 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.485 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 20.3 m120 -67.52 -18.82 65.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.811 0.305 . . . . 0.0 111.356 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.72 -12.22 56.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 p -125.48 -179.76 4.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 109.967 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.13 130.75 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.631 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -101.26 177.67 4.87 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.458 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.67 -50.89 71.69 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.905 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 31.5 p-10 -58.82 -43.63 90.68 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.431 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 96.8 mt-10 -65.76 -40.72 92.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.62 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.86 -42.34 99.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.741 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.52 -39.14 82.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -63.6 -42.89 98.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.3 -42.54 86.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.625 0.25 . . . . 0.0 110.778 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 12' ' ' PHE . 74.8 mtp -65.73 -56.43 12.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.553 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.63 179.662 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 9' ' ' ILE . 45.0 mm . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.84 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.233 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.4 -42.39 96.12 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.3 -48.13 79.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.091 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -62.78 -34.71 77.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.204 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.03 -36.24 82.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.191 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -67.47 -40.62 85.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.101 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.407 ' CD2' ' CD1' ' A' ' 27' ' ' ILE . 59.7 t80 -70.37 -49.69 46.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.05 96.57 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.55 -39.12 89.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 9.6 m-30 -68.52 -40.49 80.76 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.934 0.397 . . . . 0.0 110.674 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.0 t0 -78.85 48.14 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.59 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -36.6 -40.36 0.25 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.877 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.0 p-10 -69.73 -25.34 63.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 0.0 111.627 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.12 14.74 80.1 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.891 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.1 p-10 -64.58 -1.52 1.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.673 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 75.51 -10.23 12.69 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.438 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.6 m -130.64 131.84 45.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.574 0.226 . . . . 0.0 110.839 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.407 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 95.0 mt -97.25 113.4 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.52 165.28 19.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.748 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.99 -36.92 64.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.524 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.98 -41.32 97.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.248 0.547 . . . . 0.0 110.616 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 42.6 tt0 -72.38 -39.46 68.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.056 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.444 ' CD1' ' C ' ' A' ' 32' ' ' LEU . 2.7 tm? -61.5 -45.92 92.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.07 -38.08 70.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.807 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -62.17 -42.7 99.52 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.834 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.08 -47.19 85.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.524 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mm -63.76 -38.74 83.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.047 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -57.08 -39.81 75.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.2 t -69.29 -38.17 78.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.04 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.95 25.78 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 38' ' ' SER . 33.5 t70 62.91 20.47 12.25 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -136.14 142.49 44.22 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.429 ' C ' HD21 ' A' ' 42' ' ' ASN . 0.2 OUTLIER -148.29 80.65 8.43 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.026 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.76 170.7 6.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.853 2.369 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 m -86.47 159.33 19.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.61 -39.34 7.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.76 -55.59 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -62.69 -40.78 98.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mt -61.2 -42.71 99.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.059 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -70.83 -41.54 71.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.131 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -63.46 -38.92 93.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.725 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 71.0 mtm -69.0 -44.04 73.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.991 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.76 -45.88 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.074 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.2 t -59.12 -37.42 77.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.56 -31.57 64.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.074 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.1 p -111.03 -32.88 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.4 t70 -63.82 79.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.04 -24.28 62.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.587 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.8 p-10 -95.36 -23.2 17.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.913 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.606 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.8 38.75 93.26 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.635 ' ND2' ' HG1' ' A' ' 62' ' ' THR . 51.5 p30 -81.39 -17.04 50.38 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.526 -0.396 . . . . 0.0 111.608 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.08 7.7 60.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.635 ' HG1' ' ND2' ' A' ' 60' ' ' ASN . 82.8 p -135.91 159.74 40.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.5 mt -112.73 127.04 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -99.99 165.28 11.62 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -49.24 -54.81 14.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.425 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.16 -43.29 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.006 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.63 -44.13 82.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.063 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.505 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.43 -40.64 97.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.454 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.9 t -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.87 -42.83 85.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.544 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mmm -65.55 -47.3 76.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.931 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.419 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 17.7 mm . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 11' ' ' ASP . 8.5 p -59.22 -47.5 90.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.998 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.499 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 64.4 t0 -63.32 -54.05 43.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.957 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CD1' ' SD ' ' A' ' 72' ' ' MET . 14.9 m-30 -61.82 -52.56 63.67 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.314 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 28.6 tptp -51.66 -40.78 60.64 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.034 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -68.58 -40.37 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.113 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.5 -50.14 73.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -62.59 -49.19 76.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.843 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.5 -48.3 65.72 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tt -62.65 -39.24 93.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.071 0.462 . . . . 0.0 109.793 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -63.94 -43.16 96.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.145 0.497 . . . . 0.0 110.497 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 23' ' ' GLY . 61.1 t0 -81.91 52.21 1.9 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.254 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -38.59 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.833 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 3.4 p-10 -83.62 -24.84 31.25 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.45 15.98 80.85 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.184 -0.532 . . . . 0.0 111.928 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 49.7 p-10 -66.87 -5.44 12.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.549 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 84.32 -16.93 31.53 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.444 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 5.2 t -128.9 128.76 44.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.474 0.178 . . . . 0.0 110.946 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.44 112.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 29' ' ' VAL . 85.4 m -77.42 162.96 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.592 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.4 ' N ' ' CG2' ' A' ' 28' ' ' THR . 2.4 m -55.74 -36.81 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.469 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.74 -41.8 91.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.962 0.41 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.47 -37.8 85.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.353 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 tp -64.16 -43.96 93.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.71 72.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -63.49 -41.74 98.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.3 t -65.61 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.241 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.19 -35.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -60.43 -42.78 96.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -68.9 -35.46 76.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.961 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 11.2 mt -60.57 -43.91 96.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.728 -1.129 . . . . 0.0 112.67 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.569 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 70.1 m-20 142.01 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 124.691 1.245 . . . . 0.0 111.533 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -136.57 157.09 47.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -148.97 71.7 10.29 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.783 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.02 156.69 61.26 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.526 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 6.2 p -84.88 155.99 21.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 56.8 mp0 -40.06 -47.39 2.3 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -46.86 -51.86 15.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.047 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -70.14 -41.5 73.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.762 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -40.81 95.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -61.62 -50.5 72.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.699 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.01 -37.1 78.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.9 tpp -74.01 -47.41 37.25 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.3 mt -64.3 -44.56 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.0 p -58.09 -43.96 87.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -50.16 -28.75 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -110.13 -30.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 10.7 t0 -63.97 78.53 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.24 -36.02 80.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.694 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 3.9 p30 -90.41 -20.64 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.03 1.18 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.177 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 7.8 m120 -109.83 -12.43 14.59 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.266 0.533 . . . . 0.0 111.471 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.07 63.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -138.69 177.11 8.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.1 mt -121.5 128.44 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -98.43 171.73 7.98 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -56.1 -51.72 66.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.681 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.13 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.462 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 89.1 mt-10 -59.03 -46.23 88.74 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.9 t80 -68.33 -26.57 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.85 -43.05 89.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 110.108 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.9 t -66.53 -41.87 88.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.36 -41.39 84.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.99 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.466 ' SD ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 mtp -65.86 -51.62 57.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.468 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.769 179.295 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 9' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.54 -46.39 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.868 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.36 -54.88 29.97 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.981 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 69' ' ' LEU . 49.9 m-85 -59.09 -47.85 83.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -59.42 -33.75 71.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.456 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.0 -41.64 81.94 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.078 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.47 -46.76 84.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.967 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.51 -49.47 73.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.87 85.42 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.84 -39.71 95.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.9 m-30 -64.44 -41.0 96.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.076 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 27.8 t0 -82.19 53.84 2.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.135 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -38.62 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.684 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.1 p-10 -89.2 -25.01 22.0 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.41 18.45 79.16 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.74 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 46.6 p-10 -66.8 -10.71 50.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.774 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.81 -15.74 60.98 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.1 p -133.18 132.89 42.1 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.687 0.28 . . . . 0.0 110.835 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.1 mt -95.43 113.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.6 m -78.55 164.1 24.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.636 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -55.32 -33.91 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.763 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.44 -42.63 74.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.282 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -65.03 -38.19 90.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.207 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.95 -43.67 91.94 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.39 74.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.916 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 m -60.68 -43.28 97.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.758 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.21 -46.38 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.238 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.08 -43.88 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.951 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -56.16 -41.65 75.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.342 0.591 . . . . 0.0 110.582 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -66.29 -37.48 85.51 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.089 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 35.6 mt -61.73 -44.08 97.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.564 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 10.9 t70 141.12 10.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 124.003 0.815 . . . . 0.0 111.352 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -128.72 164.75 22.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 110.075 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -154.16 70.72 6.31 Favored Pre-proline 0 C--O 1.232 0.176 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.47 154.68 73.05 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.726 2.284 . . . . 0.0 111.206 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.5 m -80.32 164.68 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -42.36 -49.34 5.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.39 -58.12 4.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.472 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.61 -41.68 90.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.188 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.0 mt -61.37 -42.98 99.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -67.43 -53.37 29.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -59.65 -37.74 79.52 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.556 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.4 mmt -71.42 -48.86 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.608 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASP . 57.7 mt -64.88 -45.18 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -58.62 -46.96 85.92 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -45.77 -27.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.4 p -116.14 -27.51 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 52' ' ' ILE . 26.1 t0 -59.37 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.69 -35.13 75.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.1 m-20 -82.96 -23.66 33.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.462 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.1 26.97 68.17 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 30.1 p-10 -81.58 -16.42 51.66 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.739 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.69 7.8 50.19 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.453 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 49.5 p -134.23 167.12 21.27 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.0 mt -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.843 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -102.87 171.64 7.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -53.51 -50.29 65.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.309 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -57.56 -43.96 84.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.233 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 80.6 mt-10 -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.815 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 83.5 t80 -62.24 -44.47 96.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.378 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.425 ' CD1' ' CD2' ' A' ' 12' ' ' PHE . 57.3 tp -62.18 -42.44 99.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.183 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -64.77 -44.57 89.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.136 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -44.81 86.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.787 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 76.0 mtp -70.96 -50.77 30.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.87 179.122 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mm . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.4 t -63.37 -47.3 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.12 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.31 -44.02 92.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.266 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.09 -44.61 97.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.83 -37.66 76.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.177 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -65.43 -35.71 81.74 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.139 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.32 -43.29 86.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.107 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -69.59 -48.82 58.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.749 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.25 95.06 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.87 -38.48 91.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.902 0.382 . . . . 0.0 110.057 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 8.9 m-30 -68.85 -41.87 77.87 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.662 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 22' ' ' ASP . 27.4 t0 -79.37 47.13 0.79 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.219 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -36.49 -25.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.693 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.5 m-20 -76.78 -27.44 55.27 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.61 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.53 10.26 85.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 49.3 p-10 -71.73 -9.74 58.73 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.798 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.96 -7.04 81.99 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 p -131.65 134.14 45.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.867 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.69 117.18 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 p -83.9 166.27 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.699 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 t -56.72 -43.98 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.03 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.42 -39.14 86.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.03 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 91.9 mt-10 -71.15 -42.57 68.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.132 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -44.83 95.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.88 69.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.808 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -62.36 -42.59 99.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.887 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.2 -46.99 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.511 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 41' ' ' GLN . 5.3 mm -62.94 -39.64 85.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.16 -40.72 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.502 ' C ' ' H ' ' A' ' 40' ' ' ASP . 51.1 m -67.91 -37.17 81.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.82 25.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 38' ' ' SER . 90.3 m-20 63.27 20.52 12.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.288 0.368 . . . . 0.0 111.931 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.411 ' O ' ' O ' ' A' ' 36' ' ' ILE . 86.8 mt-30 -137.04 148.47 46.83 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -154.17 79.69 5.0 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.07 170.01 5.4 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.669 2.246 . . . . 0.0 111.113 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -91.49 165.1 13.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 49' ' ' GLN . 80.9 mm-40 -42.17 -46.47 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.897 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 1.5 mm-40 -56.66 -62.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.831 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.9 -45.75 93.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.063 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.21 -43.78 98.32 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' GLU . 57.1 tt0 -71.92 -42.67 66.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.269 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.56 -36.8 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.612 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.9 mmt -69.01 -45.18 71.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.692 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.96 -43.98 88.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.1 m -57.69 -38.45 75.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.874 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -49.08 -29.03 4.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -115.47 -27.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 14.2 t0 -62.99 76.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -61.54 -22.57 65.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.351 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 3.4 p-10 -101.14 -23.54 14.44 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.736 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 69.07 35.11 77.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.295 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.546 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 47.9 p30 -76.56 -17.85 58.99 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.624 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.01 8.79 60.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 p -139.77 162.56 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.8 mt -115.63 127.58 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.546 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 53.3 mp0 -98.5 171.39 8.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -56.25 -52.27 65.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.355 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 29.1 p-10 -56.79 -42.44 79.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.326 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 94.4 mt-10 -65.36 -44.01 89.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -66.55 -33.59 76.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.4 tp -66.74 -43.7 83.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.906 0.384 . . . . 0.0 110.565 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.9 m -72.5 -45.68 58.27 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.243 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 tp -48.74 -52.74 22.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.163 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 ttp -67.92 -47.32 69.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.636 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.774 179.498 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 13' ' ' LYS . 24.2 mm . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.48 -46.8 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.075 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.25 -50.76 66.69 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.935 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -62.91 -51.67 66.05 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.463 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.3 tppp? -54.27 -37.7 65.01 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.886 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -68.32 -38.84 81.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.081 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.01 -52.31 63.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.174 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -62.62 -48.68 78.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.766 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.58 84.81 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.97 -38.44 91.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.839 0.352 . . . . 0.0 110.064 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.59 -46.07 70.33 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.176 0.512 . . . . 0.0 110.219 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 22' ' ' ASP . 31.8 t0 -78.8 43.32 0.49 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -37.48 -23.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.875 -178.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.0 p-10 -83.3 -27.16 29.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 111.674 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 82.55 15.64 73.06 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.033 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 55.8 p30 -70.18 -6.11 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 -11.84 26.96 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.445 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 10.3 m -131.79 133.08 44.34 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.3 mt -98.45 115.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -79.5 160.53 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.99 -42.2 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.483 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.92 -40.93 97.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.272 0.558 . . . . 0.0 110.223 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 76.6 tt0 -69.27 -35.23 75.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.273 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -62.99 -43.58 98.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.05 72.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.681 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -61.77 -41.93 98.34 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.72 -48.44 75.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.264 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.4 mt -61.52 -36.88 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -59.81 -41.72 91.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.414 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.4 m -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 86.1 mt -59.83 -41.98 92.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.452 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 30.2 t0 131.54 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.623 1.202 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.522 HE21 ' C ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -141.2 156.06 45.97 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.8 -0.563 . . . . 0.0 110.015 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -149.34 76.18 9.34 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.832 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 172.11 2.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.629 2.219 . . . . 0.0 111.261 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -85.53 160.29 19.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 57.7 mp0 -43.45 -41.67 4.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.5 -57.58 8.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.818 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 51.3 mp0 -58.62 -39.36 80.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.229 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.4 -43.41 98.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.988 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -73.36 -49.87 24.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.179 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.01 -38.72 87.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.594 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.5 ttm -67.73 -47.39 69.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 56' ' ' ASP . 75.3 mt -64.02 -44.31 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 t -59.22 -42.09 90.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.99 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -48.27 -32.63 7.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.017 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -112.93 -30.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.9 t0 -61.53 81.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.37 -26.7 65.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.419 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 2.0 p30 -96.74 -21.98 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.675 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.11 40.62 95.11 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.5 p-10 -82.67 -16.92 46.38 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.517 -0.402 . . . . 0.0 111.554 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.92 4.64 58.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.461 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 55.5 p -135.56 165.4 25.62 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.01 126.8 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -94.38 170.37 9.54 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -56.68 -51.52 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.682 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -61.18 -42.09 97.95 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.228 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 74.2 mt-10 -64.8 -44.98 88.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.129 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.52 -41.11 98.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.71 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.14 -41.8 99.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.952 0.406 . . . . 0.0 110.875 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.85 -43.49 98.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.224 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.9 tp -61.68 -39.23 90.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 110.761 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 45.3 mtp -61.07 -49.66 76.46 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.021 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.204 178.79 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 t -56.06 -44.61 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.786 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.72 -54.37 46.08 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.099 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -56.55 -48.53 77.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -38.16 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -64.15 -41.41 97.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.074 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.02 -46.68 86.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.909 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -62.68 -50.76 69.88 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.806 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.19 -46.23 79.6 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.83 -40.6 95.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.1 m-30 -63.68 -41.76 98.12 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.041 0.448 . . . . 0.0 110.037 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 34.9 t0 -78.38 54.33 1.4 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.349 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -39.18 -30.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.632 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.9 p-10 -82.34 -23.85 34.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.39 16.11 80.97 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.7 p-10 -65.88 -9.79 32.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.354 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -15.98 58.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 6.9 t -130.85 130.58 43.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 0.187 . . . . 0.0 110.761 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.34 112.38 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -79.96 167.29 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.621 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 30' ' ' GLU . 2.4 m -55.63 -39.87 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 73.1 mm-40 -63.09 -42.85 99.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -66.51 -41.17 89.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.139 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -45.0 94.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.49 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.03 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 m -60.19 -44.69 94.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.659 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.35 -46.64 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.154 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.46 -39.42 81.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -54.89 -42.48 72.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.88 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 40' ' ' ASP . 7.6 t -65.09 -39.69 93.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.21 19.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.388 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.559 ' H ' ' C ' ' A' ' 38' ' ' SER . 34.3 m-20 69.08 20.05 7.82 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.871 0.732 . . . . 0.0 111.252 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -133.74 142.78 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.019 -0.425 . . . . 0.0 109.965 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -140.54 70.94 31.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.63 157.6 46.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.7 2.267 . . . . 0.0 111.309 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 45' ' ' GLU . 60.9 p -83.73 154.26 23.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 44' ' ' THR . 97.1 mt-10 -38.41 -47.54 1.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.991 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -46.06 -60.32 2.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.33 -41.75 98.81 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.181 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -42.2 98.23 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.122 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -63.65 -51.92 63.03 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.211 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -60.51 -35.43 75.92 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.558 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 70.9 mtm -74.61 -47.74 30.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.04 -43.66 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.843 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -59.12 -45.74 90.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' O ' ' CD ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -46.21 -25.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -118.18 -24.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -59.89 81.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.58 -34.53 77.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.28 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.3 m-20 -80.52 -24.11 39.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.702 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.17 23.15 65.9 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 26.8 p-10 -78.7 -18.42 54.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.122 0.461 . . . . 0.0 111.452 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.24 14.09 29.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.439 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 48.3 p -141.4 172.45 12.66 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mt -121.57 129.13 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -100.26 172.12 7.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -53.99 -49.3 69.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.743 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.76 -42.0 96.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.182 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 92.3 mt-10 -68.21 -45.65 72.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.966 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.8 t80 -60.75 -46.01 92.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.776 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.96 -40.28 95.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 110.116 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 67' ' ' GLU . 81.4 p -63.75 -45.63 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.641 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.15 -42.54 86.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 53.3 mtp -67.92 -54.7 16.71 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.407 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.602 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.884 178.884 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.1 mm . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.45 -46.35 95.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.154 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.85 -42.9 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.976 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.41 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -61.05 -48.23 82.71 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -61.48 -32.39 72.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -66.83 -39.53 87.69 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 110.17 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -65.22 -42.01 93.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.983 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.68 -49.02 70.1 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.868 0.366 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.16 -44.36 93.2 Favored Glycine 0 C--N 1.329 0.194 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.79 -40.2 96.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.996 0.427 . . . . 0.0 110.063 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -65.74 -40.46 92.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.228 0.537 . . . . 0.0 110.456 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 23' ' ' GLY . 66.3 t0 -80.6 60.37 3.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' NZ ' ' CB ' ' A' ' 21' ' ' LYS . 9.3 mtmp? -37.23 -27.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.891 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.8 p-10 -97.16 -12.55 22.93 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 63.97 23.36 67.57 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.27 -0.49 . . . . 0.0 111.886 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -66.6 -12.0 55.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.206 0.503 . . . . 0.0 110.776 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.73 -14.49 64.02 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 m -132.65 132.14 42.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 0.0 110.91 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.66 111.74 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 m -75.15 154.89 37.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.59 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -54.98 -29.57 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.48 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.52 -41.71 72.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.544 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 68.9 mt-10 -68.76 -41.73 78.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.68 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.79 -46.84 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.86 73.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.877 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -63.1 -43.85 97.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.14 -48.8 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.104 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mm -63.52 -38.38 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -55.31 -40.77 71.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.845 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.583 ' C ' ' H ' ' A' ' 40' ' ' ASP . 26.0 m -66.85 -33.57 75.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.674 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.67 23.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.583 ' H ' ' C ' ' A' ' 38' ' ' SER . 99.7 m-20 63.7 14.22 8.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -137.95 146.52 43.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -142.74 83.88 11.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.083 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.95 169.17 10.81 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.856 2.371 . . . . 0.0 111.071 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p -89.61 162.04 15.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -42.66 -46.21 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -50.55 -52.03 42.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.99 -42.73 97.1 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.234 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.0 -47.17 85.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.938 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -64.83 -50.88 64.93 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.175 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.3 t0 -59.15 -34.09 71.66 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.503 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.9 ttp -74.79 -45.53 43.01 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.774 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' ASP . 81.8 mt -64.57 -44.23 96.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.6 m -61.8 -46.51 89.2 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.046 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -45.07 -29.63 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.44 -33.38 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 52' ' ' ILE . 53.7 t0 -65.41 98.1 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.98 -24.4 61.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.828 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -100.32 -24.57 14.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.42 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.425 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.42 37.3 85.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.283 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 13.7 m120 -70.95 -17.91 62.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.958 0.379 . . . . 0.0 111.422 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.38 -2.56 56.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -131.43 174.42 10.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.4 mt -116.51 120.8 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.991 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -88.7 169.87 11.29 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -55.81 -49.04 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.759 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.63 -38.15 89.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.01 0.433 . . . . 0.0 110.249 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 97.5 mt-10 -67.33 -41.22 85.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.826 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -67.33 -38.55 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.502 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -41.37 96.48 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.08 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.6 p -69.95 -45.86 66.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.022 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.12 -44.13 93.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 110.334 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.41 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 tpt -54.62 -51.95 63.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.909 179.131 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.457 -0.1 0 N-CA-C 110.608 -0.145 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 11' ' ' ASP . 9.3 p -61.52 -47.76 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.967 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.488 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 8.8 t70 -62.1 -45.87 91.57 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.874 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CD2' ' SD ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.21 -42.92 99.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.319 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -60.43 -35.47 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.203 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.16 -37.13 83.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.383 0.611 . . . . 0.0 109.748 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.36 82.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.249 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -67.89 -47.42 68.9 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.882 0.372 . . . . 0.0 110.966 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.15 -42.77 98.71 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 tp -62.87 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.114 0.483 . . . . 0.0 110.133 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.19 -36.54 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.33 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.1 t0 -92.53 49.42 1.48 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.182 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -36.5 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.846 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.2 m-20 -70.59 -28.11 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.358 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.76 10.34 85.83 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -69.04 -10.71 58.96 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.867 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.86 -6.31 83.78 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -131.3 134.48 46.41 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.715 0.293 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.7 mt -100.56 113.34 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -82.24 165.14 20.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 30' ' ' GLU . 3.2 m -57.37 -44.5 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.735 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 45.6 tt0 -58.67 -40.11 82.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.21 0.528 . . . . 0.0 109.899 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 97.0 mt-10 -70.23 -40.87 74.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.433 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.18 -45.46 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.85 -39.38 68.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -65.63 -39.8 91.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.776 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.78 -46.4 92.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.488 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.36 -38.88 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -57.53 -41.28 80.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.525 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -68.62 -31.89 71.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.086 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 76.3 mt -59.13 -42.76 91.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.751 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 36.2 p-10 137.83 17.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.181 0.926 . . . . 0.0 111.301 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -153.94 169.71 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -153.99 84.23 4.13 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.184 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.99 179.49 0.29 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.729 2.286 . . . . 0.0 110.994 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 50.6 p -89.59 155.03 19.52 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -41.53 -36.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 0.0 110.185 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -57.24 -53.46 57.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.532 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' OE1' ' OG1' ' A' ' 44' ' ' THR . 2.7 mp0 -60.94 -40.79 94.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.82 -42.96 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -72.99 -45.85 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.284 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.92 -39.92 93.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.532 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -67.59 -44.31 78.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.608 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 56' ' ' ASP . 73.3 mt -66.67 -44.28 89.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -40.05 90.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -50.89 -33.82 25.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.9 p -111.21 -32.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 33.5 t0 -64.02 76.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.231 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.19 -25.67 61.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.67 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.415 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 2.0 p30 -95.66 -23.09 17.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.546 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.89 36.48 81.9 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 52.6 p-10 -77.52 -17.09 58.28 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.578 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.58 3.73 62.57 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 6.2 p -134.56 163.76 29.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.7 mt -116.4 128.82 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -104.52 164.7 11.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -45.99 -60.2 2.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.9 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -48.89 -43.3 38.98 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.43 -42.25 75.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.041 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 38.2 t80 -64.43 -37.33 87.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.41 -44.86 93.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.582 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.0 m -65.69 -43.7 88.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.89 -43.0 99.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.658 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.587 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 60.4 mtp -60.04 -44.85 94.39 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.2 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.172 179.437 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 9' ' ' ILE . 31.1 mm . . . . . 0 CA--C 1.521 -0.163 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.35 -42.5 95.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.093 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.58 -49.76 71.87 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.876 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.43 -47.22 85.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -60.37 -38.19 83.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.13 -38.05 89.37 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.332 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.06 62.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.834 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -69.35 -46.7 66.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.727 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.49 95.64 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -38.85 92.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 5.6 m-30 -72.34 -39.09 68.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.596 0.713 . . . . 0.0 110.649 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.2 t0 -87.39 50.42 2.0 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.468 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -35.57 -28.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.449 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.2 m-20 -72.51 -28.08 62.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.49 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.57 11.13 85.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -70.22 -9.86 57.11 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.822 -179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.31 -2.48 85.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -133.08 136.88 46.15 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.654 0.264 . . . . 0.0 110.951 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -103.23 115.33 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.7 m -81.97 162.9 22.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.99 -34.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.368 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.18 -39.05 89.43 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 109.988 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 93.9 mt-10 -71.3 -36.96 71.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.166 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.64 -44.6 95.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.86 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.594 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -64.47 -40.3 95.43 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.4 -46.12 87.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.341 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.67 -41.64 91.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.74 -0.384 . . . . 0.0 109.982 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -57.26 -39.57 75.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.533 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -68.8 -34.49 75.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.551 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 76.3 mt -59.56 -41.85 91.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 116.936 -1.507 . . . . 0.0 112.613 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.551 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 87.8 m-20 134.14 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.164 1.54 . . . . 0.0 111.449 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -147.59 161.35 41.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -150.2 78.59 7.85 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.27 -177.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.605 2.203 . . . . 0.0 111.347 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -90.42 148.33 22.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -42.33 -28.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.135 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.83 -51.21 69.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.441 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -65.92 -37.07 85.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.776 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.67 -42.84 99.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.844 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.71 -44.63 48.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.511 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -62.46 -39.02 92.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.577 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.55 -44.34 78.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 56' ' ' ASP . 81.9 mt -66.34 -44.46 90.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.898 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -61.19 -37.07 81.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.014 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -56.16 -34.46 66.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.002 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 10.6 p -108.86 -30.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 52' ' ' ILE . 48.7 t0 -64.2 77.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -56.17 -24.58 42.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.314 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 3.9 p-10 -95.41 -23.22 17.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.602 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.36 37.85 86.5 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.352 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 47.3 p-10 -80.47 -15.7 56.11 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.57 -0.37 . . . . 0.0 111.514 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.14 4.18 69.08 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 33.3 p -133.99 157.77 45.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.5 mt -111.09 127.64 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 10.7 pt-20 -95.69 174.79 6.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.757 0.313 . . . . 0.0 110.263 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.07 -50.38 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.72 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -57.57 -58.86 6.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.307 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 94.8 mt-10 -51.97 -43.59 63.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.081 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -62.54 -46.0 90.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.07 -43.3 95.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 m -65.33 -44.71 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.314 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.248 0.547 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.55 -43.06 98.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.227 179.34 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.576 0.227 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.79 -47.8 91.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.101 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.22 -45.34 85.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.974 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.3 -48.13 81.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.061 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.76 -35.42 79.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.081 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -63.84 -36.82 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.06 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -68.31 -37.21 80.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.345 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.45 -48.92 65.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 111.123 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.69 -42.32 96.24 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.7 tp -62.46 -39.14 92.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 109.926 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.25 -36.7 79.85 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.334 0.588 . . . . 0.0 110.693 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 34.4 t0 -86.42 51.41 2.22 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.46 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -36.29 -30.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.719 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 6.2 m-20 -70.51 -28.08 64.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.556 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.32 8.68 87.63 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.694 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -68.57 -17.37 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.731 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 95.2 -7.03 69.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 m -127.62 129.76 47.82 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.612 0.206 . . . . 0.0 111.016 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.7 mt -100.32 114.25 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.22 165.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.18 -38.59 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.524 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -61.17 -40.52 94.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.958 0.408 . . . . 0.0 110.195 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 94.1 mt-10 -70.52 -38.37 74.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.224 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -45.48 94.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -57.76 -41.44 81.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.88 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -62.24 -43.65 98.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.1 -47.43 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.48 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.94 -38.59 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' ALA . 42.7 ttm180 -58.57 -41.31 85.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.648 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 t -86.8 -12.99 46.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.589 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 3.4 tt -65.11 -41.12 95.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.497 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 15.5 m-20 150.99 0.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.901 0.751 . . . . 0.0 111.678 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -155.02 172.44 18.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -153.93 76.87 5.81 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.24 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.16 176.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.46 2.107 . . . . 0.0 111.285 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -86.22 161.75 18.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.479 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.5 mp0 -47.35 -41.24 19.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -54.24 -53.18 57.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.415 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.97 -40.75 96.67 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.161 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mp -62.66 -45.91 90.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.025 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -69.39 -46.51 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.75 -36.99 84.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.3 ttp -69.17 -45.76 69.21 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 52' ' ' ILE . 75.5 mt -65.61 -44.94 93.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.98 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -59.13 -39.52 82.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.796 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -52.0 -31.49 29.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.751 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -109.87 -32.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.2 t70 -64.34 77.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.21 -30.0 48.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.433 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 15.3 p-10 -92.19 -18.85 22.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.67 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 65.31 42.86 95.93 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -87.01 -16.68 35.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.018 0.409 . . . . 0.0 111.64 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.08 16.23 58.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 m -140.19 151.64 45.38 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mt -112.31 126.33 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -103.26 179.66 4.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -57.37 -58.59 7.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.813 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 37.4 p-10 -56.52 -41.57 76.95 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.257 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 97.3 mt-10 -66.0 -46.23 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.908 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.87 -35.78 81.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.396 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.436 ' CD2' ' C ' ' A' ' 69' ' ' LEU . 7.4 tt -62.76 -43.61 98.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.927 0.394 . . . . 0.0 110.18 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -65.06 -45.28 85.97 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.438 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.61 -43.13 99.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.995 0.426 . . . . 0.0 110.736 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.472 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 4.3 tpt -59.6 -50.07 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.301 179.483 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 9' ' ' ILE . 70.9 mt . . . . . 0 N--CA 1.457 -0.117 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.6 t -55.55 -44.99 78.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.93 -51.56 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.835 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -59.03 -48.85 80.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.755 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -37.27 70.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.225 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.33 -41.5 85.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.314 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.62 -48.87 77.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.104 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.37 -49.25 74.58 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.901 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -45.72 82.14 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.97 -39.41 94.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.226 0.536 . . . . 0.0 109.559 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.99 -41.87 95.03 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.387 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' ASP . 12.8 t0 -83.34 53.77 2.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.808 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -39.54 -18.58 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.573 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -86.12 -28.67 23.86 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.307 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.21 11.59 84.88 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.742 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.78 -18.12 65.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.727 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.1 -13.64 60.25 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.401 ' SG ' ' OE2' ' A' ' 64' ' ' GLU . 3.5 m -131.69 132.75 44.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.7 0.286 . . . . 0.0 111.151 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -97.05 114.3 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -78.95 165.07 23.88 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' A' ' 30' ' ' GLU . 3.6 m -55.84 -41.23 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.495 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 75.9 mt-10 -60.7 -42.77 97.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.0 mt-10 -68.33 -42.89 78.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.303 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.466 ' C ' ' CD1' ' A' ' 32' ' ' LEU . 2.5 tm? -62.16 -46.8 87.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.55 -39.23 64.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.165 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -63.46 -43.18 98.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.928 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.4 -48.81 81.71 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.478 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -64.68 -40.57 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.0 -42.16 89.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 m -79.45 -20.99 46.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.583 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.511 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 5.3 tt -63.71 -45.39 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 4.1 m-20 153.3 0.91 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.47 0.482 . . . . 0.0 111.301 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -141.88 155.74 45.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -135.55 78.27 50.59 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.28 155.42 70.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.617 2.211 . . . . 0.0 110.911 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.3 p -85.2 161.39 19.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' THR . 80.4 tt0 -40.16 -47.77 2.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 109.805 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.23 -58.32 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -60.61 -42.37 96.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.8 mt -62.05 -43.5 98.7 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.155 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.86 -52.05 58.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.884 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -37.72 84.13 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.695 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.7 mmt -72.23 -48.68 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.7 mt -64.02 -45.17 97.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.954 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.2 p -58.98 -44.74 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -45.07 -27.42 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.5 p -115.61 -30.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 t70 -59.03 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.41 -35.13 73.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.297 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 21.7 p-10 -89.61 -22.41 22.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.45 63.33 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' ' HG1' ' A' ' 62' ' ' THR . 52.3 p30 -107.95 -16.7 14.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 117.001 0.4 . . . . 0.0 111.614 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 98.15 15.57 35.42 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.504 ' HG1' ' ND2' ' A' ' 60' ' ' ASN . 56.1 p -141.33 165.51 27.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -119.41 126.09 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.401 ' OE2' ' SG ' ' A' ' 26' ' ' CYS . 80.4 mm-40 -100.24 174.12 6.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.247 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -54.54 -50.85 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.773 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.85 -41.98 98.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.335 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.02 -46.15 75.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.383 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.11 -45.51 93.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.19 -41.62 97.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.576 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 t -63.49 -46.76 84.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.518 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.41 -41.02 93.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.793 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 ttt -69.33 -51.16 39.69 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.025 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.504 179.213 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -110.35 31.43 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.89 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.419 ' CG1' ' H ' ' A' ' 4' ' ' LEU . 3.3 pt -105.63 -101.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.819 0.342 . . . . 0.0 110.265 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.419 ' H ' ' CG1' ' A' ' 3' ' ' ILE . 55.6 tp -63.58 -35.36 80.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 110.009 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -69.77 96.38 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.533 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 97.3 mt-10 -99.51 82.26 2.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.665 0.269 . . . . 0.0 110.972 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -91.08 -51.33 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.71 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -63.93 -44.2 93.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.358 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.59 -44.13 96.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.308 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 6' ' ' GLU . 23.0 t -57.24 -45.88 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.654 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -58.64 -54.75 43.54 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.768 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -60.83 -49.1 78.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.941 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -60.82 -34.31 74.35 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' VAL . 84.3 tt0 -68.61 -42.61 77.88 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.087 0.47 . . . . 0.0 110.527 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -40.05 88.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 81.7 t80 -65.78 -49.62 67.67 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.96 -42.65 96.93 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.56 -41.31 94.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -64.09 -39.4 93.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLY . 36.3 t0 -80.18 54.79 2.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -39.02 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.54 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.3 m-20 -86.42 -27.22 24.29 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.186 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.75 12.53 84.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.697 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 47.5 p30 -66.39 -16.61 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.747 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 104.98 -12.53 49.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -140.9 145.21 35.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.729 0.3 . . . . 0.0 111.151 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 4.6 mp -105.31 120.15 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -81.75 169.09 17.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.708 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.37 -43.53 77.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.149 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.43 -43.25 99.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.14 0.495 . . . . 0.0 110.328 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.7 mt-10 -66.96 -40.02 87.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.041 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.92 -45.45 92.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.71 61.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -61.77 -42.58 99.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.749 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.68 -49.7 67.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 36' ' ' ILE . 1.3 mp -61.14 -39.04 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -56.45 -41.29 76.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.447 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 40' ' ' ASP . 42.3 m -65.79 -37.18 85.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.856 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.04 22.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 38' ' ' SER . 62.5 m-20 66.21 16.58 10.49 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.333 0.395 . . . . 0.0 112.03 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -136.92 145.53 44.39 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -149.94 82.18 6.67 Favored Pre-proline 0 C--N 1.331 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.36 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.71 163.98 34.99 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.947 2.431 . . . . 0.0 110.729 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 11.5 p -82.66 159.08 22.73 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 44' ' ' THR . 79.3 tt0 -38.33 -47.28 1.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 109.82 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.84 -63.1 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' O ' ' SD ' ' A' ' 51' ' ' MET . 15.4 mp0 -56.02 -41.39 74.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.86 -43.01 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -65.45 -52.35 53.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.419 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 65.5 t0 -58.88 -38.04 77.93 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.17 -47.92 47.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.821 178.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.22 -47.33 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.888 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -58.2 -45.61 87.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -44.2 -29.86 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.821 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -114.98 -31.12 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.66 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t70 -58.9 86.22 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.03 -34.99 70.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.5 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 18.7 p-10 -93.2 -21.9 19.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.844 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.66 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.74 64.77 3.69 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 53.9 p30 -107.79 -13.22 15.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 117.045 0.422 . . . . 0.0 111.547 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.08 7.48 58.46 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.419 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 32.9 p -135.06 164.39 27.74 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 mt -121.03 128.34 76.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -103.92 174.29 5.94 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.54 -52.1 64.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.565 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.82 -45.11 86.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.133 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -44.76 84.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.245 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.76 -44.36 96.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.59 -42.05 99.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.779 0.323 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 74' ' ' LYS . 10.2 t -63.92 -45.81 87.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.246 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.77 -42.09 88.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.547 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttt -71.81 -51.63 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.946 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.47 -30.92 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.519 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 70' ' ' SER . 64.0 tttp -67.33 -32.29 73.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -93.7 -11.37 31.65 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.21 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.45 22.77 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.285 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -54.72 -20.89 9.29 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.195 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 30.2 p-10 -54.87 -55.09 34.23 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.443 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.436 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 46.1 p . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.568 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 53.85 50.2 17.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.465 ' H ' ' CD1' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -84.91 153.02 3.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.079 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.528 ' H ' ' CD2' ' A' ' 4' ' ' LEU . 2.0 pt? -62.96 -26.61 68.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.319 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.422 ' O ' ' OE1' ' A' ' 8' ' ' GLN . 81.5 p -52.68 -39.01 61.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.846 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.51 48.78 0.27 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.801 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -88.17 -54.34 4.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.784 0.326 . . . . 0.0 110.642 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.526 ' H ' ' CD ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -64.49 -37.84 88.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.252 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.5 mt -62.93 -43.92 99.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.328 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.55 -47.71 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.078 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -66.1 -44.71 83.58 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.979 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.77 -49.57 75.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.971 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -60.03 -32.36 70.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.335 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.19 -39.63 89.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.168 0.509 . . . . 0.0 109.985 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.7 -46.99 85.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.705 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.56 -49.01 75.09 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.85 -45.79 78.72 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 tt -62.8 -39.48 94.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.248 0.547 . . . . 0.0 109.728 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.28 -42.96 96.18 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.278 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 57.8 t0 -81.23 54.15 2.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.195 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -37.75 -32.54 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.605 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p-10 -81.21 -25.42 36.73 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.704 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 77.38 14.51 82.44 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 51.6 p-10 -62.33 -4.03 1.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.978 0.389 . . . . 0.0 110.691 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 84.71 -17.0 33.03 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 9.0 m -130.43 130.5 44.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.611 0.244 . . . . 0.0 110.915 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.1 mt -93.77 111.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -77.66 164.58 25.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.59 -35.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.554 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -42.23 91.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.149 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.55 -38.05 83.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.332 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.55 -44.89 92.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.66 72.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.677 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -62.48 -43.32 99.1 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.76 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.83 -48.11 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.615 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -65.83 -39.73 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.172 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -59.52 -42.45 92.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.712 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 t -83.13 -14.41 53.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 11.0 tp -65.4 -43.25 91.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 2.7 m-20 155.66 -1.04 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.259 0.349 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -148.5 163.52 36.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -137.51 75.09 45.57 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 111.341 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.82 162.9 29.99 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.795 2.33 . . . . 0.0 111.003 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -82.54 152.22 26.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -39.38 -41.9 1.0 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.842 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.43 -50.69 51.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.482 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.93 -41.84 99.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.159 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.22 -42.43 99.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.196 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.26 -51.28 66.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.19 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.68 -36.39 78.64 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.559 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.0 mtt -71.45 -47.0 58.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.964 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 52' ' ' ILE . 79.7 mt -64.66 -43.43 96.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t -58.69 -45.14 90.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.897 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 54' ' ' GLU . 3.6 tm-20 -51.04 -28.66 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.031 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -110.73 -32.55 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -63.52 80.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.93 -35.38 64.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.019 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -90.39 -20.06 23.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.551 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.81 39.89 97.87 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.244 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.511 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 48.2 p30 -83.73 -17.09 42.45 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.718 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.66 56.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 43.8 p -133.08 165.52 24.55 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.66 130.94 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -104.28 176.12 5.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.323 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -56.03 -52.39 64.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.857 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -60.51 -44.5 95.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.005 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -63.41 -45.22 92.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.961 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.73 -41.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.68 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.25 -39.61 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.317 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.5 m -62.56 -45.9 90.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.325 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.43 -40.89 98.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.439 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 1.1 tpt -62.97 -53.64 50.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.289 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.67 -24.69 67.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 110.398 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -70.98 -28.85 64.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.931 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -84.62 -36.92 21.68 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.297 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -104.46 14.47 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.593 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 73' ' ' ALA . 56.8 tttm -44.65 -28.57 0.62 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.156 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -54.66 -55.61 27.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.355 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.703 179.665 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -154.19 -174.81 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.395 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.8 mt 67.73 63.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 O-C-N 123.729 0.643 . . . . 0.0 110.635 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.92 -37.41 58.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.507 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t -156.68 -15.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.275 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 68.96 73.56 0.26 Allowed 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.939 0.774 . . . . 0.0 110.58 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -93.21 -57.51 2.59 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.709 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.5 -37.01 82.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.249 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 mm -62.47 -43.11 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.85 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.016 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -57.06 -54.18 49.68 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -62.14 -50.82 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.889 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -54.42 -38.12 65.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.161 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.41 -39.89 89.25 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.959 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.84 -48.5 80.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.967 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' ' CD1' ' A' ' 27' ' ' ILE . 61.7 t80 -62.89 -49.06 76.31 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.806 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.18 -47.92 65.69 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.31 -38.52 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.9 m-30 -66.39 -46.14 77.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.509 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 14.6 t70 -79.19 50.58 1.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.92 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -39.51 -26.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.836 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 42.7 p-10 -81.3 -27.71 34.94 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.642 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 80.21 12.73 82.88 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.895 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 53.7 p30 -63.78 -10.07 17.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.157 0.478 . . . . 0.0 110.658 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.36 61.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 3.8 m -133.73 135.38 43.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.605 0.241 . . . . 0.0 111.095 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 65.4 mt -99.58 115.54 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -77.85 165.18 24.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.551 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.18 -40.21 76.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.537 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.19 -42.28 98.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -69.28 -39.33 78.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.381 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -45.2 93.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.66 -39.17 73.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -62.53 -44.33 96.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.972 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.94 -44.74 99.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.848 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mm -62.74 -41.7 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -57.1 -41.59 79.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.952 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 t -73.28 -33.13 65.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 29.4 mt -61.58 -44.26 97.34 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 9.8 p30 147.38 2.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.661 0.601 . . . . 0.0 111.497 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -129.07 165.04 21.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -152.14 70.74 7.73 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.01 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.72 152.85 79.77 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.666 2.244 . . . . 0.0 111.015 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.9 p -82.43 162.45 22.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -40.54 -46.96 2.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.953 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.93 -54.05 22.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.493 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -64.62 -43.71 92.86 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.459 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 mt -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.875 0.369 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.48 -50.33 67.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.436 -0.505 . . . . 0.0 109.871 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 67.7 t0 -61.89 -35.04 77.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.396 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.5 ttp -72.37 -48.49 41.28 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.8 mt -64.21 -44.18 97.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.6 m -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -46.29 -27.45 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.6 p -115.75 -24.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 14.1 t0 -63.77 77.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.03 -34.42 77.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.427 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 19.1 p-10 -87.86 -23.28 24.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.649 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.74 67.87 1.9 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.275 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 51.4 p30 -112.89 -15.21 12.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.936 0.368 . . . . 0.0 111.536 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.99 10.19 57.7 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.517 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 64.6 p -141.05 170.77 15.1 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.54 127.4 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -99.01 167.55 10.66 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -52.78 -49.48 65.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.464 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.34 -42.4 95.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.154 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.89 -43.9 86.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.1 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.83 -44.01 97.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.355 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -63.35 -41.81 98.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 74' ' ' LYS . 72.1 m -64.95 -48.88 72.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.742 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.0 tp -58.92 -41.18 86.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 110.651 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.1 mmm -68.59 -57.62 5.47 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.095 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.11 -29.99 70.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 70' ' ' SER . 64.4 tttp -65.62 -36.22 83.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.669 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -71.64 -44.92 63.49 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.823 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 78' ' ' ASP . 1.7 p -79.49 -7.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.389 . . . . 0.0 110.738 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -47.35 -14.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.173 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 76' ' ' VAL . 52.6 t0 -57.74 -54.75 43.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.503 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.544 -179.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -94.25 7.37 45.6 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.933 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.424 HG12 ' H ' ' A' ' 5' ' ' SER . 21.1 tt -130.55 130.46 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.185 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 6' ' ' GLU . 91.7 mt -77.65 -20.23 54.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.163 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.424 ' H ' HG12 ' A' ' 3' ' ' ILE . 1.6 m -58.7 -6.81 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 4' ' ' LEU . 96.9 mt-10 -137.51 45.14 2.2 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 110.928 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -93.69 -64.56 1.07 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.4 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -64.24 -31.95 73.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.591 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mm -64.07 -43.79 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.064 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.83 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.831 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.68 -44.63 96.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.929 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.43 -49.86 69.84 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.008 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -64.1 -34.05 77.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.47 -38.07 88.72 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.321 0.581 . . . . 0.0 110.268 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.68 -39.07 87.96 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.176 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -69.92 -48.58 57.99 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.16 92.17 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.96 -37.04 85.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -70.33 -40.12 74.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 110.557 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 23' ' ' GLY . 32.2 t0 -78.01 50.83 0.91 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.208 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -37.02 -31.2 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.695 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 22.6 m-20 -75.28 -28.14 59.64 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.543 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.81 7.47 88.26 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.9 p-10 -68.26 -8.14 36.74 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.91 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.66 -6.82 83.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 m -130.51 131.83 45.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 110.799 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.6 mt -98.72 114.89 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.2 p -82.65 163.68 21.24 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -58.18 -38.97 71.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.511 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -62.54 -40.57 97.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.264 0.554 . . . . 0.0 110.645 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 31.9 tt0 -71.49 -36.75 71.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.036 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -45.06 95.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.03 -40.29 73.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.799 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -61.64 -43.4 98.93 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.803 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.449 ' O ' ' OG ' ' A' ' 38' ' ' SER . 75.6 t -67.19 -48.89 77.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.189 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mm -63.61 -36.92 78.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -57.06 -40.36 76.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -66.45 -36.19 82.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.662 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 40' ' ' ASP . 84.9 mt -70.46 26.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.4 OUTLIER 60.48 19.85 9.59 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -138.62 150.67 46.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -154.74 83.86 3.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.72 170.85 3.15 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.61 2.206 . . . . 0.0 110.931 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 45' ' ' GLU . 55.2 m -84.7 168.64 15.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.495 ' N ' ' CG2' ' A' ' 44' ' ' THR . 80.4 mt-10 -53.05 -45.66 68.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.253 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 18.2 pt-20 -56.84 -44.49 82.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.888 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 50.6 mt-10 -64.81 -43.82 91.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.957 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.37 -44.86 96.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.823 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -67.74 -47.78 68.3 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -61.47 -40.26 93.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.0 tpp -69.87 -46.44 65.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 56' ' ' ASP . 82.1 mt -65.23 -44.33 95.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.4 p -61.67 -36.09 79.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.933 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -56.74 -32.01 65.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.782 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.42 -26.75 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 52.3 t0 -73.27 85.83 1.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.88 65.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.709 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -101.11 -23.37 14.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.223 -178.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.89 38.78 85.41 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 19.5 m120 -72.99 -16.54 61.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.874 0.337 . . . . 0.0 111.332 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.2 1.61 64.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.8 p -137.18 166.89 22.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.5 mt -114.46 126.02 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.74 178.66 4.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.321 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -56.8 -52.59 64.45 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.757 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.43 -43.31 96.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.901 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 95.3 mt-10 -65.65 -44.55 86.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.958 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -61.19 -43.09 99.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.458 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -40.76 97.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 74' ' ' LYS . 10.3 t -63.22 -45.4 91.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.262 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.42 -42.12 86.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.966 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.5 tpp -77.09 -41.08 43.61 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.246 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -71.85 -36.04 70.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.454 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -75.12 -27.57 59.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.474 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -83.59 -30.33 27.06 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.05 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.24 27.71 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.134 0.492 . . . . 0.0 110.611 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 73' ' ' ALA . 53.9 tttm -55.15 -37.23 66.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -50.39 -54.94 18.02 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.683 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.4 m . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.66 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 3' ' ' ILE . 70.9 m-20 -144.95 141.01 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.832 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 2' ' ' ASP . 94.3 mt 57.56 144.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.136 0.493 . . . . 0.0 110.668 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' A' ' 5' ' ' SER . 10.7 mp -63.1 -39.34 94.42 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 118.291 -0.862 . . . . 0.0 110.332 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 5.7 m 105.95 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 125.128 1.517 . . . . 0.0 110.891 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -75.77 26.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.233 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' A' ' 5' ' ' SER . 80.9 tt0 -91.93 -57.3 2.77 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 110.673 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -62.19 -33.6 74.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.434 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.18 -43.89 98.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.082 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.86 -48.43 88.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.827 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.65 -47.37 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.926 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -60.04 -46.95 87.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -57.24 -36.4 70.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.31 -38.12 89.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.963 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.99 -44.4 92.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.092 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -65.87 -49.44 68.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.877 0.37 . . . . 0.0 111.186 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.82 -45.28 86.34 Favored Glycine 0 C--N 1.33 0.231 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -65.32 -41.49 93.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.502 0.668 . . . . 0.0 110.376 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLY . 19.1 t70 -81.05 58.06 3.33 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.544 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -36.73 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.51 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -80.02 -27.51 39.5 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.33 7.23 82.21 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -64.29 -19.11 65.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.667 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.32 -11.95 51.4 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.467 ' SG ' ' OE1' ' A' ' 64' ' ' GLU . 57.3 m -128.06 127.56 43.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.92 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.29 111.96 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.12 166.93 19.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.9 t -55.7 -44.12 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.447 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -53.96 -43.19 69.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.858 0.361 . . . . 0.0 110.198 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.75 -46.03 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.746 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.12 -46.66 88.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.6 -41.77 66.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.151 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.468 ' HG1' ' NH2' ' A' ' 37' ' ' ARG . 3.3 m -65.11 -39.76 93.57 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.349 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.2 -48.63 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.04 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 36' ' ' ILE . 47.0 mm -61.67 -43.68 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.361 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH2' ' HG1' ' A' ' 34' ' ' THR . 88.6 mtm180 -60.35 -41.8 94.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.352 0.596 . . . . 0.0 110.626 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -75.38 -22.64 57.34 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.737 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 3.2 tt -66.17 -44.88 82.77 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 5.1 m-20 151.11 2.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.844 0.715 . . . . 0.0 111.418 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -143.33 154.01 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -133.24 79.09 62.45 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.63 159.29 53.28 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.858 2.372 . . . . 0.0 110.839 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -86.21 162.25 18.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -40.66 -47.91 2.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -47.31 -58.98 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.713 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.05 -41.88 97.43 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.396 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.02 -43.46 98.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.882 0.373 . . . . 0.0 110.256 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 53' ' ' SER . 85.8 mm-40 -64.07 -49.69 71.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.969 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -61.28 -36.0 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.6 mtp -72.93 -46.95 49.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.83 -45.19 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.665 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' GLN . 65.1 m -58.15 -45.27 87.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -48.62 -27.47 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -113.73 -32.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.83 81.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.51 -32.68 71.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.419 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.0 p-10 -93.21 -21.87 19.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.804 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.82 31.68 78.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 49.4 p-10 -73.41 -16.91 61.32 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.524 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.19 6.28 55.69 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.413 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 31.7 p -139.94 173.66 11.3 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.8 mt -121.92 128.31 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 13.4 tp10 -94.66 168.13 11.03 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.461 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 14.7 t80 -54.72 -50.49 68.2 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.702 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.48 -39.78 88.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.103 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.46 -42.28 92.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.243 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.78 -40.28 96.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.64 -41.01 98.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 74' ' ' LYS . 15.6 t -64.32 -44.78 90.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.532 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 tp -58.81 -40.93 85.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.9 mmm -66.8 -56.63 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.339 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.61 -32.55 74.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.648 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 70' ' ' SER . 55.3 tttp -62.28 -34.78 77.23 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.455 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 mtpm? -81.15 -43.89 18.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.234 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.461 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 52.8 t -77.84 -1.7 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.627 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.71 -10.8 0.49 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.171 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 76' ' ' VAL . 21.5 p-10 -55.71 -55.71 28.97 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.516 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.432 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 4.2 t . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.521 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.22 -45.73 86.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 111.474 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.9 mm 58.66 98.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.631 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 3.9 mm? -59.79 -35.99 75.8 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.069 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.441 ' HG ' ' C ' ' A' ' 4' ' ' LEU . 2.0 m 82.33 -113.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.757 0.66 . . . . 0.0 110.787 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 5' ' ' SER . 38.8 tt0 79.75 55.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.589 0.556 . . . . 0.0 110.104 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -95.63 -50.61 4.87 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.156 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -63.38 -41.15 98.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.767 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.49 -42.6 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.263 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.6 t -57.7 -47.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.935 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -65.28 -48.63 72.52 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.012 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.598 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.29 -48.7 80.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -59.03 -33.45 70.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.84 -38.6 86.71 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.185 0.517 . . . . 0.0 110.182 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.7 -46.39 85.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.91 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.04 -48.63 73.17 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.53 84.97 Favored Glycine 0 C--N 1.33 0.23 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.92 -37.99 89.43 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.1 m-30 -66.09 -41.51 90.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.374 0.606 . . . . 0.0 110.058 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ASP . 25.8 t0 -83.97 56.39 3.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.239 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -38.48 -19.04 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.697 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.1 m-20 -88.37 -26.89 21.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.378 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.08 11.47 83.98 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.729 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -65.18 -17.19 64.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.722 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -13.06 56.56 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 m -134.06 136.66 44.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.711 0.291 . . . . 0.0 111.111 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.5 mt -97.54 113.92 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.426 ' CG2' ' N ' ' A' ' 29' ' ' VAL . 89.4 m -78.3 164.85 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 28' ' ' THR . 8.2 t -56.12 -46.49 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.36 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.03 -41.57 83.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 94.4 mt-10 -67.26 -41.54 85.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.317 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -44.42 96.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.38 70.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.859 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -61.38 -44.38 97.25 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.789 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.0 -47.97 85.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.082 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mm -61.73 -38.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.09 -41.24 78.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.294 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 40' ' ' ASP . 37.6 m -64.82 -35.67 81.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.92 21.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 38' ' ' SER . 98.1 m-20 63.3 18.41 10.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -134.0 139.41 46.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.29 76.73 37.2 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 120.754 0.311 . . . . 0.0 111.169 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.9 169.38 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.992 2.462 . . . . 0.0 111.092 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 47' ' ' GLU . 6.9 p -86.72 149.73 24.68 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 57.1 mp0 -39.6 -42.72 1.22 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.44 -49.03 36.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.195 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 44' ' ' THR . 46.0 tp10 -66.48 -41.85 88.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.211 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.56 -43.05 99.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.126 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -62.97 -51.21 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.293 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.92 -33.16 71.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.479 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.6 ttp -74.74 -45.84 41.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 56' ' ' ASP . 80.4 mt -63.42 -43.95 98.7 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.864 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -63.94 -45.51 88.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.209 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.34 -33.4 65.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.209 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.43 -32.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 58.8 t0 -74.56 104.98 5.46 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.53 64.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.538 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 2.4 p30 -95.58 -23.22 17.16 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.622 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 63.08 41.22 99.85 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.472 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 49.6 p30 -80.3 -16.44 54.64 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.73 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.91 -0.84 51.75 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.458 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 18.5 p -129.83 170.87 13.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -118.99 125.27 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -95.22 167.3 11.44 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -53.72 -49.7 67.53 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.681 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.01 -41.24 87.25 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.233 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.73 -42.34 86.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.259 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -65.39 -41.08 94.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.881 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.2 tp -62.59 -41.59 99.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.522 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -66.16 -44.98 82.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.39 -42.0 98.78 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.107 0.48 . . . . 0.0 111.182 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.598 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 27.0 ttt -60.97 -49.05 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.07 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -65.68 -49.27 69.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.3 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -51.79 -22.33 3.56 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -86.79 -42.74 13.05 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.668 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.443 ' C ' ' H ' ' A' ' 78' ' ' ASP . 31.7 t -98.22 15.22 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 120.947 0.403 . . . . 0.0 110.412 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 73' ' ' ALA . 61.2 tttp -59.06 -7.64 1.19 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.115 0.483 . . . . 0.0 109.935 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 76' ' ' VAL . 68.3 t0 -53.45 -56.81 13.75 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.559 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.331 179.821 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -75.15 106.62 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.516 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 88.9 mt -70.09 -91.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.677 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 5' ' ' SER . 42.5 tp -90.47 -13.87 33.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 121.101 -0.24 . . . . 0.0 111.017 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 3.2 m 152.77 -78.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.922 0.391 . . . . 0.0 110.154 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -80.71 87.35 5.83 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -94.33 -66.85 0.89 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.701 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -60.98 -36.52 79.64 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.665 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.35 -44.19 97.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.066 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.4 -46.72 95.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.045 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -60.41 -39.71 88.37 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.55 -56.21 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -39.32 81.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -64.72 -35.54 81.38 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.979 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.59 82.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.464 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -68.15 -47.26 68.53 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.32 98.13 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.16 -37.56 87.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 0.0 109.688 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -70.99 -38.64 72.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 t0 -87.62 48.91 1.71 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.156 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -35.41 -28.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.363 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.6 m-20 -71.91 -28.04 63.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.512 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.44 8.64 87.62 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -68.48 -9.82 51.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.848 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.83 -5.65 84.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.9 m -129.03 131.57 47.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.69 0.281 . . . . 0.0 111.096 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.5 mt -100.27 114.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 ' HG1' ' H ' ' A' ' 31' ' ' GLU . 7.3 p -82.2 164.12 21.45 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.21 -42.26 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.615 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.4 -38.86 78.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 0.0 110.229 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' H ' ' HG1' ' A' ' 28' ' ' THR . 95.8 mt-10 -71.28 -37.92 71.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.442 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.31 -44.59 96.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.29 76.48 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.78 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -64.1 -41.3 97.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.43 -47.39 80.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.498 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.88 -38.5 82.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -59.44 -40.91 88.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.657 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.34 -34.99 65.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.381 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 38.0 mt -61.4 -41.93 97.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 112.641 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.56 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 71.8 m-20 141.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.345 1.028 . . . . 0.0 111.18 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -137.76 158.19 44.88 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 13.2 p-10 -155.42 69.04 5.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.956 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.79 169.53 5.61 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.678 2.252 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 64.8 p -80.44 148.69 30.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' THR . 75.5 mt-10 -37.69 -36.67 0.19 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.887 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -55.22 -53.37 56.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.386 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 12.8 mp0 -61.08 -41.75 97.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.95 -42.14 97.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -68.12 -42.6 79.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.318 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.13 -39.62 95.21 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.744 0.306 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 mtm -69.57 -44.01 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.211 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' ASP . 85.6 mt -66.18 -44.42 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.989 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -33.93 75.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.072 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -59.57 -33.63 71.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.788 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.6 p -109.92 -31.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 43.9 t0 -64.56 77.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -55.82 -23.68 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.266 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -97.46 -22.53 16.52 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.607 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.09 46.21 89.27 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.749 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -88.97 -17.19 29.98 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.63 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.636 ' N ' HD21 ' A' ' 60' ' ' ASN . . . 95.63 10.63 56.53 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.749 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 33.1 p -139.47 159.4 42.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.1 mt -113.83 128.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.42 171.89 8.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.37 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.67 -52.49 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.875 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.7 -41.29 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.6 -45.08 84.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.023 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.7 -42.29 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tt -63.97 -42.12 97.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -63.0 -46.08 89.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.231 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.8 tp -63.11 -40.29 97.21 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 110.551 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mmm -59.3 -42.72 92.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.613 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.621 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.27 -50.64 67.13 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.346 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -52.52 -28.03 18.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.691 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.22 -40.27 18.29 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.32 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.38 37.73 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.958 0.408 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 73' ' ' ALA . 38.3 ttpt -60.96 -44.71 96.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.083 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -74.2 -59.85 2.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.843 -179.916 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 49.0 p30 -74.49 154.06 38.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.004 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 3' ' ' ILE . 13.6 mm 57.86 114.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.863 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 5' ' ' SER . 0.6 OUTLIER -72.41 -20.41 61.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.991 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER 82.22 51.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 O-C-N 123.525 0.516 . . . . 0.0 110.927 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.559 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 6.4 mp0 -79.81 44.34 0.64 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.857 0.361 . . . . 0.0 110.945 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.18 -57.69 2.92 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.801 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -67.57 -36.96 81.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.697 0.284 . . . . 0.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.3 mm -62.49 -44.77 99.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.06 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.4 t -63.95 -46.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.443 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.51 -42.74 91.75 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.12 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.25 -51.95 65.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.065 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.93 -32.09 71.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.247 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.31 -39.6 89.42 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.963 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.65 -45.87 88.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.896 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.76 -49.56 74.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.54 84.5 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.2 tp -61.73 -40.64 95.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.002 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 4.6 m-30 -65.16 -43.08 92.94 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.239 0.543 . . . . 0.0 110.274 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 22' ' ' ASP . 34.5 t0 -81.56 50.47 1.49 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.739 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.5 m-20 -89.51 -27.85 20.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.109 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.05 14.27 82.09 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -69.23 -16.36 63.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.666 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.28 62.32 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.6 m -134.06 136.71 44.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.725 0.298 . . . . 0.0 111.08 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.4 mt -100.1 117.27 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.5 m -77.82 162.7 26.7 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.686 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.6 t -57.03 -46.86 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.496 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -58.39 -42.49 87.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 110.273 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' CD ' ' OD2' ' A' ' 22' ' ' ASP . 63.2 tt0 -66.8 -35.79 80.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.275 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -64.01 -43.15 96.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.1 -40.2 70.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -43.23 99.25 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -65.42 -48.44 83.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.105 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.3 -39.69 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.94 -41.88 71.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.548 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.5 t -64.86 -39.65 93.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.42 20.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 38' ' ' SER . 12.7 m-20 67.56 18.64 9.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -135.29 147.66 49.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -150.95 72.56 8.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.53 167.35 13.41 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.768 2.312 . . . . 0.0 111.022 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.4 p -83.26 153.42 24.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 44' ' ' THR . 77.3 mm-40 -38.49 -45.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 110.137 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -47.11 -55.71 7.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' O ' ' SD ' ' A' ' 51' ' ' MET . 50.1 mt-10 -60.16 -41.16 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.217 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.19 -42.52 98.73 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.029 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -65.29 -53.81 38.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -59.17 -38.06 78.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.528 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.26 -48.19 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.28 -44.48 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 m -57.52 -45.6 84.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -45.81 -29.56 1.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -112.72 -29.28 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 9.5 t0 -60.68 81.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.23 -36.25 77.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 8.0 p30 -92.38 -21.14 20.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.827 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.75 69.47 1.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.417 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 6.6 m120 -109.76 -11.75 14.69 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.116 0.458 . . . . 0.0 111.428 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.14 3.91 65.06 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -138.54 170.85 15.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -120.03 127.71 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.027 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -104.75 175.52 5.47 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -57.07 -54.75 43.2 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.646 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 33.0 p-10 -54.06 -46.0 71.83 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.094 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.498 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 99.5 mt-10 -64.04 -41.85 97.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.863 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 59.0 t80 -63.3 -37.57 87.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.08 -43.25 99.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.308 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 74' ' ' LYS . 58.8 m -65.46 -44.9 85.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.084 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -45.67 80.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.43 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 75.2 mtp -65.91 -49.46 67.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.016 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.34 -35.01 79.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.492 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 70' ' ' SER . 32.9 ttmt -62.7 -31.71 72.67 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -83.95 -35.71 23.79 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.944 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 t -99.34 16.81 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.247 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' ALA . 49.1 tptt -58.93 -33.09 70.19 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.096 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -56.06 -54.16 48.27 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.781 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.1 m . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.63 179.622 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -97.65 81.86 2.98 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 4' ' ' LEU . 6.1 tp -157.12 -58.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.372 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.488 ' H ' ' CG2' ' A' ' 3' ' ' ILE . 11.8 mt -74.05 -51.82 14.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 0.0 110.647 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 6' ' ' GLU . 2.8 p 73.86 -63.21 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.417 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' N ' ' OG ' ' A' ' 5' ' ' SER . 83.6 mt-10 76.69 59.44 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.079 0.862 . . . . 0.0 110.973 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -93.95 -68.39 0.8 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.028 0.442 . . . . 0.0 110.145 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.435 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 14.5 pt20 -61.58 -28.19 69.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.189 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 9' ' ' ILE . 38.9 mm -63.08 -45.46 98.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.077 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.11 -47.2 93.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.814 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.1 -42.56 99.61 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.834 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.435 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.5 m-30 -60.3 -46.37 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -59.71 -33.55 71.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -66.62 -37.91 85.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.252 0.549 . . . . 0.0 110.168 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.03 85.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.917 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -63.3 -47.44 82.29 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 111.084 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.05 91.89 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.19 -39.0 93.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.023 0.44 . . . . 0.0 110.229 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -67.54 -40.42 85.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.278 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 23' ' ' GLY . 34.5 t0 -81.82 58.34 3.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.922 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -37.54 -21.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.843 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 m-20 -88.15 -26.36 22.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.586 0.231 . . . . 0.0 111.443 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 74.51 10.14 82.36 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -64.3 -17.58 63.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -11.72 56.38 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.9 m -130.71 131.39 44.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.853 0.359 . . . . 0.0 111.326 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.2 mt -96.99 114.28 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.3 p -79.16 165.66 23.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 t -57.67 -44.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.589 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 54.0 mp0 -56.94 -41.68 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.009 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.58 -41.59 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.468 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.21 -44.86 94.14 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -55.3 -40.33 70.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.407 ' HG1' ' NH2' ' A' ' 37' ' ' ARG . 4.5 m -63.36 -42.85 98.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.866 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.98 -49.34 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.694 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mm -65.64 -41.13 89.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 49.2 ttp180 -57.75 -40.97 80.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.362 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -85.05 -14.05 48.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.526 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 9.9 tp -68.08 -43.4 78.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 3.4 t70 154.63 -4.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.414 0.446 . . . . 0.0 111.108 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -139.92 158.74 43.59 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -135.19 72.06 67.07 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.83 155.74 62.08 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.664 2.243 . . . . 0.0 110.913 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -82.88 156.78 23.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -40.03 -43.8 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -50.48 -52.43 38.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.52 -42.88 99.81 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.142 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.08 -42.31 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.54 -49.77 75.34 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.076 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.52 -35.26 75.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.69 0.281 . . . . 0.0 110.446 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -72.96 -45.84 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.813 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' A' ' 56' ' ' ASP . 85.1 mt -64.8 -44.5 96.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.956 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -45.7 91.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.552 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -57.77 -31.66 66.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 m -106.63 -24.51 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 52' ' ' ILE . 66.7 t0 -81.57 95.94 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.41 68.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.795 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -94.91 -24.15 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.244 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.516 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.28 35.35 82.48 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.069 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.485 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 20.3 m120 -67.52 -18.82 65.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.811 0.305 . . . . 0.0 111.356 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.72 -12.22 56.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 p -125.48 -179.76 4.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 109.967 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.13 130.75 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.631 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -101.26 177.67 4.87 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.458 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.67 -50.89 71.69 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.905 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 31.5 p-10 -58.82 -43.63 90.68 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.431 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 96.8 mt-10 -65.76 -40.72 92.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.62 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.86 -42.34 99.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.741 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.52 -39.14 82.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 74' ' ' LYS . 20.8 m -63.6 -42.89 98.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.3 -42.54 86.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.625 0.25 . . . . 0.0 110.778 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 12' ' ' PHE . 74.8 mtp -65.73 -56.43 12.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.553 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -63.39 -34.55 77.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.63 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 70' ' ' SER . 5.7 tmtm? -64.17 -31.89 73.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -92.22 -13.3 30.72 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.701 0.286 . . . . 0.0 110.366 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.464 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 91.9 t -114.19 5.36 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.937 0.399 . . . . 0.0 110.419 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 73' ' ' ALA . 48.6 tttp -56.7 -13.46 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.016 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -58.22 -57.66 11.87 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.505 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.501 -179.942 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -68.48 137.1 54.16 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.639 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.411 HD11 ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -111.72 37.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.136 -179.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.0 mt -59.87 -49.8 76.3 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.103 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.419 ' C ' ' H ' ' A' ' 7' ' ' GLU . 4.3 p 176.44 5.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.69 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -78.0 19.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.03 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 5' ' ' SER . 84.7 tt0 -89.03 -63.51 1.28 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.58 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -65.14 -36.11 83.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.452 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 9' ' ' ILE . 45.0 mm -61.85 -47.46 93.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.84 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.233 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.4 -42.39 96.12 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.3 -48.13 79.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.091 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -62.78 -34.71 77.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.204 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.03 -36.24 82.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.191 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -67.47 -40.62 85.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.101 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.407 ' CD2' ' CD1' ' A' ' 27' ' ' ILE . 59.7 t80 -70.37 -49.69 46.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.05 96.57 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.55 -39.12 89.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 9.6 m-30 -68.52 -40.49 80.76 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.934 0.397 . . . . 0.0 110.674 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.0 t0 -78.85 48.14 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.59 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -36.6 -40.36 0.25 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.877 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.0 p-10 -69.73 -25.34 63.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 0.0 111.627 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.12 14.74 80.1 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.891 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.1 p-10 -64.58 -1.52 1.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.673 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 75.51 -10.23 12.69 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.438 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.6 m -130.64 131.84 45.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.574 0.226 . . . . 0.0 110.839 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.407 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 95.0 mt -97.25 113.4 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.52 165.28 19.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.748 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.99 -36.92 64.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.524 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.98 -41.32 97.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.248 0.547 . . . . 0.0 110.616 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 42.6 tt0 -72.38 -39.46 68.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.056 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.444 ' CD1' ' C ' ' A' ' 32' ' ' LEU . 2.7 tm? -61.5 -45.92 92.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.07 -38.08 70.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.807 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -62.17 -42.7 99.52 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.834 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.08 -47.19 85.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.524 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mm -63.76 -38.74 83.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.047 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -57.08 -39.81 75.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.2 t -69.29 -38.17 78.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.04 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.95 25.78 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 38' ' ' SER . 33.5 t70 62.91 20.47 12.25 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -136.14 142.49 44.22 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.429 ' C ' HD21 ' A' ' 42' ' ' ASN . 0.2 OUTLIER -148.29 80.65 8.43 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.026 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.76 170.7 6.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.853 2.369 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 m -86.47 159.33 19.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.61 -39.34 7.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.76 -55.59 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -62.69 -40.78 98.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mt -61.2 -42.71 99.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.059 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -70.83 -41.54 71.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.131 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -63.46 -38.92 93.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.725 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 71.0 mtm -69.0 -44.04 73.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.991 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.76 -45.88 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.074 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.2 t -59.12 -37.42 77.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.56 -31.57 64.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.074 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.1 p -111.03 -32.88 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.4 t70 -63.82 79.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.04 -24.28 62.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.587 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.8 p-10 -95.36 -23.2 17.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.913 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.606 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.8 38.75 93.26 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.635 ' ND2' ' HG1' ' A' ' 62' ' ' THR . 51.5 p30 -81.39 -17.04 50.38 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.526 -0.396 . . . . 0.0 111.608 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.08 7.7 60.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.635 ' HG1' ' ND2' ' A' ' 60' ' ' ASN . 82.8 p -135.91 159.74 40.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.5 mt -112.73 127.04 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -99.99 165.28 11.62 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -49.24 -54.81 14.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.425 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.16 -43.29 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.006 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.63 -44.13 82.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.063 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.505 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.43 -40.64 97.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.454 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.48 ' HG ' ' HZ1' ' A' ' 74' ' ' LYS . 46.9 t -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.87 -42.83 85.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.544 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mmm -65.55 -47.3 76.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.931 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -65.65 -31.23 72.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HZ1' ' HG ' ' A' ' 70' ' ' SER . 33.4 mttp -66.22 -34.48 78.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.481 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -85.68 -35.46 20.87 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.207 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.74 13.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.087 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 73' ' ' ALA . 49.6 tttm -46.8 -34.34 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.08 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -49.34 -55.34 13.18 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.422 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.803 -1.094 . . . . 0.0 110.501 179.751 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -142.48 93.06 2.48 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.15 -73.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.217 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 62.8 mt -44.1 -35.88 2.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 0.0 110.183 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.573 ' C ' ' H ' ' A' ' 7' ' ' GLU . 8.0 t -167.97 -144.68 0.05 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.144 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 62.85 -41.26 0.18 Allowed 'General case' 0 C--O 1.221 -0.415 0 O-C-N 123.662 0.602 . . . . 0.0 111.111 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.573 ' H ' ' C ' ' A' ' 5' ' ' SER . 82.6 tt0 -66.35 -44.45 83.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.271 0.557 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 13.7 mt-30 -78.39 -35.52 47.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.89 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 17.7 mm -70.6 -46.77 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.434 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 11' ' ' ASP . 8.5 p -59.22 -47.5 90.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.998 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.499 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 64.4 t0 -63.32 -54.05 43.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.957 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 14.9 m-30 -61.82 -52.56 63.67 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.314 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 28.6 tptp -51.66 -40.78 60.64 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.034 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -68.58 -40.37 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.113 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.5 -50.14 73.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -62.59 -49.19 76.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.843 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.5 -48.3 65.72 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tt -62.65 -39.24 93.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.071 0.462 . . . . 0.0 109.793 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -63.94 -43.16 96.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.145 0.497 . . . . 0.0 110.497 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 23' ' ' GLY . 61.1 t0 -81.91 52.21 1.9 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.254 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -38.59 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.833 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 3.4 p-10 -83.62 -24.84 31.25 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.45 15.98 80.85 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.184 -0.532 . . . . 0.0 111.928 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 49.7 p-10 -66.87 -5.44 12.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.549 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 84.32 -16.93 31.53 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.444 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 5.2 t -128.9 128.76 44.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.474 0.178 . . . . 0.0 110.946 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.44 112.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 29' ' ' VAL . 85.4 m -77.42 162.96 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.592 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.4 ' N ' ' CG2' ' A' ' 28' ' ' THR . 2.4 m -55.74 -36.81 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.469 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.74 -41.8 91.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.962 0.41 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.47 -37.8 85.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.353 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 tp -64.16 -43.96 93.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.71 72.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -63.49 -41.74 98.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.3 t -65.61 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.241 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.19 -35.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -60.43 -42.78 96.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -68.9 -35.46 76.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.961 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 11.2 mt -60.57 -43.91 96.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.728 -1.129 . . . . 0.0 112.67 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.569 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 70.1 m-20 142.01 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 124.691 1.245 . . . . 0.0 111.533 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -136.57 157.09 47.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -148.97 71.7 10.29 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.783 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.02 156.69 61.26 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.526 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 6.2 p -84.88 155.99 21.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 56.8 mp0 -40.06 -47.39 2.3 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -46.86 -51.86 15.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.047 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -70.14 -41.5 73.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.762 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -40.81 95.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -61.62 -50.5 72.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.699 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.01 -37.1 78.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.9 tpp -74.01 -47.41 37.25 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.3 mt -64.3 -44.56 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.0 p -58.09 -43.96 87.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -50.16 -28.75 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -110.13 -30.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 10.7 t0 -63.97 78.53 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.24 -36.02 80.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.694 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 3.9 p30 -90.41 -20.64 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.03 1.18 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.177 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 7.8 m120 -109.83 -12.43 14.59 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.266 0.533 . . . . 0.0 111.471 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.07 63.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -138.69 177.11 8.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.1 mt -121.5 128.44 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -98.43 171.73 7.98 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -56.1 -51.72 66.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.681 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.13 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.462 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 89.1 mt-10 -59.03 -46.23 88.74 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.9 t80 -68.33 -26.57 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.85 -43.05 89.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 110.108 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 74' ' ' LYS . 13.9 t -66.53 -41.87 88.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.36 -41.39 84.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.99 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.466 ' SD ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 mtp -65.86 -51.62 57.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.468 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -67.83 -33.83 75.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.769 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 70' ' ' SER . 13.0 ttmm -65.01 -30.88 71.9 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.714 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -81.51 -41.04 22.29 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.217 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.73 29.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.217 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 73' ' ' ALA . 77.4 tttt -52.94 -35.4 58.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.899 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 79' ' ' THR . 34.8 p-10 -52.46 -52.17 55.57 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.635 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.496 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 1.2 t . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.885 -1.055 . . . . 0.0 110.55 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 66.8 t0 -170.97 -120.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.664 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.5 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 19.3 mm 64.91 -0.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.612 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.477 ' O ' ' OG ' ' A' ' 5' ' ' SER . 10.3 mp -57.43 -33.12 67.57 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 4' ' ' LEU . 4.9 p 74.47 -53.28 0.68 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.937 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 5' ' ' SER . 60.4 tt0 78.42 56.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.704 0.627 . . . . 0.0 110.447 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -94.97 -48.42 5.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -43.41 98.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.184 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 9' ' ' ILE . 1.6 mp -59.83 -41.95 87.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.914 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.54 -46.39 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.868 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.36 -54.88 29.97 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.981 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 69' ' ' LEU . 49.9 m-85 -59.09 -47.85 83.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -59.42 -33.75 71.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.456 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.0 -41.64 81.94 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.078 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.47 -46.76 84.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.967 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.51 -49.47 73.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.87 85.42 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.84 -39.71 95.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.9 m-30 -64.44 -41.0 96.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.076 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 27.8 t0 -82.19 53.84 2.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.135 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -38.62 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.684 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.1 p-10 -89.2 -25.01 22.0 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.41 18.45 79.16 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.74 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 46.6 p-10 -66.8 -10.71 50.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.774 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.81 -15.74 60.98 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.1 p -133.18 132.89 42.1 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.687 0.28 . . . . 0.0 110.835 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.1 mt -95.43 113.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.6 m -78.55 164.1 24.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.636 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -55.32 -33.91 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.763 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.44 -42.63 74.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.282 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -65.03 -38.19 90.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.207 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.95 -43.67 91.94 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.39 74.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.916 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 m -60.68 -43.28 97.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.758 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.21 -46.38 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.238 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.08 -43.88 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.951 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -56.16 -41.65 75.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.342 0.591 . . . . 0.0 110.582 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -66.29 -37.48 85.51 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.089 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 35.6 mt -61.73 -44.08 97.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.564 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 10.9 t70 141.12 10.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 124.003 0.815 . . . . 0.0 111.352 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -128.72 164.75 22.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 110.075 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -154.16 70.72 6.31 Favored Pre-proline 0 C--O 1.232 0.176 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.47 154.68 73.05 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.726 2.284 . . . . 0.0 111.206 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.5 m -80.32 164.68 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -42.36 -49.34 5.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.39 -58.12 4.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.472 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.61 -41.68 90.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.188 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.0 mt -61.37 -42.98 99.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -67.43 -53.37 29.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -59.65 -37.74 79.52 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.556 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.4 mmt -71.42 -48.86 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.608 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASP . 57.7 mt -64.88 -45.18 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -58.62 -46.96 85.92 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -45.77 -27.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.4 p -116.14 -27.51 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 52' ' ' ILE . 26.1 t0 -59.37 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.69 -35.13 75.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.1 m-20 -82.96 -23.66 33.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.462 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.1 26.97 68.17 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 30.1 p-10 -81.58 -16.42 51.66 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.739 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.69 7.8 50.19 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.453 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 49.5 p -134.23 167.12 21.27 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.0 mt -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.843 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -102.87 171.64 7.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -53.51 -50.29 65.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.309 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -57.56 -43.96 84.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.233 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 80.6 mt-10 -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.815 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 83.5 t80 -62.24 -44.47 96.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.378 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.425 ' CD1' ' CD2' ' A' ' 12' ' ' PHE . 57.3 tp -62.18 -42.44 99.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.183 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 74' ' ' LYS . 67.7 m -64.77 -44.57 89.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.136 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -44.81 86.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.787 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 76.0 mtp -70.96 -50.77 30.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.93 -31.95 73.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.87 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 70' ' ' SER . 36.6 ttmt -66.3 -33.75 76.44 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.514 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -81.94 -38.84 24.61 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.325 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.477 ' C ' ' H ' ' A' ' 78' ' ' ASP . 59.7 t -85.6 -1.27 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.634 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -49.33 -13.69 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.131 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 76' ' ' VAL . 93.2 m-20 -60.65 -60.2 4.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.676 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.374 179.961 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 52.98 83.45 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.407 ' CG1' ' H ' ' A' ' 4' ' ' LEU . 5.8 pt -90.09 -108.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.498 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.407 ' H ' ' CG1' ' A' ' 3' ' ' ILE . 10.3 mp -79.08 -10.06 59.72 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.3 p -52.69 -40.19 62.71 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -73.65 79.12 1.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.88 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -94.73 -60.78 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 110.531 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -64.98 -32.65 74.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.28 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mm -62.97 -44.21 99.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.052 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.4 t -63.37 -47.3 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.12 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.31 -44.02 92.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.266 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.09 -44.61 97.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.83 -37.66 76.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.177 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -65.43 -35.71 81.74 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.139 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.32 -43.29 86.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.107 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -69.59 -48.82 58.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.749 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.25 95.06 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.87 -38.48 91.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.902 0.382 . . . . 0.0 110.057 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 8.9 m-30 -68.85 -41.87 77.87 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.662 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 22' ' ' ASP . 27.4 t0 -79.37 47.13 0.79 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.219 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -36.49 -25.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.693 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.5 m-20 -76.78 -27.44 55.27 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.61 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.53 10.26 85.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -71.73 -9.74 58.73 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.798 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.96 -7.04 81.99 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 p -131.65 134.14 45.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.867 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.69 117.18 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 p -83.9 166.27 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.699 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 t -56.72 -43.98 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.03 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.42 -39.14 86.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.03 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 91.9 mt-10 -71.15 -42.57 68.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.132 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -44.83 95.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.88 69.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.808 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -62.36 -42.59 99.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.887 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.2 -46.99 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.511 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 41' ' ' GLN . 5.3 mm -62.94 -39.64 85.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.16 -40.72 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.502 ' C ' ' H ' ' A' ' 40' ' ' ASP . 51.1 m -67.91 -37.17 81.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.82 25.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 38' ' ' SER . 90.3 m-20 63.27 20.52 12.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.288 0.368 . . . . 0.0 111.931 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.411 ' O ' ' O ' ' A' ' 36' ' ' ILE . 86.8 mt-30 -137.04 148.47 46.83 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -154.17 79.69 5.0 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.07 170.01 5.4 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.669 2.246 . . . . 0.0 111.113 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -91.49 165.1 13.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 49' ' ' GLN . 80.9 mm-40 -42.17 -46.47 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.897 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 1.5 mm-40 -56.66 -62.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.831 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.9 -45.75 93.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.063 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.21 -43.78 98.32 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' GLU . 57.1 tt0 -71.92 -42.67 66.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.269 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.56 -36.8 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.612 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.9 mmt -69.01 -45.18 71.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.692 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.96 -43.98 88.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.1 m -57.69 -38.45 75.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.874 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -49.08 -29.03 4.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -115.47 -27.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 14.2 t0 -62.99 76.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -61.54 -22.57 65.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.351 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -101.14 -23.54 14.44 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.736 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 69.07 35.11 77.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.295 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.546 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 47.9 p30 -76.56 -17.85 58.99 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.624 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.01 8.79 60.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 p -139.77 162.56 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.8 mt -115.63 127.58 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.546 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 53.3 mp0 -98.5 171.39 8.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -56.25 -52.27 65.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.355 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 29.1 p-10 -56.79 -42.44 79.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.326 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 94.4 mt-10 -65.36 -44.01 89.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -66.55 -33.59 76.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.4 tp -66.74 -43.7 83.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.906 0.384 . . . . 0.0 110.565 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 74' ' ' LYS . 72.9 m -72.5 -45.68 58.27 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.243 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 tp -48.74 -52.74 22.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.163 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 ttp -67.92 -47.32 69.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.636 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -63.51 -34.83 78.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.774 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 70' ' ' SER . 9.8 mtpm? -63.26 -35.66 81.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.186 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -79.92 -42.27 24.43 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.692 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.97 23.28 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.149 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 73' ' ' ALA . 88.3 tttt -55.44 -36.21 66.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.948 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 30.3 p-10 -56.02 -55.74 29.23 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.843 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.41 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 53.7 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -64.46 -76.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.063 0.458 . . . . 0.0 111.26 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.3 pt -49.29 139.58 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.644 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.498 ' O ' ' C ' ' A' ' 5' ' ' SER . 83.3 mt -59.26 -52.61 64.93 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.982 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.653 ' C ' ' H ' ' A' ' 7' ' ' GLU . 32.6 t 24.11 -98.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.814 0.696 . . . . 0.0 111.554 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 61.01 -35.0 0.09 Allowed 'General case' 0 C--O 1.225 -0.205 0 O-C-N 123.483 0.489 . . . . 0.0 110.952 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.653 ' H ' ' C ' ' A' ' 5' ' ' SER . 80.7 mm-40 -72.31 -56.13 6.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.682 0.277 . . . . 0.0 110.663 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -66.72 -34.95 78.99 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.324 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 13' ' ' LYS . 24.2 mm -63.55 -46.55 94.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.028 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.48 -46.8 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.075 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.25 -50.76 66.69 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.935 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -62.91 -51.67 66.05 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.463 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.3 tppp? -54.27 -37.7 65.01 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.886 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -68.32 -38.84 81.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.081 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.01 -52.31 63.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.174 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -62.62 -48.68 78.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.766 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.58 84.81 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.97 -38.44 91.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.839 0.352 . . . . 0.0 110.064 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.59 -46.07 70.33 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.176 0.512 . . . . 0.0 110.219 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 22' ' ' ASP . 31.8 t0 -78.8 43.32 0.49 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -37.48 -23.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.875 -178.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.0 p-10 -83.3 -27.16 29.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 111.674 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 82.55 15.64 73.06 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.033 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 55.8 p30 -70.18 -6.11 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 -11.84 26.96 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.445 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 10.3 m -131.79 133.08 44.34 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.3 mt -98.45 115.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -79.5 160.53 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.99 -42.2 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.483 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.92 -40.93 97.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.272 0.558 . . . . 0.0 110.223 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 76.6 tt0 -69.27 -35.23 75.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.273 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -62.99 -43.58 98.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.05 72.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.681 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -61.77 -41.93 98.34 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.72 -48.44 75.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.264 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.4 mt -61.52 -36.88 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -59.81 -41.72 91.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.414 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.4 m -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 86.1 mt -59.83 -41.98 92.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.452 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 30.2 t0 131.54 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.623 1.202 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.522 HE21 ' C ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -141.2 156.06 45.97 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.8 -0.563 . . . . 0.0 110.015 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -149.34 76.18 9.34 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.832 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 172.11 2.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.629 2.219 . . . . 0.0 111.261 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -85.53 160.29 19.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 57.7 mp0 -43.45 -41.67 4.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.5 -57.58 8.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.818 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 51.3 mp0 -58.62 -39.36 80.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.229 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.4 -43.41 98.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.988 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -73.36 -49.87 24.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.179 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.01 -38.72 87.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.594 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.5 ttm -67.73 -47.39 69.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 56' ' ' ASP . 75.3 mt -64.02 -44.31 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 t -59.22 -42.09 90.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.99 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -48.27 -32.63 7.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.017 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -112.93 -30.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.9 t0 -61.53 81.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.37 -26.7 65.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.419 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 2.0 p30 -96.74 -21.98 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.675 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.11 40.62 95.11 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.5 p-10 -82.67 -16.92 46.38 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.517 -0.402 . . . . 0.0 111.554 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.92 4.64 58.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.461 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 55.5 p -135.56 165.4 25.62 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.01 126.8 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -94.38 170.37 9.54 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -56.68 -51.52 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.682 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -61.18 -42.09 97.95 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.228 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -64.8 -44.98 88.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.129 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.52 -41.11 98.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.71 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.14 -41.8 99.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.952 0.406 . . . . 0.0 110.875 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.85 -43.49 98.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.224 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.9 tp -61.68 -39.23 90.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 110.761 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 45.3 mtp -61.07 -49.66 76.46 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.021 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -66.6 -26.7 67.22 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.204 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -66.07 -34.3 77.76 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.197 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -84.41 -38.18 20.55 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.43 ' O ' ' OG1' ' A' ' 79' ' ' THR . 3.2 t -100.8 18.73 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.373 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 73' ' ' ALA . 21.0 ptmt -46.72 -40.95 14.3 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.155 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 79' ' ' THR . 34.0 p-10 -65.15 -59.25 4.31 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.796 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.446 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 2.1 m . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.521 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -84.42 1.33 45.83 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.094 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 mm -77.93 134.35 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.0 mt -50.02 -44.39 51.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.15 0.5 . . . . 0.0 110.409 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.8 t 62.88 -130.41 0.52 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.847 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 78.7 mt-10 -83.84 39.29 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.099 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -71.0 -57.16 4.82 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.596 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -65.19 -39.43 92.84 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.421 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.81 -43.69 97.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.082 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 6' ' ' GLU . 7.9 t -56.06 -44.61 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.786 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.72 -54.37 46.08 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.099 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -56.55 -48.53 77.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -38.16 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -64.15 -41.41 97.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.074 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.02 -46.68 86.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.909 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -62.68 -50.76 69.88 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.806 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.19 -46.23 79.6 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.83 -40.6 95.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.1 m-30 -63.68 -41.76 98.12 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.041 0.448 . . . . 0.0 110.037 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 34.9 t0 -78.38 54.33 1.4 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.349 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -39.18 -30.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.632 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.9 p-10 -82.34 -23.85 34.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.39 16.11 80.97 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.7 p-10 -65.88 -9.79 32.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.354 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -15.98 58.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 6.9 t -130.85 130.58 43.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 0.187 . . . . 0.0 110.761 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.34 112.38 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -79.96 167.29 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.621 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 30' ' ' GLU . 2.4 m -55.63 -39.87 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 73.1 mm-40 -63.09 -42.85 99.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -66.51 -41.17 89.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.139 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -45.0 94.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.49 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.03 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 m -60.19 -44.69 94.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.659 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.35 -46.64 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.154 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.46 -39.42 81.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -54.89 -42.48 72.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.88 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 40' ' ' ASP . 7.6 t -65.09 -39.69 93.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.21 19.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.388 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.559 ' H ' ' C ' ' A' ' 38' ' ' SER . 34.3 m-20 69.08 20.05 7.82 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.871 0.732 . . . . 0.0 111.252 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -133.74 142.78 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.019 -0.425 . . . . 0.0 109.965 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -140.54 70.94 31.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.63 157.6 46.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.7 2.267 . . . . 0.0 111.309 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 45' ' ' GLU . 60.9 p -83.73 154.26 23.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 44' ' ' THR . 97.1 mt-10 -38.41 -47.54 1.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.991 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -46.06 -60.32 2.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.33 -41.75 98.81 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.181 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -42.2 98.23 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.122 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -63.65 -51.92 63.03 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.211 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -60.51 -35.43 75.92 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.558 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 70.9 mtm -74.61 -47.74 30.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.04 -43.66 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.843 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -59.12 -45.74 90.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' O ' ' CD ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -46.21 -25.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -118.18 -24.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -59.89 81.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.58 -34.53 77.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.28 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.3 m-20 -80.52 -24.11 39.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.702 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.17 23.15 65.9 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.439 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 26.8 p-10 -78.7 -18.42 54.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.122 0.461 . . . . 0.0 111.452 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.24 14.09 29.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.439 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 48.3 p -141.4 172.45 12.66 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mt -121.57 129.13 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -100.26 172.12 7.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -53.99 -49.3 69.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.743 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.76 -42.0 96.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.182 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 92.3 mt-10 -68.21 -45.65 72.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.966 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.8 t80 -60.75 -46.01 92.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.776 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.96 -40.28 95.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 110.116 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 74' ' ' LYS . 81.4 p -63.75 -45.63 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.641 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.15 -42.54 86.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 53.3 mtp -67.92 -54.7 16.71 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.407 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.24 -30.87 71.9 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.884 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' SER . 5.3 tmtm? -67.07 -32.54 73.79 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.59 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.77 -44.13 14.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 78' ' ' ASP . 4.1 t -91.06 14.48 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.739 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 73' ' ' ALA . 86.8 tttt -47.2 -14.04 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.106 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 76' ' ' VAL . 45.5 t0 -56.23 -57.15 13.46 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.493 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.577 179.375 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -82.75 17.02 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.913 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 2.6 mp -101.23 113.66 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.403 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.99 -39.17 93.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.321 0.581 . . . . 0.0 109.998 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.5 t -59.42 113.13 2.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.359 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 68.09 75.16 0.28 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 123.736 0.648 . . . . 0.0 110.304 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -94.42 -60.8 1.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.896 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -63.0 -34.55 77.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.428 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.1 mm -63.3 -44.98 99.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.133 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.45 -46.35 95.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.154 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.85 -42.9 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.976 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.41 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -61.05 -48.23 82.71 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -61.48 -32.39 72.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -66.83 -39.53 87.69 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 110.17 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -65.22 -42.01 93.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.983 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.68 -49.02 70.1 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.868 0.366 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.16 -44.36 93.2 Favored Glycine 0 C--N 1.329 0.194 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.79 -40.2 96.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.996 0.427 . . . . 0.0 110.063 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -65.74 -40.46 92.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.228 0.537 . . . . 0.0 110.456 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 23' ' ' GLY . 66.3 t0 -80.6 60.37 3.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' NZ ' ' CB ' ' A' ' 21' ' ' LYS . 9.3 mtmp? -37.23 -27.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.891 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.8 p-10 -97.16 -12.55 22.93 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 63.97 23.36 67.57 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.27 -0.49 . . . . 0.0 111.886 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -66.6 -12.0 55.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.206 0.503 . . . . 0.0 110.776 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.73 -14.49 64.02 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 m -132.65 132.14 42.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 0.0 110.91 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.66 111.74 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 m -75.15 154.89 37.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.59 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -54.98 -29.57 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.48 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.52 -41.71 72.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.544 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 68.9 mt-10 -68.76 -41.73 78.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.68 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.79 -46.84 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.86 73.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.877 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -63.1 -43.85 97.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.14 -48.8 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.104 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mm -63.52 -38.38 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -55.31 -40.77 71.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.845 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.583 ' C ' ' H ' ' A' ' 40' ' ' ASP . 26.0 m -66.85 -33.57 75.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.674 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.67 23.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.583 ' H ' ' C ' ' A' ' 38' ' ' SER . 99.7 m-20 63.7 14.22 8.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -137.95 146.52 43.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -142.74 83.88 11.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.083 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.95 169.17 10.81 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.856 2.371 . . . . 0.0 111.071 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p -89.61 162.04 15.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -42.66 -46.21 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -50.55 -52.03 42.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.99 -42.73 97.1 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.234 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.0 -47.17 85.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.938 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -64.83 -50.88 64.93 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.175 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.3 t0 -59.15 -34.09 71.66 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.503 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.9 ttp -74.79 -45.53 43.01 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.774 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' ASP . 81.8 mt -64.57 -44.23 96.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.6 m -61.8 -46.51 89.2 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.046 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' OE2' ' NZ ' ' A' ' 74' ' ' LYS . 80.6 tt0 -45.07 -29.63 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.44 -33.38 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 52' ' ' ILE . 53.7 t0 -65.41 98.1 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.98 -24.4 61.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.828 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -100.32 -24.57 14.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.42 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.425 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.42 37.3 85.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.283 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 13.7 m120 -70.95 -17.91 62.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.958 0.379 . . . . 0.0 111.422 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.38 -2.56 56.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -131.43 174.42 10.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.4 mt -116.51 120.8 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.991 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -88.7 169.87 11.29 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -55.81 -49.04 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.759 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.63 -38.15 89.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.01 0.433 . . . . 0.0 110.249 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 97.5 mt-10 -67.33 -41.22 85.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.826 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -67.33 -38.55 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.502 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -41.37 96.48 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.08 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.6 p -69.95 -45.86 66.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.022 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.12 -44.13 93.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 110.334 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.41 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 tpt -54.62 -51.95 63.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.602 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.75 -39.47 93.68 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.909 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' NZ ' ' OE2' ' A' ' 54' ' ' GLU . 63.5 tttm -58.9 -23.79 61.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.094 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -86.83 -43.23 12.64 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.834 0.35 . . . . 0.0 110.426 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -112.92 37.58 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.064 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 73' ' ' ALA . 17.5 ttmm -55.94 -32.4 63.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -53.0 -57.34 10.68 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.433 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.614 179.743 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.3 148.69 48.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.486 ' H ' ' CD1' ' A' ' 3' ' ' ILE . 1.6 mp -40.16 156.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.461 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 4.0 mm? -64.76 -29.6 70.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.087 0.47 . . . . 0.0 109.948 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.3 p -65.23 74.05 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.573 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 4' ' ' LEU . 95.6 mt-10 -75.61 74.22 2.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.976 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -95.74 -38.81 10.17 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.324 0.583 . . . . 0.0 110.483 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -80.75 -40.93 24.38 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.873 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.15 -44.81 91.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.608 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 11' ' ' ASP . 9.3 p -61.52 -47.76 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.967 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.488 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 8.8 t70 -62.1 -45.87 91.57 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.874 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CD2' ' SD ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.21 -42.92 99.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.319 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -60.43 -35.47 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.203 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.16 -37.13 83.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.383 0.611 . . . . 0.0 109.748 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.36 82.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.249 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -67.89 -47.42 68.9 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.882 0.372 . . . . 0.0 110.966 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.15 -42.77 98.71 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 tp -62.87 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.114 0.483 . . . . 0.0 110.133 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.19 -36.54 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.33 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.1 t0 -92.53 49.42 1.48 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.182 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -36.5 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.846 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.2 m-20 -70.59 -28.11 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.358 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.76 10.34 85.83 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -69.04 -10.71 58.96 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.867 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.86 -6.31 83.78 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -131.3 134.48 46.41 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.715 0.293 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.7 mt -100.56 113.34 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -82.24 165.14 20.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 30' ' ' GLU . 3.2 m -57.37 -44.5 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.735 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 45.6 tt0 -58.67 -40.11 82.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.21 0.528 . . . . 0.0 109.899 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 97.0 mt-10 -70.23 -40.87 74.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.433 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.18 -45.46 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.85 -39.38 68.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -65.63 -39.8 91.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.776 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.78 -46.4 92.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.488 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.36 -38.88 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -57.53 -41.28 80.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.525 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -68.62 -31.89 71.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.086 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 76.3 mt -59.13 -42.76 91.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.751 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 36.2 p-10 137.83 17.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.181 0.926 . . . . 0.0 111.301 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -153.94 169.71 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -153.99 84.23 4.13 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.184 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.99 179.49 0.29 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.729 2.286 . . . . 0.0 110.994 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 50.6 p -89.59 155.03 19.52 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -41.53 -36.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 0.0 110.185 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -57.24 -53.46 57.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.532 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' OE1' ' OG1' ' A' ' 44' ' ' THR . 2.7 mp0 -60.94 -40.79 94.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.82 -42.96 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -72.99 -45.85 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.284 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.92 -39.92 93.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.532 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -67.59 -44.31 78.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.608 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 56' ' ' ASP . 73.3 mt -66.67 -44.28 89.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -40.05 90.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -50.89 -33.82 25.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.9 p -111.21 -32.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 33.5 t0 -64.02 76.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.231 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.19 -25.67 61.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.67 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.415 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 2.0 p30 -95.66 -23.09 17.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.546 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.89 36.48 81.9 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 52.6 p-10 -77.52 -17.09 58.28 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.578 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.58 3.73 62.57 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 6.2 p -134.56 163.76 29.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.7 mt -116.4 128.82 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -104.52 164.7 11.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -45.99 -60.2 2.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.9 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -48.89 -43.3 38.98 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.43 -42.25 75.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.041 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 38.2 t80 -64.43 -37.33 87.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.41 -44.86 93.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.582 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.0 m -65.69 -43.7 88.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.89 -43.0 99.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.658 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.587 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 60.4 mtp -60.04 -44.85 94.39 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.2 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -58.14 -50.84 72.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.172 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.26 -25.15 63.83 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.686 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -90.45 -20.8 22.33 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.537 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.18 41.07 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 73' ' ' ALA . 25.8 pttm -63.28 -20.23 65.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.239 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -56.8 -59.93 4.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.42 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.593 -179.753 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.2 p30 -92.12 55.59 2.64 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.856 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 tt -147.59 137.93 17.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.456 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.48 -46.09 90.08 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.196 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t 74.46 166.39 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.381 0.426 . . . . 0.0 110.72 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.01 41.5 2.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.066 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -93.84 -64.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -66.1 -34.78 78.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.322 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 9' ' ' ILE . 31.1 mm -63.95 -43.9 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.297 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.35 -42.5 95.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.093 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.58 -49.76 71.87 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.876 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.43 -47.22 85.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -60.37 -38.19 83.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.13 -38.05 89.37 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.332 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.06 62.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.834 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -69.35 -46.7 66.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.727 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.49 95.64 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -38.85 92.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 5.6 m-30 -72.34 -39.09 68.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.596 0.713 . . . . 0.0 110.649 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.2 t0 -87.39 50.42 2.0 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.468 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -35.57 -28.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.449 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.2 m-20 -72.51 -28.08 62.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.49 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.57 11.13 85.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -70.22 -9.86 57.11 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.822 -179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.31 -2.48 85.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -133.08 136.88 46.15 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.654 0.264 . . . . 0.0 110.951 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -103.23 115.33 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.7 m -81.97 162.9 22.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.99 -34.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.368 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.18 -39.05 89.43 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 109.988 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -71.3 -36.96 71.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.166 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.64 -44.6 95.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.86 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.594 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -64.47 -40.3 95.43 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.4 -46.12 87.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.341 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.67 -41.64 91.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.74 -0.384 . . . . 0.0 109.982 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -57.26 -39.57 75.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.533 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -68.8 -34.49 75.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.551 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 76.3 mt -59.56 -41.85 91.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 116.936 -1.507 . . . . 0.0 112.613 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.551 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 87.8 m-20 134.14 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.164 1.54 . . . . 0.0 111.449 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -147.59 161.35 41.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -150.2 78.59 7.85 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.27 -177.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.605 2.203 . . . . 0.0 111.347 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -90.42 148.33 22.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -42.33 -28.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.135 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.83 -51.21 69.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.441 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -65.92 -37.07 85.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.776 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.67 -42.84 99.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.844 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.71 -44.63 48.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.511 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -62.46 -39.02 92.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.577 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.55 -44.34 78.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 56' ' ' ASP . 81.9 mt -66.34 -44.46 90.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.898 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -61.19 -37.07 81.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.014 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -56.16 -34.46 66.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.002 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 10.6 p -108.86 -30.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 52' ' ' ILE . 48.7 t0 -64.2 77.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -56.17 -24.58 42.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.314 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 3.9 p-10 -95.41 -23.22 17.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.602 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.36 37.85 86.5 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.352 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 47.3 p-10 -80.47 -15.7 56.11 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.57 -0.37 . . . . 0.0 111.514 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.14 4.18 69.08 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 33.3 p -133.99 157.77 45.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.5 mt -111.09 127.64 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 10.7 pt-20 -95.69 174.79 6.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.757 0.313 . . . . 0.0 110.263 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.07 -50.38 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.72 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -57.57 -58.86 6.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.307 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 94.8 mt-10 -51.97 -43.59 63.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.081 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -62.54 -46.0 90.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.07 -43.3 95.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 m -65.33 -44.71 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.314 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.248 0.547 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.55 -43.06 98.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -59.0 -51.69 68.97 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.227 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.64 -19.97 59.5 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.14 -34.46 17.87 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.286 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.0 33.89 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.093 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 73' ' ' ALA . 36.5 ttpt -59.12 -46.63 87.83 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.027 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 79' ' ' THR . 30.2 p-10 -71.7 -56.4 5.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.256 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.474 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 2.3 t . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.599 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -86.09 171.22 11.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.789 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 3' ' ' ILE . 78.5 mt 58.69 37.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.289 0.566 . . . . 0.0 110.871 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.501 ' CD2' ' H ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -61.17 -43.88 98.19 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.662 -0.415 . . . . 0.0 109.909 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.7 p -104.09 165.53 10.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.124 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -126.25 41.63 3.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.764 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -91.58 -60.3 1.91 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.913 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -62.35 -35.72 79.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.352 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.3 mt -62.99 -44.21 99.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.399 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.79 -47.8 91.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.101 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.22 -45.34 85.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.974 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.3 -48.13 81.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.061 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.76 -35.42 79.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.081 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -63.84 -36.82 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.06 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -68.31 -37.21 80.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.345 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.45 -48.92 65.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 111.123 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.69 -42.32 96.24 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.7 tp -62.46 -39.14 92.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 109.926 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.25 -36.7 79.85 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.334 0.588 . . . . 0.0 110.693 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 34.4 t0 -86.42 51.41 2.22 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.46 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -36.29 -30.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.719 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 20' ' ' ASP . 6.2 m-20 -70.51 -28.08 64.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.556 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.32 8.68 87.63 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.694 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -68.57 -17.37 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.731 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 95.2 -7.03 69.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 m -127.62 129.76 47.82 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.612 0.206 . . . . 0.0 111.016 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.7 mt -100.32 114.25 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.22 165.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.18 -38.59 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.524 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -61.17 -40.52 94.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.958 0.408 . . . . 0.0 110.195 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.52 -38.37 74.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.224 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -45.48 94.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -57.76 -41.44 81.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.88 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -62.24 -43.65 98.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.1 -47.43 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.48 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.94 -38.59 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' ALA . 42.7 ttm180 -58.57 -41.31 85.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.648 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 t -86.8 -12.99 46.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.589 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 3.4 tt -65.11 -41.12 95.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.497 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 15.5 m-20 150.99 0.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.901 0.751 . . . . 0.0 111.678 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -155.02 172.44 18.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -153.93 76.87 5.81 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.24 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.16 176.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.46 2.107 . . . . 0.0 111.285 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -86.22 161.75 18.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.479 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.5 mp0 -47.35 -41.24 19.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -54.24 -53.18 57.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.415 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.97 -40.75 96.67 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.161 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mp -62.66 -45.91 90.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.025 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -69.39 -46.51 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.75 -36.99 84.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.3 ttp -69.17 -45.76 69.21 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 52' ' ' ILE . 75.5 mt -65.61 -44.94 93.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.98 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -59.13 -39.52 82.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.796 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -52.0 -31.49 29.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.751 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -109.87 -32.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.2 t70 -64.34 77.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.21 -30.0 48.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.433 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 15.3 p-10 -92.19 -18.85 22.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.67 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 65.31 42.86 95.93 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -87.01 -16.68 35.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.018 0.409 . . . . 0.0 111.64 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.08 16.23 58.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 m -140.19 151.64 45.38 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mt -112.31 126.33 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -103.26 179.66 4.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -57.37 -58.59 7.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.813 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 37.4 p-10 -56.52 -41.57 76.95 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.257 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 97.3 mt-10 -66.0 -46.23 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.908 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.87 -35.78 81.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.396 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.436 ' CD2' ' C ' ' A' ' 69' ' ' LEU . 7.4 tt -62.76 -43.61 98.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.927 0.394 . . . . 0.0 110.18 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -65.06 -45.28 85.97 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.438 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.61 -43.13 99.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.995 0.426 . . . . 0.0 110.736 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.472 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 4.3 tpt -59.6 -50.07 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -61.35 -50.25 73.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -53.53 -24.66 14.01 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -75.56 -52.98 9.38 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.147 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 78' ' ' ASP . 46.4 t -76.89 -42.86 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.728 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 73' ' ' ALA . 53.8 tttp -60.32 -6.0 1.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 110.061 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 76' ' ' VAL . 66.4 t0 -64.14 -33.94 76.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.427 -179.879 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 t70 63.75 -156.31 0.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.4 mt -131.93 -7.39 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.549 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.25 -14.1 23.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.847 0.356 . . . . 0.0 110.246 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 p -47.05 151.56 0.64 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.364 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -159.3 54.68 0.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.829 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -95.01 -61.71 1.44 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.177 0.513 . . . . 0.0 110.629 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -55.02 -37.94 67.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 9' ' ' ILE . 70.9 mt -62.11 -43.25 97.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.384 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.6 t -55.55 -44.99 78.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.93 -51.56 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.835 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -59.03 -48.85 80.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.755 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -37.27 70.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.225 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.33 -41.5 85.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.314 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.62 -48.87 77.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.104 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.37 -49.25 74.58 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.901 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -45.72 82.14 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.97 -39.41 94.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.226 0.536 . . . . 0.0 109.559 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.99 -41.87 95.03 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.387 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' ASP . 12.8 t0 -83.34 53.77 2.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.808 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -39.54 -18.58 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.573 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -86.12 -28.67 23.86 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.307 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.21 11.59 84.88 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.742 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.78 -18.12 65.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.727 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.1 -13.64 60.25 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' SG ' ' OE2' ' A' ' 64' ' ' GLU . 3.5 m -131.69 132.75 44.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.7 0.286 . . . . 0.0 111.151 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -97.05 114.3 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -78.95 165.07 23.88 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' A' ' 30' ' ' GLU . 3.6 m -55.84 -41.23 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.495 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 75.9 mt-10 -60.7 -42.77 97.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -68.33 -42.89 78.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.303 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.466 ' CD1' ' C ' ' A' ' 32' ' ' LEU . 2.5 tm? -62.16 -46.8 87.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.55 -39.23 64.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.165 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -63.46 -43.18 98.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.928 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.4 -48.81 81.71 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.478 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -64.68 -40.57 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.0 -42.16 89.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 m -79.45 -20.99 46.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.583 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.511 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 5.3 tt -63.71 -45.39 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 4.1 m-20 153.3 0.91 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.47 0.482 . . . . 0.0 111.301 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -141.88 155.74 45.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -135.55 78.27 50.59 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.28 155.42 70.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.617 2.211 . . . . 0.0 110.911 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.3 p -85.2 161.39 19.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' THR . 80.4 tt0 -40.16 -47.77 2.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 109.805 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.23 -58.32 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -60.61 -42.37 96.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.8 mt -62.05 -43.5 98.7 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.155 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.86 -52.05 58.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.884 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -37.72 84.13 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.695 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.7 mmt -72.23 -48.68 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.7 mt -64.02 -45.17 97.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.954 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.2 p -58.98 -44.74 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -45.07 -27.42 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.5 p -115.61 -30.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 t70 -59.03 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.41 -35.13 73.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.297 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 21.7 p-10 -89.61 -22.41 22.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.45 63.33 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' ' HG1' ' A' ' 62' ' ' THR . 52.3 p30 -107.95 -16.7 14.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 117.001 0.4 . . . . 0.0 111.614 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 98.15 15.57 35.42 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.504 ' HG1' ' ND2' ' A' ' 60' ' ' ASN . 56.1 p -141.33 165.51 27.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -119.41 126.09 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.401 ' OE2' ' SG ' ' A' ' 26' ' ' CYS . 80.4 mm-40 -100.24 174.12 6.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.247 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -54.54 -50.85 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.773 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.85 -41.98 98.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.335 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.02 -46.15 75.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.383 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.11 -45.51 93.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.19 -41.62 97.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.576 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 74' ' ' LYS . 10.0 t -63.49 -46.76 84.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.518 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.41 -41.02 93.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.793 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 ttt -69.33 -51.16 39.69 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.025 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -66.81 -29.52 69.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.504 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' SER . 64.8 tttp -67.4 -33.2 74.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.486 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.6 -30.31 21.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 110.13 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.488 ' C ' ' N ' ' A' ' 78' ' ' ASP . 33.3 t -106.82 15.9 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.519 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 73' ' ' ALA . 85.3 tttt -48.65 -14.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.859 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.488 ' N ' ' C ' ' A' ' 76' ' ' VAL . 87.6 m-20 -55.03 -57.59 11.08 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.519 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.338 179.729 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 14' ' ' GLU . 23.0 t -57.24 -45.88 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.654 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -58.64 -54.75 43.54 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.768 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -60.83 -49.1 78.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.941 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -60.82 -34.31 74.35 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' VAL . 84.3 tt0 -68.61 -42.61 77.88 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.087 0.47 . . . . 0.0 110.527 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -40.05 88.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 81.7 t80 -65.78 -49.62 67.67 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.96 -42.65 96.93 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.2 tt -60.56 -41.31 94.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -64.09 -39.4 93.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLY . 36.3 t0 -80.18 54.79 2.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -39.02 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.54 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.3 m-20 -86.42 -27.22 24.29 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.186 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.75 12.53 84.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.697 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 47.5 p30 -66.39 -16.61 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.747 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 104.98 -12.53 49.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -140.9 145.21 35.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.729 0.3 . . . . 0.0 111.151 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 4.6 mp -105.31 120.15 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -81.75 169.09 17.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.708 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.37 -43.53 77.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.149 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.43 -43.25 99.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.14 0.495 . . . . 0.0 110.328 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.7 mt-10 -66.96 -40.02 87.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.041 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.92 -45.45 92.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.71 61.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -61.77 -42.58 99.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.749 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.68 -49.7 67.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 41' ' ' GLN . 1.3 mp -61.14 -39.04 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -56.45 -41.29 76.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.447 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 40' ' ' ASP . 42.3 m -65.79 -37.18 85.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.856 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.04 22.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 38' ' ' SER . 62.5 m-20 66.21 16.58 10.49 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.333 0.395 . . . . 0.0 112.03 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' ILE . 52.2 tt0 -136.92 145.53 44.39 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -149.94 82.18 6.67 Favored Pre-proline 0 C--N 1.331 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.36 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.71 163.98 34.99 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.947 2.431 . . . . 0.0 110.729 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 11.5 p -82.66 159.08 22.73 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 44' ' ' THR . 79.3 tt0 -38.33 -47.28 1.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 109.82 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.84 -63.1 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' O ' ' SD ' ' A' ' 51' ' ' MET . 15.4 mp0 -56.02 -41.39 74.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.86 -43.01 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -65.45 -52.35 53.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.419 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 65.5 t0 -58.88 -38.04 77.93 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.17 -47.92 47.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.821 178.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.22 -47.33 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.888 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -58.2 -45.61 87.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -44.2 -29.86 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.821 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -114.98 -31.12 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.66 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t70 -58.9 86.22 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.03 -34.99 70.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.5 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 18.7 p-10 -93.2 -21.9 19.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.844 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.66 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.74 64.77 3.69 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 53.9 p30 -107.79 -13.22 15.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 117.045 0.422 . . . . 0.0 111.547 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.08 7.48 58.46 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.419 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 32.9 p -135.06 164.39 27.74 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 mt -121.03 128.34 76.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -103.92 174.29 5.94 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.54 -52.1 64.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.565 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.82 -45.11 86.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.133 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -44.76 84.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.245 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.76 -44.36 96.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.59 -42.05 99.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.779 0.323 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 t -63.92 -45.81 87.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.246 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.513 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -58.77 -42.09 88.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.547 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttt -71.81 -51.63 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.946 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.519 179.134 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.5 mt . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.55 -47.71 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.078 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -66.1 -44.71 83.58 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.979 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.77 -49.57 75.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.971 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -60.03 -32.36 70.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.335 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.19 -39.63 89.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.168 0.509 . . . . 0.0 109.985 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.7 -46.99 85.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.705 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.56 -49.01 75.09 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.85 -45.79 78.72 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.2 tt -62.8 -39.48 94.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.248 0.547 . . . . 0.0 109.728 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.28 -42.96 96.18 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.278 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 57.8 t0 -81.23 54.15 2.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.195 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -37.75 -32.54 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.605 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p-10 -81.21 -25.42 36.73 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.704 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 77.38 14.51 82.44 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 51.6 p-10 -62.33 -4.03 1.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.978 0.389 . . . . 0.0 110.691 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.71 -17.0 33.03 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 9.0 m -130.43 130.5 44.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.611 0.244 . . . . 0.0 110.915 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.1 mt -93.77 111.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -77.66 164.58 25.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.59 -35.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.554 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -42.23 91.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.149 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.55 -38.05 83.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.332 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.55 -44.89 92.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.66 72.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.677 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -62.48 -43.32 99.1 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.76 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.83 -48.11 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.615 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -65.83 -39.73 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.172 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -59.52 -42.45 92.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.712 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 t -83.13 -14.41 53.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 11.0 tp -65.4 -43.25 91.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 2.7 m-20 155.66 -1.04 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.259 0.349 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -148.5 163.52 36.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -137.51 75.09 45.57 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 111.341 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.82 162.9 29.99 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.795 2.33 . . . . 0.0 111.003 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -82.54 152.22 26.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -39.38 -41.9 1.0 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.842 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.43 -50.69 51.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.482 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.93 -41.84 99.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.159 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.22 -42.43 99.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.196 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.26 -51.28 66.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.19 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.68 -36.39 78.64 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.559 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.0 mtt -71.45 -47.0 58.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.964 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.7 mt -64.66 -43.43 96.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t -58.69 -45.14 90.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.897 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 54' ' ' GLU . 3.6 tm-20 -51.04 -28.66 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.031 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -110.73 -32.55 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -63.52 80.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.93 -35.38 64.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.019 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -90.39 -20.06 23.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.551 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.81 39.89 97.87 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.244 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.511 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 48.2 p30 -83.73 -17.09 42.45 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.718 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.66 56.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 43.8 p -133.08 165.52 24.55 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.66 130.94 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 96.8 mt-10 -104.28 176.12 5.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.323 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -56.03 -52.39 64.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.857 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -60.51 -44.5 95.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.005 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 99.8 mt-10 -63.41 -45.22 92.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.961 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.73 -41.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.68 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.25 -39.61 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.317 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.5 m -62.56 -45.9 90.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.325 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.43 -40.89 98.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.439 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 1.1 tpt -62.97 -53.64 50.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.289 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 110.398 179.603 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 C--O 1.231 0.128 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.85 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.016 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -57.06 -54.18 49.68 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -62.14 -50.82 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.889 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -54.42 -38.12 65.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.161 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.41 -39.89 89.25 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.959 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.84 -48.5 80.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.967 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' ' CD1' ' A' ' 27' ' ' ILE . 61.7 t80 -62.89 -49.06 76.31 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.806 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.18 -47.92 65.69 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.31 -38.52 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.9 m-30 -66.39 -46.14 77.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.509 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 14.6 t70 -79.19 50.58 1.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.92 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -39.51 -26.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.836 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 42.7 p-10 -81.3 -27.71 34.94 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.642 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 80.21 12.73 82.88 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.895 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 53.7 p30 -63.78 -10.07 17.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.157 0.478 . . . . 0.0 110.658 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.36 61.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 3.8 m -133.73 135.38 43.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.605 0.241 . . . . 0.0 111.095 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 65.4 mt -99.58 115.54 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -77.85 165.18 24.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.551 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.18 -40.21 76.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.537 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.19 -42.28 98.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -69.28 -39.33 78.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.381 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.65 -45.2 93.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.66 -39.17 73.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -62.53 -44.33 96.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.972 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.453 HG11 ' CE2' ' A' ' 19' ' ' PHE . 49.4 t -62.94 -44.74 99.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.848 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.433 HG21 ' CD ' ' A' ' 43' ' ' PRO . 5.1 mm -62.74 -41.7 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -57.1 -41.59 79.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.952 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 t -73.28 -33.13 65.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 29.4 mt -61.58 -44.26 97.34 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 9.8 p30 147.38 2.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.661 0.601 . . . . 0.0 111.497 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -129.07 165.04 21.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -152.14 70.74 7.73 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.01 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.433 ' CD ' HG21 ' A' ' 36' ' ' ILE . 16.3 Cg_exo -66.72 152.85 79.77 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.666 2.244 . . . . 0.0 111.015 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.9 p -82.43 162.45 22.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -40.54 -46.96 2.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.953 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.93 -54.05 22.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.493 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -64.62 -43.71 92.86 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.459 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 mt -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.875 0.369 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -64.48 -50.33 67.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.436 -0.505 . . . . 0.0 109.871 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 67.7 t0 -61.89 -35.04 77.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.396 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.5 ttp -72.37 -48.49 41.28 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 HD11 ' A' ' 63' ' ' ILE . 84.8 mt -64.21 -44.18 97.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.6 m -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -46.29 -27.45 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.6 p -115.75 -24.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 14.1 t0 -63.77 77.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.03 -34.42 77.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.427 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 19.1 p-10 -87.86 -23.28 24.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.649 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.74 67.87 1.9 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.275 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 51.4 p30 -112.89 -15.21 12.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.936 0.368 . . . . 0.0 111.536 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.99 10.19 57.7 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.517 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 64.6 p -141.05 170.77 15.1 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 52' ' ' ILE . 65.1 mt -119.54 127.4 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 72.8 tt0 -99.01 167.55 10.66 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.418 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 38.6 t80 -52.78 -49.48 65.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.464 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.34 -42.4 95.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.154 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.89 -43.9 86.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.1 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.83 -44.01 97.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.355 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -63.35 -41.81 98.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.1 m -64.95 -48.88 72.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.742 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.0 tp -58.92 -41.18 86.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 110.651 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.1 mmm -68.59 -57.62 5.47 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.095 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 179.322 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mm . . . . . 0 C--O 1.231 0.129 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.83 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.831 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.68 -44.63 96.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.929 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.43 -49.86 69.84 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.008 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -64.1 -34.05 77.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.47 -38.07 88.72 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.321 0.581 . . . . 0.0 110.268 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.68 -39.07 87.96 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.176 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -69.92 -48.58 57.99 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.16 92.17 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.96 -37.04 85.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -70.33 -40.12 74.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 110.557 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' GLY . 32.2 t0 -78.01 50.83 0.91 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.208 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -37.02 -31.2 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.695 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 22.6 m-20 -75.28 -28.14 59.64 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.543 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.81 7.47 88.26 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.9 p-10 -68.26 -8.14 36.74 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.91 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.66 -6.82 83.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 m -130.51 131.83 45.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 110.799 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.6 mt -98.72 114.89 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.2 p -82.65 163.68 21.24 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 61' ' ' GLY . 1.7 m -58.18 -38.97 71.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.511 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -62.54 -40.57 97.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.264 0.554 . . . . 0.0 110.645 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 31.9 tt0 -71.49 -36.75 71.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.036 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.69 -45.06 95.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.03 -40.29 73.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.799 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -61.64 -43.4 98.93 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.803 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.19 -48.89 77.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.189 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' GLN . 2.8 mm -63.61 -36.92 78.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -57.06 -40.36 76.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -66.45 -36.19 82.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.662 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 40' ' ' ASP . 84.9 mt -70.46 26.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.4 OUTLIER 60.48 19.85 9.59 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' HG22 ' A' ' 36' ' ' ILE . 49.2 tt0 -138.62 150.67 46.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -154.74 83.86 3.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.72 170.85 3.15 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.61 2.206 . . . . 0.0 110.931 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 45' ' ' GLU . 55.2 m -84.7 168.64 15.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.627 ' N ' HG22 ' A' ' 44' ' ' THR . 80.4 mt-10 -53.05 -45.66 68.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.253 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 18.2 pt-20 -56.84 -44.49 82.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.888 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 50.6 mt-10 -64.81 -43.82 91.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.957 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.37 -44.86 96.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.823 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -67.74 -47.78 68.3 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -61.47 -40.26 93.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.0 tpp -69.87 -46.44 65.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 29' ' ' VAL . 82.1 mt -65.23 -44.33 95.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.4 p -61.67 -36.09 79.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.933 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -56.74 -32.01 65.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.782 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.42 -26.75 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 52.3 t0 -73.27 85.83 1.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.88 65.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.709 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -101.11 -23.37 14.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.223 -178.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.89 38.78 85.41 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.125 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 19.5 m120 -72.99 -16.54 61.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.874 0.337 . . . . 0.0 111.332 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 94.2 1.61 64.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.8 p -137.18 166.89 22.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.605 HD12 HD23 ' A' ' 32' ' ' LEU . 6.5 mt -114.46 126.02 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.74 178.66 4.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.321 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -56.8 -52.59 64.45 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.757 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.43 -43.31 96.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.901 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 95.3 mt-10 -65.65 -44.55 86.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.958 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -61.19 -43.09 99.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.458 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -40.76 97.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.3 t -63.22 -45.4 91.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.262 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.42 -42.12 86.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.966 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.5 tpp -77.09 -41.08 43.61 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.246 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.454 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.6 mt . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.86 -48.43 88.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.827 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.65 -47.37 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.926 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -60.04 -46.95 87.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -57.24 -36.4 70.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.31 -38.12 89.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.963 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.99 -44.4 92.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.092 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -65.87 -49.44 68.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.877 0.37 . . . . 0.0 111.186 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.82 -45.28 86.34 Favored Glycine 0 C--N 1.33 0.231 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.628 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.3 tt -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -65.32 -41.49 93.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.502 0.668 . . . . 0.0 110.376 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLY . 19.1 t70 -81.05 58.06 3.33 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.544 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -36.73 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.51 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -80.02 -27.51 39.5 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.33 7.23 82.21 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -64.29 -19.11 65.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.667 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.32 -11.95 51.4 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' OE1' ' A' ' 64' ' ' GLU . 57.3 m -128.06 127.56 43.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.92 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.29 111.96 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.478 HG22 ' OE1' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -82.12 166.93 19.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.663 HG22 HD13 ' A' ' 52' ' ' ILE . 71.9 t -55.7 -44.12 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.447 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -53.96 -43.19 69.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.858 0.361 . . . . 0.0 110.198 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.478 ' OE1' HG22 ' A' ' 28' ' ' THR . 43.9 mt-10 -67.75 -46.03 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.746 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.12 -46.66 88.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.6 -41.77 66.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.151 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.3 m -65.11 -39.76 93.57 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.349 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.2 -48.63 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.04 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.0 mm -61.67 -43.68 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.361 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -60.35 -41.8 94.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.352 0.596 . . . . 0.0 110.626 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -75.38 -22.64 57.34 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.737 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 39' ' ' LEU . 3.2 tt -66.17 -44.88 82.77 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 5.1 m-20 151.11 2.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.844 0.715 . . . . 0.0 111.418 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -143.33 154.01 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -133.24 79.09 62.45 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.63 159.29 53.28 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.858 2.372 . . . . 0.0 110.839 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -86.21 162.25 18.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 28.9 mp0 -40.66 -47.91 2.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 2.8 mm-40 -47.31 -58.98 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.713 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.05 -41.88 97.43 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.396 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.02 -43.46 98.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.882 0.373 . . . . 0.0 110.256 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.07 -49.69 71.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.969 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -61.28 -36.0 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.6 mtp -72.93 -46.95 49.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.663 HD13 HG22 ' A' ' 29' ' ' VAL . 73.3 mt -65.83 -45.19 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.665 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.1 m -58.15 -45.27 87.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -48.62 -27.47 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -113.73 -32.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.83 81.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.51 -32.68 71.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.419 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.0 p-10 -93.21 -21.87 19.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.804 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.82 31.68 78.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 49.4 p-10 -73.41 -16.91 61.32 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.524 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 99.19 6.28 55.69 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.413 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 31.7 p -139.94 173.66 11.3 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.8 mt -121.92 128.31 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 65' ' ' PHE . 13.4 tp10 -94.66 168.13 11.03 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.437 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 14.7 t80 -54.72 -50.49 68.2 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.702 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.48 -39.78 88.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.103 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.46 -42.28 92.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.243 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.78 -40.28 96.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.64 -41.01 98.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 t -64.32 -44.78 90.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.532 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 tp -58.81 -40.93 85.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.9 mmm -66.8 -56.63 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.339 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.648 179.505 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.6 t -57.7 -47.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.935 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -65.28 -48.63 72.52 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.012 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.598 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.29 -48.7 80.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -59.03 -33.45 70.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.84 -38.6 86.71 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.185 0.517 . . . . 0.0 110.182 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.7 -46.39 85.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.91 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.04 -48.63 73.17 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.53 84.97 Favored Glycine 0 C--N 1.33 0.23 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.92 -37.99 89.43 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.1 m-30 -66.09 -41.51 90.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.374 0.606 . . . . 0.0 110.058 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ASP . 25.8 t0 -83.97 56.39 3.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.239 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -38.48 -19.04 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.697 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.1 m-20 -88.37 -26.89 21.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.378 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.08 11.47 83.98 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.729 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -65.18 -17.19 64.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.722 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -13.06 56.56 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 m -134.06 136.66 44.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.711 0.291 . . . . 0.0 111.111 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.5 mt -97.54 113.92 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.578 HG22 ' N ' ' A' ' 29' ' ' VAL . 89.4 m -78.3 164.85 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.578 ' N ' HG22 ' A' ' 28' ' ' THR . 8.2 t -56.12 -46.49 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.36 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.03 -41.57 83.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 94.4 mt-10 -67.26 -41.54 85.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.317 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.688 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.69 -44.42 96.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.102 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.38 70.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.859 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -61.38 -44.38 97.25 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.789 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.0 -47.97 85.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.082 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 41' ' ' GLN . 3.0 mm -61.73 -38.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.09 -41.24 78.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.294 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 40' ' ' ASP . 37.6 m -64.82 -35.67 81.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.92 21.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 38' ' ' SER . 98.1 m-20 63.3 18.41 10.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 6.8 tp-100 -134.0 139.41 46.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.29 76.73 37.2 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 120.754 0.311 . . . . 0.0 111.169 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.9 169.38 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.992 2.462 . . . . 0.0 111.092 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 47' ' ' GLU . 6.9 p -86.72 149.73 24.68 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 57.1 mp0 -39.6 -42.72 1.22 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.44 -49.03 36.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.195 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 44' ' ' THR . 46.0 tp10 -66.48 -41.85 88.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.211 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.56 -43.05 99.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.126 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -62.97 -51.21 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.293 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.92 -33.16 71.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.479 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.6 ttp -74.74 -45.84 41.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' ASP . 80.4 mt -63.42 -43.95 98.7 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.864 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -63.94 -45.51 88.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.209 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.34 -33.4 65.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.209 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 71' ' ' LEU . 3.6 m -103.43 -32.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 58.8 t0 -74.56 104.98 5.46 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.53 64.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.538 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 2.4 p30 -95.58 -23.22 17.16 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.622 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 63.08 41.22 99.85 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.458 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 49.6 p30 -80.3 -16.44 54.64 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.73 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 101.91 -0.84 51.75 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.458 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 18.5 p -129.83 170.87 13.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.688 HD12 HD23 ' A' ' 32' ' ' LEU . 5.0 mt -118.99 125.27 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 74.4 tt0 -95.22 167.3 11.44 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.409 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 63.2 t80 -53.72 -49.7 67.53 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.681 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.01 -41.24 87.25 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.233 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.73 -42.34 86.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.259 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -65.39 -41.08 94.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.881 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.2 tp -62.59 -41.59 99.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.522 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -66.16 -44.98 82.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.506 HD13 HG11 ' A' ' 55' ' ' VAL . 37.1 tp -63.39 -42.0 98.78 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.107 0.48 . . . . 0.0 111.182 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.598 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 27.0 ttt -60.97 -49.05 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.07 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.3 179.205 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.4 -46.72 95.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.045 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -60.41 -39.71 88.37 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.55 -56.21 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -39.32 81.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -64.72 -35.54 81.38 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.979 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.59 82.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.464 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -68.15 -47.26 68.53 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.32 98.13 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 tt -63.16 -37.56 87.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 0.0 109.688 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -70.99 -38.64 72.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 t0 -87.62 48.91 1.71 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.156 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -35.41 -28.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.363 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.6 m-20 -71.91 -28.04 63.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.512 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.44 8.64 87.62 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -68.48 -9.82 51.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.848 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.83 -5.65 84.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.9 m -129.03 131.57 47.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.69 0.281 . . . . 0.0 111.096 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.5 mt -100.27 114.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 p -82.2 164.12 21.45 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 30' ' ' GLU . 7.5 p -58.21 -42.26 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.615 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' N ' HG13 ' A' ' 29' ' ' VAL . 98.9 mt-10 -58.4 -38.86 78.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 0.0 110.229 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.8 mt-10 -71.28 -37.92 71.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.442 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.31 -44.59 96.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.29 76.48 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.78 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -64.1 -41.3 97.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.43 -47.39 80.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.498 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.88 -38.5 82.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -59.44 -40.91 88.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.657 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.34 -34.99 65.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.381 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 38.0 mt -61.4 -41.93 97.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 112.641 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.56 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 71.8 m-20 141.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.345 1.028 . . . . 0.0 111.18 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -137.76 158.19 44.88 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 13.2 p-10 -155.42 69.04 5.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.956 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.79 169.53 5.61 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.678 2.252 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.435 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 64.8 p -80.44 148.69 30.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' THR . 75.5 mt-10 -37.69 -36.67 0.19 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.887 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -55.22 -53.37 56.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.386 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 12.8 mp0 -61.08 -41.75 97.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.95 -42.14 97.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -68.12 -42.6 79.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.318 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.13 -39.62 95.21 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.744 0.306 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 mtm -69.57 -44.01 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.211 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -66.18 -44.42 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.989 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -33.93 75.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.072 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -59.57 -33.63 71.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.788 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.6 p -109.92 -31.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -64.56 77.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -55.82 -23.68 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.266 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' OD1' ' CG ' ' A' ' 60' ' ' ASN . 3.3 p30 -97.46 -22.53 16.52 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.607 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.09 46.21 89.27 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.432 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 38.7 p-10 -88.97 -17.19 29.98 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.63 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.63 10.63 56.53 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.432 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 33.1 p -139.47 159.4 42.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 63' ' ' ILE . 21.1 mt -113.83 128.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.42 171.89 8.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.37 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.67 -52.49 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.875 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.7 -41.29 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.6 -45.08 84.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.023 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.7 -42.29 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tt -63.97 -42.12 97.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -63.0 -46.08 89.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.231 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.8 tp -63.11 -40.29 97.21 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 110.551 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mmm -59.3 -42.72 92.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.613 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.346 179.427 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 CA--C 1.521 -0.139 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.4 t -63.95 -46.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.443 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.51 -42.74 91.75 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.12 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.25 -51.95 65.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.065 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.93 -32.09 71.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.247 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.31 -39.6 89.42 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.963 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.65 -45.87 88.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.896 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.76 -49.56 74.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.54 84.5 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.2 tp -61.73 -40.64 95.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.002 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 4.6 m-30 -65.16 -43.08 92.94 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.239 0.543 . . . . 0.0 110.274 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 22' ' ' ASP . 34.5 t0 -81.56 50.47 1.49 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.739 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.5 m-20 -89.51 -27.85 20.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.109 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.05 14.27 82.09 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -69.23 -16.36 63.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.666 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.28 62.32 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.6 m -134.06 136.71 44.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.725 0.298 . . . . 0.0 111.08 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.4 mt -100.1 117.27 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 29' ' ' VAL . 49.5 m -77.82 162.7 26.7 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.686 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 28' ' ' THR . 13.6 t -57.03 -46.86 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.496 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -58.39 -42.49 87.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 110.273 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.431 ' CD ' ' OD2' ' A' ' 22' ' ' ASP . 63.2 tt0 -66.8 -35.79 80.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.275 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -64.01 -43.15 96.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.1 -40.2 70.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -43.23 99.25 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -65.42 -48.44 83.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.105 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 41' ' ' GLN . 97.4 mt -60.3 -39.69 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.94 -41.88 71.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.548 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.5 t -64.86 -39.65 93.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.42 20.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 38' ' ' SER . 12.7 m-20 67.56 18.64 9.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.579 ' O ' HG22 ' A' ' 36' ' ' ILE . 1.9 mp0 -135.29 147.66 49.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -150.95 72.56 8.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.53 167.35 13.41 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.768 2.312 . . . . 0.0 111.022 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.4 p -83.26 153.42 24.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 44' ' ' THR . 77.3 mm-40 -38.49 -45.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 110.137 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -47.11 -55.71 7.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' O ' ' SD ' ' A' ' 51' ' ' MET . 50.1 mt-10 -60.16 -41.16 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.217 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.19 -42.52 98.73 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.029 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -65.29 -53.81 38.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -59.17 -38.06 78.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.528 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.26 -48.19 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.28 -44.48 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 m -57.52 -45.6 84.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -45.81 -29.56 1.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -112.72 -29.28 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 9.5 t0 -60.68 81.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.23 -36.25 77.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 8.0 p30 -92.38 -21.14 20.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.827 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.75 69.47 1.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 6.6 m120 -109.76 -11.75 14.69 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.116 0.458 . . . . 0.0 111.428 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 93.14 3.91 65.06 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -138.54 170.85 15.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -120.03 127.71 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.027 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -104.75 175.52 5.47 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -57.07 -54.75 43.2 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.646 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 33.0 p-10 -54.06 -46.0 71.83 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.094 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 99.5 mt-10 -64.04 -41.85 97.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.863 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 59.0 t80 -63.3 -37.57 87.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.08 -43.25 99.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.308 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.8 m -65.46 -44.9 85.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.084 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -56.48 -45.67 80.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.43 -177.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 75.2 mtp -65.91 -49.46 67.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.016 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.492 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.11 -47.2 93.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.814 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.1 -42.56 99.61 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.834 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD2' ' SD ' ' A' ' 72' ' ' MET . 3.5 m-30 -60.3 -46.37 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -59.71 -33.55 71.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -66.62 -37.91 85.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.252 0.549 . . . . 0.0 110.168 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.03 85.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.917 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -63.3 -47.44 82.29 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 111.084 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.05 91.89 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.19 -39.0 93.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.023 0.44 . . . . 0.0 110.229 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -67.54 -40.42 85.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.278 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 23' ' ' GLY . 34.5 t0 -81.82 58.34 3.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.922 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -37.54 -21.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.843 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 m-20 -88.15 -26.36 22.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.586 0.231 . . . . 0.0 111.443 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 74.51 10.14 82.36 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -64.3 -17.58 63.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -11.72 56.38 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.9 m -130.71 131.39 44.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.853 0.359 . . . . 0.0 111.326 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.2 mt -96.99 114.28 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.3 p -79.16 165.66 23.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 t -57.67 -44.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.589 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -56.94 -41.68 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.009 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.3 mt-10 -68.58 -41.59 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.468 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.21 -44.86 94.14 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -55.3 -40.33 70.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -63.36 -42.85 98.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.866 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.98 -49.34 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.694 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mm -65.64 -41.13 89.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 49.2 ttp180 -57.75 -40.97 80.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.362 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -85.05 -14.05 48.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.526 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 9.9 tp -68.08 -43.4 78.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 3.4 t70 154.63 -4.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.414 0.446 . . . . 0.0 111.108 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -139.92 158.74 43.59 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -135.19 72.06 67.07 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.83 155.74 62.08 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.664 2.243 . . . . 0.0 110.913 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -82.88 156.78 23.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -40.03 -43.8 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 2.8 mt-10 -50.48 -52.43 38.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.52 -42.88 99.81 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.142 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.08 -42.31 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.54 -49.77 75.34 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.076 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.52 -35.26 75.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.69 0.281 . . . . 0.0 110.446 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -72.96 -45.84 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.813 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 56' ' ' ASP . 85.1 mt -64.8 -44.5 96.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.956 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -45.7 91.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.552 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -57.77 -31.66 66.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 m -106.63 -24.51 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 66.7 t0 -81.57 95.94 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.41 68.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.795 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -94.91 -24.15 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.244 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.28 35.35 82.48 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.069 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.485 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 20.3 m120 -67.52 -18.82 65.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.811 0.305 . . . . 0.0 111.356 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.72 -12.22 56.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 p -125.48 -179.76 4.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 109.967 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.13 130.75 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.631 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -101.26 177.67 4.87 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.458 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.67 -50.89 71.69 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.905 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 31.5 p-10 -58.82 -43.63 90.68 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.431 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 96.8 mt-10 -65.76 -40.72 92.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.62 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.86 -42.34 99.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.741 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.52 -39.14 82.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -63.6 -42.89 98.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.3 -42.54 86.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.625 0.25 . . . . 0.0 110.778 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 12' ' ' PHE . 74.8 mtp -65.73 -56.43 12.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.553 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.63 179.662 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.84 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.233 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.4 -42.39 96.12 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.3 -48.13 79.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.091 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -62.78 -34.71 77.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.204 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.03 -36.24 82.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.191 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -67.47 -40.62 85.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.101 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.475 ' CE2' HD12 ' A' ' 27' ' ' ILE . 59.7 t80 -70.37 -49.69 46.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.05 96.57 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.55 -39.12 89.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 9.6 m-30 -68.52 -40.49 80.76 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.934 0.397 . . . . 0.0 110.674 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.0 t0 -78.85 48.14 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.59 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -36.6 -40.36 0.25 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.877 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.0 p-10 -69.73 -25.34 63.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 0.0 111.627 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.12 14.74 80.1 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.891 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.1 p-10 -64.58 -1.52 1.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.673 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 75.51 -10.23 12.69 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.438 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.6 m -130.64 131.84 45.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.574 0.226 . . . . 0.0 110.839 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.475 HD12 ' CE2' ' A' ' 16' ' ' PHE . 95.0 mt -97.25 113.4 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -83.52 165.28 19.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.748 179.099 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.99 -36.92 64.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.524 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.98 -41.32 97.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.248 0.547 . . . . 0.0 110.616 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' H ' HG23 ' A' ' 28' ' ' THR . 42.6 tt0 -72.38 -39.46 68.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.056 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.7 tm? -61.5 -45.92 92.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.07 -38.08 70.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.807 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -62.17 -42.7 99.52 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.834 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.08 -47.19 85.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.524 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 41' ' ' GLN . 2.8 mm -63.76 -38.74 83.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.047 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -57.08 -39.81 75.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.2 t -69.29 -38.17 78.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.04 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.95 25.78 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 38' ' ' SER . 33.5 t70 62.91 20.47 12.25 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.511 ' O ' HG22 ' A' ' 36' ' ' ILE . 97.1 mm-40 -136.14 142.49 44.22 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -148.29 80.65 8.43 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.026 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.76 170.7 6.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.853 2.369 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 m -86.47 159.33 19.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.61 -39.34 7.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.76 -55.59 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -62.69 -40.78 98.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mt -61.2 -42.71 99.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.059 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -70.83 -41.54 71.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.131 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -63.46 -38.92 93.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.725 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 71.0 mtm -69.0 -44.04 73.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.991 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.76 -45.88 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.074 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.2 t -59.12 -37.42 77.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.56 -31.57 64.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.074 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.1 p -111.03 -32.88 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.4 t70 -63.82 79.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.04 -24.28 62.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.587 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.8 p-10 -95.36 -23.2 17.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.913 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.606 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.8 38.75 93.26 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 51.5 p30 -81.39 -17.04 50.38 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.526 -0.396 . . . . 0.0 111.608 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.08 7.7 60.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 82.8 p -135.91 159.74 40.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.5 mt -112.73 127.04 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 74.6 tt0 -99.99 165.28 11.62 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.411 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 27.6 t80 -49.24 -54.81 14.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.425 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.16 -43.29 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.006 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.63 -44.13 82.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.063 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.505 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.43 -40.64 97.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.454 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.9 t -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.87 -42.83 85.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.544 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mmm -65.55 -47.3 76.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.931 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.419 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 17.7 mm . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 11' ' ' ASP . 8.5 p -59.22 -47.5 90.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.998 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.56 ' N ' HG13 ' A' ' 10' ' ' VAL . 64.4 t0 -63.32 -54.05 43.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.957 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CD1' ' SD ' ' A' ' 72' ' ' MET . 14.9 m-30 -61.82 -52.56 63.67 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.314 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 28.6 tptp -51.66 -40.78 60.64 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.034 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -68.58 -40.37 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.113 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.5 -50.14 73.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -62.59 -49.19 76.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.843 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.5 -48.3 65.72 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.542 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 tt -62.65 -39.24 93.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.071 0.462 . . . . 0.0 109.793 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -63.94 -43.16 96.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.145 0.497 . . . . 0.0 110.497 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 23' ' ' GLY . 61.1 t0 -81.91 52.21 1.9 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.254 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -38.59 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.833 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 3.4 p-10 -83.62 -24.84 31.25 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.45 15.98 80.85 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.184 -0.532 . . . . 0.0 111.928 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 49.7 p-10 -66.87 -5.44 12.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.549 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 84.32 -16.93 31.53 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.444 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 5.2 t -128.9 128.76 44.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.474 0.178 . . . . 0.0 110.946 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.44 112.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.56 HG22 ' N ' ' A' ' 29' ' ' VAL . 85.4 m -77.42 162.96 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.592 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.641 HG12 HD13 ' A' ' 52' ' ' ILE . 2.4 m -55.74 -36.81 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.469 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.74 -41.8 91.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.962 0.41 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.47 -37.8 85.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.353 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 tp -64.16 -43.96 93.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.71 72.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -63.49 -41.74 98.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.3 t -65.61 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.241 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.19 -35.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -60.43 -42.78 96.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -68.9 -35.46 76.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.961 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 11.2 mt -60.57 -43.91 96.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.728 -1.129 . . . . 0.0 112.67 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.569 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 70.1 m-20 142.01 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 124.691 1.245 . . . . 0.0 111.533 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -136.57 157.09 47.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -148.97 71.7 10.29 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.783 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.02 156.69 61.26 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.526 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 6.2 p -84.88 155.99 21.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 56.8 mp0 -40.06 -47.39 2.3 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -46.86 -51.86 15.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.047 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -70.14 -41.5 73.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.762 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -40.81 95.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -61.62 -50.5 72.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.699 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.01 -37.1 78.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.9 tpp -74.01 -47.41 37.25 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.641 HD13 HG12 ' A' ' 29' ' ' VAL . 77.3 mt -64.3 -44.56 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.0 p -58.09 -43.96 87.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -50.16 -28.75 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -110.13 -30.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 10.7 t0 -63.97 78.53 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.24 -36.02 80.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.694 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 3.9 p30 -90.41 -20.64 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.03 1.18 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.177 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 7.8 m120 -109.83 -12.43 14.59 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.266 0.533 . . . . 0.0 111.471 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.07 63.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -138.69 177.11 8.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.1 mt -121.5 128.44 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -98.43 171.73 7.98 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.46 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 52.5 t80 -56.1 -51.72 66.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.681 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.13 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.462 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 89.1 mt-10 -59.03 -46.23 88.74 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.9 t80 -68.33 -26.57 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.85 -43.05 89.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 110.108 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.9 t -66.53 -41.87 88.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.36 -41.39 84.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.99 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.466 ' SD ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 mtp -65.86 -51.62 57.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.468 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.769 179.295 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.54 -46.39 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.868 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.36 -54.88 29.97 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.981 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 69' ' ' LEU . 49.9 m-85 -59.09 -47.85 83.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -59.42 -33.75 71.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.456 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.0 -41.64 81.94 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.078 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.47 -46.76 84.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.967 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.51 -49.47 73.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.87 85.42 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.84 -39.71 95.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.9 m-30 -64.44 -41.0 96.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.076 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 27.8 t0 -82.19 53.84 2.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.135 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -38.62 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.684 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.1 p-10 -89.2 -25.01 22.0 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.41 18.45 79.16 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.74 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 46.6 p-10 -66.8 -10.71 50.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.774 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.81 -15.74 60.98 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.1 p -133.18 132.89 42.1 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.687 0.28 . . . . 0.0 110.835 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.1 mt -95.43 113.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 29' ' ' VAL . 76.6 m -78.55 164.1 24.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.636 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.564 ' N ' HG22 ' A' ' 28' ' ' THR . 5.7 p -55.32 -33.91 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.763 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.44 -42.63 74.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.282 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -65.03 -38.19 90.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.207 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.95 -43.67 91.94 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.39 74.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.916 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 m -60.68 -43.28 97.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.758 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.21 -46.38 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.238 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.08 -43.88 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.951 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -56.16 -41.65 75.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.342 0.591 . . . . 0.0 110.582 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -66.29 -37.48 85.51 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.089 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 35.6 mt -61.73 -44.08 97.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.564 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 10.9 t70 141.12 10.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 124.003 0.815 . . . . 0.0 111.352 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -128.72 164.75 22.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 110.075 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -154.16 70.72 6.31 Favored Pre-proline 0 C--O 1.232 0.176 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.47 154.68 73.05 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.726 2.284 . . . . 0.0 111.206 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 45' ' ' GLU . 11.5 m -80.32 164.68 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 44' ' ' THR . 84.3 tt0 -42.36 -49.34 5.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.39 -58.12 4.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.472 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.61 -41.68 90.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.188 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.0 mt -61.37 -42.98 99.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -67.43 -53.37 29.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -59.65 -37.74 79.52 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.556 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.4 mmt -71.42 -48.86 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.608 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASP . 57.7 mt -64.88 -45.18 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -58.62 -46.96 85.92 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -45.77 -27.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.4 p -116.14 -27.51 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 52' ' ' ILE . 26.1 t0 -59.37 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.69 -35.13 75.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.1 m-20 -82.96 -23.66 33.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.462 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.1 26.97 68.17 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 30.1 p-10 -81.58 -16.42 51.66 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.739 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.69 7.8 50.19 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.453 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 49.5 p -134.23 167.12 21.27 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 52' ' ' ILE . 12.0 mt -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.843 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -102.87 171.64 7.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -53.51 -50.29 65.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.309 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -57.56 -43.96 84.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.233 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 80.6 mt-10 -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.815 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 83.5 t80 -62.24 -44.47 96.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.378 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.425 ' CD1' ' CD2' ' A' ' 12' ' ' PHE . 57.3 tp -62.18 -42.44 99.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.183 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -64.77 -44.57 89.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.136 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -57.83 -44.81 86.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.787 -178.116 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 76.0 mtp -70.96 -50.77 30.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.87 179.122 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mm . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.4 t -63.37 -47.3 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.12 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.31 -44.02 92.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.266 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.09 -44.61 97.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.83 -37.66 76.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.177 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -65.43 -35.71 81.74 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.139 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.32 -43.29 86.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.107 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -69.59 -48.82 58.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.749 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.25 95.06 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.87 -38.48 91.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.902 0.382 . . . . 0.0 110.057 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 8.9 m-30 -68.85 -41.87 77.87 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.662 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 22' ' ' ASP . 27.4 t0 -79.37 47.13 0.79 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.219 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -36.49 -25.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.693 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.5 m-20 -76.78 -27.44 55.27 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.61 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.53 10.26 85.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 49.3 p-10 -71.73 -9.74 58.73 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.798 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.96 -7.04 81.99 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 p -131.65 134.14 45.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.867 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.69 117.18 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 p -83.9 166.27 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.699 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 t -56.72 -43.98 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.03 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.42 -39.14 86.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.03 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 91.9 mt-10 -71.15 -42.57 68.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.132 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.19 -44.83 95.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.287 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.88 69.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.808 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -62.36 -42.59 99.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.887 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.2 -46.99 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.511 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 41' ' ' GLN . 5.3 mm -62.94 -39.64 85.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.16 -40.72 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 40' ' ' ASP . 51.1 m -67.91 -37.17 81.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.82 25.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 38' ' ' SER . 90.3 m-20 63.27 20.52 12.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.288 0.368 . . . . 0.0 111.931 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.526 ' O ' HG22 ' A' ' 36' ' ' ILE . 86.8 mt-30 -137.04 148.47 46.83 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -154.17 79.69 5.0 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' CD ' HG21 ' A' ' 36' ' ' ILE . 30.9 Cg_exo -61.07 170.01 5.4 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.669 2.246 . . . . 0.0 111.113 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -91.49 165.1 13.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 49' ' ' GLN . 80.9 mm-40 -42.17 -46.47 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.897 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 1.5 mm-40 -56.66 -62.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.831 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.9 -45.75 93.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.063 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.21 -43.78 98.32 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.426 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 57.1 tt0 -71.92 -42.67 66.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.269 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.56 -36.8 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.612 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.9 mmt -69.01 -45.18 71.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.692 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.96 -43.98 88.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.1 m -57.69 -38.45 75.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.874 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -49.08 -29.03 4.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -115.47 -27.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 14.2 t0 -62.99 76.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -61.54 -22.57 65.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.351 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 3.4 p-10 -101.14 -23.54 14.44 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.736 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 69.07 35.11 77.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.295 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.546 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 47.9 p30 -76.56 -17.85 58.99 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.624 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.01 8.79 60.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 p -139.77 162.56 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 HD23 ' A' ' 32' ' ' LEU . 14.8 mt -115.63 127.58 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.546 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 53.3 mp0 -98.5 171.39 8.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -56.25 -52.27 65.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.355 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 29.1 p-10 -56.79 -42.44 79.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.326 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 94.4 mt-10 -65.36 -44.01 89.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -66.55 -33.59 76.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.4 tp -66.74 -43.7 83.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.906 0.384 . . . . 0.0 110.565 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.9 m -72.5 -45.68 58.27 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.243 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 tp -48.74 -52.74 22.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.163 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 ttp -67.92 -47.32 69.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.636 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.774 179.498 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.2 mm . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.48 -46.8 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.075 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.25 -50.76 66.69 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.935 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -62.91 -51.67 66.05 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.463 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -54.27 -37.7 65.01 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.886 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -68.32 -38.84 81.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.081 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.01 -52.31 63.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.174 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -62.62 -48.68 78.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.766 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.58 84.81 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.97 -38.44 91.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.839 0.352 . . . . 0.0 110.064 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.59 -46.07 70.33 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.176 0.512 . . . . 0.0 110.219 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 23' ' ' GLY . 31.8 t0 -78.8 43.32 0.49 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.48 -23.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.875 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.0 p-10 -83.3 -27.16 29.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 111.674 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 82.55 15.64 73.06 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.033 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 55.8 p30 -70.18 -6.11 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 -11.84 26.96 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 10.3 m -131.79 133.08 44.34 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.3 mt -98.45 115.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -79.5 160.53 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 30' ' ' GLU . 7.2 p -56.99 -42.2 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.483 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.44 ' N ' HG13 ' A' ' 29' ' ' VAL . 96.8 mt-10 -61.92 -40.93 97.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.272 0.558 . . . . 0.0 110.223 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 76.6 tt0 -69.27 -35.23 75.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.273 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -62.99 -43.58 98.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.05 72.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.681 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -61.77 -41.93 98.34 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.72 -48.44 75.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.264 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.4 mt -61.52 -36.88 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -59.81 -41.72 91.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.414 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.4 m -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 86.1 mt -59.83 -41.98 92.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.452 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 30.2 t0 131.54 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.623 1.202 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -141.2 156.06 45.97 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.8 -0.563 . . . . 0.0 110.015 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -149.34 76.18 9.34 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.832 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 172.11 2.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.629 2.219 . . . . 0.0 111.261 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -85.53 160.29 19.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 57.7 mp0 -43.45 -41.67 4.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.5 -57.58 8.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.818 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 51.3 mp0 -58.62 -39.36 80.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.229 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.4 -43.41 98.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.988 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -73.36 -49.87 24.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.179 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.01 -38.72 87.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.594 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.5 ttm -67.73 -47.39 69.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.02 -44.31 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 t -59.22 -42.09 90.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.99 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -48.27 -32.63 7.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.017 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -112.93 -30.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.9 t0 -61.53 81.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.37 -26.7 65.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.419 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 2.0 p30 -96.74 -21.98 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.675 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.11 40.62 95.11 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.5 p-10 -82.67 -16.92 46.38 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.517 -0.402 . . . . 0.0 111.554 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.92 4.64 58.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.461 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 55.5 p -135.56 165.4 25.62 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.01 126.8 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -94.38 170.37 9.54 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -56.68 -51.52 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.682 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -61.18 -42.09 97.95 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.228 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 74.2 mt-10 -64.8 -44.98 88.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.129 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.52 -41.11 98.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.71 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.14 -41.8 99.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.952 0.406 . . . . 0.0 110.875 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.85 -43.49 98.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.224 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.9 tp -61.68 -39.23 90.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 110.761 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 45.3 mtp -61.07 -49.66 76.46 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.021 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.204 178.79 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 t -56.06 -44.61 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.786 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.72 -54.37 46.08 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.099 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -56.55 -48.53 77.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -38.16 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -64.15 -41.41 97.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.074 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.02 -46.68 86.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.909 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -62.68 -50.76 69.88 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.806 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.19 -46.23 79.6 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.542 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -61.83 -40.6 95.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CE2' HG11 ' A' ' 35' ' ' VAL . 5.1 m-30 -63.68 -41.76 98.12 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.041 0.448 . . . . 0.0 110.037 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 34.9 t0 -78.38 54.33 1.4 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.349 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -39.18 -30.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.632 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.9 p-10 -82.34 -23.85 34.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.39 16.11 80.97 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.7 p-10 -65.88 -9.79 32.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.354 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -15.98 58.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 6.9 t -130.85 130.58 43.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 0.187 . . . . 0.0 110.761 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.34 112.38 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -79.96 167.29 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.621 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.45 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.4 m -55.63 -39.87 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 73.1 mm-40 -63.09 -42.85 99.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -66.51 -41.17 89.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.139 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.604 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.6 -45.0 94.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.49 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.03 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 m -60.19 -44.69 94.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.659 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG11 ' CE2' ' A' ' 19' ' ' PHE . 55.0 t -63.35 -46.64 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.154 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 41' ' ' GLN . 5.2 mm -60.46 -39.42 81.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -54.89 -42.48 72.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.88 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 40' ' ' ASP . 7.6 t -65.09 -39.69 93.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.21 19.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.388 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 38' ' ' SER . 34.3 m-20 69.08 20.05 7.82 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.871 0.732 . . . . 0.0 111.252 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' HG22 ' A' ' 36' ' ' ILE . 83.6 mt-30 -133.74 142.78 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.019 -0.425 . . . . 0.0 109.965 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -140.54 70.94 31.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.63 157.6 46.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.7 2.267 . . . . 0.0 111.309 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 45' ' ' GLU . 60.9 p -83.73 154.26 23.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 44' ' ' THR . 97.1 mt-10 -38.41 -47.54 1.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.991 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -46.06 -60.32 2.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.33 -41.75 98.81 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.181 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -42.2 98.23 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.122 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -63.65 -51.92 63.03 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.211 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -60.51 -35.43 75.92 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.558 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 70.9 mtm -74.61 -47.74 30.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.04 -43.66 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.843 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -59.12 -45.74 90.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' CD ' ' O ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -46.21 -25.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -118.18 -24.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -59.89 81.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.58 -34.53 77.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.28 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.3 m-20 -80.52 -24.11 39.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.702 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.17 23.15 65.9 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 26.8 p-10 -78.7 -18.42 54.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.122 0.461 . . . . 0.0 111.452 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.24 14.09 29.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.439 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 48.3 p -141.4 172.45 12.66 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.604 HD12 HD23 ' A' ' 32' ' ' LEU . 5.4 mt -121.57 129.13 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -100.26 172.12 7.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -53.99 -49.3 69.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.743 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.76 -42.0 96.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.182 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 92.3 mt-10 -68.21 -45.65 72.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.966 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.8 t80 -60.75 -46.01 92.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.776 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.96 -40.28 95.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 110.116 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.4 p -63.75 -45.63 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.641 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.15 -42.54 86.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 53.3 mtp -67.92 -54.7 16.71 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.407 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.602 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.884 178.884 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.1 mm . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.45 -46.35 95.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.154 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.85 -42.9 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.976 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.41 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -61.05 -48.23 82.71 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -61.48 -32.39 72.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -66.83 -39.53 87.69 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 110.17 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -65.22 -42.01 93.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.983 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.68 -49.02 70.1 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.868 0.366 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.16 -44.36 93.2 Favored Glycine 0 C--N 1.329 0.194 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.79 -40.2 96.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.996 0.427 . . . . 0.0 110.063 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -65.74 -40.46 92.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.228 0.537 . . . . 0.0 110.456 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 23' ' ' GLY . 66.3 t0 -80.6 60.37 3.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' CB ' ' NZ ' ' A' ' 21' ' ' LYS . 9.3 mtmp? -37.23 -27.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.891 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.8 p-10 -97.16 -12.55 22.93 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 63.97 23.36 67.57 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.27 -0.49 . . . . 0.0 111.886 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -66.6 -12.0 55.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.206 0.503 . . . . 0.0 110.776 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.73 -14.49 64.02 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 m -132.65 132.14 42.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 0.0 110.91 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.66 111.74 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 m -75.15 154.89 37.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.59 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 61' ' ' GLY . 3.7 m -54.98 -29.57 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.48 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.52 -41.71 72.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.544 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 68.9 mt-10 -68.76 -41.73 78.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.68 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.692 HD23 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -58.79 -46.84 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.86 73.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.877 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -63.1 -43.85 97.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.14 -48.8 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.104 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.426 HG21 ' CD ' ' A' ' 43' ' ' PRO . 3.0 mm -63.52 -38.38 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -55.31 -40.77 71.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.845 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 40' ' ' ASP . 26.0 m -66.85 -33.57 75.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.674 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.67 23.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 38' ' ' SER . 99.7 m-20 63.7 14.22 8.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -137.95 146.52 43.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -142.74 83.88 11.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.083 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.426 ' CD ' HG21 ' A' ' 36' ' ' ILE . 23.1 Cg_exo -63.95 169.17 10.81 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.856 2.371 . . . . 0.0 111.071 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p -89.61 162.04 15.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -42.66 -46.21 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -50.55 -52.03 42.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.99 -42.73 97.1 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.234 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.0 -47.17 85.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.938 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -64.83 -50.88 64.93 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.175 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.3 t0 -59.15 -34.09 71.66 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.503 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.9 ttp -74.79 -45.53 43.01 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.774 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.57 -44.23 96.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.6 m -61.8 -46.51 89.2 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.046 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -45.07 -29.63 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.44 -33.38 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 53.7 t0 -65.41 98.1 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.98 -24.4 61.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.828 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -100.32 -24.57 14.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.42 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.42 37.3 85.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.283 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 13.7 m120 -70.95 -17.91 62.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.958 0.379 . . . . 0.0 111.422 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 100.38 -2.56 56.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -131.43 174.42 10.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.692 HD12 HD23 ' A' ' 32' ' ' LEU . 7.4 mt -116.51 120.8 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.991 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 68.6 tt0 -88.7 169.87 11.29 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.414 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 82.4 t80 -55.81 -49.04 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.759 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.63 -38.15 89.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.01 0.433 . . . . 0.0 110.249 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 97.5 mt-10 -67.33 -41.22 85.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.826 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -67.33 -38.55 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.502 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -41.37 96.48 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.08 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.6 p -69.95 -45.86 66.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.022 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.12 -44.13 93.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 110.334 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.41 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 tpt -54.62 -51.95 63.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.909 179.131 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.457 -0.1 0 N-CA-C 110.608 -0.145 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 11' ' ' ASP . 9.3 p -61.52 -47.76 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.967 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' N ' HG13 ' A' ' 10' ' ' VAL . 8.8 t70 -62.1 -45.87 91.57 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.874 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CD2' ' SD ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.21 -42.92 99.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.319 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -60.43 -35.47 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.203 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.16 -37.13 83.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.383 0.611 . . . . 0.0 109.748 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.36 82.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.249 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -67.89 -47.42 68.9 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.882 0.372 . . . . 0.0 110.966 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.15 -42.77 98.71 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 tp -62.87 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.114 0.483 . . . . 0.0 110.133 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.19 -36.54 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.33 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.1 t0 -92.53 49.42 1.48 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.182 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -36.5 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.846 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.2 m-20 -70.59 -28.11 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.358 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.76 10.34 85.83 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -69.04 -10.71 58.96 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.867 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.86 -6.31 83.78 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -131.3 134.48 46.41 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.715 0.293 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.7 mt -100.56 113.34 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -82.24 165.14 20.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.658 HG12 HD13 ' A' ' 52' ' ' ILE . 3.2 m -57.37 -44.5 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.735 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' N ' HG23 ' A' ' 29' ' ' VAL . 45.6 tt0 -58.67 -40.11 82.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.21 0.528 . . . . 0.0 109.899 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 97.0 mt-10 -70.23 -40.87 74.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.433 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.625 HD12 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -62.18 -45.46 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.85 -39.38 68.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -65.63 -39.8 91.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.776 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.78 -46.4 92.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.488 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.36 -38.88 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -57.53 -41.28 80.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.525 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -68.62 -31.89 71.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.086 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 76.3 mt -59.13 -42.76 91.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.751 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 36.2 p-10 137.83 17.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.181 0.926 . . . . 0.0 111.301 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -153.94 169.71 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -153.99 84.23 4.13 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.184 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.99 179.49 0.29 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.729 2.286 . . . . 0.0 110.994 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.412 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 50.6 p -89.59 155.03 19.52 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -41.53 -36.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 0.0 110.185 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 3.2 mm-40 -57.24 -53.46 57.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.532 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' OE1' ' OG1' ' A' ' 44' ' ' THR . 2.7 mp0 -60.94 -40.79 94.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.82 -42.96 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -72.99 -45.85 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.284 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.92 -39.92 93.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.532 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -67.59 -44.31 78.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.608 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.658 HD13 HG12 ' A' ' 29' ' ' VAL . 73.3 mt -66.67 -44.28 89.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -40.05 90.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -50.89 -33.82 25.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.9 p -111.21 -32.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 33.5 t0 -64.02 76.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.231 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.19 -25.67 61.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.67 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.415 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 2.0 p30 -95.66 -23.09 17.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.546 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.89 36.48 81.9 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 52.6 p-10 -77.52 -17.09 58.28 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.578 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.459 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 94.58 3.73 62.57 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 6.2 p -134.56 163.76 29.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.625 HD11 HD12 ' A' ' 32' ' ' LEU . 51.7 mt -116.4 128.82 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -104.52 164.7 11.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -45.99 -60.2 2.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.9 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -48.89 -43.3 38.98 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.43 -42.25 75.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.041 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 38.2 t80 -64.43 -37.33 87.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.41 -44.86 93.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.582 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.0 m -65.69 -43.7 88.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.89 -43.0 99.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.658 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.587 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 60.4 mtp -60.04 -44.85 94.39 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.2 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.172 179.437 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.1 mm . . . . . 0 CA--C 1.521 -0.163 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.35 -42.5 95.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.093 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.58 -49.76 71.87 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.876 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.43 -47.22 85.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -60.37 -38.19 83.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.13 -38.05 89.37 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.332 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.06 62.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.834 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -69.35 -46.7 66.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.727 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.49 95.64 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.591 ' O ' HD13 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -63.07 -38.85 92.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 5.6 m-30 -72.34 -39.09 68.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.596 0.713 . . . . 0.0 110.649 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.2 t0 -87.39 50.42 2.0 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.468 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -35.57 -28.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.449 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.2 m-20 -72.51 -28.08 62.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.49 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.57 11.13 85.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -70.22 -9.86 57.11 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.822 -179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.31 -2.48 85.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -133.08 136.88 46.15 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.654 0.264 . . . . 0.0 110.951 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -103.23 115.33 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 29' ' ' VAL . 54.7 m -81.97 162.9 22.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 28' ' ' THR . 8.7 p -58.99 -34.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.368 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.18 -39.05 89.43 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 109.988 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 93.9 mt-10 -71.3 -36.96 71.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.166 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.64 -44.6 95.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.86 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.594 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -64.47 -40.3 95.43 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.4 -46.12 87.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.341 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.67 -41.64 91.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.74 -0.384 . . . . 0.0 109.982 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -57.26 -39.57 75.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.533 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -68.8 -34.49 75.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.551 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 76.3 mt -59.56 -41.85 91.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 116.936 -1.507 . . . . 0.0 112.613 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.551 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 87.8 m-20 134.14 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.164 1.54 . . . . 0.0 111.449 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -147.59 161.35 41.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -150.2 78.59 7.85 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.27 -177.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.605 2.203 . . . . 0.0 111.347 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -90.42 148.33 22.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -42.33 -28.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.135 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.83 -51.21 69.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.441 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -65.92 -37.07 85.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.776 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.67 -42.84 99.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.844 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.71 -44.63 48.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.511 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -62.46 -39.02 92.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.577 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.55 -44.34 78.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.9 mt -66.34 -44.46 90.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.898 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -61.19 -37.07 81.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.014 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -56.16 -34.46 66.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.002 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 10.6 p -108.86 -30.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 48.7 t0 -64.2 77.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -56.17 -24.58 42.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.314 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.41 -23.22 17.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.602 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.36 37.85 86.5 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.352 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 47.3 p-10 -80.47 -15.7 56.11 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.57 -0.37 . . . . 0.0 111.514 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.14 4.18 69.08 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 33.3 p -133.99 157.77 45.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.5 mt -111.09 127.64 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 10.7 pt-20 -95.69 174.79 6.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.757 0.313 . . . . 0.0 110.263 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.07 -50.38 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.72 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -57.57 -58.86 6.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.307 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 94.8 mt-10 -51.97 -43.59 63.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.081 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -62.54 -46.0 90.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.07 -43.3 95.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 m -65.33 -44.71 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.314 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.248 0.547 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.55 -43.06 98.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.227 179.34 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.576 0.227 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.79 -47.8 91.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.101 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.22 -45.34 85.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.974 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.3 -48.13 81.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.061 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.76 -35.42 79.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.081 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -63.84 -36.82 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.06 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -68.31 -37.21 80.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.345 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.446 ' CE1' HD12 ' A' ' 27' ' ' ILE . 75.6 t80 -67.45 -48.92 65.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 111.123 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.69 -42.32 96.24 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.7 tp -62.46 -39.14 92.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 109.926 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.25 -36.7 79.85 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.334 0.588 . . . . 0.0 110.693 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 34.4 t0 -86.42 51.41 2.22 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.46 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -36.29 -30.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.719 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 6.2 m-20 -70.51 -28.08 64.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.556 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.32 8.68 87.63 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.694 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -68.57 -17.37 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.731 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 95.2 -7.03 69.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 m -127.62 129.76 47.82 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.612 0.206 . . . . 0.0 111.016 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.446 HD12 ' CE1' ' A' ' 16' ' ' PHE . 80.7 mt -100.32 114.25 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.22 165.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.18 -38.59 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.524 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -61.17 -40.52 94.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.958 0.408 . . . . 0.0 110.195 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 94.1 mt-10 -70.52 -38.37 74.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.224 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.644 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -60.97 -45.48 94.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.44 81.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.88 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -62.24 -43.65 98.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.1 -47.43 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.48 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.94 -38.59 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -58.57 -41.31 85.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 t -86.8 -12.99 46.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.589 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 3.4 tt -65.11 -41.12 95.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.497 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 15.5 m-20 150.99 0.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.901 0.751 . . . . 0.0 111.678 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -155.02 172.44 18.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -153.93 76.87 5.81 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.24 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.16 176.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.46 2.107 . . . . 0.0 111.285 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -86.22 161.75 18.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.5 mp0 -47.35 -41.24 19.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 2.4 mt-10 -54.24 -53.18 57.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.415 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.97 -40.75 96.67 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.161 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mp -62.66 -45.91 90.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.025 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -69.39 -46.51 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.75 -36.99 84.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.3 ttp -69.17 -45.76 69.21 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.5 mt -65.61 -44.94 93.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.98 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -59.13 -39.52 82.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.796 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -52.0 -31.49 29.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.751 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -109.87 -32.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.2 t70 -64.34 77.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.21 -30.0 48.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.433 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 15.3 p-10 -92.19 -18.85 22.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.67 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 65.31 42.86 95.93 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -87.01 -16.68 35.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.018 0.409 . . . . 0.0 111.64 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.08 16.23 58.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 m -140.19 151.64 45.38 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.644 HD12 HD23 ' A' ' 32' ' ' LEU . 8.6 mt -112.31 126.33 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 96.1 mt-10 -103.26 179.66 4.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -57.37 -58.59 7.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.813 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 37.4 p-10 -56.52 -41.57 76.95 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.257 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 97.3 mt-10 -66.0 -46.23 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.908 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.87 -35.78 81.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.396 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.703 HD23 ' C ' ' A' ' 69' ' ' LEU . 7.4 tt -62.76 -43.61 98.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.927 0.394 . . . . 0.0 110.18 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -65.06 -45.28 85.97 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.438 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.61 -43.13 99.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.995 0.426 . . . . 0.0 110.736 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.472 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 4.3 tpt -59.6 -50.07 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.301 179.483 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.9 mt . . . . . 0 N--CA 1.457 -0.117 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.6 t -55.55 -44.99 78.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.93 -51.56 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.835 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -59.03 -48.85 80.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.755 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -37.27 70.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.225 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.33 -41.5 85.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.314 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.62 -48.87 77.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.104 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.37 -49.25 74.58 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.901 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -45.72 82.14 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.626 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.7 tt -62.97 -39.41 94.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.226 0.536 . . . . 0.0 109.559 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.99 -41.87 95.03 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.387 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' ASP . 12.8 t0 -83.34 53.77 2.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.808 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -39.54 -18.58 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.573 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -86.12 -28.67 23.86 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.307 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.21 11.59 84.88 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.742 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.78 -18.12 65.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.727 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.1 -13.64 60.25 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.401 ' SG ' ' OE2' ' A' ' 64' ' ' GLU . 3.5 m -131.69 132.75 44.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.7 0.286 . . . . 0.0 111.151 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -97.05 114.3 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -78.95 165.07 23.88 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 30' ' ' GLU . 3.6 m -55.84 -41.23 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.495 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 29' ' ' VAL . 75.9 mt-10 -60.7 -42.77 97.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.0 mt-10 -68.33 -42.89 78.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.303 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.5 tm? -62.16 -46.8 87.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.55 -39.23 64.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.165 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -63.46 -43.18 98.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.928 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 19' ' ' PHE . 60.0 t -65.4 -48.81 81.71 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -64.68 -40.57 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.0 -42.16 89.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 m -79.45 -20.99 46.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.583 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 39' ' ' LEU . 5.3 tt -63.71 -45.39 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 4.1 m-20 153.3 0.91 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.47 0.482 . . . . 0.0 111.301 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -141.88 155.74 45.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -135.55 78.27 50.59 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.28 155.42 70.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.617 2.211 . . . . 0.0 110.911 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.3 p -85.2 161.39 19.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' THR . 80.4 tt0 -40.16 -47.77 2.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 109.805 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.23 -58.32 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -60.61 -42.37 96.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.557 ' CD2' HD12 ' A' ' 32' ' ' LEU . 12.8 mt -62.05 -43.5 98.7 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.155 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.86 -52.05 58.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.884 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -37.72 84.13 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.695 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.7 mmt -72.23 -48.68 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.7 mt -64.02 -45.17 97.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.954 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.2 p -58.98 -44.74 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -45.07 -27.42 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.5 p -115.61 -30.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 t70 -59.03 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.41 -35.13 73.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.297 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 21.7 p-10 -89.61 -22.41 22.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.45 63.33 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.478 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 52.3 p30 -107.95 -16.7 14.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 117.001 0.4 . . . . 0.0 111.614 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 98.15 15.57 35.42 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.478 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 56.1 p -141.33 165.51 27.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -119.41 126.09 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 80.4 mm-40 -100.24 174.12 6.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.247 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -54.54 -50.85 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.773 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.85 -41.98 98.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.335 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 96.8 mt-10 -67.02 -46.15 75.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.383 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.11 -45.51 93.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.19 -41.62 97.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.576 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 t -63.49 -46.76 84.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.518 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.41 -41.02 93.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.793 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 ttt -69.33 -51.16 39.69 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.025 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.504 179.213 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -110.35 31.43 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.89 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 pt -105.63 -101.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.819 0.342 . . . . 0.0 110.265 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.58 -35.36 80.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 110.009 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -69.77 96.38 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.533 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 10' ' ' VAL . 97.3 mt-10 -99.51 82.26 2.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.665 0.269 . . . . 0.0 110.972 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -91.08 -51.33 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.71 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 2.3 pt20 -63.93 -44.2 93.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.358 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.59 -44.13 96.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.308 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 6' ' ' GLU . 23.0 t -57.24 -45.88 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.654 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -58.64 -54.75 43.54 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.768 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -60.83 -49.1 78.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.941 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -60.82 -34.31 74.35 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' VAL . 84.3 tt0 -68.61 -42.61 77.88 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.087 0.47 . . . . 0.0 110.527 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -40.05 88.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 81.7 t80 -65.78 -49.62 67.67 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.96 -42.65 96.93 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.2 tt -60.56 -41.31 94.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -64.09 -39.4 93.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLY . 36.3 t0 -80.18 54.79 2.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -39.02 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.54 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.3 m-20 -86.42 -27.22 24.29 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.186 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.75 12.53 84.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.697 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 47.5 p30 -66.39 -16.61 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.747 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 104.98 -12.53 49.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -140.9 145.21 35.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.729 0.3 . . . . 0.0 111.151 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 4.6 mp -105.31 120.15 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -81.75 169.09 17.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.708 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.37 -43.53 77.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.149 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.43 -43.25 99.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.14 0.495 . . . . 0.0 110.328 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.7 mt-10 -66.96 -40.02 87.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.041 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.92 -45.45 92.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.71 61.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -61.77 -42.58 99.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.749 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.68 -49.7 67.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 41' ' ' GLN . 1.3 mp -61.14 -39.04 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -56.45 -41.29 76.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.447 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 40' ' ' ASP . 42.3 m -65.79 -37.18 85.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.856 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.04 22.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 38' ' ' SER . 62.5 m-20 66.21 16.58 10.49 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.333 0.395 . . . . 0.0 112.03 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' ILE . 52.2 tt0 -136.92 145.53 44.39 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -149.94 82.18 6.67 Favored Pre-proline 0 C--N 1.331 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.36 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.71 163.98 34.99 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.947 2.431 . . . . 0.0 110.729 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 11.5 p -82.66 159.08 22.73 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 44' ' ' THR . 79.3 tt0 -38.33 -47.28 1.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 109.82 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.84 -63.1 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' O ' ' SD ' ' A' ' 51' ' ' MET . 15.4 mp0 -56.02 -41.39 74.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.86 -43.01 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -65.45 -52.35 53.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.419 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 65.5 t0 -58.88 -38.04 77.93 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.17 -47.92 47.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.821 178.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.22 -47.33 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.888 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -58.2 -45.61 87.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -44.2 -29.86 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.821 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -114.98 -31.12 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.66 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t70 -58.9 86.22 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.03 -34.99 70.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.5 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 18.7 p-10 -93.2 -21.9 19.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.844 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.66 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.74 64.77 3.69 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 53.9 p30 -107.79 -13.22 15.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 117.045 0.422 . . . . 0.0 111.547 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.08 7.48 58.46 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.419 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 32.9 p -135.06 164.39 27.74 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 mt -121.03 128.34 76.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -103.92 174.29 5.94 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.54 -52.1 64.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.565 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.82 -45.11 86.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.133 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -44.76 84.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.245 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.76 -44.36 96.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.59 -42.05 99.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.779 0.323 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 74' ' ' LYS . 10.2 t -63.92 -45.81 87.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.246 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.513 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -58.77 -42.09 88.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.547 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttt -71.81 -51.63 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.946 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.47 -30.92 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.519 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' SER . 64.0 tttp -67.33 -32.29 73.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -93.7 -11.37 31.65 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.21 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 76' ' ' VAL . 17.4 t -128.45 22.77 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.285 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -54.72 -20.89 9.29 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.195 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 79' ' ' THR . 30.2 p-10 -54.87 -55.09 34.23 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.443 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.477 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 46.1 p . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.568 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 53.85 50.2 17.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.549 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -84.91 153.02 3.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.079 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.667 ' N ' HD23 ' A' ' 4' ' ' LEU . 2.0 pt? -62.96 -26.61 68.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.319 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.422 ' O ' ' OE1' ' A' ' 8' ' ' GLN . 81.5 p -52.68 -39.01 61.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.846 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 10' ' ' VAL . 97.4 mt-10 -73.51 48.78 0.27 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.801 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -88.17 -54.34 4.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.784 0.326 . . . . 0.0 110.642 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.601 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -64.49 -37.84 88.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.252 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.5 mt -62.93 -43.92 99.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.328 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 6' ' ' GLU . 44.9 t -60.55 -47.71 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.078 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -66.1 -44.71 83.58 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.979 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.77 -49.57 75.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.971 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -60.03 -32.36 70.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.335 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.19 -39.63 89.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.168 0.509 . . . . 0.0 109.985 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.7 -46.99 85.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.705 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.56 -49.01 75.09 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.85 -45.79 78.72 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.2 tt -62.8 -39.48 94.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.248 0.547 . . . . 0.0 109.728 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.28 -42.96 96.18 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.278 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 57.8 t0 -81.23 54.15 2.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.195 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -37.75 -32.54 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.605 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p-10 -81.21 -25.42 36.73 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.704 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 77.38 14.51 82.44 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 51.6 p-10 -62.33 -4.03 1.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.978 0.389 . . . . 0.0 110.691 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.71 -17.0 33.03 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 9.0 m -130.43 130.5 44.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.611 0.244 . . . . 0.0 110.915 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.1 mt -93.77 111.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -77.66 164.58 25.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.59 -35.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.554 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -42.23 91.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.149 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.55 -38.05 83.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.332 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.55 -44.89 92.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.66 72.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.677 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -62.48 -43.32 99.1 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.76 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.83 -48.11 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.615 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -65.83 -39.73 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.172 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -59.52 -42.45 92.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.712 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 t -83.13 -14.41 53.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 11.0 tp -65.4 -43.25 91.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 2.7 m-20 155.66 -1.04 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.259 0.349 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -148.5 163.52 36.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -137.51 75.09 45.57 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 111.341 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.82 162.9 29.99 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.795 2.33 . . . . 0.0 111.003 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -82.54 152.22 26.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -39.38 -41.9 1.0 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.842 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.43 -50.69 51.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.482 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.93 -41.84 99.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.159 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.22 -42.43 99.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.196 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.26 -51.28 66.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.19 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.68 -36.39 78.64 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.559 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.0 mtt -71.45 -47.0 58.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.964 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.7 mt -64.66 -43.43 96.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t -58.69 -45.14 90.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.897 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 3.6 tm-20 -51.04 -28.66 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.031 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -110.73 -32.55 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -63.52 80.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.93 -35.38 64.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.019 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -90.39 -20.06 23.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.551 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.81 39.89 97.87 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.244 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.511 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 48.2 p30 -83.73 -17.09 42.45 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.718 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.66 56.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 43.8 p -133.08 165.52 24.55 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.66 130.94 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 96.8 mt-10 -104.28 176.12 5.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.323 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -56.03 -52.39 64.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.857 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -60.51 -44.5 95.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.005 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 99.8 mt-10 -63.41 -45.22 92.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.961 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.73 -41.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.68 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.25 -39.61 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.317 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.5 m -62.56 -45.9 90.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.325 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.43 -40.89 98.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.439 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 1.1 tpt -62.97 -53.64 50.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.289 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.67 -24.69 67.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 110.398 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -70.98 -28.85 64.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.931 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -84.62 -36.92 21.68 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.297 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -104.46 14.47 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.593 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 73' ' ' ALA . 56.8 tttm -44.65 -28.57 0.62 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.156 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -54.66 -55.61 27.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.355 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.703 179.665 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -154.19 -174.81 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.395 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.8 mt 67.73 63.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 O-C-N 123.729 0.643 . . . . 0.0 110.635 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.92 -37.41 58.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.507 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 14.9 t -156.68 -15.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.275 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' O ' HG23 ' A' ' 10' ' ' VAL . 95.2 mt-10 68.96 73.56 0.26 Allowed 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.939 0.774 . . . . 0.0 110.58 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -93.21 -57.51 2.59 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.709 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 7.6 pt20 -61.5 -37.01 82.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.249 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 mm -62.47 -43.11 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 6' ' ' GLU . 53.7 t -61.85 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.016 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -57.06 -54.18 49.68 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -62.14 -50.82 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.889 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -54.42 -38.12 65.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.161 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.41 -39.89 89.25 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.959 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.84 -48.5 80.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.967 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' ' CD1' ' A' ' 27' ' ' ILE . 61.7 t80 -62.89 -49.06 76.31 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.806 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.18 -47.92 65.69 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.31 -38.52 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.9 m-30 -66.39 -46.14 77.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.509 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 14.6 t70 -79.19 50.58 1.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.92 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -39.51 -26.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.836 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 42.7 p-10 -81.3 -27.71 34.94 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.642 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 80.21 12.73 82.88 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.895 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 53.7 p30 -63.78 -10.07 17.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.157 0.478 . . . . 0.0 110.658 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.36 61.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 3.8 m -133.73 135.38 43.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.605 0.241 . . . . 0.0 111.095 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 65.4 mt -99.58 115.54 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -77.85 165.18 24.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.551 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.18 -40.21 76.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.537 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.19 -42.28 98.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -69.28 -39.33 78.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.381 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.65 -45.2 93.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.66 -39.17 73.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -62.53 -44.33 96.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.972 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.453 HG11 ' CE2' ' A' ' 19' ' ' PHE . 49.4 t -62.94 -44.74 99.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.848 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.433 HG21 ' CD ' ' A' ' 43' ' ' PRO . 5.1 mm -62.74 -41.7 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -57.1 -41.59 79.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.952 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 t -73.28 -33.13 65.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 29.4 mt -61.58 -44.26 97.34 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 9.8 p30 147.38 2.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.661 0.601 . . . . 0.0 111.497 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -129.07 165.04 21.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -152.14 70.74 7.73 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.01 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.433 ' CD ' HG21 ' A' ' 36' ' ' ILE . 16.3 Cg_exo -66.72 152.85 79.77 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.666 2.244 . . . . 0.0 111.015 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.9 p -82.43 162.45 22.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -40.54 -46.96 2.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.953 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.93 -54.05 22.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.493 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -64.62 -43.71 92.86 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.459 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 mt -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.875 0.369 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -64.48 -50.33 67.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.436 -0.505 . . . . 0.0 109.871 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 67.7 t0 -61.89 -35.04 77.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.396 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.5 ttp -72.37 -48.49 41.28 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 HD11 ' A' ' 63' ' ' ILE . 84.8 mt -64.21 -44.18 97.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.6 m -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -46.29 -27.45 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.6 p -115.75 -24.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 14.1 t0 -63.77 77.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.03 -34.42 77.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.427 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 19.1 p-10 -87.86 -23.28 24.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.649 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.74 67.87 1.9 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.275 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 51.4 p30 -112.89 -15.21 12.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.936 0.368 . . . . 0.0 111.536 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.99 10.19 57.7 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.517 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 64.6 p -141.05 170.77 15.1 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 52' ' ' ILE . 65.1 mt -119.54 127.4 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 72.8 tt0 -99.01 167.55 10.66 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.418 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 38.6 t80 -52.78 -49.48 65.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.464 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.34 -42.4 95.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.154 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.89 -43.9 86.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.1 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.83 -44.01 97.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.355 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -63.35 -41.81 98.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 74' ' ' LYS . 72.1 m -64.95 -48.88 72.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.742 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.0 tp -58.92 -41.18 86.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 110.651 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.1 mmm -68.59 -57.62 5.47 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.095 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.11 -29.99 70.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 70' ' ' SER . 64.4 tttp -65.62 -36.22 83.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.669 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -71.64 -44.92 63.49 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.823 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.482 ' C ' ' N ' ' A' ' 78' ' ' ASP . 1.7 p -79.49 -7.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.389 . . . . 0.0 110.738 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -47.35 -14.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.173 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.482 ' N ' ' C ' ' A' ' 76' ' ' VAL . 52.6 t0 -57.74 -54.75 43.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.503 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.414 ' O ' ' OG1' ' A' ' 79' ' ' THR . 1.3 t . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.544 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -94.25 7.37 45.6 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.933 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.519 HG12 ' H ' ' A' ' 5' ' ' SER . 21.1 tt -130.55 130.46 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.185 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.7 mt -77.65 -20.23 54.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.163 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.519 ' H ' HG12 ' A' ' 3' ' ' ILE . 1.6 m -58.7 -6.81 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' O ' HG23 ' A' ' 10' ' ' VAL . 96.9 mt-10 -137.51 45.14 2.2 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 110.928 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -93.69 -64.56 1.07 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.4 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -64.24 -31.95 73.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.591 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mm -64.07 -43.79 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.064 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 6' ' ' GLU . 79.7 t -63.83 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.831 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.68 -44.63 96.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.929 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.43 -49.86 69.84 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.008 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -64.1 -34.05 77.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.47 -38.07 88.72 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.321 0.581 . . . . 0.0 110.268 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.68 -39.07 87.96 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.176 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -69.92 -48.58 57.99 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.16 92.17 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.96 -37.04 85.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -70.33 -40.12 74.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 110.557 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' GLY . 32.2 t0 -78.01 50.83 0.91 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.208 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -37.02 -31.2 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.695 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 22.6 m-20 -75.28 -28.14 59.64 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.543 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.81 7.47 88.26 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.9 p-10 -68.26 -8.14 36.74 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.91 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.66 -6.82 83.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 m -130.51 131.83 45.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 110.799 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.6 mt -98.72 114.89 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.2 p -82.65 163.68 21.24 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 61' ' ' GLY . 1.7 m -58.18 -38.97 71.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.511 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -62.54 -40.57 97.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.264 0.554 . . . . 0.0 110.645 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 31.9 tt0 -71.49 -36.75 71.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.036 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.69 -45.06 95.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.03 -40.29 73.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.799 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -61.64 -43.4 98.93 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.803 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.19 -48.89 77.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.189 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' GLN . 2.8 mm -63.61 -36.92 78.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -57.06 -40.36 76.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -66.45 -36.19 82.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.662 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 40' ' ' ASP . 84.9 mt -70.46 26.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.4 OUTLIER 60.48 19.85 9.59 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' HG22 ' A' ' 36' ' ' ILE . 49.2 tt0 -138.62 150.67 46.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -154.74 83.86 3.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.72 170.85 3.15 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.61 2.206 . . . . 0.0 110.931 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 45' ' ' GLU . 55.2 m -84.7 168.64 15.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.627 ' N ' HG22 ' A' ' 44' ' ' THR . 80.4 mt-10 -53.05 -45.66 68.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.253 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 18.2 pt-20 -56.84 -44.49 82.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.888 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 50.6 mt-10 -64.81 -43.82 91.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.957 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.37 -44.86 96.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.823 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -67.74 -47.78 68.3 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -61.47 -40.26 93.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.0 tpp -69.87 -46.44 65.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 29' ' ' VAL . 82.1 mt -65.23 -44.33 95.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.4 p -61.67 -36.09 79.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.933 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -56.74 -32.01 65.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.782 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.42 -26.75 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 52.3 t0 -73.27 85.83 1.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.88 65.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.709 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -101.11 -23.37 14.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.223 -178.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.89 38.78 85.41 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.125 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 19.5 m120 -72.99 -16.54 61.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.874 0.337 . . . . 0.0 111.332 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 94.2 1.61 64.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.8 p -137.18 166.89 22.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.605 HD12 HD23 ' A' ' 32' ' ' LEU . 6.5 mt -114.46 126.02 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.74 178.66 4.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.321 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -56.8 -52.59 64.45 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.757 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.43 -43.31 96.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.901 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 95.3 mt-10 -65.65 -44.55 86.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.958 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -61.19 -43.09 99.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.458 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -40.76 97.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 74' ' ' LYS . 10.3 t -63.22 -45.4 91.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.262 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.42 -42.12 86.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.966 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.5 tpp -77.09 -41.08 43.61 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.246 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -71.85 -36.04 70.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.454 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -75.12 -27.57 59.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.474 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -83.59 -30.33 27.06 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.05 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.24 27.71 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.134 0.492 . . . . 0.0 110.611 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 73' ' ' ALA . 53.9 tttm -55.15 -37.23 66.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -50.39 -54.94 18.02 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.683 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.4 m . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.66 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 3' ' ' ILE . 70.9 m-20 -144.95 141.01 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.832 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.621 HG22 ' H ' ' A' ' 5' ' ' SER . 94.3 mt 57.56 144.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.136 0.493 . . . . 0.0 110.668 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' A' ' 5' ' ' SER . 10.7 mp -63.1 -39.34 94.42 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 118.291 -0.862 . . . . 0.0 110.332 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.621 ' H ' HG22 ' A' ' 3' ' ' ILE . 5.7 m 105.95 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 125.128 1.517 . . . . 0.0 110.891 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 10' ' ' VAL . 75.9 mt-10 -75.77 26.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.233 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 5' ' ' SER . 80.9 tt0 -91.93 -57.3 2.77 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 110.673 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -62.19 -33.6 74.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.434 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.18 -43.89 98.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.082 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 6' ' ' GLU . 75.7 t -60.86 -48.43 88.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.827 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.65 -47.37 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.926 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -60.04 -46.95 87.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -57.24 -36.4 70.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.31 -38.12 89.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.963 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.99 -44.4 92.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.092 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -65.87 -49.44 68.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.877 0.37 . . . . 0.0 111.186 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.82 -45.28 86.34 Favored Glycine 0 C--N 1.33 0.231 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.628 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.3 tt -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -65.32 -41.49 93.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.502 0.668 . . . . 0.0 110.376 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLY . 19.1 t70 -81.05 58.06 3.33 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.544 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -36.73 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.51 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -80.02 -27.51 39.5 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.33 7.23 82.21 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -64.29 -19.11 65.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.667 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.32 -11.95 51.4 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' OE1' ' A' ' 64' ' ' GLU . 57.3 m -128.06 127.56 43.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.92 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.29 111.96 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.478 HG22 ' OE1' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -82.12 166.93 19.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.663 HG22 HD13 ' A' ' 52' ' ' ILE . 71.9 t -55.7 -44.12 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.447 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -53.96 -43.19 69.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.858 0.361 . . . . 0.0 110.198 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.478 ' OE1' HG22 ' A' ' 28' ' ' THR . 43.9 mt-10 -67.75 -46.03 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.746 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.12 -46.66 88.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.6 -41.77 66.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.151 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.3 m -65.11 -39.76 93.57 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.349 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.2 -48.63 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.04 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.0 mm -61.67 -43.68 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.361 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -60.35 -41.8 94.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.352 0.596 . . . . 0.0 110.626 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -75.38 -22.64 57.34 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.737 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 39' ' ' LEU . 3.2 tt -66.17 -44.88 82.77 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 5.1 m-20 151.11 2.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.844 0.715 . . . . 0.0 111.418 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -143.33 154.01 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -133.24 79.09 62.45 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.63 159.29 53.28 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.858 2.372 . . . . 0.0 110.839 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -86.21 162.25 18.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 28.9 mp0 -40.66 -47.91 2.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 2.8 mm-40 -47.31 -58.98 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.713 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.05 -41.88 97.43 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.396 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.02 -43.46 98.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.882 0.373 . . . . 0.0 110.256 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.07 -49.69 71.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.969 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -61.28 -36.0 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.6 mtp -72.93 -46.95 49.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.663 HD13 HG22 ' A' ' 29' ' ' VAL . 73.3 mt -65.83 -45.19 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.665 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.1 m -58.15 -45.27 87.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -48.62 -27.47 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -113.73 -32.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.83 81.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.51 -32.68 71.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.419 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.0 p-10 -93.21 -21.87 19.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.804 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.82 31.68 78.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 49.4 p-10 -73.41 -16.91 61.32 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.524 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 99.19 6.28 55.69 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.413 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 31.7 p -139.94 173.66 11.3 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.8 mt -121.92 128.31 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 65' ' ' PHE . 13.4 tp10 -94.66 168.13 11.03 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.437 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 14.7 t80 -54.72 -50.49 68.2 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.702 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.48 -39.78 88.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.103 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.46 -42.28 92.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.243 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.78 -40.28 96.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.64 -41.01 98.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 15.6 t -64.32 -44.78 90.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.532 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 tp -58.81 -40.93 85.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.9 mmm -66.8 -56.63 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.339 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.61 -32.55 74.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.648 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 70' ' ' SER . 55.3 tttp -62.28 -34.78 77.23 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.455 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 mtpm? -81.15 -43.89 18.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.234 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 76' ' ' VAL . 52.8 t -77.84 -1.7 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.627 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.71 -10.8 0.49 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.171 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 76' ' ' VAL . 21.5 p-10 -55.71 -55.71 28.97 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.516 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.432 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 4.2 t . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.521 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.22 -45.73 86.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 111.474 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.9 mm 58.66 98.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.631 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.9 mm? -59.79 -35.99 75.8 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.069 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 6' ' ' GLU . 2.0 m 82.33 -113.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.757 0.66 . . . . 0.0 110.787 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 10' ' ' VAL . 38.8 tt0 79.75 55.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.589 0.556 . . . . 0.0 110.104 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -95.63 -50.61 4.87 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.156 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -63.38 -41.15 98.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.767 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.49 -42.6 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.263 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 6' ' ' GLU . 37.6 t -57.7 -47.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.935 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -65.28 -48.63 72.52 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.012 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.598 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.29 -48.7 80.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -59.03 -33.45 70.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.84 -38.6 86.71 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.185 0.517 . . . . 0.0 110.182 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.7 -46.39 85.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.91 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.04 -48.63 73.17 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.53 84.97 Favored Glycine 0 C--N 1.33 0.23 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.92 -37.99 89.43 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.1 m-30 -66.09 -41.51 90.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.374 0.606 . . . . 0.0 110.058 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ASP . 25.8 t0 -83.97 56.39 3.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.239 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -38.48 -19.04 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.697 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.1 m-20 -88.37 -26.89 21.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.378 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.08 11.47 83.98 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.729 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -65.18 -17.19 64.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.722 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -13.06 56.56 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 m -134.06 136.66 44.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.711 0.291 . . . . 0.0 111.111 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.5 mt -97.54 113.92 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.578 HG22 ' N ' ' A' ' 29' ' ' VAL . 89.4 m -78.3 164.85 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.578 ' N ' HG22 ' A' ' 28' ' ' THR . 8.2 t -56.12 -46.49 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.36 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.03 -41.57 83.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 94.4 mt-10 -67.26 -41.54 85.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.317 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.688 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.69 -44.42 96.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.102 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.38 70.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.859 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -61.38 -44.38 97.25 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.789 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.0 -47.97 85.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.082 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 41' ' ' GLN . 3.0 mm -61.73 -38.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.09 -41.24 78.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.294 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 40' ' ' ASP . 37.6 m -64.82 -35.67 81.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.92 21.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 38' ' ' SER . 98.1 m-20 63.3 18.41 10.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 6.8 tp-100 -134.0 139.41 46.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.29 76.73 37.2 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 120.754 0.311 . . . . 0.0 111.169 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.9 169.38 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.992 2.462 . . . . 0.0 111.092 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 47' ' ' GLU . 6.9 p -86.72 149.73 24.68 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 57.1 mp0 -39.6 -42.72 1.22 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.44 -49.03 36.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.195 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 44' ' ' THR . 46.0 tp10 -66.48 -41.85 88.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.211 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.56 -43.05 99.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.126 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -62.97 -51.21 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.293 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.92 -33.16 71.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.479 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.6 ttp -74.74 -45.84 41.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' ASP . 80.4 mt -63.42 -43.95 98.7 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.864 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -63.94 -45.51 88.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.209 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.34 -33.4 65.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.209 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 71' ' ' LEU . 3.6 m -103.43 -32.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 58.8 t0 -74.56 104.98 5.46 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.53 64.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.538 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 2.4 p30 -95.58 -23.22 17.16 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.622 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 63.08 41.22 99.85 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.458 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 49.6 p30 -80.3 -16.44 54.64 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.73 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 101.91 -0.84 51.75 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.458 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 18.5 p -129.83 170.87 13.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.688 HD12 HD23 ' A' ' 32' ' ' LEU . 5.0 mt -118.99 125.27 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 74.4 tt0 -95.22 167.3 11.44 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.409 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 63.2 t80 -53.72 -49.7 67.53 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.681 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.01 -41.24 87.25 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.233 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.73 -42.34 86.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.259 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -65.39 -41.08 94.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.881 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.2 tp -62.59 -41.59 99.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.522 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -66.16 -44.98 82.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.506 HD13 HG11 ' A' ' 55' ' ' VAL . 37.1 tp -63.39 -42.0 98.78 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.107 0.48 . . . . 0.0 111.182 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.598 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 27.0 ttt -60.97 -49.05 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.07 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -65.68 -49.27 69.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.3 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -51.79 -22.33 3.56 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -86.79 -42.74 13.05 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.668 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 76' ' ' VAL . 31.7 t -98.22 15.22 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 120.947 0.403 . . . . 0.0 110.412 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 73' ' ' ALA . 61.2 tttp -59.06 -7.64 1.19 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.115 0.483 . . . . 0.0 109.935 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 76' ' ' VAL . 68.3 t0 -53.45 -56.81 13.75 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.559 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.331 179.821 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -75.15 106.62 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.516 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.485 HD12 ' OE1' ' A' ' 7' ' ' GLU . 88.9 mt -70.09 -91.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.677 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 5' ' ' SER . 42.5 tp -90.47 -13.87 33.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 121.101 -0.24 . . . . 0.0 111.017 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 3.2 m 152.77 -78.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.922 0.391 . . . . 0.0 110.154 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 10' ' ' VAL . 75.6 mt-10 -80.71 87.35 5.83 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.883 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.485 ' OE1' HD12 ' A' ' 3' ' ' ILE . 52.8 tp10 -94.33 -66.85 0.89 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.701 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -60.98 -36.52 79.64 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.665 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.35 -44.19 97.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.066 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 6' ' ' GLU . 42.2 t -62.4 -46.72 95.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.045 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -60.41 -39.71 88.37 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.55 -56.21 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -39.32 81.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -64.72 -35.54 81.38 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.979 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.59 82.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.464 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -68.15 -47.26 68.53 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.32 98.13 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 tt -63.16 -37.56 87.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 0.0 109.688 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -70.99 -38.64 72.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 t0 -87.62 48.91 1.71 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.156 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -35.41 -28.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.363 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.6 m-20 -71.91 -28.04 63.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.512 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.44 8.64 87.62 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -68.48 -9.82 51.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.848 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.83 -5.65 84.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.9 m -129.03 131.57 47.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.69 0.281 . . . . 0.0 111.096 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.5 mt -100.27 114.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 p -82.2 164.12 21.45 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 30' ' ' GLU . 7.5 p -58.21 -42.26 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.615 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' N ' HG13 ' A' ' 29' ' ' VAL . 98.9 mt-10 -58.4 -38.86 78.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 0.0 110.229 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -71.28 -37.92 71.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.442 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.31 -44.59 96.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.29 76.48 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.78 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -64.1 -41.3 97.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.43 -47.39 80.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.498 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.88 -38.5 82.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -59.44 -40.91 88.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.657 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.34 -34.99 65.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.381 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 38.0 mt -61.4 -41.93 97.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 112.641 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.56 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 71.8 m-20 141.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.345 1.028 . . . . 0.0 111.18 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -137.76 158.19 44.88 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.493 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 13.2 p-10 -155.42 69.04 5.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.956 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.79 169.53 5.61 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.678 2.252 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.435 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 64.8 p -80.44 148.69 30.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' THR . 75.5 mt-10 -37.69 -36.67 0.19 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.887 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -55.22 -53.37 56.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.386 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 12.8 mp0 -61.08 -41.75 97.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.95 -42.14 97.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -68.12 -42.6 79.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.318 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.13 -39.62 95.21 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.744 0.306 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 mtm -69.57 -44.01 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.211 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -66.18 -44.42 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.989 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -33.93 75.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.072 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -59.57 -33.63 71.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.788 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.6 p -109.92 -31.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 43.9 t0 -64.56 77.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -55.82 -23.68 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.266 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -97.46 -22.53 16.52 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.607 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.09 46.21 89.27 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.803 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -88.97 -17.19 29.98 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.63 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.66 ' N ' HD22 ' A' ' 60' ' ' ASN . . . 95.63 10.63 56.53 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.803 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 33.1 p -139.47 159.4 42.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 63' ' ' ILE . 21.1 mt -113.83 128.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.42 171.89 8.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.37 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.67 -52.49 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.875 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.7 -41.29 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.6 -45.08 84.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.023 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.7 -42.29 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tt -63.97 -42.12 97.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -63.0 -46.08 89.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.231 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.568 HD11 ' NZ ' ' A' ' 75' ' ' LYS . 49.8 tp -63.11 -40.29 97.21 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 110.551 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mmm -59.3 -42.72 92.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.613 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.621 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.27 -50.64 67.13 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.346 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -52.52 -28.03 18.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.691 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.568 ' NZ ' HD11 ' A' ' 71' ' ' LEU . 14.5 mptt -84.22 -40.27 18.29 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.32 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.38 37.73 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.958 0.408 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 73' ' ' ALA . 38.3 ttpt -60.96 -44.71 96.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.083 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -74.2 -59.85 2.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.843 -179.916 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 2' ' ' ASP . 49.0 p30 -74.49 154.06 38.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.004 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 mm 57.86 114.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.863 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -72.41 -20.41 61.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.991 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER 82.22 51.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 O-C-N 123.525 0.516 . . . . 0.0 110.927 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 6.4 mp0 -79.81 44.34 0.64 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.857 0.361 . . . . 0.0 110.945 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.18 -57.69 2.92 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.801 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -67.57 -36.96 81.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.697 0.284 . . . . 0.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.3 mm -62.49 -44.77 99.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.06 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 6' ' ' GLU . 66.4 t -63.95 -46.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.443 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.51 -42.74 91.75 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.12 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.25 -51.95 65.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.065 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.93 -32.09 71.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.247 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.31 -39.6 89.42 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.963 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.65 -45.87 88.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.896 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.76 -49.56 74.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.54 84.5 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.2 tp -61.73 -40.64 95.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.002 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 4.6 m-30 -65.16 -43.08 92.94 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.239 0.543 . . . . 0.0 110.274 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 22' ' ' ASP . 34.5 t0 -81.56 50.47 1.49 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.739 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.5 m-20 -89.51 -27.85 20.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.109 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.05 14.27 82.09 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -69.23 -16.36 63.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.666 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.28 62.32 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.6 m -134.06 136.71 44.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.725 0.298 . . . . 0.0 111.08 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.4 mt -100.1 117.27 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 29' ' ' VAL . 49.5 m -77.82 162.7 26.7 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.686 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 28' ' ' THR . 13.6 t -57.03 -46.86 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.496 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -58.39 -42.49 87.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 110.273 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' CD ' ' OD2' ' A' ' 22' ' ' ASP . 63.2 tt0 -66.8 -35.79 80.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.275 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -64.01 -43.15 96.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.1 -40.2 70.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -43.23 99.25 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -65.42 -48.44 83.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.105 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 41' ' ' GLN . 97.4 mt -60.3 -39.69 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.94 -41.88 71.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.548 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.5 t -64.86 -39.65 93.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.42 20.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 38' ' ' SER . 12.7 m-20 67.56 18.64 9.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.579 ' O ' HG22 ' A' ' 36' ' ' ILE . 1.9 mp0 -135.29 147.66 49.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -150.95 72.56 8.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.53 167.35 13.41 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.768 2.312 . . . . 0.0 111.022 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.4 p -83.26 153.42 24.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 44' ' ' THR . 77.3 mm-40 -38.49 -45.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 110.137 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -47.11 -55.71 7.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' O ' ' SD ' ' A' ' 51' ' ' MET . 50.1 mt-10 -60.16 -41.16 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.217 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.19 -42.52 98.73 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.029 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -65.29 -53.81 38.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -59.17 -38.06 78.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.528 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.26 -48.19 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.28 -44.48 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 m -57.52 -45.6 84.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -45.81 -29.56 1.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -112.72 -29.28 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 9.5 t0 -60.68 81.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.23 -36.25 77.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 8.0 p30 -92.38 -21.14 20.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.827 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.75 69.47 1.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.417 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 6.6 m120 -109.76 -11.75 14.69 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.116 0.458 . . . . 0.0 111.428 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 93.14 3.91 65.06 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -138.54 170.85 15.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -120.03 127.71 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.027 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -104.75 175.52 5.47 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -57.07 -54.75 43.2 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.646 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 33.0 p-10 -54.06 -46.0 71.83 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.094 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 99.5 mt-10 -64.04 -41.85 97.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.863 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 59.0 t80 -63.3 -37.57 87.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.08 -43.25 99.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.308 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 74' ' ' LYS . 58.8 m -65.46 -44.9 85.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.084 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -56.48 -45.67 80.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.43 -177.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 75.2 mtp -65.91 -49.46 67.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.016 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.34 -35.01 79.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.492 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 70' ' ' SER . 32.9 ttmt -62.7 -31.71 72.67 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -83.95 -35.71 23.79 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.944 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 76' ' ' VAL . 24.2 t -99.34 16.81 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.247 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' ALA . 49.1 tptt -58.93 -33.09 70.19 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.096 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -56.06 -54.16 48.27 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.781 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.1 m . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.63 179.622 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -97.65 81.86 2.98 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.647 HG23 ' N ' ' A' ' 4' ' ' LEU . 6.1 tp -157.12 -58.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.372 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.647 ' N ' HG23 ' A' ' 3' ' ' ILE . 11.8 mt -74.05 -51.82 14.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 0.0 110.647 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 6' ' ' GLU . 2.8 p 73.86 -63.21 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.417 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' N ' ' OG ' ' A' ' 5' ' ' SER . 83.6 mt-10 76.69 59.44 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.079 0.862 . . . . 0.0 110.973 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -93.95 -68.39 0.8 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.028 0.442 . . . . 0.0 110.145 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.435 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 14.5 pt20 -61.58 -28.19 69.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.189 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.08 -45.46 98.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.077 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.11 -47.2 93.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.814 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.1 -42.56 99.61 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.834 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.435 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.5 m-30 -60.3 -46.37 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -59.71 -33.55 71.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -66.62 -37.91 85.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.252 0.549 . . . . 0.0 110.168 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.03 85.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.917 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -63.3 -47.44 82.29 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 111.084 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.05 91.89 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.19 -39.0 93.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.023 0.44 . . . . 0.0 110.229 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -67.54 -40.42 85.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.278 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 23' ' ' GLY . 34.5 t0 -81.82 58.34 3.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.922 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -37.54 -21.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.843 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 m-20 -88.15 -26.36 22.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.586 0.231 . . . . 0.0 111.443 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 74.51 10.14 82.36 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -64.3 -17.58 63.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -11.72 56.38 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.9 m -130.71 131.39 44.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.853 0.359 . . . . 0.0 111.326 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.2 mt -96.99 114.28 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.3 p -79.16 165.66 23.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 t -57.67 -44.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.589 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -56.94 -41.68 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.009 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.58 -41.59 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.468 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.21 -44.86 94.14 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -55.3 -40.33 70.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -63.36 -42.85 98.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.866 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.98 -49.34 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.694 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mm -65.64 -41.13 89.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 49.2 ttp180 -57.75 -40.97 80.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.362 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -85.05 -14.05 48.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.526 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 9.9 tp -68.08 -43.4 78.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 3.4 t70 154.63 -4.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.414 0.446 . . . . 0.0 111.108 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -139.92 158.74 43.59 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -135.19 72.06 67.07 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.83 155.74 62.08 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.664 2.243 . . . . 0.0 110.913 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -82.88 156.78 23.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -40.03 -43.8 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 2.8 mt-10 -50.48 -52.43 38.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.52 -42.88 99.81 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.142 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.08 -42.31 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.54 -49.77 75.34 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.076 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.52 -35.26 75.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.69 0.281 . . . . 0.0 110.446 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -72.96 -45.84 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.813 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 56' ' ' ASP . 85.1 mt -64.8 -44.5 96.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.956 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -45.7 91.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.552 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -57.77 -31.66 66.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 m -106.63 -24.51 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 66.7 t0 -81.57 95.94 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.41 68.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.795 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -94.91 -24.15 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.244 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.28 35.35 82.48 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.069 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.485 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 20.3 m120 -67.52 -18.82 65.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.811 0.305 . . . . 0.0 111.356 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.72 -12.22 56.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 p -125.48 -179.76 4.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 109.967 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.13 130.75 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.631 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -101.26 177.67 4.87 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.458 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.67 -50.89 71.69 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.905 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 31.5 p-10 -58.82 -43.63 90.68 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.431 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 96.8 mt-10 -65.76 -40.72 92.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.62 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.86 -42.34 99.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.741 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.52 -39.14 82.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 74' ' ' LYS . 20.8 m -63.6 -42.89 98.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.3 -42.54 86.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.625 0.25 . . . . 0.0 110.778 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 12' ' ' PHE . 74.8 mtp -65.73 -56.43 12.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.553 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -63.39 -34.55 77.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.63 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 70' ' ' SER . 5.7 tmtm? -64.17 -31.89 73.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -92.22 -13.3 30.72 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.701 0.286 . . . . 0.0 110.366 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 76' ' ' VAL . 91.9 t -114.19 5.36 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.937 0.399 . . . . 0.0 110.419 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 73' ' ' ALA . 48.6 tttp -56.7 -13.46 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.016 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -58.22 -57.66 11.87 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.505 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.501 -179.942 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -68.48 137.1 54.16 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.639 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -111.72 37.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.136 -179.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.0 mt -59.87 -49.8 76.3 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.103 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.415 ' H ' ' H ' ' A' ' 6' ' ' GLU . 4.3 p 176.44 5.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.69 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 10' ' ' VAL . 96.1 mt-10 -78.0 19.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.03 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -89.03 -63.51 1.28 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.58 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -65.14 -36.11 83.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.452 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.85 -47.46 93.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.384 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 6' ' ' GLU . 53.4 t -61.84 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.233 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.4 -42.39 96.12 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.3 -48.13 79.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.091 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -62.78 -34.71 77.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.204 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.03 -36.24 82.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.191 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -67.47 -40.62 85.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.101 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.475 ' CE2' HD12 ' A' ' 27' ' ' ILE . 59.7 t80 -70.37 -49.69 46.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.05 96.57 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.55 -39.12 89.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 9.6 m-30 -68.52 -40.49 80.76 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.934 0.397 . . . . 0.0 110.674 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.0 t0 -78.85 48.14 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.59 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -36.6 -40.36 0.25 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.877 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.0 p-10 -69.73 -25.34 63.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 0.0 111.627 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.12 14.74 80.1 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.891 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.1 p-10 -64.58 -1.52 1.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.673 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 75.51 -10.23 12.69 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.438 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.6 m -130.64 131.84 45.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.574 0.226 . . . . 0.0 110.839 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.475 HD12 ' CE2' ' A' ' 16' ' ' PHE . 95.0 mt -97.25 113.4 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -83.52 165.28 19.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.748 179.099 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.99 -36.92 64.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.524 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.98 -41.32 97.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.248 0.547 . . . . 0.0 110.616 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' H ' HG23 ' A' ' 28' ' ' THR . 42.6 tt0 -72.38 -39.46 68.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.056 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.7 tm? -61.5 -45.92 92.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.07 -38.08 70.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.807 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -62.17 -42.7 99.52 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.834 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.08 -47.19 85.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.524 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 41' ' ' GLN . 2.8 mm -63.76 -38.74 83.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.047 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -57.08 -39.81 75.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.2 t -69.29 -38.17 78.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.04 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.95 25.78 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 38' ' ' SER . 33.5 t70 62.91 20.47 12.25 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.511 ' O ' HG22 ' A' ' 36' ' ' ILE . 97.1 mm-40 -136.14 142.49 44.22 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -148.29 80.65 8.43 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.026 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.76 170.7 6.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.853 2.369 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 m -86.47 159.33 19.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.61 -39.34 7.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.76 -55.59 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -62.69 -40.78 98.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mt -61.2 -42.71 99.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.059 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -70.83 -41.54 71.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.131 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -63.46 -38.92 93.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.725 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 71.0 mtm -69.0 -44.04 73.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.991 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.76 -45.88 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.074 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.2 t -59.12 -37.42 77.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.56 -31.57 64.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.074 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.1 p -111.03 -32.88 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.4 t70 -63.82 79.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.04 -24.28 62.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.587 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.8 p-10 -95.36 -23.2 17.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.913 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.606 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.8 38.75 93.26 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 51.5 p30 -81.39 -17.04 50.38 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.526 -0.396 . . . . 0.0 111.608 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.08 7.7 60.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 82.8 p -135.91 159.74 40.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.5 mt -112.73 127.04 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 74.6 tt0 -99.99 165.28 11.62 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.411 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 27.6 t80 -49.24 -54.81 14.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.425 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.16 -43.29 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.006 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.63 -44.13 82.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.063 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.505 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.43 -40.64 97.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.454 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.489 ' HG ' ' HZ3' ' A' ' 74' ' ' LYS . 46.9 t -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.87 -42.83 85.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.544 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mmm -65.55 -47.3 76.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.931 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -65.65 -31.23 72.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.489 ' HZ3' ' HG ' ' A' ' 70' ' ' SER . 33.4 mttp -66.22 -34.48 78.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.481 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -85.68 -35.46 20.87 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.207 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 76' ' ' VAL . 22.0 t -99.74 13.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.087 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 73' ' ' ALA . 49.6 tttm -46.8 -34.34 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.08 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -49.34 -55.34 13.18 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.422 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.803 -1.094 . . . . 0.0 110.501 179.751 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -142.48 93.06 2.48 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.15 -73.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.217 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 62.8 mt -44.1 -35.88 2.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 0.0 110.183 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 7' ' ' GLU . 8.0 t -167.97 -144.68 0.05 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.144 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 62.85 -41.26 0.18 Allowed 'General case' 0 C--O 1.221 -0.415 0 O-C-N 123.662 0.602 . . . . 0.0 111.111 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 5' ' ' SER . 82.6 tt0 -66.35 -44.45 83.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.271 0.557 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 13.7 mt-30 -78.39 -35.52 47.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.89 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 17.7 mm -70.6 -46.77 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.434 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 11' ' ' ASP . 8.5 p -59.22 -47.5 90.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.998 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.56 ' N ' HG13 ' A' ' 10' ' ' VAL . 64.4 t0 -63.32 -54.05 43.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.957 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 14.9 m-30 -61.82 -52.56 63.67 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.314 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 28.6 tptp -51.66 -40.78 60.64 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.034 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -68.58 -40.37 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.113 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.5 -50.14 73.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -62.59 -49.19 76.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.843 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.5 -48.3 65.72 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.542 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 tt -62.65 -39.24 93.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.071 0.462 . . . . 0.0 109.793 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -63.94 -43.16 96.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.145 0.497 . . . . 0.0 110.497 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 23' ' ' GLY . 61.1 t0 -81.91 52.21 1.9 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.254 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -38.59 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.833 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 3.4 p-10 -83.62 -24.84 31.25 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.45 15.98 80.85 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.184 -0.532 . . . . 0.0 111.928 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 49.7 p-10 -66.87 -5.44 12.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.549 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 84.32 -16.93 31.53 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.444 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 5.2 t -128.9 128.76 44.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.474 0.178 . . . . 0.0 110.946 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.44 112.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.56 HG22 ' N ' ' A' ' 29' ' ' VAL . 85.4 m -77.42 162.96 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.592 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.641 HG12 HD13 ' A' ' 52' ' ' ILE . 2.4 m -55.74 -36.81 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.469 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.74 -41.8 91.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.962 0.41 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.47 -37.8 85.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.353 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 tp -64.16 -43.96 93.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.71 72.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -63.49 -41.74 98.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.3 t -65.61 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.241 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.19 -35.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -60.43 -42.78 96.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -68.9 -35.46 76.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.961 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 11.2 mt -60.57 -43.91 96.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.728 -1.129 . . . . 0.0 112.67 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.569 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 70.1 m-20 142.01 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 124.691 1.245 . . . . 0.0 111.533 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -136.57 157.09 47.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -148.97 71.7 10.29 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.783 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.02 156.69 61.26 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.526 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 6.2 p -84.88 155.99 21.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 56.8 mp0 -40.06 -47.39 2.3 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -46.86 -51.86 15.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.047 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -70.14 -41.5 73.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.762 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -40.81 95.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -61.62 -50.5 72.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.699 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.01 -37.1 78.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.9 tpp -74.01 -47.41 37.25 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.641 HD13 HG12 ' A' ' 29' ' ' VAL . 77.3 mt -64.3 -44.56 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.0 p -58.09 -43.96 87.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -50.16 -28.75 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -110.13 -30.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 10.7 t0 -63.97 78.53 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.24 -36.02 80.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.694 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 3.9 p30 -90.41 -20.64 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.03 1.18 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.177 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 7.8 m120 -109.83 -12.43 14.59 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.266 0.533 . . . . 0.0 111.471 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.07 63.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -138.69 177.11 8.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.1 mt -121.5 128.44 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -98.43 171.73 7.98 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.46 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 52.5 t80 -56.1 -51.72 66.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.681 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.13 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.462 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 89.1 mt-10 -59.03 -46.23 88.74 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.9 t80 -68.33 -26.57 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.85 -43.05 89.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 110.108 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 74' ' ' LYS . 13.9 t -66.53 -41.87 88.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.36 -41.39 84.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.99 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.466 ' SD ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 mtp -65.86 -51.62 57.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.468 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -67.83 -33.83 75.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.769 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 70' ' ' SER . 13.0 ttmm -65.01 -30.88 71.9 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.714 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -81.51 -41.04 22.29 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.217 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 79' ' ' THR . 2.2 t -108.73 29.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.217 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 73' ' ' ALA . 77.4 tttt -52.94 -35.4 58.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.899 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 79' ' ' THR . 34.8 p-10 -52.46 -52.17 55.57 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.635 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.496 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 1.2 t . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.885 -1.055 . . . . 0.0 110.55 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 66.8 t0 -170.97 -120.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.664 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.458 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 19.3 mm 64.91 -0.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.612 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.432 ' O ' ' OG ' ' A' ' 5' ' ' SER . 10.3 mp -57.43 -33.12 67.57 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 4' ' ' LEU . 4.9 p 74.47 -53.28 0.68 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.937 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 10' ' ' VAL . 60.4 tt0 78.42 56.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.704 0.627 . . . . 0.0 110.447 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -94.97 -48.42 5.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -43.41 98.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.184 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.6 mp -59.83 -41.95 87.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.914 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 6' ' ' GLU . 53.7 t -58.54 -46.39 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.868 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.36 -54.88 29.97 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.981 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 69' ' ' LEU . 49.9 m-85 -59.09 -47.85 83.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -59.42 -33.75 71.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.456 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.0 -41.64 81.94 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.078 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.47 -46.76 84.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.967 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.51 -49.47 73.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.87 85.42 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.84 -39.71 95.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.9 m-30 -64.44 -41.0 96.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.076 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 27.8 t0 -82.19 53.84 2.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.135 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -38.62 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.684 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.1 p-10 -89.2 -25.01 22.0 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.41 18.45 79.16 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.74 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 46.6 p-10 -66.8 -10.71 50.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.774 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.81 -15.74 60.98 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.1 p -133.18 132.89 42.1 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.687 0.28 . . . . 0.0 110.835 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.1 mt -95.43 113.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 29' ' ' VAL . 76.6 m -78.55 164.1 24.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.636 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.564 ' N ' HG22 ' A' ' 28' ' ' THR . 5.7 p -55.32 -33.91 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.763 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.44 -42.63 74.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.282 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -65.03 -38.19 90.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.207 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.95 -43.67 91.94 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.39 74.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.916 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 m -60.68 -43.28 97.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.758 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.21 -46.38 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.238 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.08 -43.88 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.951 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -56.16 -41.65 75.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.342 0.591 . . . . 0.0 110.582 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -66.29 -37.48 85.51 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.089 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 35.6 mt -61.73 -44.08 97.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.564 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 10.9 t70 141.12 10.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 124.003 0.815 . . . . 0.0 111.352 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -128.72 164.75 22.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 110.075 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -154.16 70.72 6.31 Favored Pre-proline 0 C--O 1.232 0.176 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.47 154.68 73.05 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.726 2.284 . . . . 0.0 111.206 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 45' ' ' GLU . 11.5 m -80.32 164.68 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 44' ' ' THR . 84.3 tt0 -42.36 -49.34 5.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.39 -58.12 4.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.472 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.61 -41.68 90.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.188 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.0 mt -61.37 -42.98 99.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -67.43 -53.37 29.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -59.65 -37.74 79.52 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.556 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.4 mmt -71.42 -48.86 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.608 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASP . 57.7 mt -64.88 -45.18 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -58.62 -46.96 85.92 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -45.77 -27.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.4 p -116.14 -27.51 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 52' ' ' ILE . 26.1 t0 -59.37 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.69 -35.13 75.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.1 m-20 -82.96 -23.66 33.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.462 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.1 26.97 68.17 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 30.1 p-10 -81.58 -16.42 51.66 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.739 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.69 7.8 50.19 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.453 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 49.5 p -134.23 167.12 21.27 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 52' ' ' ILE . 12.0 mt -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.843 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -102.87 171.64 7.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -53.51 -50.29 65.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.309 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -57.56 -43.96 84.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.233 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 80.6 mt-10 -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.815 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 83.5 t80 -62.24 -44.47 96.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.378 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.425 ' CD1' ' CD2' ' A' ' 12' ' ' PHE . 57.3 tp -62.18 -42.44 99.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.183 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 74' ' ' LYS . 67.7 m -64.77 -44.57 89.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.136 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -57.83 -44.81 86.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.787 -178.116 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 76.0 mtp -70.96 -50.77 30.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.93 -31.95 73.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.87 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 70' ' ' SER . 36.6 ttmt -66.3 -33.75 76.44 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.514 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -81.94 -38.84 24.61 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.325 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 76' ' ' VAL . 59.7 t -85.6 -1.27 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.634 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -49.33 -13.69 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.131 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.442 ' N ' ' C ' ' A' ' 76' ' ' VAL . 93.2 m-20 -60.65 -60.2 4.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.676 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.374 179.961 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 52.98 83.45 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.8 pt -90.09 -108.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.498 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 4' ' ' LEU . 10.3 mp -79.08 -10.06 59.72 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.3 p -52.69 -40.19 62.71 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 6' ' ' GLU . 4.1 pt-20 -73.65 79.12 1.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.88 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -94.73 -60.78 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 110.531 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 22.8 mm-40 -64.98 -32.65 74.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.28 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mm -62.97 -44.21 99.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.052 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 6' ' ' GLU . 81.4 t -63.37 -47.3 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.12 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.31 -44.02 92.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.266 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.09 -44.61 97.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.83 -37.66 76.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.177 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -65.43 -35.71 81.74 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.139 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.32 -43.29 86.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.107 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -69.59 -48.82 58.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.749 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.25 95.06 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.87 -38.48 91.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.902 0.382 . . . . 0.0 110.057 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 8.9 m-30 -68.85 -41.87 77.87 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.662 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 22' ' ' ASP . 27.4 t0 -79.37 47.13 0.79 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.219 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -36.49 -25.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.693 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.5 m-20 -76.78 -27.44 55.27 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.61 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.53 10.26 85.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -71.73 -9.74 58.73 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.798 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.96 -7.04 81.99 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 p -131.65 134.14 45.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.867 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.69 117.18 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 p -83.9 166.27 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.699 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 t -56.72 -43.98 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.03 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.42 -39.14 86.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.03 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 91.9 mt-10 -71.15 -42.57 68.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.132 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.19 -44.83 95.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.287 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.88 69.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.808 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -62.36 -42.59 99.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.887 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.2 -46.99 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.511 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 41' ' ' GLN . 5.3 mm -62.94 -39.64 85.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.16 -40.72 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 40' ' ' ASP . 51.1 m -67.91 -37.17 81.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.82 25.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 38' ' ' SER . 90.3 m-20 63.27 20.52 12.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.288 0.368 . . . . 0.0 111.931 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.526 ' O ' HG22 ' A' ' 36' ' ' ILE . 86.8 mt-30 -137.04 148.47 46.83 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -154.17 79.69 5.0 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' CD ' HG21 ' A' ' 36' ' ' ILE . 30.9 Cg_exo -61.07 170.01 5.4 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.669 2.246 . . . . 0.0 111.113 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -91.49 165.1 13.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 49' ' ' GLN . 80.9 mm-40 -42.17 -46.47 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.897 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 1.5 mm-40 -56.66 -62.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.831 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.9 -45.75 93.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.063 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.21 -43.78 98.32 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.426 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 57.1 tt0 -71.92 -42.67 66.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.269 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.56 -36.8 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.612 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.9 mmt -69.01 -45.18 71.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.692 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.96 -43.98 88.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.1 m -57.69 -38.45 75.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.874 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -49.08 -29.03 4.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -115.47 -27.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 14.2 t0 -62.99 76.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -61.54 -22.57 65.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.351 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -101.14 -23.54 14.44 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.736 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 69.07 35.11 77.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.295 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.546 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 47.9 p30 -76.56 -17.85 58.99 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.624 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.01 8.79 60.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 p -139.77 162.56 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 HD23 ' A' ' 32' ' ' LEU . 14.8 mt -115.63 127.58 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.546 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 53.3 mp0 -98.5 171.39 8.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -56.25 -52.27 65.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.355 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 29.1 p-10 -56.79 -42.44 79.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.326 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 94.4 mt-10 -65.36 -44.01 89.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -66.55 -33.59 76.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.4 tp -66.74 -43.7 83.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.906 0.384 . . . . 0.0 110.565 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 74' ' ' LYS . 72.9 m -72.5 -45.68 58.27 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.243 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 tp -48.74 -52.74 22.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.163 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 ttp -67.92 -47.32 69.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.636 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -63.51 -34.83 78.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.774 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 70' ' ' SER . 9.8 mtpm? -63.26 -35.66 81.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.186 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -79.92 -42.27 24.43 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.692 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 76' ' ' VAL . 21.2 t -97.97 23.28 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.149 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 73' ' ' ALA . 88.3 tttt -55.44 -36.21 66.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.948 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 79' ' ' THR . 30.3 p-10 -56.02 -55.74 29.23 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.843 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.507 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 53.7 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -64.46 -76.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.063 0.458 . . . . 0.0 111.26 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.3 pt -49.29 139.58 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.644 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.498 ' O ' ' C ' ' A' ' 5' ' ' SER . 83.3 mt -59.26 -52.61 64.93 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.982 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 7' ' ' GLU . 32.6 t 24.11 -98.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.814 0.696 . . . . 0.0 111.554 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.539 ' O ' HG23 ' A' ' 10' ' ' VAL . 71.7 mt-10 61.01 -35.0 0.09 Allowed 'General case' 0 C--O 1.225 -0.205 0 O-C-N 123.483 0.489 . . . . 0.0 110.952 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.629 ' H ' ' C ' ' A' ' 5' ' ' SER . 80.7 mm-40 -72.31 -56.13 6.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.682 0.277 . . . . 0.0 110.663 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 8' ' ' GLN . 6.9 mt-30 -66.72 -34.95 78.99 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.324 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.2 mm -63.55 -46.55 94.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.028 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 6' ' ' GLU . 56.1 t -60.48 -46.8 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.075 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.25 -50.76 66.69 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.935 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -62.91 -51.67 66.05 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.463 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -54.27 -37.7 65.01 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.886 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -68.32 -38.84 81.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.081 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.01 -52.31 63.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.174 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -62.62 -48.68 78.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.766 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.58 84.81 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.97 -38.44 91.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.839 0.352 . . . . 0.0 110.064 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.59 -46.07 70.33 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.176 0.512 . . . . 0.0 110.219 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 23' ' ' GLY . 31.8 t0 -78.8 43.32 0.49 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.48 -23.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.875 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.0 p-10 -83.3 -27.16 29.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 111.674 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 82.55 15.64 73.06 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.033 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 55.8 p30 -70.18 -6.11 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 -11.84 26.96 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 10.3 m -131.79 133.08 44.34 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.3 mt -98.45 115.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -79.5 160.53 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 30' ' ' GLU . 7.2 p -56.99 -42.2 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.483 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.44 ' N ' HG13 ' A' ' 29' ' ' VAL . 96.8 mt-10 -61.92 -40.93 97.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.272 0.558 . . . . 0.0 110.223 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 76.6 tt0 -69.27 -35.23 75.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.273 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -62.99 -43.58 98.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.05 72.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.681 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -61.77 -41.93 98.34 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.72 -48.44 75.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.264 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.4 mt -61.52 -36.88 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -59.81 -41.72 91.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.414 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.4 m -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 86.1 mt -59.83 -41.98 92.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.452 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 30.2 t0 131.54 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.623 1.202 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -141.2 156.06 45.97 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.8 -0.563 . . . . 0.0 110.015 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -149.34 76.18 9.34 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.832 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 172.11 2.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.629 2.219 . . . . 0.0 111.261 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -85.53 160.29 19.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 57.7 mp0 -43.45 -41.67 4.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.5 -57.58 8.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.818 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 51.3 mp0 -58.62 -39.36 80.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.229 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.4 -43.41 98.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.988 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -73.36 -49.87 24.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.179 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.01 -38.72 87.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.594 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.5 ttm -67.73 -47.39 69.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.02 -44.31 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 t -59.22 -42.09 90.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.99 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -48.27 -32.63 7.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.017 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -112.93 -30.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.9 t0 -61.53 81.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.37 -26.7 65.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.419 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 2.0 p30 -96.74 -21.98 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.675 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.11 40.62 95.11 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.5 p-10 -82.67 -16.92 46.38 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.517 -0.402 . . . . 0.0 111.554 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.92 4.64 58.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.461 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 55.5 p -135.56 165.4 25.62 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.01 126.8 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -94.38 170.37 9.54 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -56.68 -51.52 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.682 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -61.18 -42.09 97.95 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.228 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -64.8 -44.98 88.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.129 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.52 -41.11 98.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.71 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.14 -41.8 99.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.952 0.406 . . . . 0.0 110.875 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.85 -43.49 98.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.224 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.9 tp -61.68 -39.23 90.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 110.761 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 45.3 mtp -61.07 -49.66 76.46 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.021 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -66.6 -26.7 67.22 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.204 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -66.07 -34.3 77.76 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.197 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -84.41 -38.18 20.55 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.8 18.73 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.373 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 73' ' ' ALA . 21.0 ptmt -46.72 -40.95 14.3 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.155 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 79' ' ' THR . 34.0 p-10 -65.15 -59.25 4.31 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.796 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.516 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 2.1 m . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.521 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -84.42 1.33 45.83 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.094 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 mm -77.93 134.35 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.0 mt -50.02 -44.39 51.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.15 0.5 . . . . 0.0 110.409 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.8 t 62.88 -130.41 0.52 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.847 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 10' ' ' VAL . 78.7 mt-10 -83.84 39.29 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.099 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -71.0 -57.16 4.82 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.68 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -65.19 -39.43 92.84 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.421 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.81 -43.69 97.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.082 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 6' ' ' GLU . 7.9 t -56.06 -44.61 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.786 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.72 -54.37 46.08 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.099 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -56.55 -48.53 77.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -38.16 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -64.15 -41.41 97.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.074 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.02 -46.68 86.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.909 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -62.68 -50.76 69.88 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.806 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.19 -46.23 79.6 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.542 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -61.83 -40.6 95.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CE2' HG11 ' A' ' 35' ' ' VAL . 5.1 m-30 -63.68 -41.76 98.12 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.041 0.448 . . . . 0.0 110.037 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 34.9 t0 -78.38 54.33 1.4 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.349 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -39.18 -30.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.632 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.9 p-10 -82.34 -23.85 34.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.39 16.11 80.97 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.7 p-10 -65.88 -9.79 32.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.354 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -15.98 58.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 6.9 t -130.85 130.58 43.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 0.187 . . . . 0.0 110.761 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.34 112.38 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -79.96 167.29 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.621 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.45 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.4 m -55.63 -39.87 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 73.1 mm-40 -63.09 -42.85 99.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -66.51 -41.17 89.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.139 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.604 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.6 -45.0 94.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.49 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.03 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 m -60.19 -44.69 94.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.659 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG11 ' CE2' ' A' ' 19' ' ' PHE . 55.0 t -63.35 -46.64 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.154 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 41' ' ' GLN . 5.2 mm -60.46 -39.42 81.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -54.89 -42.48 72.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.88 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 40' ' ' ASP . 7.6 t -65.09 -39.69 93.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.21 19.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.388 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 38' ' ' SER . 34.3 m-20 69.08 20.05 7.82 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.871 0.732 . . . . 0.0 111.252 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' HG22 ' A' ' 36' ' ' ILE . 83.6 mt-30 -133.74 142.78 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.019 -0.425 . . . . 0.0 109.965 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -140.54 70.94 31.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.63 157.6 46.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.7 2.267 . . . . 0.0 111.309 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 45' ' ' GLU . 60.9 p -83.73 154.26 23.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 44' ' ' THR . 97.1 mt-10 -38.41 -47.54 1.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.991 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -46.06 -60.32 2.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.33 -41.75 98.81 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.181 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -42.2 98.23 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.122 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -63.65 -51.92 63.03 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.211 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -60.51 -35.43 75.92 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.558 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 70.9 mtm -74.61 -47.74 30.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.04 -43.66 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.843 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -59.12 -45.74 90.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' CD ' ' O ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -46.21 -25.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -118.18 -24.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -59.89 81.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.58 -34.53 77.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.28 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.3 m-20 -80.52 -24.11 39.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.702 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.17 23.15 65.9 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.439 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 26.8 p-10 -78.7 -18.42 54.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.122 0.461 . . . . 0.0 111.452 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.24 14.09 29.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.439 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 48.3 p -141.4 172.45 12.66 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.604 HD12 HD23 ' A' ' 32' ' ' LEU . 5.4 mt -121.57 129.13 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -100.26 172.12 7.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -53.99 -49.3 69.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.743 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.76 -42.0 96.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.182 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 92.3 mt-10 -68.21 -45.65 72.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.966 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.8 t80 -60.75 -46.01 92.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.776 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.96 -40.28 95.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 110.116 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 74' ' ' LYS . 81.4 p -63.75 -45.63 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.641 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.15 -42.54 86.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 53.3 mtp -67.92 -54.7 16.71 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.407 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.24 -30.87 71.9 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.884 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' SER . 5.3 tmtm? -67.07 -32.54 73.79 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.59 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.77 -44.13 14.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 78' ' ' ASP . 4.1 t -91.06 14.48 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.739 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 73' ' ' ALA . 86.8 tttt -47.2 -14.04 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.106 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 76' ' ' VAL . 45.5 t0 -56.23 -57.15 13.46 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.493 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.577 179.375 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.429 ' C ' HD12 ' A' ' 3' ' ' ILE . 96.1 m-20 -82.75 17.02 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.913 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.6 mp -101.23 113.66 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.403 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.621 ' O ' HD23 ' A' ' 4' ' ' LEU . 1.2 tt -62.99 -39.17 93.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.321 0.581 . . . . 0.0 109.998 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.5 t -59.42 113.13 2.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.359 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 10' ' ' VAL . 84.0 mt-10 68.09 75.16 0.28 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 123.736 0.648 . . . . 0.0 110.304 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -94.42 -60.8 1.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.896 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -63.0 -34.55 77.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.428 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.1 mm -63.3 -44.98 99.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.133 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 6' ' ' GLU . 75.1 t -63.45 -46.35 95.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.154 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.85 -42.9 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.976 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.41 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -61.05 -48.23 82.71 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -61.48 -32.39 72.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -66.83 -39.53 87.69 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 110.17 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -65.22 -42.01 93.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.983 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.68 -49.02 70.1 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.868 0.366 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.16 -44.36 93.2 Favored Glycine 0 C--N 1.329 0.194 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.79 -40.2 96.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.996 0.427 . . . . 0.0 110.063 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -65.74 -40.46 92.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.228 0.537 . . . . 0.0 110.456 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 23' ' ' GLY . 66.3 t0 -80.6 60.37 3.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' CB ' ' NZ ' ' A' ' 21' ' ' LYS . 9.3 mtmp? -37.23 -27.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.891 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.8 p-10 -97.16 -12.55 22.93 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 63.97 23.36 67.57 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.27 -0.49 . . . . 0.0 111.886 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -66.6 -12.0 55.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.206 0.503 . . . . 0.0 110.776 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.73 -14.49 64.02 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 m -132.65 132.14 42.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 0.0 110.91 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.66 111.74 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 m -75.15 154.89 37.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.59 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 61' ' ' GLY . 3.7 m -54.98 -29.57 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.48 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.52 -41.71 72.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.544 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 68.9 mt-10 -68.76 -41.73 78.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.68 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.692 HD23 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -58.79 -46.84 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.86 73.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.877 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -63.1 -43.85 97.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.14 -48.8 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.104 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.426 HG21 ' CD ' ' A' ' 43' ' ' PRO . 3.0 mm -63.52 -38.38 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -55.31 -40.77 71.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.845 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 40' ' ' ASP . 26.0 m -66.85 -33.57 75.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.674 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.67 23.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 38' ' ' SER . 99.7 m-20 63.7 14.22 8.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -137.95 146.52 43.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -142.74 83.88 11.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.083 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.426 ' CD ' HG21 ' A' ' 36' ' ' ILE . 23.1 Cg_exo -63.95 169.17 10.81 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.856 2.371 . . . . 0.0 111.071 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p -89.61 162.04 15.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -42.66 -46.21 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -50.55 -52.03 42.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.99 -42.73 97.1 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.234 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.0 -47.17 85.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.938 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -64.83 -50.88 64.93 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.175 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.3 t0 -59.15 -34.09 71.66 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.503 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.9 ttp -74.79 -45.53 43.01 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.774 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.57 -44.23 96.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.6 m -61.8 -46.51 89.2 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.046 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' OE2' ' NZ ' ' A' ' 74' ' ' LYS . 80.6 tt0 -45.07 -29.63 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.44 -33.38 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 53.7 t0 -65.41 98.1 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.98 -24.4 61.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.828 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -100.32 -24.57 14.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.42 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.42 37.3 85.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.283 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 13.7 m120 -70.95 -17.91 62.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.958 0.379 . . . . 0.0 111.422 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 100.38 -2.56 56.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -131.43 174.42 10.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.692 HD12 HD23 ' A' ' 32' ' ' LEU . 7.4 mt -116.51 120.8 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.991 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 68.6 tt0 -88.7 169.87 11.29 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.414 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 82.4 t80 -55.81 -49.04 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.759 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.63 -38.15 89.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.01 0.433 . . . . 0.0 110.249 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 97.5 mt-10 -67.33 -41.22 85.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.826 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -67.33 -38.55 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.502 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -41.37 96.48 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.08 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.6 p -69.95 -45.86 66.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.022 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.12 -44.13 93.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 110.334 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.41 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 tpt -54.62 -51.95 63.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.602 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.75 -39.47 93.68 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.909 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' NZ ' ' OE2' ' A' ' 54' ' ' GLU . 63.5 tttm -58.9 -23.79 61.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.094 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -86.83 -43.23 12.64 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.834 0.35 . . . . 0.0 110.426 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -112.92 37.58 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.064 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 73' ' ' ALA . 17.5 ttmm -55.94 -32.4 63.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -53.0 -57.34 10.68 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.433 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.614 179.743 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.3 148.69 48.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 3' ' ' ILE . 1.6 mp -40.16 156.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.461 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 4' ' ' LEU . 4.0 mm? -64.76 -29.6 70.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.087 0.47 . . . . 0.0 109.948 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.3 p -65.23 74.05 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.573 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 4' ' ' LEU . 95.6 mt-10 -75.61 74.22 2.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.976 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -95.74 -38.81 10.17 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.324 0.583 . . . . 0.0 110.483 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -80.75 -40.93 24.38 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.873 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.15 -44.81 91.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.608 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 11' ' ' ASP . 9.3 p -61.52 -47.76 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.967 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' N ' HG13 ' A' ' 10' ' ' VAL . 8.8 t70 -62.1 -45.87 91.57 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.874 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CD2' ' SD ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.21 -42.92 99.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.319 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -60.43 -35.47 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.203 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.16 -37.13 83.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.383 0.611 . . . . 0.0 109.748 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.36 82.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.249 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -67.89 -47.42 68.9 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.882 0.372 . . . . 0.0 110.966 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.15 -42.77 98.71 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 tp -62.87 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.114 0.483 . . . . 0.0 110.133 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.19 -36.54 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.33 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.1 t0 -92.53 49.42 1.48 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.182 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -36.5 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.846 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.2 m-20 -70.59 -28.11 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.358 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.76 10.34 85.83 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -69.04 -10.71 58.96 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.867 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.86 -6.31 83.78 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -131.3 134.48 46.41 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.715 0.293 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.7 mt -100.56 113.34 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -82.24 165.14 20.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.658 HG12 HD13 ' A' ' 52' ' ' ILE . 3.2 m -57.37 -44.5 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.735 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' N ' HG23 ' A' ' 29' ' ' VAL . 45.6 tt0 -58.67 -40.11 82.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.21 0.528 . . . . 0.0 109.899 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 97.0 mt-10 -70.23 -40.87 74.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.433 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.625 HD12 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -62.18 -45.46 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.85 -39.38 68.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -65.63 -39.8 91.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.776 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.78 -46.4 92.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.488 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.36 -38.88 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -57.53 -41.28 80.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.525 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -68.62 -31.89 71.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.086 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 76.3 mt -59.13 -42.76 91.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.751 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 36.2 p-10 137.83 17.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.181 0.926 . . . . 0.0 111.301 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -153.94 169.71 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -153.99 84.23 4.13 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.184 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.99 179.49 0.29 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.729 2.286 . . . . 0.0 110.994 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.412 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 50.6 p -89.59 155.03 19.52 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -41.53 -36.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 0.0 110.185 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 3.2 mm-40 -57.24 -53.46 57.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.532 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' OE1' ' OG1' ' A' ' 44' ' ' THR . 2.7 mp0 -60.94 -40.79 94.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.82 -42.96 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -72.99 -45.85 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.284 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.92 -39.92 93.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.532 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -67.59 -44.31 78.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.608 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.658 HD13 HG12 ' A' ' 29' ' ' VAL . 73.3 mt -66.67 -44.28 89.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -40.05 90.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -50.89 -33.82 25.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.9 p -111.21 -32.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 33.5 t0 -64.02 76.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.231 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.19 -25.67 61.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.67 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.415 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 2.0 p30 -95.66 -23.09 17.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.546 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.89 36.48 81.9 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 52.6 p-10 -77.52 -17.09 58.28 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.578 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 94.58 3.73 62.57 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 6.2 p -134.56 163.76 29.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.625 HD11 HD12 ' A' ' 32' ' ' LEU . 51.7 mt -116.4 128.82 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -104.52 164.7 11.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -45.99 -60.2 2.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.9 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -48.89 -43.3 38.98 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.43 -42.25 75.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.041 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 38.2 t80 -64.43 -37.33 87.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.41 -44.86 93.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.582 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.0 m -65.69 -43.7 88.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.89 -43.0 99.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.658 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.587 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 60.4 mtp -60.04 -44.85 94.39 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.2 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -58.14 -50.84 72.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.172 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.26 -25.15 63.83 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.686 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -90.45 -20.8 22.33 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.537 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.18 41.07 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 73' ' ' ALA . 25.8 pttm -63.28 -20.23 65.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.239 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -56.8 -59.93 4.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.42 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.593 -179.753 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.2 p30 -92.12 55.59 2.64 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.856 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 tt -147.59 137.93 17.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.456 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.48 -46.09 90.08 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.196 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t 74.46 166.39 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.381 0.426 . . . . 0.0 110.72 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 10' ' ' VAL . 96.8 mt-10 -134.01 41.5 2.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.066 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -93.84 -64.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.402 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 23.2 mm-40 -66.1 -34.78 78.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.1 mm -63.95 -43.9 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.297 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 6' ' ' GLU . 72.5 t -64.35 -42.5 95.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.093 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.58 -49.76 71.87 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.876 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.43 -47.22 85.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -60.37 -38.19 83.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.13 -38.05 89.37 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.332 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.06 62.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.834 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -69.35 -46.7 66.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.727 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.49 95.64 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.591 ' O ' HD13 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -63.07 -38.85 92.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 5.6 m-30 -72.34 -39.09 68.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.596 0.713 . . . . 0.0 110.649 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.2 t0 -87.39 50.42 2.0 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.468 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -35.57 -28.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.449 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.2 m-20 -72.51 -28.08 62.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.49 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.57 11.13 85.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -70.22 -9.86 57.11 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.822 -179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.31 -2.48 85.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -133.08 136.88 46.15 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.654 0.264 . . . . 0.0 110.951 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -103.23 115.33 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 29' ' ' VAL . 54.7 m -81.97 162.9 22.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 28' ' ' THR . 8.7 p -58.99 -34.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.368 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.18 -39.05 89.43 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 109.988 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -71.3 -36.96 71.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.166 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.64 -44.6 95.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.86 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.594 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -64.47 -40.3 95.43 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.4 -46.12 87.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.341 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.67 -41.64 91.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.74 -0.384 . . . . 0.0 109.982 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -57.26 -39.57 75.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.533 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -68.8 -34.49 75.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.551 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 76.3 mt -59.56 -41.85 91.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 116.936 -1.507 . . . . 0.0 112.613 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.551 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 87.8 m-20 134.14 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.164 1.54 . . . . 0.0 111.449 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -147.59 161.35 41.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -150.2 78.59 7.85 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.27 -177.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.605 2.203 . . . . 0.0 111.347 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -90.42 148.33 22.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -42.33 -28.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.135 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.83 -51.21 69.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.441 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -65.92 -37.07 85.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.776 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.67 -42.84 99.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.844 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.71 -44.63 48.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.511 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -62.46 -39.02 92.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.577 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.55 -44.34 78.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.9 mt -66.34 -44.46 90.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.898 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -61.19 -37.07 81.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.014 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -56.16 -34.46 66.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.002 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 10.6 p -108.86 -30.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 48.7 t0 -64.2 77.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -56.17 -24.58 42.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.314 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.41 -23.22 17.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.602 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.36 37.85 86.5 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.352 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 47.3 p-10 -80.47 -15.7 56.11 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.57 -0.37 . . . . 0.0 111.514 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.14 4.18 69.08 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 33.3 p -133.99 157.77 45.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.5 mt -111.09 127.64 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 10.7 pt-20 -95.69 174.79 6.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.757 0.313 . . . . 0.0 110.263 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.07 -50.38 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.72 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -57.57 -58.86 6.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.307 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 94.8 mt-10 -51.97 -43.59 63.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.081 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -62.54 -46.0 90.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.07 -43.3 95.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 m -65.33 -44.71 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.314 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.248 0.547 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.55 -43.06 98.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -59.0 -51.69 68.97 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.227 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.64 -19.97 59.5 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.14 -34.46 17.87 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.286 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.0 33.89 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.093 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 73' ' ' ALA . 36.5 ttpt -59.12 -46.63 87.83 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.027 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 79' ' ' THR . 30.2 p-10 -71.7 -56.4 5.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.256 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.517 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 2.3 t . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.599 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -86.09 171.22 11.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.789 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.732 ' O ' HG22 ' A' ' 3' ' ' ILE . 78.5 mt 58.69 37.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.289 0.566 . . . . 0.0 110.871 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.64 ' H ' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -61.17 -43.88 98.19 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.662 -0.415 . . . . 0.0 109.909 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.7 p -104.09 165.53 10.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.124 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 10' ' ' VAL . 95.4 mt-10 -126.25 41.63 3.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.764 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -91.58 -60.3 1.91 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.913 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -62.35 -35.72 79.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.352 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.497 ' CD1' HG23 ' A' ' 3' ' ' ILE . 80.3 mt -62.99 -44.21 99.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.399 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 6' ' ' GLU . 53.6 t -60.79 -47.8 91.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.101 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.22 -45.34 85.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.974 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.3 -48.13 81.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.061 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.76 -35.42 79.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.081 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -63.84 -36.82 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.06 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -68.31 -37.21 80.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.345 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.446 ' CE1' HD12 ' A' ' 27' ' ' ILE . 75.6 t80 -67.45 -48.92 65.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 111.123 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.69 -42.32 96.24 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.7 tp -62.46 -39.14 92.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 109.926 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.25 -36.7 79.85 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.334 0.588 . . . . 0.0 110.693 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 34.4 t0 -86.42 51.41 2.22 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.46 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -36.29 -30.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.719 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 20' ' ' ASP . 6.2 m-20 -70.51 -28.08 64.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.556 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.32 8.68 87.63 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.694 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -68.57 -17.37 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.731 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 95.2 -7.03 69.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 m -127.62 129.76 47.82 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.612 0.206 . . . . 0.0 111.016 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.446 HD12 ' CE1' ' A' ' 16' ' ' PHE . 80.7 mt -100.32 114.25 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.22 165.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.18 -38.59 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.524 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -61.17 -40.52 94.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.958 0.408 . . . . 0.0 110.195 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.52 -38.37 74.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.224 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.644 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -60.97 -45.48 94.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.44 81.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.88 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -62.24 -43.65 98.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.1 -47.43 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.48 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.94 -38.59 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -58.57 -41.31 85.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 t -86.8 -12.99 46.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.589 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 3.4 tt -65.11 -41.12 95.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.497 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 15.5 m-20 150.99 0.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.901 0.751 . . . . 0.0 111.678 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -155.02 172.44 18.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -153.93 76.87 5.81 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.24 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.16 176.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.46 2.107 . . . . 0.0 111.285 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -86.22 161.75 18.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.5 mp0 -47.35 -41.24 19.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 2.4 mt-10 -54.24 -53.18 57.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.415 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.97 -40.75 96.67 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.161 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mp -62.66 -45.91 90.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.025 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -69.39 -46.51 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.75 -36.99 84.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.3 ttp -69.17 -45.76 69.21 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.5 mt -65.61 -44.94 93.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.98 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -59.13 -39.52 82.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.796 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -52.0 -31.49 29.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.751 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -109.87 -32.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.2 t70 -64.34 77.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.21 -30.0 48.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.433 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 15.3 p-10 -92.19 -18.85 22.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.67 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 65.31 42.86 95.93 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -87.01 -16.68 35.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.018 0.409 . . . . 0.0 111.64 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.08 16.23 58.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 m -140.19 151.64 45.38 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.644 HD12 HD23 ' A' ' 32' ' ' LEU . 8.6 mt -112.31 126.33 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 96.1 mt-10 -103.26 179.66 4.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -57.37 -58.59 7.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.813 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 37.4 p-10 -56.52 -41.57 76.95 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.257 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 97.3 mt-10 -66.0 -46.23 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.908 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.87 -35.78 81.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.396 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.703 HD23 ' C ' ' A' ' 69' ' ' LEU . 7.4 tt -62.76 -43.61 98.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.927 0.394 . . . . 0.0 110.18 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -65.06 -45.28 85.97 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.438 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.61 -43.13 99.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.995 0.426 . . . . 0.0 110.736 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.472 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 4.3 tpt -59.6 -50.07 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -61.35 -50.25 73.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -53.53 -24.66 14.01 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -75.56 -52.98 9.38 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.147 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.413 ' C ' ' H ' ' A' ' 78' ' ' ASP . 46.4 t -76.89 -42.86 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.728 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 73' ' ' ALA . 53.8 tttp -60.32 -6.0 1.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 110.061 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 66.4 t0 -64.14 -33.94 76.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.427 -179.879 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 t70 63.75 -156.31 0.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 3' ' ' ILE . 95.4 mt -131.93 -7.39 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.549 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.25 -14.1 23.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.847 0.356 . . . . 0.0 110.246 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 p -47.05 151.56 0.64 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.364 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 10' ' ' VAL . 65.8 tt0 -159.3 54.68 0.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.829 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -95.01 -61.71 1.44 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.177 0.513 . . . . 0.0 110.629 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -55.02 -37.94 67.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.9 mt -62.11 -43.25 97.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.384 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 6' ' ' GLU . 37.6 t -55.55 -44.99 78.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.93 -51.56 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.835 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -59.03 -48.85 80.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.755 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -37.27 70.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.225 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.33 -41.5 85.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.314 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.62 -48.87 77.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.104 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.37 -49.25 74.58 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.901 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -45.72 82.14 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.626 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.7 tt -62.97 -39.41 94.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.226 0.536 . . . . 0.0 109.559 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.99 -41.87 95.03 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.387 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' ASP . 12.8 t0 -83.34 53.77 2.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.808 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -39.54 -18.58 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.573 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -86.12 -28.67 23.86 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.307 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.21 11.59 84.88 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.742 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.78 -18.12 65.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.727 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.1 -13.64 60.25 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' SG ' ' OE2' ' A' ' 64' ' ' GLU . 3.5 m -131.69 132.75 44.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.7 0.286 . . . . 0.0 111.151 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -97.05 114.3 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -78.95 165.07 23.88 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 30' ' ' GLU . 3.6 m -55.84 -41.23 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.495 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 29' ' ' VAL . 75.9 mt-10 -60.7 -42.77 97.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -68.33 -42.89 78.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.303 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.5 tm? -62.16 -46.8 87.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.55 -39.23 64.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.165 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -63.46 -43.18 98.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.928 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 19' ' ' PHE . 60.0 t -65.4 -48.81 81.71 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -64.68 -40.57 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.0 -42.16 89.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 m -79.45 -20.99 46.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.583 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 39' ' ' LEU . 5.3 tt -63.71 -45.39 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 4.1 m-20 153.3 0.91 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.47 0.482 . . . . 0.0 111.301 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -141.88 155.74 45.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -135.55 78.27 50.59 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.28 155.42 70.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.617 2.211 . . . . 0.0 110.911 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.3 p -85.2 161.39 19.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' THR . 80.4 tt0 -40.16 -47.77 2.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 109.805 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.23 -58.32 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -60.61 -42.37 96.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.557 ' CD2' HD12 ' A' ' 32' ' ' LEU . 12.8 mt -62.05 -43.5 98.7 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.155 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.86 -52.05 58.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.884 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -37.72 84.13 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.695 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.7 mmt -72.23 -48.68 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.7 mt -64.02 -45.17 97.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.954 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.2 p -58.98 -44.74 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -45.07 -27.42 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.5 p -115.61 -30.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 t70 -59.03 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.41 -35.13 73.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.297 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 21.7 p-10 -89.61 -22.41 22.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.45 63.33 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.478 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 52.3 p30 -107.95 -16.7 14.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 117.001 0.4 . . . . 0.0 111.614 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 98.15 15.57 35.42 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.478 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 56.1 p -141.33 165.51 27.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -119.41 126.09 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 80.4 mm-40 -100.24 174.12 6.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.247 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -54.54 -50.85 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.773 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.85 -41.98 98.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.335 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 96.8 mt-10 -67.02 -46.15 75.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.383 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.11 -45.51 93.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.19 -41.62 97.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.576 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 74' ' ' LYS . 10.0 t -63.49 -46.76 84.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.518 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.41 -41.02 93.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.793 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 ttt -69.33 -51.16 39.69 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.025 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -66.81 -29.52 69.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.504 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' SER . 64.8 tttp -67.4 -33.2 74.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.486 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.6 -30.31 21.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 110.13 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 76' ' ' VAL . 33.3 t -106.82 15.9 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.519 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 73' ' ' ALA . 85.3 tttt -48.65 -14.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.859 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.488 ' N ' ' C ' ' A' ' 76' ' ' VAL . 87.6 m-20 -55.03 -57.59 11.08 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.519 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.338 179.729 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 14' ' ' GLU . 23.0 t -57.24 -45.88 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.654 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -58.64 -54.75 43.54 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.768 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -60.83 -49.1 78.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.941 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -60.82 -34.31 74.35 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' VAL . 84.3 tt0 -68.61 -42.61 77.88 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.087 0.47 . . . . 0.0 110.527 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -40.05 88.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 81.7 t80 -65.78 -49.62 67.67 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.96 -42.65 96.93 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.2 tt -60.56 -41.31 94.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -64.09 -39.4 93.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLY . 36.3 t0 -80.18 54.79 2.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -39.02 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.54 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.3 m-20 -86.42 -27.22 24.29 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.186 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.75 12.53 84.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.697 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 47.5 p30 -66.39 -16.61 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.747 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 104.98 -12.53 49.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -140.9 145.21 35.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.729 0.3 . . . . 0.0 111.151 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 4.6 mp -105.31 120.15 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -81.75 169.09 17.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.708 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.37 -43.53 77.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.149 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.43 -43.25 99.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.14 0.495 . . . . 0.0 110.328 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.7 mt-10 -66.96 -40.02 87.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.041 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.92 -45.45 92.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.71 61.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -61.77 -42.58 99.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.749 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.68 -49.7 67.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 41' ' ' GLN . 1.3 mp -61.14 -39.04 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -56.45 -41.29 76.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.447 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 40' ' ' ASP . 42.3 m -65.79 -37.18 85.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.856 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.04 22.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 38' ' ' SER . 62.5 m-20 66.21 16.58 10.49 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.333 0.395 . . . . 0.0 112.03 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' ILE . 52.2 tt0 -136.92 145.53 44.39 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -149.94 82.18 6.67 Favored Pre-proline 0 C--N 1.331 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.36 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.71 163.98 34.99 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.947 2.431 . . . . 0.0 110.729 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 11.5 p -82.66 159.08 22.73 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 44' ' ' THR . 79.3 tt0 -38.33 -47.28 1.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 109.82 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.84 -63.1 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' O ' ' SD ' ' A' ' 51' ' ' MET . 15.4 mp0 -56.02 -41.39 74.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.86 -43.01 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -65.45 -52.35 53.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.419 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 65.5 t0 -58.88 -38.04 77.93 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.17 -47.92 47.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.821 178.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.22 -47.33 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.888 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -58.2 -45.61 87.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -44.2 -29.86 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.821 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -114.98 -31.12 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.66 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t70 -58.9 86.22 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.03 -34.99 70.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.5 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 18.7 p-10 -93.2 -21.9 19.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.844 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.66 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.74 64.77 3.69 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 53.9 p30 -107.79 -13.22 15.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 117.045 0.422 . . . . 0.0 111.547 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.08 7.48 58.46 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.419 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 32.9 p -135.06 164.39 27.74 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 mt -121.03 128.34 76.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -103.92 174.29 5.94 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.54 -52.1 64.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.565 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.82 -45.11 86.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.133 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -44.76 84.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.245 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.76 -44.36 96.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.59 -42.05 99.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.779 0.323 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 t -63.92 -45.81 87.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.246 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.513 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -58.77 -42.09 88.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.547 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttt -71.81 -51.63 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.946 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.519 179.134 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.5 mt . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.55 -47.71 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.078 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -66.1 -44.71 83.58 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.979 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.77 -49.57 75.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.971 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -60.03 -32.36 70.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.335 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.19 -39.63 89.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.168 0.509 . . . . 0.0 109.985 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.7 -46.99 85.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.705 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.56 -49.01 75.09 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.85 -45.79 78.72 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.2 tt -62.8 -39.48 94.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.248 0.547 . . . . 0.0 109.728 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.28 -42.96 96.18 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.278 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 57.8 t0 -81.23 54.15 2.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.195 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -37.75 -32.54 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.605 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p-10 -81.21 -25.42 36.73 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.704 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 77.38 14.51 82.44 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 51.6 p-10 -62.33 -4.03 1.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.978 0.389 . . . . 0.0 110.691 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.71 -17.0 33.03 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 9.0 m -130.43 130.5 44.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.611 0.244 . . . . 0.0 110.915 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.1 mt -93.77 111.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -77.66 164.58 25.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.59 -35.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.554 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -42.23 91.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.149 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.55 -38.05 83.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.332 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.55 -44.89 92.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.66 72.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.677 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -62.48 -43.32 99.1 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.76 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.83 -48.11 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.615 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -65.83 -39.73 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.172 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -59.52 -42.45 92.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.712 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 t -83.13 -14.41 53.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 11.0 tp -65.4 -43.25 91.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 2.7 m-20 155.66 -1.04 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.259 0.349 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -148.5 163.52 36.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -137.51 75.09 45.57 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 111.341 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.82 162.9 29.99 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.795 2.33 . . . . 0.0 111.003 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -82.54 152.22 26.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -39.38 -41.9 1.0 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.842 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.43 -50.69 51.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.482 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.93 -41.84 99.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.159 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.22 -42.43 99.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.196 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.26 -51.28 66.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.19 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.68 -36.39 78.64 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.559 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.0 mtt -71.45 -47.0 58.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.964 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.7 mt -64.66 -43.43 96.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t -58.69 -45.14 90.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.897 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 54' ' ' GLU . 3.6 tm-20 -51.04 -28.66 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.031 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -110.73 -32.55 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -63.52 80.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.93 -35.38 64.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.019 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -90.39 -20.06 23.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.551 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.81 39.89 97.87 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.244 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.511 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 48.2 p30 -83.73 -17.09 42.45 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.718 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.66 56.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 43.8 p -133.08 165.52 24.55 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.66 130.94 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 96.8 mt-10 -104.28 176.12 5.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.323 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -56.03 -52.39 64.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.857 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -60.51 -44.5 95.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.005 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 99.8 mt-10 -63.41 -45.22 92.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.961 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.73 -41.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.68 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.25 -39.61 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.317 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.5 m -62.56 -45.9 90.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.325 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.43 -40.89 98.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.439 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 1.1 tpt -62.97 -53.64 50.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.289 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 110.398 179.603 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 C--O 1.231 0.128 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.85 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.016 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -57.06 -54.18 49.68 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -62.14 -50.82 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.889 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -54.42 -38.12 65.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.161 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.41 -39.89 89.25 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.959 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.84 -48.5 80.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.967 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' ' CD1' ' A' ' 27' ' ' ILE . 61.7 t80 -62.89 -49.06 76.31 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.806 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.18 -47.92 65.69 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.31 -38.52 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.9 m-30 -66.39 -46.14 77.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.509 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 14.6 t70 -79.19 50.58 1.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.92 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -39.51 -26.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.836 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 42.7 p-10 -81.3 -27.71 34.94 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.642 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 80.21 12.73 82.88 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.895 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 53.7 p30 -63.78 -10.07 17.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.157 0.478 . . . . 0.0 110.658 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.36 61.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 3.8 m -133.73 135.38 43.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.605 0.241 . . . . 0.0 111.095 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 65.4 mt -99.58 115.54 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -77.85 165.18 24.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.551 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.18 -40.21 76.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.537 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.19 -42.28 98.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -69.28 -39.33 78.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.381 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.65 -45.2 93.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.66 -39.17 73.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -62.53 -44.33 96.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.972 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.453 HG11 ' CE2' ' A' ' 19' ' ' PHE . 49.4 t -62.94 -44.74 99.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.848 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.433 HG21 ' CD ' ' A' ' 43' ' ' PRO . 5.1 mm -62.74 -41.7 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -57.1 -41.59 79.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.952 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 t -73.28 -33.13 65.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 29.4 mt -61.58 -44.26 97.34 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 9.8 p30 147.38 2.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.661 0.601 . . . . 0.0 111.497 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -129.07 165.04 21.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -152.14 70.74 7.73 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.01 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.433 ' CD ' HG21 ' A' ' 36' ' ' ILE . 16.3 Cg_exo -66.72 152.85 79.77 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.666 2.244 . . . . 0.0 111.015 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.9 p -82.43 162.45 22.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -40.54 -46.96 2.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.953 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.93 -54.05 22.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.493 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -64.62 -43.71 92.86 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.459 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 mt -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.875 0.369 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.48 -50.33 67.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.436 -0.505 . . . . 0.0 109.871 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 67.7 t0 -61.89 -35.04 77.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.396 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.5 ttp -72.37 -48.49 41.28 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 HD11 ' A' ' 63' ' ' ILE . 84.8 mt -64.21 -44.18 97.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.6 m -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -46.29 -27.45 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.6 p -115.75 -24.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 14.1 t0 -63.77 77.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.03 -34.42 77.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.427 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 19.1 p-10 -87.86 -23.28 24.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.649 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.74 67.87 1.9 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.275 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 51.4 p30 -112.89 -15.21 12.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.936 0.368 . . . . 0.0 111.536 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.99 10.19 57.7 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.517 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 64.6 p -141.05 170.77 15.1 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 52' ' ' ILE . 65.1 mt -119.54 127.4 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 72.8 tt0 -99.01 167.55 10.66 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.418 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 38.6 t80 -52.78 -49.48 65.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.464 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.34 -42.4 95.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.154 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.89 -43.9 86.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.1 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.83 -44.01 97.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.355 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -63.35 -41.81 98.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.1 m -64.95 -48.88 72.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.742 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.0 tp -58.92 -41.18 86.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 110.651 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.1 mmm -68.59 -57.62 5.47 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.095 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 179.322 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mm . . . . . 0 C--O 1.231 0.129 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.83 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.831 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.68 -44.63 96.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.929 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.43 -49.86 69.84 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.008 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -64.1 -34.05 77.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.47 -38.07 88.72 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.321 0.581 . . . . 0.0 110.268 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.68 -39.07 87.96 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.176 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -69.92 -48.58 57.99 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.16 92.17 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.96 -37.04 85.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -70.33 -40.12 74.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 110.557 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' GLY . 32.2 t0 -78.01 50.83 0.91 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.208 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -37.02 -31.2 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.695 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 22.6 m-20 -75.28 -28.14 59.64 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.543 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.81 7.47 88.26 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.9 p-10 -68.26 -8.14 36.74 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.91 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.66 -6.82 83.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 m -130.51 131.83 45.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 110.799 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.6 mt -98.72 114.89 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.2 p -82.65 163.68 21.24 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 61' ' ' GLY . 1.7 m -58.18 -38.97 71.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.511 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -62.54 -40.57 97.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.264 0.554 . . . . 0.0 110.645 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 31.9 tt0 -71.49 -36.75 71.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.036 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.69 -45.06 95.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.03 -40.29 73.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.799 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -61.64 -43.4 98.93 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.803 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.19 -48.89 77.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.189 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' GLN . 2.8 mm -63.61 -36.92 78.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -57.06 -40.36 76.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -66.45 -36.19 82.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.662 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 40' ' ' ASP . 84.9 mt -70.46 26.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.4 OUTLIER 60.48 19.85 9.59 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' HG22 ' A' ' 36' ' ' ILE . 49.2 tt0 -138.62 150.67 46.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -154.74 83.86 3.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.72 170.85 3.15 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.61 2.206 . . . . 0.0 110.931 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 45' ' ' GLU . 55.2 m -84.7 168.64 15.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.627 ' N ' HG22 ' A' ' 44' ' ' THR . 80.4 mt-10 -53.05 -45.66 68.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.253 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 18.2 pt-20 -56.84 -44.49 82.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.888 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 50.6 mt-10 -64.81 -43.82 91.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.957 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.37 -44.86 96.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.823 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -67.74 -47.78 68.3 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -61.47 -40.26 93.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.0 tpp -69.87 -46.44 65.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 29' ' ' VAL . 82.1 mt -65.23 -44.33 95.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.4 p -61.67 -36.09 79.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.933 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -56.74 -32.01 65.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.782 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.42 -26.75 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 52.3 t0 -73.27 85.83 1.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.88 65.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.709 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -101.11 -23.37 14.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.223 -178.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.89 38.78 85.41 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.125 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 19.5 m120 -72.99 -16.54 61.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.874 0.337 . . . . 0.0 111.332 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 94.2 1.61 64.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.8 p -137.18 166.89 22.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.605 HD12 HD23 ' A' ' 32' ' ' LEU . 6.5 mt -114.46 126.02 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.74 178.66 4.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.321 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -56.8 -52.59 64.45 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.757 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.43 -43.31 96.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.901 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 95.3 mt-10 -65.65 -44.55 86.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.958 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -61.19 -43.09 99.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.458 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -40.76 97.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.3 t -63.22 -45.4 91.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.262 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.42 -42.12 86.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.966 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.5 tpp -77.09 -41.08 43.61 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.246 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.454 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.6 mt . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.86 -48.43 88.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.827 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.65 -47.37 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.926 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -60.04 -46.95 87.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -57.24 -36.4 70.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.31 -38.12 89.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.963 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.99 -44.4 92.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.092 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -65.87 -49.44 68.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.877 0.37 . . . . 0.0 111.186 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.82 -45.28 86.34 Favored Glycine 0 C--N 1.33 0.231 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.628 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.3 tt -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -65.32 -41.49 93.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.502 0.668 . . . . 0.0 110.376 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLY . 19.1 t70 -81.05 58.06 3.33 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.544 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -36.73 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.51 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -80.02 -27.51 39.5 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.33 7.23 82.21 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -64.29 -19.11 65.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.667 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.32 -11.95 51.4 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' OE1' ' A' ' 64' ' ' GLU . 57.3 m -128.06 127.56 43.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.92 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.29 111.96 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.478 HG22 ' OE1' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -82.12 166.93 19.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.663 HG22 HD13 ' A' ' 52' ' ' ILE . 71.9 t -55.7 -44.12 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.447 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -53.96 -43.19 69.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.858 0.361 . . . . 0.0 110.198 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.478 ' OE1' HG22 ' A' ' 28' ' ' THR . 43.9 mt-10 -67.75 -46.03 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.746 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.12 -46.66 88.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.6 -41.77 66.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.151 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.3 m -65.11 -39.76 93.57 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.349 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.2 -48.63 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.04 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.0 mm -61.67 -43.68 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.361 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -60.35 -41.8 94.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.352 0.596 . . . . 0.0 110.626 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -75.38 -22.64 57.34 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.737 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 39' ' ' LEU . 3.2 tt -66.17 -44.88 82.77 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 5.1 m-20 151.11 2.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.844 0.715 . . . . 0.0 111.418 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -143.33 154.01 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -133.24 79.09 62.45 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.63 159.29 53.28 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.858 2.372 . . . . 0.0 110.839 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -86.21 162.25 18.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 28.9 mp0 -40.66 -47.91 2.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 2.8 mm-40 -47.31 -58.98 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.713 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.05 -41.88 97.43 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.396 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.02 -43.46 98.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.882 0.373 . . . . 0.0 110.256 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.07 -49.69 71.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.969 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -61.28 -36.0 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.6 mtp -72.93 -46.95 49.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.663 HD13 HG22 ' A' ' 29' ' ' VAL . 73.3 mt -65.83 -45.19 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.665 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.1 m -58.15 -45.27 87.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -48.62 -27.47 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -113.73 -32.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.83 81.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.51 -32.68 71.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.419 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.0 p-10 -93.21 -21.87 19.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.804 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.82 31.68 78.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 49.4 p-10 -73.41 -16.91 61.32 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.524 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 99.19 6.28 55.69 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.413 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 31.7 p -139.94 173.66 11.3 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.8 mt -121.92 128.31 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 65' ' ' PHE . 13.4 tp10 -94.66 168.13 11.03 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.437 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 14.7 t80 -54.72 -50.49 68.2 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.702 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.48 -39.78 88.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.103 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.46 -42.28 92.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.243 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.78 -40.28 96.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.64 -41.01 98.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 t -64.32 -44.78 90.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.532 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 tp -58.81 -40.93 85.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.9 mmm -66.8 -56.63 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.339 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.648 179.505 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.6 t -57.7 -47.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.935 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -65.28 -48.63 72.52 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.012 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.598 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.29 -48.7 80.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -59.03 -33.45 70.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.84 -38.6 86.71 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.185 0.517 . . . . 0.0 110.182 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.7 -46.39 85.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.91 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.04 -48.63 73.17 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.53 84.97 Favored Glycine 0 C--N 1.33 0.23 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.92 -37.99 89.43 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.1 m-30 -66.09 -41.51 90.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.374 0.606 . . . . 0.0 110.058 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ASP . 25.8 t0 -83.97 56.39 3.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.239 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -38.48 -19.04 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.697 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.1 m-20 -88.37 -26.89 21.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.378 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.08 11.47 83.98 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.729 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -65.18 -17.19 64.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.722 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -13.06 56.56 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 m -134.06 136.66 44.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.711 0.291 . . . . 0.0 111.111 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.5 mt -97.54 113.92 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.578 HG22 ' N ' ' A' ' 29' ' ' VAL . 89.4 m -78.3 164.85 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.578 ' N ' HG22 ' A' ' 28' ' ' THR . 8.2 t -56.12 -46.49 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.36 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.03 -41.57 83.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 94.4 mt-10 -67.26 -41.54 85.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.317 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.688 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.69 -44.42 96.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.38 70.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.859 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -61.38 -44.38 97.25 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.789 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.0 -47.97 85.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.082 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 41' ' ' GLN . 3.0 mm -61.73 -38.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.09 -41.24 78.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.294 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 40' ' ' ASP . 37.6 m -64.82 -35.67 81.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.92 21.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 38' ' ' SER . 98.1 m-20 63.3 18.41 10.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 6.8 tp-100 -134.0 139.41 46.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.29 76.73 37.2 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 120.754 0.311 . . . . 0.0 111.169 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.9 169.38 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.992 2.462 . . . . 0.0 111.092 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 47' ' ' GLU . 6.9 p -86.72 149.73 24.68 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 57.1 mp0 -39.6 -42.72 1.22 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.44 -49.03 36.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.195 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 44' ' ' THR . 46.0 tp10 -66.48 -41.85 88.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.211 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.56 -43.05 99.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.126 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -62.97 -51.21 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.293 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.92 -33.16 71.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.479 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.6 ttp -74.74 -45.84 41.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' ASP . 80.4 mt -63.42 -43.95 98.7 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.864 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -63.94 -45.51 88.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.209 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.34 -33.4 65.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.209 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 71' ' ' LEU . 3.6 m -103.43 -32.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 58.8 t0 -74.56 104.98 5.46 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.53 64.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.538 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 2.4 p30 -95.58 -23.22 17.16 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.622 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 63.08 41.22 99.85 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.458 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 49.6 p30 -80.3 -16.44 54.64 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.73 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 101.91 -0.84 51.75 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.458 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 18.5 p -129.83 170.87 13.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.688 HD12 HD23 ' A' ' 32' ' ' LEU . 5.0 mt -118.99 125.27 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 74.4 tt0 -95.22 167.3 11.44 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.409 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 63.2 t80 -53.72 -49.7 67.53 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.681 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.01 -41.24 87.25 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.233 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.73 -42.34 86.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.259 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -65.39 -41.08 94.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.881 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.2 tp -62.59 -41.59 99.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.522 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -66.16 -44.98 82.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.506 HD13 HG11 ' A' ' 55' ' ' VAL . 37.1 tp -63.39 -42.0 98.78 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.107 0.48 . . . . 0.0 111.182 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.598 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 27.0 ttt -60.97 -49.05 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.07 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.3 179.205 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.4 -46.72 95.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.045 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -60.41 -39.71 88.37 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.55 -56.21 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -39.32 81.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -64.72 -35.54 81.38 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.979 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.59 82.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.464 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -68.15 -47.26 68.53 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.32 98.13 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 tt -63.16 -37.56 87.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 0.0 109.688 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -70.99 -38.64 72.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 t0 -87.62 48.91 1.71 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.156 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -35.41 -28.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.363 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.6 m-20 -71.91 -28.04 63.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.512 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.44 8.64 87.62 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -68.48 -9.82 51.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.848 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.83 -5.65 84.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.9 m -129.03 131.57 47.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.69 0.281 . . . . 0.0 111.096 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.5 mt -100.27 114.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 p -82.2 164.12 21.45 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 30' ' ' GLU . 7.5 p -58.21 -42.26 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.615 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' N ' HG13 ' A' ' 29' ' ' VAL . 98.9 mt-10 -58.4 -38.86 78.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 0.0 110.229 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.8 mt-10 -71.28 -37.92 71.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.442 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.31 -44.59 96.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.29 76.48 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.78 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -64.1 -41.3 97.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.43 -47.39 80.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.498 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.88 -38.5 82.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -59.44 -40.91 88.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.657 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.34 -34.99 65.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.381 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 38.0 mt -61.4 -41.93 97.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 112.641 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.56 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 71.8 m-20 141.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.345 1.028 . . . . 0.0 111.18 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -137.76 158.19 44.88 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.493 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 13.2 p-10 -155.42 69.04 5.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.956 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.79 169.53 5.61 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.678 2.252 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.435 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 64.8 p -80.44 148.69 30.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' THR . 75.5 mt-10 -37.69 -36.67 0.19 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.887 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -55.22 -53.37 56.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.386 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 12.8 mp0 -61.08 -41.75 97.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.95 -42.14 97.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -68.12 -42.6 79.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.318 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.13 -39.62 95.21 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.744 0.306 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 mtm -69.57 -44.01 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.211 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -66.18 -44.42 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.989 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -33.93 75.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.072 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -59.57 -33.63 71.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.788 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.6 p -109.92 -31.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 43.9 t0 -64.56 77.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -55.82 -23.68 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.266 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' OD1' ' CG ' ' A' ' 60' ' ' ASN . 3.3 p30 -97.46 -22.53 16.52 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.607 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.09 46.21 89.27 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.803 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -88.97 -17.19 29.98 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.63 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.66 ' N ' HD22 ' A' ' 60' ' ' ASN . . . 95.63 10.63 56.53 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.803 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 33.1 p -139.47 159.4 42.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 63' ' ' ILE . 21.1 mt -113.83 128.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.42 171.89 8.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.37 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.67 -52.49 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.875 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.7 -41.29 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.6 -45.08 84.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.023 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.7 -42.29 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tt -63.97 -42.12 97.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -63.0 -46.08 89.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.231 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.8 tp -63.11 -40.29 97.21 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 110.551 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mmm -59.3 -42.72 92.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.613 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.346 179.427 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 CA--C 1.521 -0.139 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.4 t -63.95 -46.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.443 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.51 -42.74 91.75 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.12 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.25 -51.95 65.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.065 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.93 -32.09 71.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.247 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.31 -39.6 89.42 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.963 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.65 -45.87 88.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.896 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.76 -49.56 74.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.54 84.5 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.2 tp -61.73 -40.64 95.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.002 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 4.6 m-30 -65.16 -43.08 92.94 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.239 0.543 . . . . 0.0 110.274 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 22' ' ' ASP . 34.5 t0 -81.56 50.47 1.49 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.739 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.5 m-20 -89.51 -27.85 20.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.109 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.05 14.27 82.09 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -69.23 -16.36 63.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.666 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.28 62.32 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.6 m -134.06 136.71 44.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.725 0.298 . . . . 0.0 111.08 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.4 mt -100.1 117.27 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 29' ' ' VAL . 49.5 m -77.82 162.7 26.7 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.686 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 28' ' ' THR . 13.6 t -57.03 -46.86 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.496 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -58.39 -42.49 87.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 110.273 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.431 ' CD ' ' OD2' ' A' ' 22' ' ' ASP . 63.2 tt0 -66.8 -35.79 80.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.275 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -64.01 -43.15 96.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.1 -40.2 70.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -43.23 99.25 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -65.42 -48.44 83.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.105 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 41' ' ' GLN . 97.4 mt -60.3 -39.69 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.94 -41.88 71.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.548 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.5 t -64.86 -39.65 93.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.42 20.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 38' ' ' SER . 12.7 m-20 67.56 18.64 9.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.579 ' O ' HG22 ' A' ' 36' ' ' ILE . 1.9 mp0 -135.29 147.66 49.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -150.95 72.56 8.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.53 167.35 13.41 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.768 2.312 . . . . 0.0 111.022 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.4 p -83.26 153.42 24.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 44' ' ' THR . 77.3 mm-40 -38.49 -45.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 110.137 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -47.11 -55.71 7.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' O ' ' SD ' ' A' ' 51' ' ' MET . 50.1 mt-10 -60.16 -41.16 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.217 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.19 -42.52 98.73 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.029 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -65.29 -53.81 38.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -59.17 -38.06 78.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.528 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.26 -48.19 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.28 -44.48 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 m -57.52 -45.6 84.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -45.81 -29.56 1.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -112.72 -29.28 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 9.5 t0 -60.68 81.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.23 -36.25 77.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 8.0 p30 -92.38 -21.14 20.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.827 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.75 69.47 1.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 6.6 m120 -109.76 -11.75 14.69 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.116 0.458 . . . . 0.0 111.428 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 93.14 3.91 65.06 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -138.54 170.85 15.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -120.03 127.71 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.027 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -104.75 175.52 5.47 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -57.07 -54.75 43.2 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.646 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 33.0 p-10 -54.06 -46.0 71.83 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.094 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 99.5 mt-10 -64.04 -41.85 97.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.863 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 59.0 t80 -63.3 -37.57 87.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.08 -43.25 99.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.308 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.8 m -65.46 -44.9 85.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.084 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -56.48 -45.67 80.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.43 -177.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 75.2 mtp -65.91 -49.46 67.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.016 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.492 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.11 -47.2 93.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.814 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.1 -42.56 99.61 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.834 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD2' ' SD ' ' A' ' 72' ' ' MET . 3.5 m-30 -60.3 -46.37 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -59.71 -33.55 71.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -66.62 -37.91 85.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.252 0.549 . . . . 0.0 110.168 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.03 85.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.917 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -63.3 -47.44 82.29 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 111.084 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.05 91.89 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.19 -39.0 93.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.023 0.44 . . . . 0.0 110.229 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -67.54 -40.42 85.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.278 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 23' ' ' GLY . 34.5 t0 -81.82 58.34 3.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.922 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -37.54 -21.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.843 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 m-20 -88.15 -26.36 22.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.586 0.231 . . . . 0.0 111.443 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 74.51 10.14 82.36 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -64.3 -17.58 63.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -11.72 56.38 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.9 m -130.71 131.39 44.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.853 0.359 . . . . 0.0 111.326 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.2 mt -96.99 114.28 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.3 p -79.16 165.66 23.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 t -57.67 -44.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.589 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -56.94 -41.68 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.009 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.3 mt-10 -68.58 -41.59 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.468 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.21 -44.86 94.14 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -55.3 -40.33 70.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -63.36 -42.85 98.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.866 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.98 -49.34 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.694 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mm -65.64 -41.13 89.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 49.2 ttp180 -57.75 -40.97 80.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.362 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -85.05 -14.05 48.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.526 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 9.9 tp -68.08 -43.4 78.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 3.4 t70 154.63 -4.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.414 0.446 . . . . 0.0 111.108 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -139.92 158.74 43.59 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -135.19 72.06 67.07 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.83 155.74 62.08 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.664 2.243 . . . . 0.0 110.913 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -82.88 156.78 23.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -40.03 -43.8 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 2.8 mt-10 -50.48 -52.43 38.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.52 -42.88 99.81 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.142 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.08 -42.31 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.54 -49.77 75.34 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.076 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.52 -35.26 75.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.69 0.281 . . . . 0.0 110.446 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -72.96 -45.84 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.813 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 56' ' ' ASP . 85.1 mt -64.8 -44.5 96.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.956 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -45.7 91.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.552 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -57.77 -31.66 66.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 m -106.63 -24.51 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 66.7 t0 -81.57 95.94 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.41 68.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.795 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -94.91 -24.15 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.244 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.28 35.35 82.48 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.069 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.485 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 20.3 m120 -67.52 -18.82 65.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.811 0.305 . . . . 0.0 111.356 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.72 -12.22 56.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 p -125.48 -179.76 4.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 109.967 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.13 130.75 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.631 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -101.26 177.67 4.87 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.458 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.67 -50.89 71.69 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.905 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 31.5 p-10 -58.82 -43.63 90.68 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.431 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 96.8 mt-10 -65.76 -40.72 92.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.62 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.86 -42.34 99.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.741 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.52 -39.14 82.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -63.6 -42.89 98.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.3 -42.54 86.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.625 0.25 . . . . 0.0 110.778 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 12' ' ' PHE . 74.8 mtp -65.73 -56.43 12.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.553 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.63 179.662 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.84 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.233 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.4 -42.39 96.12 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.3 -48.13 79.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.091 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -62.78 -34.71 77.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.204 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.03 -36.24 82.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.191 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -67.47 -40.62 85.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.101 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.475 ' CE2' HD12 ' A' ' 27' ' ' ILE . 59.7 t80 -70.37 -49.69 46.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.05 96.57 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.55 -39.12 89.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 9.6 m-30 -68.52 -40.49 80.76 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.934 0.397 . . . . 0.0 110.674 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.0 t0 -78.85 48.14 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.59 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -36.6 -40.36 0.25 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.877 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.0 p-10 -69.73 -25.34 63.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 0.0 111.627 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.12 14.74 80.1 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.891 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.1 p-10 -64.58 -1.52 1.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.673 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 75.51 -10.23 12.69 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.438 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.6 m -130.64 131.84 45.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.574 0.226 . . . . 0.0 110.839 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.475 HD12 ' CE2' ' A' ' 16' ' ' PHE . 95.0 mt -97.25 113.4 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -83.52 165.28 19.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.748 179.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.99 -36.92 64.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.524 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.98 -41.32 97.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.248 0.547 . . . . 0.0 110.616 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' H ' HG23 ' A' ' 28' ' ' THR . 42.6 tt0 -72.38 -39.46 68.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.056 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.7 tm? -61.5 -45.92 92.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.07 -38.08 70.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.807 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -62.17 -42.7 99.52 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.834 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.08 -47.19 85.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.524 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 41' ' ' GLN . 2.8 mm -63.76 -38.74 83.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.047 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -57.08 -39.81 75.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.2 t -69.29 -38.17 78.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.04 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.95 25.78 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 38' ' ' SER . 33.5 t70 62.91 20.47 12.25 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.511 ' O ' HG22 ' A' ' 36' ' ' ILE . 97.1 mm-40 -136.14 142.49 44.22 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.451 HD22 ' C ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -148.29 80.65 8.43 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.026 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.76 170.7 6.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.853 2.369 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 m -86.47 159.33 19.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.61 -39.34 7.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.76 -55.59 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -62.69 -40.78 98.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mt -61.2 -42.71 99.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.059 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -70.83 -41.54 71.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.131 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -63.46 -38.92 93.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.725 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 71.0 mtm -69.0 -44.04 73.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.991 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.76 -45.88 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.074 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.2 t -59.12 -37.42 77.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.56 -31.57 64.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.074 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.1 p -111.03 -32.88 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.4 t70 -63.82 79.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.04 -24.28 62.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.587 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.8 p-10 -95.36 -23.2 17.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.913 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.606 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.8 38.75 93.26 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 51.5 p30 -81.39 -17.04 50.38 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.526 -0.396 . . . . 0.0 111.608 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.08 7.7 60.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 82.8 p -135.91 159.74 40.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.5 mt -112.73 127.04 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 74.6 tt0 -99.99 165.28 11.62 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.411 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 27.6 t80 -49.24 -54.81 14.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.425 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.16 -43.29 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.006 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.63 -44.13 82.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.063 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.505 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.43 -40.64 97.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.454 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.9 t -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.87 -42.83 85.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.544 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mmm -65.55 -47.3 76.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.931 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.419 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 17.7 mm . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 11' ' ' ASP . 8.5 p -59.22 -47.5 90.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.998 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.56 ' N ' HG13 ' A' ' 10' ' ' VAL . 64.4 t0 -63.32 -54.05 43.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.957 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CD1' ' SD ' ' A' ' 72' ' ' MET . 14.9 m-30 -61.82 -52.56 63.67 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.314 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 28.6 tptp -51.66 -40.78 60.64 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.034 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -68.58 -40.37 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.113 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.5 -50.14 73.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -62.59 -49.19 76.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.843 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.5 -48.3 65.72 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.542 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 tt -62.65 -39.24 93.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.071 0.462 . . . . 0.0 109.793 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -63.94 -43.16 96.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.145 0.497 . . . . 0.0 110.497 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 23' ' ' GLY . 61.1 t0 -81.91 52.21 1.9 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.254 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -38.59 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.833 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 3.4 p-10 -83.62 -24.84 31.25 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.45 15.98 80.85 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.184 -0.532 . . . . 0.0 111.928 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 49.7 p-10 -66.87 -5.44 12.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.549 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 84.32 -16.93 31.53 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.444 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 5.2 t -128.9 128.76 44.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.474 0.178 . . . . 0.0 110.946 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.44 112.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.56 HG22 ' N ' ' A' ' 29' ' ' VAL . 85.4 m -77.42 162.96 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.592 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.641 HG12 HD13 ' A' ' 52' ' ' ILE . 2.4 m -55.74 -36.81 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.469 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.74 -41.8 91.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.962 0.41 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.47 -37.8 85.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.353 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 tp -64.16 -43.96 93.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.71 72.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -63.49 -41.74 98.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.3 t -65.61 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.241 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.19 -35.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -60.43 -42.78 96.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -68.9 -35.46 76.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.961 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 11.2 mt -60.57 -43.91 96.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.728 -1.129 . . . . 0.0 112.67 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.569 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 70.1 m-20 142.01 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 124.691 1.245 . . . . 0.0 111.533 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -136.57 157.09 47.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -148.97 71.7 10.29 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.783 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.02 156.69 61.26 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.526 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 6.2 p -84.88 155.99 21.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 56.8 mp0 -40.06 -47.39 2.3 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -46.86 -51.86 15.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.047 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -70.14 -41.5 73.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.762 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -40.81 95.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -61.62 -50.5 72.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.699 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.01 -37.1 78.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.9 tpp -74.01 -47.41 37.25 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.641 HD13 HG12 ' A' ' 29' ' ' VAL . 77.3 mt -64.3 -44.56 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.0 p -58.09 -43.96 87.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -50.16 -28.75 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -110.13 -30.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 10.7 t0 -63.97 78.53 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.24 -36.02 80.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.694 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 3.9 p30 -90.41 -20.64 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.03 1.18 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.177 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 7.8 m120 -109.83 -12.43 14.59 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.266 0.533 . . . . 0.0 111.471 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.07 63.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -138.69 177.11 8.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.1 mt -121.5 128.44 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -98.43 171.73 7.98 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.46 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 52.5 t80 -56.1 -51.72 66.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.681 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.13 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.462 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 89.1 mt-10 -59.03 -46.23 88.74 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.9 t80 -68.33 -26.57 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.85 -43.05 89.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 110.108 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.9 t -66.53 -41.87 88.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.36 -41.39 84.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.99 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.466 ' SD ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 mtp -65.86 -51.62 57.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.468 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.769 179.295 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.54 -46.39 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.868 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.36 -54.88 29.97 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.981 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 69' ' ' LEU . 49.9 m-85 -59.09 -47.85 83.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -59.42 -33.75 71.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.456 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.0 -41.64 81.94 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.078 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.47 -46.76 84.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.967 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.51 -49.47 73.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.87 85.42 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.84 -39.71 95.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.9 m-30 -64.44 -41.0 96.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.076 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 27.8 t0 -82.19 53.84 2.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.135 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -38.62 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.684 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.1 p-10 -89.2 -25.01 22.0 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.41 18.45 79.16 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.74 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 46.6 p-10 -66.8 -10.71 50.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.774 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.81 -15.74 60.98 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.1 p -133.18 132.89 42.1 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.687 0.28 . . . . 0.0 110.835 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.1 mt -95.43 113.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 29' ' ' VAL . 76.6 m -78.55 164.1 24.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.636 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.564 ' N ' HG22 ' A' ' 28' ' ' THR . 5.7 p -55.32 -33.91 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.763 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.44 -42.63 74.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.282 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -65.03 -38.19 90.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.207 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.95 -43.67 91.94 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.39 74.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.916 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 m -60.68 -43.28 97.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.758 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.21 -46.38 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.238 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.08 -43.88 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.951 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -56.16 -41.65 75.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.342 0.591 . . . . 0.0 110.582 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -66.29 -37.48 85.51 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.089 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 35.6 mt -61.73 -44.08 97.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.564 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 10.9 t70 141.12 10.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 124.003 0.815 . . . . 0.0 111.352 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -128.72 164.75 22.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 110.075 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -154.16 70.72 6.31 Favored Pre-proline 0 C--O 1.232 0.176 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.47 154.68 73.05 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.726 2.284 . . . . 0.0 111.206 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 45' ' ' GLU . 11.5 m -80.32 164.68 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 44' ' ' THR . 84.3 tt0 -42.36 -49.34 5.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.39 -58.12 4.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.472 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.61 -41.68 90.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.188 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.0 mt -61.37 -42.98 99.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -67.43 -53.37 29.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -59.65 -37.74 79.52 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.556 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.4 mmt -71.42 -48.86 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.608 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASP . 57.7 mt -64.88 -45.18 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -58.62 -46.96 85.92 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -45.77 -27.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.4 p -116.14 -27.51 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 52' ' ' ILE . 26.1 t0 -59.37 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.69 -35.13 75.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.1 m-20 -82.96 -23.66 33.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.462 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.1 26.97 68.17 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 30.1 p-10 -81.58 -16.42 51.66 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.739 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.69 7.8 50.19 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.453 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 49.5 p -134.23 167.12 21.27 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 52' ' ' ILE . 12.0 mt -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.843 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -102.87 171.64 7.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -53.51 -50.29 65.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.309 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -57.56 -43.96 84.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.233 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 80.6 mt-10 -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.815 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 83.5 t80 -62.24 -44.47 96.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.378 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.425 ' CD1' ' CD2' ' A' ' 12' ' ' PHE . 57.3 tp -62.18 -42.44 99.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.183 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -64.77 -44.57 89.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.136 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -57.83 -44.81 86.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.787 -178.116 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 76.0 mtp -70.96 -50.77 30.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.87 179.122 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mm . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.4 t -63.37 -47.3 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.12 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.31 -44.02 92.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.266 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.09 -44.61 97.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.83 -37.66 76.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.177 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -65.43 -35.71 81.74 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.139 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.32 -43.29 86.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.107 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -69.59 -48.82 58.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.749 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.25 95.06 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.87 -38.48 91.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.902 0.382 . . . . 0.0 110.057 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 8.9 m-30 -68.85 -41.87 77.87 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.662 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 22' ' ' ASP . 27.4 t0 -79.37 47.13 0.79 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.219 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -36.49 -25.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.693 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.5 m-20 -76.78 -27.44 55.27 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.61 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.53 10.26 85.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 49.3 p-10 -71.73 -9.74 58.73 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.798 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.96 -7.04 81.99 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 p -131.65 134.14 45.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.867 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.69 117.18 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 p -83.9 166.27 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.699 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 t -56.72 -43.98 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.03 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.42 -39.14 86.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.03 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 91.9 mt-10 -71.15 -42.57 68.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.132 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.19 -44.83 95.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.287 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.88 69.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.808 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -62.36 -42.59 99.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.887 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.2 -46.99 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.511 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 41' ' ' GLN . 5.3 mm -62.94 -39.64 85.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.16 -40.72 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 40' ' ' ASP . 51.1 m -67.91 -37.17 81.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.82 25.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 38' ' ' SER . 90.3 m-20 63.27 20.52 12.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.288 0.368 . . . . 0.0 111.931 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.526 ' O ' HG22 ' A' ' 36' ' ' ILE . 86.8 mt-30 -137.04 148.47 46.83 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -154.17 79.69 5.0 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' CD ' HG21 ' A' ' 36' ' ' ILE . 30.9 Cg_exo -61.07 170.01 5.4 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.669 2.246 . . . . 0.0 111.113 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -91.49 165.1 13.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 49' ' ' GLN . 80.9 mm-40 -42.17 -46.47 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.897 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 1.5 mm-40 -56.66 -62.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.831 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.9 -45.75 93.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.063 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.21 -43.78 98.32 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.426 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 57.1 tt0 -71.92 -42.67 66.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.269 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.56 -36.8 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.612 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.9 mmt -69.01 -45.18 71.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.692 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.96 -43.98 88.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.1 m -57.69 -38.45 75.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.874 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -49.08 -29.03 4.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -115.47 -27.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 14.2 t0 -62.99 76.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -61.54 -22.57 65.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.351 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 3.4 p-10 -101.14 -23.54 14.44 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.736 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 69.07 35.11 77.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.295 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.546 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 47.9 p30 -76.56 -17.85 58.99 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.624 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.01 8.79 60.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 p -139.77 162.56 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 HD23 ' A' ' 32' ' ' LEU . 14.8 mt -115.63 127.58 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.546 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 53.3 mp0 -98.5 171.39 8.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -56.25 -52.27 65.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.355 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 29.1 p-10 -56.79 -42.44 79.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.326 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 94.4 mt-10 -65.36 -44.01 89.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -66.55 -33.59 76.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.4 tp -66.74 -43.7 83.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.906 0.384 . . . . 0.0 110.565 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.9 m -72.5 -45.68 58.27 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.243 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 tp -48.74 -52.74 22.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.163 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 ttp -67.92 -47.32 69.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.636 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.774 179.498 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.2 mm . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.48 -46.8 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.075 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.25 -50.76 66.69 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.935 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -62.91 -51.67 66.05 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.463 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -54.27 -37.7 65.01 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.886 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -68.32 -38.84 81.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.081 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.01 -52.31 63.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.174 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -62.62 -48.68 78.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.766 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.58 84.81 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.97 -38.44 91.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.839 0.352 . . . . 0.0 110.064 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.59 -46.07 70.33 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.176 0.512 . . . . 0.0 110.219 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 23' ' ' GLY . 31.8 t0 -78.8 43.32 0.49 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.48 -23.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.875 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.0 p-10 -83.3 -27.16 29.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 111.674 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 82.55 15.64 73.06 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.033 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 55.8 p30 -70.18 -6.11 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 -11.84 26.96 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 10.3 m -131.79 133.08 44.34 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.3 mt -98.45 115.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -79.5 160.53 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 30' ' ' GLU . 7.2 p -56.99 -42.2 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.483 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.44 ' N ' HG13 ' A' ' 29' ' ' VAL . 96.8 mt-10 -61.92 -40.93 97.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.272 0.558 . . . . 0.0 110.223 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 76.6 tt0 -69.27 -35.23 75.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.273 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -62.99 -43.58 98.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.05 72.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.681 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -61.77 -41.93 98.34 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.72 -48.44 75.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.264 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.4 mt -61.52 -36.88 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -59.81 -41.72 91.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.414 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.4 m -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 86.1 mt -59.83 -41.98 92.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.452 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 30.2 t0 131.54 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.623 1.202 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.537 HE21 ' C ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -141.2 156.06 45.97 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.8 -0.563 . . . . 0.0 110.015 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -149.34 76.18 9.34 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.832 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 172.11 2.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.629 2.219 . . . . 0.0 111.261 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -85.53 160.29 19.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 57.7 mp0 -43.45 -41.67 4.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.5 -57.58 8.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.818 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 51.3 mp0 -58.62 -39.36 80.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.229 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.4 -43.41 98.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.988 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -73.36 -49.87 24.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.179 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.01 -38.72 87.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.594 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.5 ttm -67.73 -47.39 69.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.02 -44.31 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 t -59.22 -42.09 90.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.99 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -48.27 -32.63 7.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.017 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -112.93 -30.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.9 t0 -61.53 81.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.37 -26.7 65.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.419 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 2.0 p30 -96.74 -21.98 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.675 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.11 40.62 95.11 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.5 p-10 -82.67 -16.92 46.38 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.517 -0.402 . . . . 0.0 111.554 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.92 4.64 58.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.461 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 55.5 p -135.56 165.4 25.62 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.01 126.8 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -94.38 170.37 9.54 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -56.68 -51.52 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.682 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -61.18 -42.09 97.95 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.228 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 74.2 mt-10 -64.8 -44.98 88.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.129 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.52 -41.11 98.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.71 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.14 -41.8 99.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.952 0.406 . . . . 0.0 110.875 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.85 -43.49 98.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.224 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.9 tp -61.68 -39.23 90.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 110.761 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 45.3 mtp -61.07 -49.66 76.46 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.021 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.204 178.79 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 t -56.06 -44.61 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.786 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.72 -54.37 46.08 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.099 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -56.55 -48.53 77.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -38.16 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -64.15 -41.41 97.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.074 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.02 -46.68 86.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.909 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -62.68 -50.76 69.88 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.806 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.19 -46.23 79.6 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.542 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -61.83 -40.6 95.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CE2' HG11 ' A' ' 35' ' ' VAL . 5.1 m-30 -63.68 -41.76 98.12 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.041 0.448 . . . . 0.0 110.037 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 34.9 t0 -78.38 54.33 1.4 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.349 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -39.18 -30.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.632 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.9 p-10 -82.34 -23.85 34.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.39 16.11 80.97 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.7 p-10 -65.88 -9.79 32.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.354 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -15.98 58.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 6.9 t -130.85 130.58 43.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 0.187 . . . . 0.0 110.761 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.34 112.38 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -79.96 167.29 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.621 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.45 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.4 m -55.63 -39.87 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 73.1 mm-40 -63.09 -42.85 99.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -66.51 -41.17 89.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.139 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.604 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.6 -45.0 94.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.49 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.03 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 m -60.19 -44.69 94.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.659 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG11 ' CE2' ' A' ' 19' ' ' PHE . 55.0 t -63.35 -46.64 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.154 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 41' ' ' GLN . 5.2 mm -60.46 -39.42 81.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -54.89 -42.48 72.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.88 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 40' ' ' ASP . 7.6 t -65.09 -39.69 93.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.21 19.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.388 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 38' ' ' SER . 34.3 m-20 69.08 20.05 7.82 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.871 0.732 . . . . 0.0 111.252 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' HG22 ' A' ' 36' ' ' ILE . 83.6 mt-30 -133.74 142.78 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.019 -0.425 . . . . 0.0 109.965 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -140.54 70.94 31.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.63 157.6 46.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.7 2.267 . . . . 0.0 111.309 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 45' ' ' GLU . 60.9 p -83.73 154.26 23.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 44' ' ' THR . 97.1 mt-10 -38.41 -47.54 1.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.991 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -46.06 -60.32 2.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.33 -41.75 98.81 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.181 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -42.2 98.23 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.122 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -63.65 -51.92 63.03 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.211 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -60.51 -35.43 75.92 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.558 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 70.9 mtm -74.61 -47.74 30.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.04 -43.66 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.843 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -59.12 -45.74 90.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' CD ' ' O ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -46.21 -25.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -118.18 -24.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -59.89 81.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.58 -34.53 77.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.28 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.3 m-20 -80.52 -24.11 39.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.702 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.17 23.15 65.9 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 26.8 p-10 -78.7 -18.42 54.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.122 0.461 . . . . 0.0 111.452 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.24 14.09 29.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.439 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 48.3 p -141.4 172.45 12.66 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.604 HD12 HD23 ' A' ' 32' ' ' LEU . 5.4 mt -121.57 129.13 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -100.26 172.12 7.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -53.99 -49.3 69.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.743 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.76 -42.0 96.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.182 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 92.3 mt-10 -68.21 -45.65 72.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.966 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.8 t80 -60.75 -46.01 92.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.776 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.96 -40.28 95.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 110.116 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.4 p -63.75 -45.63 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.641 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.15 -42.54 86.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 53.3 mtp -67.92 -54.7 16.71 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.407 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.602 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.884 178.884 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.1 mm . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.45 -46.35 95.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.154 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.85 -42.9 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.976 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.41 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -61.05 -48.23 82.71 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -61.48 -32.39 72.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -66.83 -39.53 87.69 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 110.17 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -65.22 -42.01 93.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.983 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.68 -49.02 70.1 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.868 0.366 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.16 -44.36 93.2 Favored Glycine 0 C--N 1.329 0.194 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.79 -40.2 96.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.996 0.427 . . . . 0.0 110.063 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -65.74 -40.46 92.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.228 0.537 . . . . 0.0 110.456 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 23' ' ' GLY . 66.3 t0 -80.6 60.37 3.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' CB ' ' NZ ' ' A' ' 21' ' ' LYS . 9.3 mtmp? -37.23 -27.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.891 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.8 p-10 -97.16 -12.55 22.93 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 63.97 23.36 67.57 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.27 -0.49 . . . . 0.0 111.886 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -66.6 -12.0 55.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.206 0.503 . . . . 0.0 110.776 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.73 -14.49 64.02 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 m -132.65 132.14 42.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 0.0 110.91 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.66 111.74 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 m -75.15 154.89 37.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.59 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 61' ' ' GLY . 3.7 m -54.98 -29.57 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.48 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.52 -41.71 72.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.544 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 68.9 mt-10 -68.76 -41.73 78.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.68 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.692 HD23 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -58.79 -46.84 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.86 73.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.877 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -63.1 -43.85 97.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.14 -48.8 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.104 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.426 HG21 ' CD ' ' A' ' 43' ' ' PRO . 3.0 mm -63.52 -38.38 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -55.31 -40.77 71.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.845 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 40' ' ' ASP . 26.0 m -66.85 -33.57 75.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.674 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.67 23.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 38' ' ' SER . 99.7 m-20 63.7 14.22 8.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -137.95 146.52 43.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -142.74 83.88 11.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.083 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.426 ' CD ' HG21 ' A' ' 36' ' ' ILE . 23.1 Cg_exo -63.95 169.17 10.81 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.856 2.371 . . . . 0.0 111.071 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p -89.61 162.04 15.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -42.66 -46.21 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -50.55 -52.03 42.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.99 -42.73 97.1 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.234 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.0 -47.17 85.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.938 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -64.83 -50.88 64.93 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.175 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.3 t0 -59.15 -34.09 71.66 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.503 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.9 ttp -74.79 -45.53 43.01 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.774 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.57 -44.23 96.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.6 m -61.8 -46.51 89.2 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.046 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -45.07 -29.63 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.44 -33.38 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 53.7 t0 -65.41 98.1 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.98 -24.4 61.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.828 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -100.32 -24.57 14.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.42 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.42 37.3 85.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.283 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 13.7 m120 -70.95 -17.91 62.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.958 0.379 . . . . 0.0 111.422 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 100.38 -2.56 56.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -131.43 174.42 10.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.692 HD12 HD23 ' A' ' 32' ' ' LEU . 7.4 mt -116.51 120.8 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.991 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 68.6 tt0 -88.7 169.87 11.29 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.414 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 82.4 t80 -55.81 -49.04 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.759 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.63 -38.15 89.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.01 0.433 . . . . 0.0 110.249 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 97.5 mt-10 -67.33 -41.22 85.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.826 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -67.33 -38.55 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.502 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -41.37 96.48 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.08 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.6 p -69.95 -45.86 66.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.022 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.12 -44.13 93.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 110.334 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.41 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 tpt -54.62 -51.95 63.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.909 179.131 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.457 -0.1 0 N-CA-C 110.608 -0.145 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 11' ' ' ASP . 9.3 p -61.52 -47.76 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.967 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' N ' HG13 ' A' ' 10' ' ' VAL . 8.8 t70 -62.1 -45.87 91.57 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.874 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CD2' ' SD ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.21 -42.92 99.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.319 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -60.43 -35.47 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.203 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.16 -37.13 83.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.383 0.611 . . . . 0.0 109.748 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.36 82.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.249 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -67.89 -47.42 68.9 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.882 0.372 . . . . 0.0 110.966 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.15 -42.77 98.71 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 tp -62.87 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.114 0.483 . . . . 0.0 110.133 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.19 -36.54 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.33 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.1 t0 -92.53 49.42 1.48 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.182 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -36.5 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.846 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.2 m-20 -70.59 -28.11 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.358 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.76 10.34 85.83 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -69.04 -10.71 58.96 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.867 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.86 -6.31 83.78 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -131.3 134.48 46.41 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.715 0.293 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.7 mt -100.56 113.34 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -82.24 165.14 20.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.658 HG12 HD13 ' A' ' 52' ' ' ILE . 3.2 m -57.37 -44.5 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.735 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' N ' HG23 ' A' ' 29' ' ' VAL . 45.6 tt0 -58.67 -40.11 82.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.21 0.528 . . . . 0.0 109.899 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 97.0 mt-10 -70.23 -40.87 74.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.433 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.625 HD12 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -62.18 -45.46 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.85 -39.38 68.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -65.63 -39.8 91.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.776 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.78 -46.4 92.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.488 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.36 -38.88 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -57.53 -41.28 80.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.525 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -68.62 -31.89 71.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.086 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 76.3 mt -59.13 -42.76 91.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.751 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 36.2 p-10 137.83 17.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.181 0.926 . . . . 0.0 111.301 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -153.94 169.71 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -153.99 84.23 4.13 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.184 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.99 179.49 0.29 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.729 2.286 . . . . 0.0 110.994 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.412 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 50.6 p -89.59 155.03 19.52 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -41.53 -36.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 0.0 110.185 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 3.2 mm-40 -57.24 -53.46 57.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.532 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' OE1' ' OG1' ' A' ' 44' ' ' THR . 2.7 mp0 -60.94 -40.79 94.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.82 -42.96 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -72.99 -45.85 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.284 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.92 -39.92 93.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.532 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -67.59 -44.31 78.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.608 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.658 HD13 HG12 ' A' ' 29' ' ' VAL . 73.3 mt -66.67 -44.28 89.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -40.05 90.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -50.89 -33.82 25.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.9 p -111.21 -32.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 33.5 t0 -64.02 76.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.231 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.19 -25.67 61.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.67 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.415 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 2.0 p30 -95.66 -23.09 17.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.546 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.89 36.48 81.9 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 52.6 p-10 -77.52 -17.09 58.28 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.578 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.459 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 94.58 3.73 62.57 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 6.2 p -134.56 163.76 29.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.625 HD11 HD12 ' A' ' 32' ' ' LEU . 51.7 mt -116.4 128.82 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -104.52 164.7 11.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -45.99 -60.2 2.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.9 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -48.89 -43.3 38.98 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.43 -42.25 75.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.041 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 38.2 t80 -64.43 -37.33 87.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.41 -44.86 93.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.582 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.0 m -65.69 -43.7 88.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.89 -43.0 99.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.658 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.587 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 60.4 mtp -60.04 -44.85 94.39 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.2 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.172 179.437 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.1 mm . . . . . 0 CA--C 1.521 -0.163 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.35 -42.5 95.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.093 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.58 -49.76 71.87 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.876 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.43 -47.22 85.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -60.37 -38.19 83.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.13 -38.05 89.37 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.332 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.06 62.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.834 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -69.35 -46.7 66.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.727 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.49 95.64 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.591 ' O ' HD13 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -63.07 -38.85 92.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 5.6 m-30 -72.34 -39.09 68.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.596 0.713 . . . . 0.0 110.649 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.2 t0 -87.39 50.42 2.0 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.468 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -35.57 -28.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.449 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.2 m-20 -72.51 -28.08 62.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.49 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.57 11.13 85.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -70.22 -9.86 57.11 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.822 -179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.31 -2.48 85.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -133.08 136.88 46.15 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.654 0.264 . . . . 0.0 110.951 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -103.23 115.33 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 29' ' ' VAL . 54.7 m -81.97 162.9 22.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 28' ' ' THR . 8.7 p -58.99 -34.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.368 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.18 -39.05 89.43 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 109.988 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 93.9 mt-10 -71.3 -36.96 71.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.166 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.64 -44.6 95.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.86 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.594 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -64.47 -40.3 95.43 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.4 -46.12 87.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.341 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.67 -41.64 91.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.74 -0.384 . . . . 0.0 109.982 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -57.26 -39.57 75.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.533 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -68.8 -34.49 75.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.551 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 76.3 mt -59.56 -41.85 91.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 116.936 -1.507 . . . . 0.0 112.613 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.551 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 87.8 m-20 134.14 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.164 1.54 . . . . 0.0 111.449 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -147.59 161.35 41.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -150.2 78.59 7.85 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.27 -177.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.605 2.203 . . . . 0.0 111.347 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -90.42 148.33 22.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -42.33 -28.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.135 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.83 -51.21 69.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.441 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -65.92 -37.07 85.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.776 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.67 -42.84 99.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.844 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.71 -44.63 48.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.511 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -62.46 -39.02 92.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.577 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.55 -44.34 78.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.9 mt -66.34 -44.46 90.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.898 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -61.19 -37.07 81.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.014 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -56.16 -34.46 66.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.002 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 10.6 p -108.86 -30.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 48.7 t0 -64.2 77.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -56.17 -24.58 42.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.314 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.41 -23.22 17.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.602 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.36 37.85 86.5 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.352 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 47.3 p-10 -80.47 -15.7 56.11 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.57 -0.37 . . . . 0.0 111.514 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.14 4.18 69.08 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 33.3 p -133.99 157.77 45.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.5 mt -111.09 127.64 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 10.7 pt-20 -95.69 174.79 6.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.757 0.313 . . . . 0.0 110.263 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.07 -50.38 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.72 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -57.57 -58.86 6.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.307 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 94.8 mt-10 -51.97 -43.59 63.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.081 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -62.54 -46.0 90.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.07 -43.3 95.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 m -65.33 -44.71 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.314 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.248 0.547 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.55 -43.06 98.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.227 179.34 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.576 0.227 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.79 -47.8 91.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.101 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.22 -45.34 85.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.974 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.3 -48.13 81.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.061 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.76 -35.42 79.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.081 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -63.84 -36.82 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.06 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -68.31 -37.21 80.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.345 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.446 ' CE1' HD12 ' A' ' 27' ' ' ILE . 75.6 t80 -67.45 -48.92 65.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 111.123 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.69 -42.32 96.24 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.7 tp -62.46 -39.14 92.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 109.926 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.25 -36.7 79.85 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.334 0.588 . . . . 0.0 110.693 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 34.4 t0 -86.42 51.41 2.22 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.46 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -36.29 -30.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.719 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 6.2 m-20 -70.51 -28.08 64.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.556 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.32 8.68 87.63 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.694 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -68.57 -17.37 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.731 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 95.2 -7.03 69.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 m -127.62 129.76 47.82 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.612 0.206 . . . . 0.0 111.016 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.446 HD12 ' CE1' ' A' ' 16' ' ' PHE . 80.7 mt -100.32 114.25 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.22 165.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.18 -38.59 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.524 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -61.17 -40.52 94.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.958 0.408 . . . . 0.0 110.195 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 94.1 mt-10 -70.52 -38.37 74.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.224 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.644 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -60.97 -45.48 94.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.44 81.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.88 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -62.24 -43.65 98.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.1 -47.43 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.48 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.94 -38.59 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -58.57 -41.31 85.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 t -86.8 -12.99 46.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.589 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 3.4 tt -65.11 -41.12 95.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.497 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 15.5 m-20 150.99 0.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.901 0.751 . . . . 0.0 111.678 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -155.02 172.44 18.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -153.93 76.87 5.81 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.24 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.16 176.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.46 2.107 . . . . 0.0 111.285 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -86.22 161.75 18.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.5 mp0 -47.35 -41.24 19.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 2.4 mt-10 -54.24 -53.18 57.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.415 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.97 -40.75 96.67 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.161 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mp -62.66 -45.91 90.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.025 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -69.39 -46.51 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.75 -36.99 84.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.3 ttp -69.17 -45.76 69.21 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.5 mt -65.61 -44.94 93.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.98 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -59.13 -39.52 82.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.796 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -52.0 -31.49 29.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.751 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -109.87 -32.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.2 t70 -64.34 77.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.21 -30.0 48.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.433 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 15.3 p-10 -92.19 -18.85 22.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.67 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 65.31 42.86 95.93 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -87.01 -16.68 35.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.018 0.409 . . . . 0.0 111.64 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.08 16.23 58.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 m -140.19 151.64 45.38 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.644 HD12 HD23 ' A' ' 32' ' ' LEU . 8.6 mt -112.31 126.33 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 96.1 mt-10 -103.26 179.66 4.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -57.37 -58.59 7.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.813 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 37.4 p-10 -56.52 -41.57 76.95 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.257 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 97.3 mt-10 -66.0 -46.23 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.908 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.87 -35.78 81.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.396 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.703 HD23 ' C ' ' A' ' 69' ' ' LEU . 7.4 tt -62.76 -43.61 98.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.927 0.394 . . . . 0.0 110.18 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -65.06 -45.28 85.97 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.438 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.61 -43.13 99.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.995 0.426 . . . . 0.0 110.736 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.472 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 4.3 tpt -59.6 -50.07 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.301 179.483 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.9 mt . . . . . 0 N--CA 1.457 -0.117 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.6 t -55.55 -44.99 78.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.93 -51.56 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.835 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -59.03 -48.85 80.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.755 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -37.27 70.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.225 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.33 -41.5 85.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.314 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.62 -48.87 77.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.104 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.37 -49.25 74.58 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.901 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -45.72 82.14 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.626 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.7 tt -62.97 -39.41 94.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.226 0.536 . . . . 0.0 109.559 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.99 -41.87 95.03 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.387 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' ASP . 12.8 t0 -83.34 53.77 2.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.808 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -39.54 -18.58 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.573 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -86.12 -28.67 23.86 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.307 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.21 11.59 84.88 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.742 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.78 -18.12 65.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.727 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.1 -13.64 60.25 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.401 ' SG ' ' OE2' ' A' ' 64' ' ' GLU . 3.5 m -131.69 132.75 44.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.7 0.286 . . . . 0.0 111.151 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -97.05 114.3 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -78.95 165.07 23.88 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 30' ' ' GLU . 3.6 m -55.84 -41.23 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.495 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 29' ' ' VAL . 75.9 mt-10 -60.7 -42.77 97.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.0 mt-10 -68.33 -42.89 78.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.303 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.5 tm? -62.16 -46.8 87.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.55 -39.23 64.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.165 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -63.46 -43.18 98.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.928 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 19' ' ' PHE . 60.0 t -65.4 -48.81 81.71 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -64.68 -40.57 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.0 -42.16 89.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 m -79.45 -20.99 46.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.583 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 39' ' ' LEU . 5.3 tt -63.71 -45.39 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 4.1 m-20 153.3 0.91 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.47 0.482 . . . . 0.0 111.301 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -141.88 155.74 45.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -135.55 78.27 50.59 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.28 155.42 70.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.617 2.211 . . . . 0.0 110.911 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.3 p -85.2 161.39 19.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' THR . 80.4 tt0 -40.16 -47.77 2.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 109.805 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.23 -58.32 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -60.61 -42.37 96.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.557 ' CD2' HD12 ' A' ' 32' ' ' LEU . 12.8 mt -62.05 -43.5 98.7 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.155 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.86 -52.05 58.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.884 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -37.72 84.13 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.695 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.7 mmt -72.23 -48.68 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.7 mt -64.02 -45.17 97.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.954 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.2 p -58.98 -44.74 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -45.07 -27.42 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.5 p -115.61 -30.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 t70 -59.03 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.41 -35.13 73.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.297 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 21.7 p-10 -89.61 -22.41 22.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.45 63.33 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.478 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 52.3 p30 -107.95 -16.7 14.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 117.001 0.4 . . . . 0.0 111.614 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 98.15 15.57 35.42 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.478 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 56.1 p -141.33 165.51 27.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -119.41 126.09 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 80.4 mm-40 -100.24 174.12 6.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.247 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -54.54 -50.85 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.773 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.85 -41.98 98.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.335 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 96.8 mt-10 -67.02 -46.15 75.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.383 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.11 -45.51 93.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.19 -41.62 97.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.576 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 t -63.49 -46.76 84.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.518 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.41 -41.02 93.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.793 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 ttt -69.33 -51.16 39.69 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.025 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.504 179.213 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -110.35 31.43 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.89 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 pt -105.63 -101.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.819 0.342 . . . . 0.0 110.265 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.58 -35.36 80.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 110.009 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -69.77 96.38 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.533 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 10' ' ' VAL . 97.3 mt-10 -99.51 82.26 2.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.665 0.269 . . . . 0.0 110.972 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -91.08 -51.33 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.71 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 2.3 pt20 -63.93 -44.2 93.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.358 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.59 -44.13 96.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.308 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 6' ' ' GLU . 23.0 t -57.24 -45.88 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.654 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -58.64 -54.75 43.54 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.768 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -60.83 -49.1 78.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.941 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -60.82 -34.31 74.35 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' VAL . 84.3 tt0 -68.61 -42.61 77.88 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.087 0.47 . . . . 0.0 110.527 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -40.05 88.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 81.7 t80 -65.78 -49.62 67.67 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.96 -42.65 96.93 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.2 tt -60.56 -41.31 94.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -64.09 -39.4 93.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLY . 36.3 t0 -80.18 54.79 2.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -39.02 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.54 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.3 m-20 -86.42 -27.22 24.29 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.186 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.75 12.53 84.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.697 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 47.5 p30 -66.39 -16.61 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.747 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 104.98 -12.53 49.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -140.9 145.21 35.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.729 0.3 . . . . 0.0 111.151 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 4.6 mp -105.31 120.15 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -81.75 169.09 17.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.708 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.37 -43.53 77.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.149 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.43 -43.25 99.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.14 0.495 . . . . 0.0 110.328 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.7 mt-10 -66.96 -40.02 87.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.041 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.92 -45.45 92.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.71 61.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -61.77 -42.58 99.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.749 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.68 -49.7 67.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 41' ' ' GLN . 1.3 mp -61.14 -39.04 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -56.45 -41.29 76.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.447 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 40' ' ' ASP . 42.3 m -65.79 -37.18 85.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.856 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.04 22.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 38' ' ' SER . 62.5 m-20 66.21 16.58 10.49 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.333 0.395 . . . . 0.0 112.03 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' ILE . 52.2 tt0 -136.92 145.53 44.39 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -149.94 82.18 6.67 Favored Pre-proline 0 C--N 1.331 -0.196 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.36 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.71 163.98 34.99 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.947 2.431 . . . . 0.0 110.729 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 11.5 p -82.66 159.08 22.73 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 44' ' ' THR . 79.3 tt0 -38.33 -47.28 1.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 109.82 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.84 -63.1 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' O ' ' SD ' ' A' ' 51' ' ' MET . 15.4 mp0 -56.02 -41.39 74.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.86 -43.01 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -65.45 -52.35 53.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.419 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 65.5 t0 -58.88 -38.04 77.93 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.17 -47.92 47.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.821 178.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.22 -47.33 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.888 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -58.2 -45.61 87.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -44.2 -29.86 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.821 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -114.98 -31.12 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.66 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t70 -58.9 86.22 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.03 -34.99 70.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.5 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 18.7 p-10 -93.2 -21.9 19.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.844 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.66 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.74 64.77 3.69 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 53.9 p30 -107.79 -13.22 15.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 117.045 0.422 . . . . 0.0 111.547 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.08 7.48 58.46 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.419 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 32.9 p -135.06 164.39 27.74 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 mt -121.03 128.34 76.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -103.92 174.29 5.94 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.54 -52.1 64.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.565 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.82 -45.11 86.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.133 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -44.76 84.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.245 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.76 -44.36 96.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.59 -42.05 99.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.779 0.323 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 74' ' ' LYS . 10.2 t -63.92 -45.81 87.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.246 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.513 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -58.77 -42.09 88.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.547 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttt -71.81 -51.63 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.946 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.47 -30.92 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.519 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' SER . 64.0 tttp -67.33 -32.29 73.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -93.7 -11.37 31.65 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.21 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 76' ' ' VAL . 17.4 t -128.45 22.77 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.285 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -54.72 -20.89 9.29 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.195 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 79' ' ' THR . 30.2 p-10 -54.87 -55.09 34.23 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.443 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.477 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 46.1 p . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.568 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 53.85 50.2 17.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.549 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -84.91 153.02 3.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.079 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.667 ' N ' HD23 ' A' ' 4' ' ' LEU . 2.0 pt? -62.96 -26.61 68.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.319 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.422 ' O ' ' OE1' ' A' ' 8' ' ' GLN . 81.5 p -52.68 -39.01 61.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.846 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 10' ' ' VAL . 97.4 mt-10 -73.51 48.78 0.27 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.801 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -88.17 -54.34 4.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.784 0.326 . . . . 0.0 110.642 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.601 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -64.49 -37.84 88.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.252 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.5 mt -62.93 -43.92 99.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.328 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 6' ' ' GLU . 44.9 t -60.55 -47.71 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.078 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -66.1 -44.71 83.58 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.979 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.77 -49.57 75.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.971 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -60.03 -32.36 70.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.335 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.19 -39.63 89.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.168 0.509 . . . . 0.0 109.985 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.7 -46.99 85.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.705 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.56 -49.01 75.09 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.85 -45.79 78.72 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.2 tt -62.8 -39.48 94.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.248 0.547 . . . . 0.0 109.728 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.28 -42.96 96.18 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.278 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 57.8 t0 -81.23 54.15 2.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.195 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -37.75 -32.54 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.605 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p-10 -81.21 -25.42 36.73 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.704 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 77.38 14.51 82.44 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 51.6 p-10 -62.33 -4.03 1.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.978 0.389 . . . . 0.0 110.691 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.71 -17.0 33.03 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 9.0 m -130.43 130.5 44.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.611 0.244 . . . . 0.0 110.915 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.1 mt -93.77 111.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -77.66 164.58 25.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.59 -35.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.554 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -42.23 91.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.149 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.55 -38.05 83.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.332 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.55 -44.89 92.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.66 72.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.677 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -62.48 -43.32 99.1 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.76 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.83 -48.11 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.615 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -65.83 -39.73 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.172 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -59.52 -42.45 92.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.712 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.6 t -83.13 -14.41 53.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 11.0 tp -65.4 -43.25 91.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 2.7 m-20 155.66 -1.04 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.259 0.349 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -148.5 163.52 36.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -137.51 75.09 45.57 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 111.341 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.82 162.9 29.99 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.795 2.33 . . . . 0.0 111.003 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -82.54 152.22 26.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -39.38 -41.9 1.0 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.842 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.43 -50.69 51.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.482 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.93 -41.84 99.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.159 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.22 -42.43 99.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.196 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.26 -51.28 66.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.19 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.68 -36.39 78.64 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.559 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.0 mtt -71.45 -47.0 58.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.964 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.7 mt -64.66 -43.43 96.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t -58.69 -45.14 90.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.897 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 3.6 tm-20 -51.04 -28.66 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.031 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -110.73 -32.55 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -63.52 80.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.93 -35.38 64.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.019 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -90.39 -20.06 23.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.551 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.81 39.89 97.87 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.244 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.511 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 48.2 p30 -83.73 -17.09 42.45 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.718 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.66 56.89 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 43.8 p -133.08 165.52 24.55 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.66 130.94 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 96.8 mt-10 -104.28 176.12 5.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.323 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -56.03 -52.39 64.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.857 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -60.51 -44.5 95.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.005 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 99.8 mt-10 -63.41 -45.22 92.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.961 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.73 -41.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.68 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.25 -39.61 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.317 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.5 m -62.56 -45.9 90.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.325 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.43 -40.89 98.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.439 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 1.1 tpt -62.97 -53.64 50.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.289 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.67 -24.69 67.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 110.398 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -70.98 -28.85 64.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.931 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -84.62 -36.92 21.68 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.297 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -104.46 14.47 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.593 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 73' ' ' ALA . 56.8 tttm -44.65 -28.57 0.62 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.156 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -54.66 -55.61 27.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.355 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.703 179.665 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -154.19 -174.81 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.395 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.8 mt 67.73 63.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 O-C-N 123.729 0.643 . . . . 0.0 110.635 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.92 -37.41 58.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.507 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 14.9 t -156.68 -15.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.275 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' O ' HG23 ' A' ' 10' ' ' VAL . 95.2 mt-10 68.96 73.56 0.26 Allowed 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.939 0.774 . . . . 0.0 110.58 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -93.21 -57.51 2.59 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.709 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -61.5 -37.01 82.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.249 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 mm -62.47 -43.11 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 6' ' ' GLU . 53.7 t -61.85 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.016 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -57.06 -54.18 49.68 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -62.14 -50.82 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.889 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -54.42 -38.12 65.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.161 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.41 -39.89 89.25 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.959 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.84 -48.5 80.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.967 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' ' CD1' ' A' ' 27' ' ' ILE . 61.7 t80 -62.89 -49.06 76.31 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.806 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.18 -47.92 65.69 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.31 -38.52 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.9 m-30 -66.39 -46.14 77.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.509 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 14.6 t70 -79.19 50.58 1.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.92 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -39.51 -26.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.836 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 42.7 p-10 -81.3 -27.71 34.94 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.642 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 80.21 12.73 82.88 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.895 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 53.7 p30 -63.78 -10.07 17.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.157 0.478 . . . . 0.0 110.658 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.36 61.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 3.8 m -133.73 135.38 43.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.605 0.241 . . . . 0.0 111.095 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 65.4 mt -99.58 115.54 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -77.85 165.18 24.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.551 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.18 -40.21 76.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.537 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.19 -42.28 98.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -69.28 -39.33 78.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.381 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.65 -45.2 93.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.66 -39.17 73.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -62.53 -44.33 96.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.972 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.453 HG11 ' CE2' ' A' ' 19' ' ' PHE . 49.4 t -62.94 -44.74 99.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.848 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.433 HG21 ' CD ' ' A' ' 43' ' ' PRO . 5.1 mm -62.74 -41.7 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -57.1 -41.59 79.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.952 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 t -73.28 -33.13 65.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 29.4 mt -61.58 -44.26 97.34 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 9.8 p30 147.38 2.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.661 0.601 . . . . 0.0 111.497 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -129.07 165.04 21.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -152.14 70.74 7.73 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.01 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.433 ' CD ' HG21 ' A' ' 36' ' ' ILE . 16.3 Cg_exo -66.72 152.85 79.77 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.666 2.244 . . . . 0.0 111.015 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.9 p -82.43 162.45 22.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -40.54 -46.96 2.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.953 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.93 -54.05 22.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.493 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -64.62 -43.71 92.86 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.459 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 mt -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.875 0.369 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.48 -50.33 67.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.436 -0.505 . . . . 0.0 109.871 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 67.7 t0 -61.89 -35.04 77.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.396 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.5 ttp -72.37 -48.49 41.28 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 HD11 ' A' ' 63' ' ' ILE . 84.8 mt -64.21 -44.18 97.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.6 m -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -46.29 -27.45 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.6 p -115.75 -24.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 14.1 t0 -63.77 77.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.03 -34.42 77.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.427 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 19.1 p-10 -87.86 -23.28 24.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.649 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.74 67.87 1.9 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.275 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 51.4 p30 -112.89 -15.21 12.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.936 0.368 . . . . 0.0 111.536 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.99 10.19 57.7 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.517 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 64.6 p -141.05 170.77 15.1 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 52' ' ' ILE . 65.1 mt -119.54 127.4 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 72.8 tt0 -99.01 167.55 10.66 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.418 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 38.6 t80 -52.78 -49.48 65.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.464 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.34 -42.4 95.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.154 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.89 -43.9 86.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.1 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.83 -44.01 97.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.355 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -63.35 -41.81 98.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 74' ' ' LYS . 72.1 m -64.95 -48.88 72.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.742 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.0 tp -58.92 -41.18 86.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 110.651 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.1 mmm -68.59 -57.62 5.47 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.095 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.11 -29.99 70.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 70' ' ' SER . 64.4 tttp -65.62 -36.22 83.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.669 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -71.64 -44.92 63.49 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.823 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.482 ' C ' ' N ' ' A' ' 78' ' ' ASP . 1.7 p -79.49 -7.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.389 . . . . 0.0 110.738 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -47.35 -14.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.173 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.482 ' N ' ' C ' ' A' ' 76' ' ' VAL . 52.6 t0 -57.74 -54.75 43.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.503 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.414 ' O ' ' OG1' ' A' ' 79' ' ' THR . 1.3 t . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.544 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -94.25 7.37 45.6 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.933 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.519 HG12 ' H ' ' A' ' 5' ' ' SER . 21.1 tt -130.55 130.46 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.185 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.7 mt -77.65 -20.23 54.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.163 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.519 ' H ' HG12 ' A' ' 3' ' ' ILE . 1.6 m -58.7 -6.81 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' O ' HG23 ' A' ' 10' ' ' VAL . 96.9 mt-10 -137.51 45.14 2.2 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 110.928 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -93.69 -64.56 1.07 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.4 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -64.24 -31.95 73.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.591 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mm -64.07 -43.79 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.064 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 6' ' ' GLU . 79.7 t -63.83 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.831 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.68 -44.63 96.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.929 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.43 -49.86 69.84 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.008 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -64.1 -34.05 77.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.47 -38.07 88.72 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.321 0.581 . . . . 0.0 110.268 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.68 -39.07 87.96 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.176 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -69.92 -48.58 57.99 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.16 92.17 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.96 -37.04 85.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -70.33 -40.12 74.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 110.557 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' GLY . 32.2 t0 -78.01 50.83 0.91 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.208 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -37.02 -31.2 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.695 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 22.6 m-20 -75.28 -28.14 59.64 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.543 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.81 7.47 88.26 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.9 p-10 -68.26 -8.14 36.74 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.91 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.66 -6.82 83.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 m -130.51 131.83 45.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 110.799 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.6 mt -98.72 114.89 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.2 p -82.65 163.68 21.24 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 61' ' ' GLY . 1.7 m -58.18 -38.97 71.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.511 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -62.54 -40.57 97.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.264 0.554 . . . . 0.0 110.645 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 31.9 tt0 -71.49 -36.75 71.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.036 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.69 -45.06 95.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.03 -40.29 73.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.799 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -61.64 -43.4 98.93 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.803 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.19 -48.89 77.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.189 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' GLN . 2.8 mm -63.61 -36.92 78.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -57.06 -40.36 76.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -66.45 -36.19 82.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.662 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 40' ' ' ASP . 84.9 mt -70.46 26.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.4 OUTLIER 60.48 19.85 9.59 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' HG22 ' A' ' 36' ' ' ILE . 49.2 tt0 -138.62 150.67 46.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -154.74 83.86 3.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.72 170.85 3.15 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.61 2.206 . . . . 0.0 110.931 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 45' ' ' GLU . 55.2 m -84.7 168.64 15.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.627 ' N ' HG22 ' A' ' 44' ' ' THR . 80.4 mt-10 -53.05 -45.66 68.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.253 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 18.2 pt-20 -56.84 -44.49 82.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.888 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 50.6 mt-10 -64.81 -43.82 91.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.957 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.37 -44.86 96.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.823 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -67.74 -47.78 68.3 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -61.47 -40.26 93.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.0 tpp -69.87 -46.44 65.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 29' ' ' VAL . 82.1 mt -65.23 -44.33 95.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.4 p -61.67 -36.09 79.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.933 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -56.74 -32.01 65.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.782 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.42 -26.75 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 52.3 t0 -73.27 85.83 1.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.88 65.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.709 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -101.11 -23.37 14.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.223 -178.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.89 38.78 85.41 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.125 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 19.5 m120 -72.99 -16.54 61.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.874 0.337 . . . . 0.0 111.332 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 94.2 1.61 64.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.8 p -137.18 166.89 22.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.605 HD12 HD23 ' A' ' 32' ' ' LEU . 6.5 mt -114.46 126.02 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.74 178.66 4.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.321 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -56.8 -52.59 64.45 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.757 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.43 -43.31 96.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.901 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 95.3 mt-10 -65.65 -44.55 86.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.958 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -61.19 -43.09 99.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.458 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -40.76 97.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 74' ' ' LYS . 10.3 t -63.22 -45.4 91.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.262 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.42 -42.12 86.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.966 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.5 tpp -77.09 -41.08 43.61 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.246 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -71.85 -36.04 70.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.454 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -75.12 -27.57 59.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.474 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -83.59 -30.33 27.06 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.05 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.24 27.71 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.134 0.492 . . . . 0.0 110.611 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 73' ' ' ALA . 53.9 tttm -55.15 -37.23 66.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -50.39 -54.94 18.02 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.683 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.4 m . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.66 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 3' ' ' ILE . 70.9 m-20 -144.95 141.01 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.832 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.621 HG22 ' H ' ' A' ' 5' ' ' SER . 94.3 mt 57.56 144.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.136 0.493 . . . . 0.0 110.668 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' A' ' 5' ' ' SER . 10.7 mp -63.1 -39.34 94.42 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 118.291 -0.862 . . . . 0.0 110.332 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.621 ' H ' HG22 ' A' ' 3' ' ' ILE . 5.7 m 105.95 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 125.128 1.517 . . . . 0.0 110.891 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 10' ' ' VAL . 75.9 mt-10 -75.77 26.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.233 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 5' ' ' SER . 80.9 tt0 -91.93 -57.3 2.77 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 110.673 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -62.19 -33.6 74.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.434 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.18 -43.89 98.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.082 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 6' ' ' GLU . 75.7 t -60.86 -48.43 88.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.827 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.65 -47.37 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.926 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -60.04 -46.95 87.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -57.24 -36.4 70.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.31 -38.12 89.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.963 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.99 -44.4 92.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.092 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -65.87 -49.44 68.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.877 0.37 . . . . 0.0 111.186 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.82 -45.28 86.34 Favored Glycine 0 C--N 1.33 0.231 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.628 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.3 tt -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -65.32 -41.49 93.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.502 0.668 . . . . 0.0 110.376 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLY . 19.1 t70 -81.05 58.06 3.33 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.544 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -36.73 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.51 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -80.02 -27.51 39.5 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.33 7.23 82.21 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -64.29 -19.11 65.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.667 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.32 -11.95 51.4 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' OE1' ' A' ' 64' ' ' GLU . 57.3 m -128.06 127.56 43.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.92 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.29 111.96 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.478 HG22 ' OE1' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -82.12 166.93 19.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.663 HG22 HD13 ' A' ' 52' ' ' ILE . 71.9 t -55.7 -44.12 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.447 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -53.96 -43.19 69.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.858 0.361 . . . . 0.0 110.198 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.478 ' OE1' HG22 ' A' ' 28' ' ' THR . 43.9 mt-10 -67.75 -46.03 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.746 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.12 -46.66 88.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.6 -41.77 66.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.151 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.3 m -65.11 -39.76 93.57 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.349 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.2 -48.63 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.04 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.0 mm -61.67 -43.68 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.361 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -60.35 -41.8 94.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.352 0.596 . . . . 0.0 110.626 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -75.38 -22.64 57.34 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.737 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 39' ' ' LEU . 3.2 tt -66.17 -44.88 82.77 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 5.1 m-20 151.11 2.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 O-C-N 123.844 0.715 . . . . 0.0 111.418 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -143.33 154.01 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -133.24 79.09 62.45 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.63 159.29 53.28 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.858 2.372 . . . . 0.0 110.839 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -86.21 162.25 18.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 28.9 mp0 -40.66 -47.91 2.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 2.8 mm-40 -47.31 -58.98 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.713 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.05 -41.88 97.43 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.396 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.02 -43.46 98.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.882 0.373 . . . . 0.0 110.256 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.07 -49.69 71.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.969 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -61.28 -36.0 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.6 mtp -72.93 -46.95 49.67 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.663 HD13 HG22 ' A' ' 29' ' ' VAL . 73.3 mt -65.83 -45.19 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.665 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.1 m -58.15 -45.27 87.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -48.62 -27.47 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -113.73 -32.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.83 81.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.51 -32.68 71.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.419 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.0 p-10 -93.21 -21.87 19.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.804 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.82 31.68 78.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 49.4 p-10 -73.41 -16.91 61.32 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.524 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 99.19 6.28 55.69 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.413 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 31.7 p -139.94 173.66 11.3 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.8 mt -121.92 128.31 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 65' ' ' PHE . 13.4 tp10 -94.66 168.13 11.03 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.437 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 14.7 t80 -54.72 -50.49 68.2 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.702 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.48 -39.78 88.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.103 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.46 -42.28 92.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.243 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.78 -40.28 96.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.64 -41.01 98.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 15.6 t -64.32 -44.78 90.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.532 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 tp -58.81 -40.93 85.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.9 mmm -66.8 -56.63 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.339 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.61 -32.55 74.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.648 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 70' ' ' SER . 55.3 tttp -62.28 -34.78 77.23 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.455 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 mtpm? -81.15 -43.89 18.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.234 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 76' ' ' VAL . 52.8 t -77.84 -1.7 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.627 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.71 -10.8 0.49 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.171 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 76' ' ' VAL . 21.5 p-10 -55.71 -55.71 28.97 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.516 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.432 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 4.2 t . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.521 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.22 -45.73 86.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 111.474 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.9 mm 58.66 98.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.631 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.9 mm? -59.79 -35.99 75.8 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.069 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 6' ' ' GLU . 2.0 m 82.33 -113.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.757 0.66 . . . . 0.0 110.787 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 10' ' ' VAL . 38.8 tt0 79.75 55.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.589 0.556 . . . . 0.0 110.104 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -95.63 -50.61 4.87 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.156 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -63.38 -41.15 98.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.767 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.49 -42.6 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.263 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 6' ' ' GLU . 37.6 t -57.7 -47.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.935 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -65.28 -48.63 72.52 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.012 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.598 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 3.3 m-85 -61.29 -48.7 80.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -59.03 -33.45 70.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.84 -38.6 86.71 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.185 0.517 . . . . 0.0 110.182 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.7 -46.39 85.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.91 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.04 -48.63 73.17 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.53 84.97 Favored Glycine 0 C--N 1.33 0.23 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.92 -37.99 89.43 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.1 m-30 -66.09 -41.51 90.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.374 0.606 . . . . 0.0 110.058 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ASP . 25.8 t0 -83.97 56.39 3.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.239 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -38.48 -19.04 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.697 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.1 m-20 -88.37 -26.89 21.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.378 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 75.08 11.47 83.98 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.729 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -65.18 -17.19 64.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.722 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -13.06 56.56 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.1 m -134.06 136.66 44.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.711 0.291 . . . . 0.0 111.111 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.5 mt -97.54 113.92 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.578 HG22 ' N ' ' A' ' 29' ' ' VAL . 89.4 m -78.3 164.85 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.578 ' N ' HG22 ' A' ' 28' ' ' THR . 8.2 t -56.12 -46.49 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.36 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.03 -41.57 83.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 94.4 mt-10 -67.26 -41.54 85.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.317 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.688 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.69 -44.42 96.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.38 70.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.859 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -61.38 -44.38 97.25 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.789 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.0 -47.97 85.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.082 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 41' ' ' GLN . 3.0 mm -61.73 -38.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.09 -41.24 78.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.294 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 40' ' ' ASP . 37.6 m -64.82 -35.67 81.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.92 21.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 38' ' ' SER . 98.1 m-20 63.3 18.41 10.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 6.8 tp-100 -134.0 139.41 46.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.29 76.73 37.2 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 120.754 0.311 . . . . 0.0 111.169 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.9 169.38 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.992 2.462 . . . . 0.0 111.092 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 47' ' ' GLU . 6.9 p -86.72 149.73 24.68 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 57.1 mp0 -39.6 -42.72 1.22 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.44 -49.03 36.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.195 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 44' ' ' THR . 46.0 tp10 -66.48 -41.85 88.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.211 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.56 -43.05 99.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.126 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -62.97 -51.21 67.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.293 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.92 -33.16 71.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.479 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.6 ttp -74.74 -45.84 41.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' ASP . 80.4 mt -63.42 -43.95 98.7 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.864 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -63.94 -45.51 88.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.209 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.34 -33.4 65.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.209 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 71' ' ' LEU . 3.6 m -103.43 -32.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 58.8 t0 -74.56 104.98 5.46 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.53 64.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.538 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 2.4 p30 -95.58 -23.22 17.16 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.622 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 63.08 41.22 99.85 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.458 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 49.6 p30 -80.3 -16.44 54.64 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.73 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 101.91 -0.84 51.75 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.458 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 18.5 p -129.83 170.87 13.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.688 HD12 HD23 ' A' ' 32' ' ' LEU . 5.0 mt -118.99 125.27 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 74.4 tt0 -95.22 167.3 11.44 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.409 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 63.2 t80 -53.72 -49.7 67.53 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.681 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.01 -41.24 87.25 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.233 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.73 -42.34 86.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.259 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -65.39 -41.08 94.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.881 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.2 tp -62.59 -41.59 99.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.522 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -66.16 -44.98 82.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.506 HD13 HG11 ' A' ' 55' ' ' VAL . 37.1 tp -63.39 -42.0 98.78 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.107 0.48 . . . . 0.0 111.182 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.598 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 27.0 ttt -60.97 -49.05 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.07 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -65.68 -49.27 69.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.3 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -51.79 -22.33 3.56 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -86.79 -42.74 13.05 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.668 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 76' ' ' VAL . 31.7 t -98.22 15.22 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 120.947 0.403 . . . . 0.0 110.412 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 73' ' ' ALA . 61.2 tttp -59.06 -7.64 1.19 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.115 0.483 . . . . 0.0 109.935 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 76' ' ' VAL . 68.3 t0 -53.45 -56.81 13.75 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.559 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.331 179.821 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -75.15 106.62 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.516 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.485 HD12 ' OE1' ' A' ' 7' ' ' GLU . 88.9 mt -70.09 -91.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.677 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 5' ' ' SER . 42.5 tp -90.47 -13.87 33.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 121.101 -0.24 . . . . 0.0 111.017 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 3.2 m 152.77 -78.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.922 0.391 . . . . 0.0 110.154 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 10' ' ' VAL . 75.6 mt-10 -80.71 87.35 5.83 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.883 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.485 ' OE1' HD12 ' A' ' 3' ' ' ILE . 52.8 tp10 -94.33 -66.85 0.89 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.701 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -60.98 -36.52 79.64 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.665 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.35 -44.19 97.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.066 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 6' ' ' GLU . 42.2 t -62.4 -46.72 95.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.045 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -60.41 -39.71 88.37 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.55 -56.21 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -39.32 81.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -64.72 -35.54 81.38 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.979 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.59 82.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.464 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -68.15 -47.26 68.53 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.32 98.13 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 tt -63.16 -37.56 87.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 0.0 109.688 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -70.99 -38.64 72.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 t0 -87.62 48.91 1.71 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.156 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -35.41 -28.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.363 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.6 m-20 -71.91 -28.04 63.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.512 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.44 8.64 87.62 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -68.48 -9.82 51.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.848 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.83 -5.65 84.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.9 m -129.03 131.57 47.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.69 0.281 . . . . 0.0 111.096 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.5 mt -100.27 114.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 p -82.2 164.12 21.45 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 30' ' ' GLU . 7.5 p -58.21 -42.26 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.615 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' N ' HG13 ' A' ' 29' ' ' VAL . 98.9 mt-10 -58.4 -38.86 78.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 0.0 110.229 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -71.28 -37.92 71.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.442 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.31 -44.59 96.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.29 76.48 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.78 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -64.1 -41.3 97.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.43 -47.39 80.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.498 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.88 -38.5 82.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -59.44 -40.91 88.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.657 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.34 -34.99 65.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.381 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 38.0 mt -61.4 -41.93 97.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 112.641 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.56 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 71.8 m-20 141.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.345 1.028 . . . . 0.0 111.18 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -137.76 158.19 44.88 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.493 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 13.2 p-10 -155.42 69.04 5.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.956 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.79 169.53 5.61 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.678 2.252 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.435 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 64.8 p -80.44 148.69 30.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' THR . 75.5 mt-10 -37.69 -36.67 0.19 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.887 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -55.22 -53.37 56.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.386 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 12.8 mp0 -61.08 -41.75 97.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.95 -42.14 97.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -68.12 -42.6 79.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.318 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.13 -39.62 95.21 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.744 0.306 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 mtm -69.57 -44.01 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.211 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -66.18 -44.42 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.989 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -61.86 -33.93 75.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.072 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -59.57 -33.63 71.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.788 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.6 p -109.92 -31.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 43.9 t0 -64.56 77.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -55.82 -23.68 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.266 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -97.46 -22.53 16.52 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.607 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.09 46.21 89.27 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.803 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -88.97 -17.19 29.98 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.63 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.66 ' N ' HD22 ' A' ' 60' ' ' ASN . . . 95.63 10.63 56.53 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.803 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 33.1 p -139.47 159.4 42.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 63' ' ' ILE . 21.1 mt -113.83 128.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.42 171.89 8.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.37 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.67 -52.49 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.875 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.7 -41.29 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.6 -45.08 84.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.023 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.7 -42.29 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tt -63.97 -42.12 97.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -63.0 -46.08 89.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.231 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.568 HD11 ' NZ ' ' A' ' 75' ' ' LYS . 49.8 tp -63.11 -40.29 97.21 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 110.551 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mmm -59.3 -42.72 92.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.613 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.621 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.27 -50.64 67.13 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.346 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -52.52 -28.03 18.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.691 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.568 ' NZ ' HD11 ' A' ' 71' ' ' LEU . 14.5 mptt -84.22 -40.27 18.29 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.32 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.38 37.73 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.958 0.408 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 73' ' ' ALA . 38.3 ttpt -60.96 -44.71 96.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.083 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -74.2 -59.85 2.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.843 -179.916 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 2' ' ' ASP . 49.0 p30 -74.49 154.06 38.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.004 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 mm 57.86 114.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.863 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -72.41 -20.41 61.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.991 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER 82.22 51.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 O-C-N 123.525 0.516 . . . . 0.0 110.927 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 6.4 mp0 -79.81 44.34 0.64 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.857 0.361 . . . . 0.0 110.945 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.18 -57.69 2.92 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.801 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -67.57 -36.96 81.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.697 0.284 . . . . 0.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.3 mm -62.49 -44.77 99.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.06 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 6' ' ' GLU . 66.4 t -63.95 -46.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.443 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.51 -42.74 91.75 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.12 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -62.25 -51.95 65.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.065 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.93 -32.09 71.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.247 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.31 -39.6 89.42 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.963 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.65 -45.87 88.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.896 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.76 -49.56 74.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.54 84.5 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.2 tp -61.73 -40.64 95.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.002 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 4.6 m-30 -65.16 -43.08 92.94 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.239 0.543 . . . . 0.0 110.274 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 22' ' ' ASP . 34.5 t0 -81.56 50.47 1.49 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.739 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.5 m-20 -89.51 -27.85 20.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.109 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.05 14.27 82.09 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.666 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -69.23 -16.36 63.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.666 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.28 62.32 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.6 m -134.06 136.71 44.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.725 0.298 . . . . 0.0 111.08 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.4 mt -100.1 117.27 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 29' ' ' VAL . 49.5 m -77.82 162.7 26.7 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.686 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 28' ' ' THR . 13.6 t -57.03 -46.86 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.496 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -58.39 -42.49 87.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 110.273 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' CD ' ' OD2' ' A' ' 22' ' ' ASP . 63.2 tt0 -66.8 -35.79 80.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.275 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -64.01 -43.15 96.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.1 -40.2 70.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -43.23 99.25 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -65.42 -48.44 83.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.105 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 41' ' ' GLN . 97.4 mt -60.3 -39.69 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.94 -41.88 71.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.548 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.5 t -64.86 -39.65 93.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.42 20.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 38' ' ' SER . 12.7 m-20 67.56 18.64 9.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.579 ' O ' HG22 ' A' ' 36' ' ' ILE . 1.9 mp0 -135.29 147.66 49.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -150.95 72.56 8.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.53 167.35 13.41 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.768 2.312 . . . . 0.0 111.022 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.4 p -83.26 153.42 24.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 44' ' ' THR . 77.3 mm-40 -38.49 -45.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 110.137 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -47.11 -55.71 7.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' O ' ' SD ' ' A' ' 51' ' ' MET . 50.1 mt-10 -60.16 -41.16 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.217 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.19 -42.52 98.73 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.029 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -65.29 -53.81 38.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -59.17 -38.06 78.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.528 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -72.26 -48.19 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.28 -44.48 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 m -57.52 -45.6 84.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -45.81 -29.56 1.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 57' ' ' ALA . 4.5 p -112.72 -29.28 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 9.5 t0 -60.68 81.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.23 -36.25 77.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 8.0 p30 -92.38 -21.14 20.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.827 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.75 69.47 1.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.417 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 6.6 m120 -109.76 -11.75 14.69 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.116 0.458 . . . . 0.0 111.428 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 29' ' ' VAL . . . 93.14 3.91 65.06 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -138.54 170.85 15.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -120.03 127.71 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.027 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -104.75 175.52 5.47 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -57.07 -54.75 43.2 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.646 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 33.0 p-10 -54.06 -46.0 71.83 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.094 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 99.5 mt-10 -64.04 -41.85 97.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.863 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 59.0 t80 -63.3 -37.57 87.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.08 -43.25 99.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.308 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 74' ' ' LYS . 58.8 m -65.46 -44.9 85.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.084 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -56.48 -45.67 80.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.43 -177.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 75.2 mtp -65.91 -49.46 67.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.016 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.34 -35.01 79.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.492 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 70' ' ' SER . 32.9 ttmt -62.7 -31.71 72.67 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -83.95 -35.71 23.79 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.944 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 76' ' ' VAL . 24.2 t -99.34 16.81 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.247 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' ALA . 49.1 tptt -58.93 -33.09 70.19 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.096 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -56.06 -54.16 48.27 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.781 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.1 m . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.63 179.622 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -97.65 81.86 2.98 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.647 HG23 ' N ' ' A' ' 4' ' ' LEU . 6.1 tp -157.12 -58.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.372 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.647 ' N ' HG23 ' A' ' 3' ' ' ILE . 11.8 mt -74.05 -51.82 14.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 0.0 110.647 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 6' ' ' GLU . 2.8 p 73.86 -63.21 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.417 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' N ' ' OG ' ' A' ' 5' ' ' SER . 83.6 mt-10 76.69 59.44 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.079 0.862 . . . . 0.0 110.973 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -93.95 -68.39 0.8 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.028 0.442 . . . . 0.0 110.145 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.435 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 14.5 pt20 -61.58 -28.19 69.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.189 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.08 -45.46 98.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.077 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -63.11 -47.2 93.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.814 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.1 -42.56 99.61 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.834 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.435 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.5 m-30 -60.3 -46.37 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -59.71 -33.55 71.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -66.62 -37.91 85.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.252 0.549 . . . . 0.0 110.168 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.03 85.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.917 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -63.3 -47.44 82.29 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 111.084 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.05 91.89 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.19 -39.0 93.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.023 0.44 . . . . 0.0 110.229 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -67.54 -40.42 85.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.278 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 23' ' ' GLY . 34.5 t0 -81.82 58.34 3.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.922 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -37.54 -21.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.843 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 m-20 -88.15 -26.36 22.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.586 0.231 . . . . 0.0 111.443 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 74.51 10.14 82.36 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -64.3 -17.58 63.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.69 -11.72 56.38 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.9 m -130.71 131.39 44.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.853 0.359 . . . . 0.0 111.326 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.2 mt -96.99 114.28 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.3 p -79.16 165.66 23.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 t -57.67 -44.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.589 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -56.94 -41.68 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.009 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.58 -41.59 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.468 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.21 -44.86 94.14 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -55.3 -40.33 70.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -63.36 -42.85 98.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.866 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.98 -49.34 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.694 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mm -65.64 -41.13 89.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 49.2 ttp180 -57.75 -40.97 80.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.362 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -85.05 -14.05 48.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.526 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 9.9 tp -68.08 -43.4 78.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 3.4 t70 154.63 -4.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.414 0.446 . . . . 0.0 111.108 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -139.92 158.74 43.59 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -135.19 72.06 67.07 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.83 155.74 62.08 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.664 2.243 . . . . 0.0 110.913 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -82.88 156.78 23.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -40.03 -43.8 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 2.8 mt-10 -50.48 -52.43 38.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.52 -42.88 99.81 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.142 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.08 -42.31 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.54 -49.77 75.34 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.076 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.52 -35.26 75.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.69 0.281 . . . . 0.0 110.446 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -72.96 -45.84 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.813 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 56' ' ' ASP . 85.1 mt -64.8 -44.5 96.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.956 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -45.7 91.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.552 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -57.77 -31.66 66.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 m -106.63 -24.51 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 66.7 t0 -81.57 95.94 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.41 68.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.795 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -94.91 -24.15 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.244 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.28 35.35 82.48 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.069 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.485 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 20.3 m120 -67.52 -18.82 65.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.811 0.305 . . . . 0.0 111.356 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.72 -12.22 56.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 p -125.48 -179.76 4.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 109.967 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.13 130.75 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.631 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -101.26 177.67 4.87 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.458 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.67 -50.89 71.69 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.905 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 31.5 p-10 -58.82 -43.63 90.68 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.431 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 96.8 mt-10 -65.76 -40.72 92.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.62 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.86 -42.34 99.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.741 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.52 -39.14 82.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 74' ' ' LYS . 20.8 m -63.6 -42.89 98.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mt -58.3 -42.54 86.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.625 0.25 . . . . 0.0 110.778 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 12' ' ' PHE . 74.8 mtp -65.73 -56.43 12.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.553 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -63.39 -34.55 77.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.63 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 70' ' ' SER . 5.7 tmtm? -64.17 -31.89 73.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -92.22 -13.3 30.72 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.701 0.286 . . . . 0.0 110.366 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 76' ' ' VAL . 91.9 t -114.19 5.36 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.937 0.399 . . . . 0.0 110.419 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 73' ' ' ALA . 48.6 tttp -56.7 -13.46 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.016 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -58.22 -57.66 11.87 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.505 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.501 -179.942 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -68.48 137.1 54.16 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.639 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -111.72 37.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.136 -179.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.0 mt -59.87 -49.8 76.3 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.103 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.415 ' H ' ' H ' ' A' ' 6' ' ' GLU . 4.3 p 176.44 5.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.69 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 10' ' ' VAL . 96.1 mt-10 -78.0 19.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.03 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -89.03 -63.51 1.28 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.58 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -65.14 -36.11 83.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.452 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.85 -47.46 93.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.384 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 6' ' ' GLU . 53.4 t -61.84 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.233 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.4 -42.39 96.12 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.3 -48.13 79.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.091 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -62.78 -34.71 77.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.204 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -66.03 -36.24 82.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.191 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -67.47 -40.62 85.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.101 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.475 ' CE2' HD12 ' A' ' 27' ' ' ILE . 59.7 t80 -70.37 -49.69 46.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.05 96.57 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.55 -39.12 89.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 9.6 m-30 -68.52 -40.49 80.76 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.934 0.397 . . . . 0.0 110.674 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.0 t0 -78.85 48.14 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.59 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -36.6 -40.36 0.25 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.877 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.0 p-10 -69.73 -25.34 63.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 0.0 111.627 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.12 14.74 80.1 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.891 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.1 p-10 -64.58 -1.52 1.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.673 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 75.51 -10.23 12.69 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.438 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.6 m -130.64 131.84 45.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.574 0.226 . . . . 0.0 110.839 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.475 HD12 ' CE2' ' A' ' 16' ' ' PHE . 95.0 mt -97.25 113.4 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -83.52 165.28 19.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.748 179.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.99 -36.92 64.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.524 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.98 -41.32 97.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.248 0.547 . . . . 0.0 110.616 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' H ' HG23 ' A' ' 28' ' ' THR . 42.6 tt0 -72.38 -39.46 68.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.056 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.7 tm? -61.5 -45.92 92.17 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.07 -38.08 70.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.807 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -62.17 -42.7 99.52 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.834 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.08 -47.19 85.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.524 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 41' ' ' GLN . 2.8 mm -63.76 -38.74 83.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.047 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -57.08 -39.81 75.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 40' ' ' ASP . 34.2 t -69.29 -38.17 78.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.04 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.95 25.78 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 38' ' ' SER . 33.5 t70 62.91 20.47 12.25 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.511 ' O ' HG22 ' A' ' 36' ' ' ILE . 97.1 mm-40 -136.14 142.49 44.22 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.451 HD22 ' C ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -148.29 80.65 8.43 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.026 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.76 170.7 6.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.853 2.369 . . . . 0.0 111.027 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 m -86.47 159.33 19.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.61 -39.34 7.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.76 -55.59 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -62.69 -40.78 98.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mt -61.2 -42.71 99.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.059 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -70.83 -41.54 71.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.131 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -63.46 -38.92 93.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.725 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 71.0 mtm -69.0 -44.04 73.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.991 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.76 -45.88 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.074 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.2 t -59.12 -37.42 77.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.56 -31.57 64.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.074 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.1 p -111.03 -32.88 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.4 t70 -63.82 79.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.04 -24.28 62.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.587 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 7.8 p-10 -95.36 -23.2 17.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.913 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.606 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.8 38.75 93.26 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 51.5 p30 -81.39 -17.04 50.38 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.526 -0.396 . . . . 0.0 111.608 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.08 7.7 60.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 82.8 p -135.91 159.74 40.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.5 mt -112.73 127.04 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 74.6 tt0 -99.99 165.28 11.62 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.411 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 27.6 t80 -49.24 -54.81 14.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.425 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.16 -43.29 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.006 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.63 -44.13 82.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.063 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.505 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.43 -40.64 97.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.454 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.489 ' HG ' ' HZ3' ' A' ' 74' ' ' LYS . 46.9 t -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.87 -42.83 85.34 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.544 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mmm -65.55 -47.3 76.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.931 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -65.65 -31.23 72.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.489 ' HZ3' ' HG ' ' A' ' 70' ' ' SER . 33.4 mttp -66.22 -34.48 78.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.481 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -85.68 -35.46 20.87 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.207 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 76' ' ' VAL . 22.0 t -99.74 13.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.087 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 73' ' ' ALA . 49.6 tttm -46.8 -34.34 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.08 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -49.34 -55.34 13.18 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.422 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.803 -1.094 . . . . 0.0 110.501 179.751 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -142.48 93.06 2.48 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.15 -73.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.217 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 62.8 mt -44.1 -35.88 2.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 0.0 110.183 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 7' ' ' GLU . 8.0 t -167.97 -144.68 0.05 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.144 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 62.85 -41.26 0.18 Allowed 'General case' 0 C--O 1.221 -0.415 0 O-C-N 123.662 0.602 . . . . 0.0 111.111 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 5' ' ' SER . 82.6 tt0 -66.35 -44.45 83.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.271 0.557 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 13.7 mt-30 -78.39 -35.52 47.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.89 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 17.7 mm -70.6 -46.77 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.434 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 11' ' ' ASP . 8.5 p -59.22 -47.5 90.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.998 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.56 ' N ' HG13 ' A' ' 10' ' ' VAL . 64.4 t0 -63.32 -54.05 43.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.957 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 14.9 m-30 -61.82 -52.56 63.67 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.314 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 28.6 tptp -51.66 -40.78 60.64 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.034 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -68.58 -40.37 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.113 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.5 -50.14 73.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -62.59 -49.19 76.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.843 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.5 -48.3 65.72 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.542 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 tt -62.65 -39.24 93.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.071 0.462 . . . . 0.0 109.793 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -63.94 -43.16 96.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.145 0.497 . . . . 0.0 110.497 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 23' ' ' GLY . 61.1 t0 -81.91 52.21 1.9 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.254 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -38.59 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.833 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 3.4 p-10 -83.62 -24.84 31.25 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 77.45 15.98 80.85 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.184 -0.532 . . . . 0.0 111.928 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 49.7 p-10 -66.87 -5.44 12.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.549 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 84.32 -16.93 31.53 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.444 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 5.2 t -128.9 128.76 44.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.474 0.178 . . . . 0.0 110.946 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.44 112.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.56 HG22 ' N ' ' A' ' 29' ' ' VAL . 85.4 m -77.42 162.96 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.592 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.641 HG12 HD13 ' A' ' 52' ' ' ILE . 2.4 m -55.74 -36.81 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.469 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.74 -41.8 91.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.962 0.41 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.47 -37.8 85.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.353 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 tp -64.16 -43.96 93.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.71 72.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -63.49 -41.74 98.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.3 t -65.61 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.241 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.19 -35.3 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -60.43 -42.78 96.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -68.9 -35.46 76.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.961 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.569 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 11.2 mt -60.57 -43.91 96.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.728 -1.129 . . . . 0.0 112.67 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.569 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 70.1 m-20 142.01 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 124.691 1.245 . . . . 0.0 111.533 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -136.57 157.09 47.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -148.97 71.7 10.29 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.783 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.02 156.69 61.26 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.526 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 45' ' ' GLU . 6.2 p -84.88 155.99 21.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 56.8 mp0 -40.06 -47.39 2.3 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -46.86 -51.86 15.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.047 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -70.14 -41.5 73.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.762 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -40.81 95.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -61.62 -50.5 72.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.699 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.01 -37.1 78.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.9 tpp -74.01 -47.41 37.25 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.641 HD13 HG12 ' A' ' 29' ' ' VAL . 77.3 mt -64.3 -44.56 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.0 p -58.09 -43.96 87.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -50.16 -28.75 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.0 p -110.13 -30.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 10.7 t0 -63.97 78.53 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.24 -36.02 80.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.694 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 3.9 p30 -90.41 -20.64 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.03 1.18 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.177 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 7.8 m120 -109.83 -12.43 14.59 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.266 0.533 . . . . 0.0 111.471 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.07 63.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -138.69 177.11 8.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.1 mt -121.5 128.44 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -98.43 171.73 7.98 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.46 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 52.5 t80 -56.1 -51.72 66.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.681 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.13 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.462 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 89.1 mt-10 -59.03 -46.23 88.74 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.9 t80 -68.33 -26.57 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.85 -43.05 89.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 110.108 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 74' ' ' LYS . 13.9 t -66.53 -41.87 88.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.36 -41.39 84.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.99 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.466 ' SD ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 mtp -65.86 -51.62 57.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.468 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -67.83 -33.83 75.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.769 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 70' ' ' SER . 13.0 ttmm -65.01 -30.88 71.9 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.714 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -81.51 -41.04 22.29 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.217 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 79' ' ' THR . 2.2 t -108.73 29.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.217 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 73' ' ' ALA . 77.4 tttt -52.94 -35.4 58.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.899 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 79' ' ' THR . 34.8 p-10 -52.46 -52.17 55.57 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.635 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.496 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 1.2 t . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.885 -1.055 . . . . 0.0 110.55 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 66.8 t0 -170.97 -120.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.664 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.458 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 19.3 mm 64.91 -0.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.612 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.432 ' O ' ' OG ' ' A' ' 5' ' ' SER . 10.3 mp -57.43 -33.12 67.57 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 4' ' ' LEU . 4.9 p 74.47 -53.28 0.68 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.937 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 10' ' ' VAL . 60.4 tt0 78.42 56.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.704 0.627 . . . . 0.0 110.447 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -94.97 -48.42 5.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -43.41 98.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.184 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.6 mp -59.83 -41.95 87.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.914 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 6' ' ' GLU . 53.7 t -58.54 -46.39 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.868 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.36 -54.88 29.97 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.981 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 69' ' ' LEU . 49.9 m-85 -59.09 -47.85 83.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -59.42 -33.75 71.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.456 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.0 -41.64 81.94 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.078 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.47 -46.76 84.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.967 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.51 -49.47 73.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.87 85.42 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.84 -39.71 95.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.9 m-30 -64.44 -41.0 96.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.076 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 27.8 t0 -82.19 53.84 2.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.135 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -38.62 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.684 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.1 p-10 -89.2 -25.01 22.0 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.41 18.45 79.16 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.74 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 46.6 p-10 -66.8 -10.71 50.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.774 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.81 -15.74 60.98 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 21.1 p -133.18 132.89 42.1 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.687 0.28 . . . . 0.0 110.835 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.1 mt -95.43 113.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 29' ' ' VAL . 76.6 m -78.55 164.1 24.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.636 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.564 ' N ' HG22 ' A' ' 28' ' ' THR . 5.7 p -55.32 -33.91 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.763 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.44 -42.63 74.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.282 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -65.03 -38.19 90.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.207 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.95 -43.67 91.94 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.39 74.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.916 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 m -60.68 -43.28 97.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.758 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.21 -46.38 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.238 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.08 -43.88 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.951 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -56.16 -41.65 75.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.342 0.591 . . . . 0.0 110.582 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -66.29 -37.48 85.51 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.089 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 35.6 mt -61.73 -44.08 97.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.564 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 10.9 t70 141.12 10.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 124.003 0.815 . . . . 0.0 111.352 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -128.72 164.75 22.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 110.075 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -154.16 70.72 6.31 Favored Pre-proline 0 C--O 1.232 0.176 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.47 154.68 73.05 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.726 2.284 . . . . 0.0 111.206 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 45' ' ' GLU . 11.5 m -80.32 164.68 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 44' ' ' THR . 84.3 tt0 -42.36 -49.34 5.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.39 -58.12 4.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.472 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.61 -41.68 90.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.188 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.0 mt -61.37 -42.98 99.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -67.43 -53.37 29.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -59.65 -37.74 79.52 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.556 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.4 mmt -71.42 -48.86 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.608 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASP . 57.7 mt -64.88 -45.18 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -58.62 -46.96 85.92 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -45.77 -27.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.4 p -116.14 -27.51 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 52' ' ' ILE . 26.1 t0 -59.37 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -60.69 -35.13 75.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.1 m-20 -82.96 -23.66 33.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.462 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.1 26.97 68.17 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 30.1 p-10 -81.58 -16.42 51.66 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.739 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.69 7.8 50.19 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.453 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 49.5 p -134.23 167.12 21.27 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 52' ' ' ILE . 12.0 mt -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.843 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -102.87 171.64 7.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -53.51 -50.29 65.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.309 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -57.56 -43.96 84.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.233 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 80.6 mt-10 -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.815 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 83.5 t80 -62.24 -44.47 96.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.378 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.425 ' CD1' ' CD2' ' A' ' 12' ' ' PHE . 57.3 tp -62.18 -42.44 99.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.183 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 74' ' ' LYS . 67.7 m -64.77 -44.57 89.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.136 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -57.83 -44.81 86.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.787 -178.116 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 76.0 mtp -70.96 -50.77 30.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.93 -31.95 73.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.87 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 70' ' ' SER . 36.6 ttmt -66.3 -33.75 76.44 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.514 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -81.94 -38.84 24.61 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.325 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 76' ' ' VAL . 59.7 t -85.6 -1.27 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.634 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -49.33 -13.69 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.131 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.442 ' N ' ' C ' ' A' ' 76' ' ' VAL . 93.2 m-20 -60.65 -60.2 4.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.676 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.374 179.961 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 52.98 83.45 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.8 pt -90.09 -108.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.498 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 4' ' ' LEU . 10.3 mp -79.08 -10.06 59.72 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.3 p -52.69 -40.19 62.71 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 6' ' ' GLU . 4.1 pt-20 -73.65 79.12 1.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.88 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -94.73 -60.78 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 110.531 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 22.8 mm-40 -64.98 -32.65 74.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.28 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mm -62.97 -44.21 99.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.052 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 6' ' ' GLU . 81.4 t -63.37 -47.3 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.12 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.31 -44.02 92.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.266 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.09 -44.61 97.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.83 -37.66 76.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.177 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -65.43 -35.71 81.74 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.139 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -66.32 -43.29 86.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.107 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -69.59 -48.82 58.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.749 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.25 95.06 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.87 -38.48 91.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.902 0.382 . . . . 0.0 110.057 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 8.9 m-30 -68.85 -41.87 77.87 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.662 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 22' ' ' ASP . 27.4 t0 -79.37 47.13 0.79 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.219 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -36.49 -25.84 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.693 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 20' ' ' ASP . 11.5 m-20 -76.78 -27.44 55.27 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.61 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 80.53 10.26 85.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -71.73 -9.74 58.73 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.798 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 86.96 -7.04 81.99 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 p -131.65 134.14 45.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.867 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.69 117.18 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 p -83.9 166.27 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.699 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.8 t -56.72 -43.98 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.03 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.42 -39.14 86.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.03 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 91.9 mt-10 -71.15 -42.57 68.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.132 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.19 -44.83 95.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.287 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.88 69.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.808 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -62.36 -42.59 99.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.887 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.2 -46.99 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.511 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 41' ' ' GLN . 5.3 mm -62.94 -39.64 85.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.16 -40.72 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 40' ' ' ASP . 51.1 m -67.91 -37.17 81.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.82 25.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 38' ' ' SER . 90.3 m-20 63.27 20.52 12.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.288 0.368 . . . . 0.0 111.931 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.526 ' O ' HG22 ' A' ' 36' ' ' ILE . 86.8 mt-30 -137.04 148.47 46.83 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -154.17 79.69 5.0 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' CD ' HG21 ' A' ' 36' ' ' ILE . 30.9 Cg_exo -61.07 170.01 5.4 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.669 2.246 . . . . 0.0 111.113 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -91.49 165.1 13.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 49' ' ' GLN . 80.9 mm-40 -42.17 -46.47 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.897 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 1.5 mm-40 -56.66 -62.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.831 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.9 -45.75 93.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.063 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.21 -43.78 98.32 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.426 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 57.1 tt0 -71.92 -42.67 66.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.269 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.56 -36.8 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.612 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.9 mmt -69.01 -45.18 71.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.692 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.96 -43.98 88.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.1 m -57.69 -38.45 75.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.874 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -49.08 -29.03 4.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -115.47 -27.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 14.2 t0 -62.99 76.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -61.54 -22.57 65.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.351 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -101.14 -23.54 14.44 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.736 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 69.07 35.11 77.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.295 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.546 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 47.9 p30 -76.56 -17.85 58.99 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.624 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 94.01 8.79 60.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 p -139.77 162.56 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 HD23 ' A' ' 32' ' ' LEU . 14.8 mt -115.63 127.58 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.546 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 53.3 mp0 -98.5 171.39 8.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -56.25 -52.27 65.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.355 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 29.1 p-10 -56.79 -42.44 79.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.326 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 94.4 mt-10 -65.36 -44.01 89.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -66.55 -33.59 76.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.4 tp -66.74 -43.7 83.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.906 0.384 . . . . 0.0 110.565 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 74' ' ' LYS . 72.9 m -72.5 -45.68 58.27 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.243 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 tp -48.74 -52.74 22.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.163 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 ttp -67.92 -47.32 69.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.636 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -63.51 -34.83 78.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.774 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 70' ' ' SER . 9.8 mtpm? -63.26 -35.66 81.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.186 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -79.92 -42.27 24.43 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.692 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 76' ' ' VAL . 21.2 t -97.97 23.28 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.149 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 73' ' ' ALA . 88.3 tttt -55.44 -36.21 66.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.948 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 79' ' ' THR . 30.3 p-10 -56.02 -55.74 29.23 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.843 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.507 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 53.7 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -64.46 -76.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.063 0.458 . . . . 0.0 111.26 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.3 pt -49.29 139.58 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.644 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.498 ' O ' ' C ' ' A' ' 5' ' ' SER . 83.3 mt -59.26 -52.61 64.93 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.982 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 7' ' ' GLU . 32.6 t 24.11 -98.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.814 0.696 . . . . 0.0 111.554 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.539 ' O ' HG23 ' A' ' 10' ' ' VAL . 71.7 mt-10 61.01 -35.0 0.09 Allowed 'General case' 0 C--O 1.225 -0.205 0 O-C-N 123.483 0.489 . . . . 0.0 110.952 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.629 ' H ' ' C ' ' A' ' 5' ' ' SER . 80.7 mm-40 -72.31 -56.13 6.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.682 0.277 . . . . 0.0 110.663 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 8' ' ' GLN . 6.9 mt-30 -66.72 -34.95 78.99 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.324 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.2 mm -63.55 -46.55 94.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.028 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 6' ' ' GLU . 56.1 t -60.48 -46.8 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.075 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.25 -50.76 66.69 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.935 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -62.91 -51.67 66.05 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.463 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -54.27 -37.7 65.01 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.886 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -68.32 -38.84 81.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.081 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.01 -52.31 63.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.174 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -62.62 -48.68 78.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.766 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.58 84.81 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.97 -38.44 91.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.839 0.352 . . . . 0.0 110.064 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.59 -46.07 70.33 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.176 0.512 . . . . 0.0 110.219 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 23' ' ' GLY . 31.8 t0 -78.8 43.32 0.49 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.48 -23.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.875 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.0 p-10 -83.3 -27.16 29.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 111.674 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 82.55 15.64 73.06 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.033 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 55.8 p30 -70.18 -6.11 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 -11.84 26.96 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 10.3 m -131.79 133.08 44.34 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.3 mt -98.45 115.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -79.5 160.53 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 30' ' ' GLU . 7.2 p -56.99 -42.2 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.483 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.44 ' N ' HG13 ' A' ' 29' ' ' VAL . 96.8 mt-10 -61.92 -40.93 97.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.272 0.558 . . . . 0.0 110.223 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 76.6 tt0 -69.27 -35.23 75.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.273 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -62.99 -43.58 98.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.05 72.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.681 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 m -61.77 -41.93 98.34 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.72 -48.44 75.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.264 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.4 mt -61.52 -36.88 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -59.81 -41.72 91.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.414 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.4 m -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 86.1 mt -59.83 -41.98 92.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.452 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 30.2 t0 131.54 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.623 1.202 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.537 HE21 ' C ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -141.2 156.06 45.97 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.8 -0.563 . . . . 0.0 110.015 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -149.34 76.18 9.34 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.832 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 172.11 2.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.629 2.219 . . . . 0.0 111.261 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -85.53 160.29 19.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 57.7 mp0 -43.45 -41.67 4.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.5 -57.58 8.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.818 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 51.3 mp0 -58.62 -39.36 80.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.229 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.4 -43.41 98.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.988 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -73.36 -49.87 24.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.179 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.01 -38.72 87.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.594 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.5 ttm -67.73 -47.39 69.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.02 -44.31 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 t -59.22 -42.09 90.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.99 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -48.27 -32.63 7.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.017 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -112.93 -30.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.9 t0 -61.53 81.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.37 -26.7 65.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.419 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 2.0 p30 -96.74 -21.98 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.675 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 66.11 40.62 95.11 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.5 p-10 -82.67 -16.92 46.38 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.517 -0.402 . . . . 0.0 111.554 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.92 4.64 58.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.461 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 55.5 p -135.56 165.4 25.62 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.01 126.8 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -94.38 170.37 9.54 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -56.68 -51.52 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.682 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -61.18 -42.09 97.95 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.228 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -64.8 -44.98 88.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.129 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.52 -41.11 98.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.71 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.14 -41.8 99.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.952 0.406 . . . . 0.0 110.875 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.85 -43.49 98.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.224 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.9 tp -61.68 -39.23 90.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 110.761 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 45.3 mtp -61.07 -49.66 76.46 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.021 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -66.6 -26.7 67.22 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.204 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -66.07 -34.3 77.76 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.197 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -84.41 -38.18 20.55 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.8 18.73 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.373 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 73' ' ' ALA . 21.0 ptmt -46.72 -40.95 14.3 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.155 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 79' ' ' THR . 34.0 p-10 -65.15 -59.25 4.31 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.796 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.516 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 2.1 m . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.521 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -84.42 1.33 45.83 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.094 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 mm -77.93 134.35 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.0 mt -50.02 -44.39 51.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.15 0.5 . . . . 0.0 110.409 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.8 t 62.88 -130.41 0.52 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.847 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 10' ' ' VAL . 78.7 mt-10 -83.84 39.29 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.099 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -71.0 -57.16 4.82 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.68 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -65.19 -39.43 92.84 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.421 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.81 -43.69 97.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.082 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 6' ' ' GLU . 7.9 t -56.06 -44.61 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.786 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.72 -54.37 46.08 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.099 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -56.55 -48.53 77.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -38.16 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -64.15 -41.41 97.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.074 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -63.02 -46.68 86.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.909 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -62.68 -50.76 69.88 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.806 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.19 -46.23 79.6 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.542 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -61.83 -40.6 95.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CE2' HG11 ' A' ' 35' ' ' VAL . 5.1 m-30 -63.68 -41.76 98.12 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.041 0.448 . . . . 0.0 110.037 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 34.9 t0 -78.38 54.33 1.4 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.349 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -39.18 -30.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.632 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.9 p-10 -82.34 -23.85 34.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 76.39 16.11 80.97 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 26' ' ' CYS . 53.7 p-10 -65.88 -9.79 32.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.354 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -15.98 58.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 6.9 t -130.85 130.58 43.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 0.187 . . . . 0.0 110.761 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -95.34 112.38 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -79.96 167.29 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.621 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.45 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.4 m -55.63 -39.87 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 73.1 mm-40 -63.09 -42.85 99.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -66.51 -41.17 89.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.139 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.604 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -62.6 -45.0 94.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.49 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.03 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 m -60.19 -44.69 94.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.659 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG11 ' CE2' ' A' ' 19' ' ' PHE . 55.0 t -63.35 -46.64 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.154 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 41' ' ' GLN . 5.2 mm -60.46 -39.42 81.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -54.89 -42.48 72.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.88 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 40' ' ' ASP . 7.6 t -65.09 -39.69 93.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.21 19.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.388 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 38' ' ' SER . 34.3 m-20 69.08 20.05 7.82 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.871 0.732 . . . . 0.0 111.252 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' HG22 ' A' ' 36' ' ' ILE . 83.6 mt-30 -133.74 142.78 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.019 -0.425 . . . . 0.0 109.965 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -140.54 70.94 31.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.63 157.6 46.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.7 2.267 . . . . 0.0 111.309 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 45' ' ' GLU . 60.9 p -83.73 154.26 23.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 44' ' ' THR . 97.1 mt-10 -38.41 -47.54 1.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.991 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -46.06 -60.32 2.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.33 -41.75 98.81 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.181 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -42.2 98.23 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.122 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -63.65 -51.92 63.03 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.211 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -60.51 -35.43 75.92 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.558 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 70.9 mtm -74.61 -47.74 30.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.04 -43.66 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.843 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -59.12 -45.74 90.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' CD ' ' O ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -46.21 -25.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.7 p -118.18 -24.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -59.89 81.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.58 -34.53 77.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.28 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 8.3 m-20 -80.52 -24.11 39.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.702 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.17 23.15 65.9 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.439 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 26.8 p-10 -78.7 -18.42 54.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.122 0.461 . . . . 0.0 111.452 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.24 14.09 29.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.439 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 48.3 p -141.4 172.45 12.66 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.604 HD12 HD23 ' A' ' 32' ' ' LEU . 5.4 mt -121.57 129.13 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -100.26 172.12 7.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -53.99 -49.3 69.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.743 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.76 -42.0 96.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.182 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 92.3 mt-10 -68.21 -45.65 72.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.966 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 91.8 t80 -60.75 -46.01 92.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.776 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.96 -40.28 95.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 110.116 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 74' ' ' LYS . 81.4 p -63.75 -45.63 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.641 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.15 -42.54 86.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 53.3 mtp -67.92 -54.7 16.71 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.407 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.24 -30.87 71.9 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.884 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' SER . 5.3 tmtm? -67.07 -32.54 73.79 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.59 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.77 -44.13 14.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 78' ' ' ASP . 4.1 t -91.06 14.48 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.739 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 73' ' ' ALA . 86.8 tttt -47.2 -14.04 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.106 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 76' ' ' VAL . 45.5 t0 -56.23 -57.15 13.46 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.493 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.577 179.375 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.429 ' C ' HD12 ' A' ' 3' ' ' ILE . 96.1 m-20 -82.75 17.02 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.913 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.6 mp -101.23 113.66 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.403 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.621 ' O ' HD23 ' A' ' 4' ' ' LEU . 1.2 tt -62.99 -39.17 93.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.321 0.581 . . . . 0.0 109.998 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.5 t -59.42 113.13 2.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.359 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 10' ' ' VAL . 84.0 mt-10 68.09 75.16 0.28 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 123.736 0.648 . . . . 0.0 110.304 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -94.42 -60.8 1.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.896 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -63.0 -34.55 77.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.428 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.1 mm -63.3 -44.98 99.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.133 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 6' ' ' GLU . 75.1 t -63.45 -46.35 95.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.154 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.85 -42.9 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.976 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.41 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -61.05 -48.23 82.71 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -61.48 -32.39 72.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -66.83 -39.53 87.69 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 110.17 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -65.22 -42.01 93.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.983 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.68 -49.02 70.1 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.868 0.366 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.16 -44.36 93.2 Favored Glycine 0 C--N 1.329 0.194 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.79 -40.2 96.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.996 0.427 . . . . 0.0 110.063 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.3 m-30 -65.74 -40.46 92.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.228 0.537 . . . . 0.0 110.456 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 23' ' ' GLY . 66.3 t0 -80.6 60.37 3.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' CB ' ' NZ ' ' A' ' 21' ' ' LYS . 9.3 mtmp? -37.23 -27.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.891 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 4.8 p-10 -97.16 -12.55 22.93 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 63.97 23.36 67.57 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.27 -0.49 . . . . 0.0 111.886 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -66.6 -12.0 55.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.206 0.503 . . . . 0.0 110.776 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.73 -14.49 64.02 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.1 m -132.65 132.14 42.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 0.0 110.91 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.66 111.74 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.7 m -75.15 154.89 37.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.59 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 61' ' ' GLY . 3.7 m -54.98 -29.57 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.48 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.52 -41.71 72.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.544 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 68.9 mt-10 -68.76 -41.73 78.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.68 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.692 HD23 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -58.79 -46.84 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.86 73.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.877 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -63.1 -43.85 97.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.14 -48.8 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.104 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.426 HG21 ' CD ' ' A' ' 43' ' ' PRO . 3.0 mm -63.52 -38.38 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -55.31 -40.77 71.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.845 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 40' ' ' ASP . 26.0 m -66.85 -33.57 75.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.674 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.67 23.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 38' ' ' SER . 99.7 m-20 63.7 14.22 8.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -137.95 146.52 43.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -142.74 83.88 11.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.083 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.426 ' CD ' HG21 ' A' ' 36' ' ' ILE . 23.1 Cg_exo -63.95 169.17 10.81 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.856 2.371 . . . . 0.0 111.071 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p -89.61 162.04 15.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -42.66 -46.21 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -50.55 -52.03 42.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.51 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.99 -42.73 97.1 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.234 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.0 -47.17 85.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.938 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -64.83 -50.88 64.93 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.175 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.3 t0 -59.15 -34.09 71.66 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.503 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.9 ttp -74.79 -45.53 43.01 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.774 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.57 -44.23 96.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.6 m -61.8 -46.51 89.2 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.046 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' OE2' ' NZ ' ' A' ' 74' ' ' LYS . 80.6 tt0 -45.07 -29.63 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.44 -33.38 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 53.7 t0 -65.41 98.1 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.98 -24.4 61.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.828 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -100.32 -24.57 14.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.42 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 68.42 37.3 85.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.283 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 13.7 m120 -70.95 -17.91 62.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.958 0.379 . . . . 0.0 111.422 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 100.38 -2.56 56.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -131.43 174.42 10.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.692 HD12 HD23 ' A' ' 32' ' ' LEU . 7.4 mt -116.51 120.8 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.991 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 65' ' ' PHE . 68.6 tt0 -88.7 169.87 11.29 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.414 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 82.4 t80 -55.81 -49.04 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.759 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.63 -38.15 89.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.01 0.433 . . . . 0.0 110.249 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 97.5 mt-10 -67.33 -41.22 85.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.826 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -67.33 -38.55 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.502 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -41.37 96.48 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.08 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.6 p -69.95 -45.86 66.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.022 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.12 -44.13 93.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 110.334 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.41 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 tpt -54.62 -51.95 63.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.602 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -64.75 -39.47 93.68 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.909 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' NZ ' ' OE2' ' A' ' 54' ' ' GLU . 63.5 tttm -58.9 -23.79 61.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.094 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -86.83 -43.23 12.64 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.834 0.35 . . . . 0.0 110.426 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -112.92 37.58 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.064 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 73' ' ' ALA . 17.5 ttmm -55.94 -32.4 63.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -53.0 -57.34 10.68 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.433 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.614 179.743 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.3 148.69 48.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 3' ' ' ILE . 1.6 mp -40.16 156.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.461 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 4' ' ' LEU . 4.0 mm? -64.76 -29.6 70.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.087 0.47 . . . . 0.0 109.948 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.3 p -65.23 74.05 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.573 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 4' ' ' LEU . 95.6 mt-10 -75.61 74.22 2.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.976 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -95.74 -38.81 10.17 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.324 0.583 . . . . 0.0 110.483 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -80.75 -40.93 24.38 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.873 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.15 -44.81 91.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.608 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 11' ' ' ASP . 9.3 p -61.52 -47.76 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.967 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' N ' HG13 ' A' ' 10' ' ' VAL . 8.8 t70 -62.1 -45.87 91.57 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.874 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CD2' ' SD ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.21 -42.92 99.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.319 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -60.43 -35.47 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.203 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.16 -37.13 83.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.383 0.611 . . . . 0.0 109.748 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.36 82.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.249 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -67.89 -47.42 68.9 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.882 0.372 . . . . 0.0 110.966 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.15 -42.77 98.71 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 tp -62.87 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.114 0.483 . . . . 0.0 110.133 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.19 -36.54 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.33 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.1 t0 -92.53 49.42 1.48 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.182 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -36.5 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.846 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.2 m-20 -70.59 -28.11 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.358 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.76 10.34 85.83 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -69.04 -10.71 58.96 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.867 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.86 -6.31 83.78 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -131.3 134.48 46.41 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.715 0.293 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.7 mt -100.56 113.34 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -82.24 165.14 20.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.658 HG12 HD13 ' A' ' 52' ' ' ILE . 3.2 m -57.37 -44.5 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.735 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' N ' HG23 ' A' ' 29' ' ' VAL . 45.6 tt0 -58.67 -40.11 82.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.21 0.528 . . . . 0.0 109.899 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 97.0 mt-10 -70.23 -40.87 74.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.433 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.625 HD12 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -62.18 -45.46 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.85 -39.38 68.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -65.63 -39.8 91.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.776 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.78 -46.4 92.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.488 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.36 -38.88 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -57.53 -41.28 80.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.525 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -68.62 -31.89 71.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.086 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 76.3 mt -59.13 -42.76 91.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.751 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' LEU . 36.2 p-10 137.83 17.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.181 0.926 . . . . 0.0 111.301 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -153.94 169.71 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -153.99 84.23 4.13 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.184 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.99 179.49 0.29 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.729 2.286 . . . . 0.0 110.994 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.412 ' OG1' ' OE1' ' A' ' 47' ' ' GLU . 50.6 p -89.59 155.03 19.52 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -41.53 -36.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 0.0 110.185 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 3.2 mm-40 -57.24 -53.46 57.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.532 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' OE1' ' OG1' ' A' ' 44' ' ' THR . 2.7 mp0 -60.94 -40.79 94.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.82 -42.96 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -72.99 -45.85 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.284 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.92 -39.92 93.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.532 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.9 mmt -67.59 -44.31 78.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.608 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.658 HD13 HG12 ' A' ' 29' ' ' VAL . 73.3 mt -66.67 -44.28 89.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -40.05 90.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -50.89 -33.82 25.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 57' ' ' ALA . 14.9 p -111.21 -32.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 33.5 t0 -64.02 76.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.231 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -58.19 -25.67 61.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.67 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.415 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 2.0 p30 -95.66 -23.09 17.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.546 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.89 36.48 81.9 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 52.6 p-10 -77.52 -17.09 58.28 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.578 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' O ' HG13 ' A' ' 29' ' ' VAL . . . 94.58 3.73 62.57 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 6.2 p -134.56 163.76 29.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.625 HD11 HD12 ' A' ' 32' ' ' LEU . 51.7 mt -116.4 128.82 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -104.52 164.7 11.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -45.99 -60.2 2.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.9 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -48.89 -43.3 38.98 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.43 -42.25 75.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.041 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' CE2' ' SD ' ' A' ' 72' ' ' MET . 38.2 t80 -64.43 -37.33 87.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.41 -44.86 93.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.582 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.0 m -65.69 -43.7 88.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.89 -43.0 99.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.658 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.587 ' SD ' ' CE2' ' A' ' 68' ' ' PHE . 60.4 mtp -60.04 -44.85 94.39 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.2 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -58.14 -50.84 72.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.172 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.26 -25.15 63.83 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.686 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -90.45 -20.8 22.33 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.537 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.18 41.07 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 73' ' ' ALA . 25.8 pttm -63.28 -20.23 65.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.239 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -56.8 -59.93 4.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.42 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.593 -179.753 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.2 p30 -92.12 55.59 2.64 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.856 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 tt -147.59 137.93 17.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.456 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.48 -46.09 90.08 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.196 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t 74.46 166.39 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.381 0.426 . . . . 0.0 110.72 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 10' ' ' VAL . 96.8 mt-10 -134.01 41.5 2.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.066 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -93.84 -64.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.402 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 23.2 mm-40 -66.1 -34.78 78.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.1 mm -63.95 -43.9 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.297 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 6' ' ' GLU . 72.5 t -64.35 -42.5 95.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.093 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.58 -49.76 71.87 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.876 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.43 -47.22 85.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -60.37 -38.19 83.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.13 -38.05 89.37 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.332 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.06 62.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.834 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -69.35 -46.7 66.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.727 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.49 95.64 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.591 ' O ' HD13 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -63.07 -38.85 92.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 5.6 m-30 -72.34 -39.09 68.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.596 0.713 . . . . 0.0 110.649 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 23' ' ' GLY . 33.2 t0 -87.39 50.42 2.0 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.468 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -35.57 -28.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.449 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.2 m-20 -72.51 -28.08 62.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.49 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 78.57 11.13 85.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -70.22 -9.86 57.11 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.822 -179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 88.31 -2.48 85.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -133.08 136.88 46.15 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.654 0.264 . . . . 0.0 110.951 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -103.23 115.33 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 29' ' ' VAL . 54.7 m -81.97 162.9 22.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 28' ' ' THR . 8.7 p -58.99 -34.18 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.368 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -66.18 -39.05 89.43 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 109.988 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -71.3 -36.96 71.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.166 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.64 -44.6 95.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.86 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.594 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -64.47 -40.3 95.43 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.4 -46.12 87.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.341 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.67 -41.64 91.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.74 -0.384 . . . . 0.0 109.982 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -57.26 -39.57 75.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.533 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -68.8 -34.49 75.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.551 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 76.3 mt -59.56 -41.85 91.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 116.936 -1.507 . . . . 0.0 112.613 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.551 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 87.8 m-20 134.14 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.164 1.54 . . . . 0.0 111.449 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -147.59 161.35 41.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -150.2 78.59 7.85 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.27 -177.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.605 2.203 . . . . 0.0 111.347 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -90.42 148.33 22.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -42.33 -28.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.135 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.83 -51.21 69.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.441 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -65.92 -37.07 85.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.776 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.67 -42.84 99.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.844 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.71 -44.63 48.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.511 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -62.46 -39.02 92.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.577 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.55 -44.34 78.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.9 mt -66.34 -44.46 90.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.898 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -61.19 -37.07 81.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.014 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -56.16 -34.46 66.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.002 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 10.6 p -108.86 -30.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 48.7 t0 -64.2 77.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -56.17 -24.58 42.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.314 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.41 -23.22 17.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.602 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 68.36 37.85 86.5 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.352 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 47.3 p-10 -80.47 -15.7 56.11 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.57 -0.37 . . . . 0.0 111.514 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.14 4.18 69.08 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 33.3 p -133.99 157.77 45.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.5 mt -111.09 127.64 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 10.7 pt-20 -95.69 174.79 6.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.757 0.313 . . . . 0.0 110.263 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.07 -50.38 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.72 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -57.57 -58.86 6.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.307 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 64' ' ' GLU . 94.8 mt-10 -51.97 -43.59 63.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.081 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -62.54 -46.0 90.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.07 -43.3 95.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 m -65.33 -44.71 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.314 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.248 0.547 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.55 -43.06 98.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -59.0 -51.69 68.97 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.227 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.64 -19.97 59.5 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.14 -34.46 17.87 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.286 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.0 33.89 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.093 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 73' ' ' ALA . 36.5 ttpt -59.12 -46.63 87.83 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.027 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 79' ' ' THR . 30.2 p-10 -71.7 -56.4 5.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.256 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.517 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 2.3 t . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.599 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -86.09 171.22 11.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.789 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.732 ' O ' HG22 ' A' ' 3' ' ' ILE . 78.5 mt 58.69 37.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.289 0.566 . . . . 0.0 110.871 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.64 ' H ' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -61.17 -43.88 98.19 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.662 -0.415 . . . . 0.0 109.909 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.7 p -104.09 165.53 10.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.124 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 10' ' ' VAL . 95.4 mt-10 -126.25 41.63 3.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.764 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -91.58 -60.3 1.91 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.913 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -62.35 -35.72 79.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.352 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.497 ' CD1' HG23 ' A' ' 3' ' ' ILE . 80.3 mt -62.99 -44.21 99.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.399 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 6' ' ' GLU . 53.6 t -60.79 -47.8 91.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.101 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.22 -45.34 85.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.974 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CE2' ' CG ' ' A' ' 72' ' ' MET . 3.2 m-85 -62.3 -48.13 81.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.061 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.76 -35.42 79.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.081 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -63.84 -36.82 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.06 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -68.31 -37.21 80.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.345 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.446 ' CE1' HD12 ' A' ' 27' ' ' ILE . 75.6 t80 -67.45 -48.92 65.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 111.123 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.69 -42.32 96.24 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.7 tp -62.46 -39.14 92.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 109.926 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -68.25 -36.7 79.85 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.334 0.588 . . . . 0.0 110.693 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 34.4 t0 -86.42 51.41 2.22 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.46 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -36.29 -30.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.719 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 20' ' ' ASP . 6.2 m-20 -70.51 -28.08 64.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.556 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.32 8.68 87.63 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.694 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -68.57 -17.37 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.731 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 95.2 -7.03 69.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 m -127.62 129.76 47.82 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.612 0.206 . . . . 0.0 111.016 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.446 HD12 ' CE1' ' A' ' 16' ' ' PHE . 80.7 mt -100.32 114.25 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.22 165.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.18 -38.59 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.524 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -61.17 -40.52 94.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.958 0.408 . . . . 0.0 110.195 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.52 -38.37 74.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.224 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.644 HD23 HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -60.97 -45.48 94.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.44 81.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.88 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -62.24 -43.65 98.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.1 -47.43 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.48 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.94 -38.59 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -58.57 -41.31 85.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 t -86.8 -12.99 46.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.589 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' ASP . 3.4 tt -65.11 -41.12 95.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.497 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 15.5 m-20 150.99 0.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.901 0.751 . . . . 0.0 111.678 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -155.02 172.44 18.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -153.93 76.87 5.81 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.24 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.16 176.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.46 2.107 . . . . 0.0 111.285 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -86.22 161.75 18.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.5 mp0 -47.35 -41.24 19.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 2.4 mt-10 -54.24 -53.18 57.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.415 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.97 -40.75 96.67 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.161 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mp -62.66 -45.91 90.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.025 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -69.39 -46.51 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.75 -36.99 84.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.3 ttp -69.17 -45.76 69.21 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.5 mt -65.61 -44.94 93.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.98 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -59.13 -39.52 82.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.796 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -52.0 -31.49 29.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.751 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 7.5 p -109.87 -32.31 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.2 t70 -64.34 77.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -54.21 -30.0 48.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.433 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 15.3 p-10 -92.19 -18.85 22.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.67 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 65.31 42.86 95.93 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -87.01 -16.68 35.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.018 0.409 . . . . 0.0 111.64 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.08 16.23 58.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 m -140.19 151.64 45.38 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.644 HD12 HD23 ' A' ' 32' ' ' LEU . 8.6 mt -112.31 126.33 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 96.1 mt-10 -103.26 179.66 4.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -57.37 -58.59 7.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.813 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 67' ' ' GLU . 37.4 p-10 -56.52 -41.57 76.95 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.257 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 97.3 mt-10 -66.0 -46.23 78.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.908 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.87 -35.78 81.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.396 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.703 HD23 ' C ' ' A' ' 69' ' ' LEU . 7.4 tt -62.76 -43.61 98.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.927 0.394 . . . . 0.0 110.18 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -65.06 -45.28 85.97 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.438 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.61 -43.13 99.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.995 0.426 . . . . 0.0 110.736 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.472 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 4.3 tpt -59.6 -50.07 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -61.35 -50.25 73.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -53.53 -24.66 14.01 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -75.56 -52.98 9.38 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.147 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.413 ' C ' ' H ' ' A' ' 78' ' ' ASP . 46.4 t -76.89 -42.86 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.728 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 73' ' ' ALA . 53.8 tttp -60.32 -6.0 1.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 110.061 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 66.4 t0 -64.14 -33.94 76.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.427 -179.879 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 t70 63.75 -156.31 0.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 3' ' ' ILE . 95.4 mt -131.93 -7.39 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.549 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.25 -14.1 23.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.847 0.356 . . . . 0.0 110.246 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 p -47.05 151.56 0.64 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.364 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 10' ' ' VAL . 65.8 tt0 -159.3 54.68 0.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.829 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -95.01 -61.71 1.44 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.177 0.513 . . . . 0.0 110.629 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -55.02 -37.94 67.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.9 mt -62.11 -43.25 97.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.384 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 6' ' ' GLU . 37.6 t -55.55 -44.99 78.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.93 -51.56 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.835 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -59.03 -48.85 80.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.755 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -37.27 70.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.225 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.33 -41.5 85.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.314 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.62 -48.87 77.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.104 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.37 -49.25 74.58 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.901 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.31 -45.72 82.14 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.626 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.7 tt -62.97 -39.41 94.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.226 0.536 . . . . 0.0 109.559 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.2 m-30 -64.99 -41.87 95.03 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.387 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' ASP . 12.8 t0 -83.34 53.77 2.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.808 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -39.54 -18.58 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.573 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.5 m-20 -86.12 -28.67 23.86 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.307 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 79.21 11.59 84.88 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.742 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.78 -18.12 65.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.727 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.1 -13.64 60.25 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' SG ' ' OE2' ' A' ' 64' ' ' GLU . 3.5 m -131.69 132.75 44.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.7 0.286 . . . . 0.0 111.151 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -97.05 114.3 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -78.95 165.07 23.88 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 30' ' ' GLU . 3.6 m -55.84 -41.23 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.495 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 29' ' ' VAL . 75.9 mt-10 -60.7 -42.77 97.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -68.33 -42.89 78.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.303 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.5 tm? -62.16 -46.8 87.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.55 -39.23 64.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.165 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 m -63.46 -43.18 98.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.928 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 19' ' ' PHE . 60.0 t -65.4 -48.81 81.71 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mm -64.68 -40.57 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.0 -42.16 89.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 m -79.45 -20.99 46.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.583 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 39' ' ' LEU . 5.3 tt -63.71 -45.39 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 4.1 m-20 153.3 0.91 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.47 0.482 . . . . 0.0 111.301 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -141.88 155.74 45.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -135.55 78.27 50.59 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.28 155.42 70.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.617 2.211 . . . . 0.0 110.911 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' GLU . 20.3 p -85.2 161.39 19.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' THR . 80.4 tt0 -40.16 -47.77 2.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 109.805 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.23 -58.32 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -60.61 -42.37 96.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.557 ' CD2' HD12 ' A' ' 32' ' ' LEU . 12.8 mt -62.05 -43.5 98.7 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.155 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.86 -52.05 58.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.884 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -37.72 84.13 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.695 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.7 mmt -72.23 -48.68 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.7 mt -64.02 -45.17 97.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.954 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.2 p -58.98 -44.74 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -45.07 -27.42 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 57' ' ' ALA . 5.5 p -115.61 -30.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 t70 -59.03 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -59.41 -35.13 73.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.297 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 21.7 p-10 -89.61 -22.41 22.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.45 63.33 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.478 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 52.3 p30 -107.95 -16.7 14.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 117.001 0.4 . . . . 0.0 111.614 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 98.15 15.57 35.42 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.478 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 56.1 p -141.33 165.51 27.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -119.41 126.09 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 80.4 mm-40 -100.24 174.12 6.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.247 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -54.54 -50.85 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.773 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.85 -41.98 98.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.335 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 96.8 mt-10 -67.02 -46.15 75.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.383 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.11 -45.51 93.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.19 -41.62 97.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.576 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 74' ' ' LYS . 10.0 t -63.49 -46.76 84.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.518 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.41 -41.02 93.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.793 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 ttt -69.33 -51.16 39.69 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.025 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -66.81 -29.52 69.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.504 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' SER . 64.8 tttp -67.4 -33.2 74.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.486 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.6 -30.31 21.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 110.13 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 76' ' ' VAL . 33.3 t -106.82 15.9 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.519 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 73' ' ' ALA . 85.3 tttt -48.65 -14.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.859 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.488 ' N ' ' C ' ' A' ' 76' ' ' VAL . 87.6 m-20 -55.03 -57.59 11.08 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.519 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.338 179.729 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_